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ABSTRACT
Neurotrophin-3 (NT-3) is a member of the nerve growth factor family of
neurotrophins. These molecules regulate aspects of sensory neuron survival,
proliferation, phenotype, regeneration, and nociception. NT-3 presumably acts upon
binding to its preferred receptors, trkC and p75, but much of the literature concerning its
role involves embryological studies; little is known regarding its role in the adult, aside
from its part in proprioception. Here, the effect of a 7 day intrathecal infusion of NT-3
on the phenotype of intact or axotomized adult rat dorsal root ganglion (DRG) neurons
was examined. Serial sections were processed for in situ hybridization and computer-
assisted image analysis was undertaken to characterize the NT-3 responsive
subpopulation and to compare relative levels of mRNA for neurotrophin receptors,
neuropeptides, cytoskeletal elements, injury- and regeneration-associated molecules, and
other markers in individual neurons. 125I_NGF was utilized to determine the influence of
NT-3 on high-affinity NGF binding site densities. Data show that ,..- 40% of neurons
coexpress trkC and p75 mRNAs; some of these cells also exhibit transcripts for trkA,
NFM, Tal a-tubulin, a-CGRP, SP, galanin, NPY, GAP-43, cjun, and SNAP-25 -
establishing the presence of potentially functionally significant micropopulations within
the trkC-positive subset. Following injury, levels of many biochemical markers are
altered in a positive or negative fashion. In all cases described here, if the marker
colocalizes with trkC, post-trauma treatment with NT-3 allows for a return towards
normal message levels, suggesting a role for NT-3 in the maintenance of normal adult
phenotype in these cells. In the intact state, NT-3 effects a reduction in trkA, high-
affinity NGF binding sites, and SP levels, within non-trkC neurons. The importance of
these markers in nociception suggests a role for NT-3 in analgesia. But, in addition, NT-
3 also reduces SNAP-25 mRNA levels in otherwise normal trkC-expressing cells, which
might negatively alter their functioning. Together, these data indicate that multiple
subsets of mature DRG neurons are responsive to NT-3, not all of which express trkC,
and not all of which respond to the neurotrophin in the same manner: these factors must
be taken into account when considering therapeutic applications for NT-3.
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1. INTRODUCTION
1.1 General Introduction to the Neurotrophins and their Receptors
1.1.1 The Neurotrophins
The neurotrophins are a family of structurally related small proteins, '"
120 amino acids long, that share'" 50% amino acid homology (reviewed in: Ebendal,
1992) and are represented by five known molecules: nerve growth factor (NGF)
(reviewed in: Levi-Montalcini, 1987a, 1987b), brain-derived neurotrophic factor
(BDNF) (Barde et al., 1982; Leibrock et al., 1989), neurotrophin-3 (NT-3;
hippocampus-derived neurotrophic factor, HDNF) (Emfors et al., 1990a; Hohn et al.,
1990; Kaisho et al., 1990; Maisonpierre et al., 1990a; Rosenthal et al., 1990),
neurotrophin-4/5 (NT-4/5) (Berkemeier et al., 1991; Hallbook et al., 1991; Ip et al.,
1992a), and neurotrophin-6 (NT-6) (Gotz et al., 1994). Of these, NGF was the initial
molecule to be identified, a phenomenon that facilitated the discovery of the other family
members.
The basis for the discovery of NGF (reviewed in: Levi-Montalcini, 1987a,
1987b) was a series of experiments conducted by E. Bueker during the late 1940s.
Portions of mouse sarcoma were implanted along one side of the spinal cord of chicken
embryos; 3-5 days later, the dorsal root ganglia (DRG) at the level of, and ipsilateral to,
the tumor were enlarged. Furthering these observations, V. Hamburger and R. Levi-
Montalcini (Levi-Montalcini and Hamburger, 1951; Levi-Montalcini, 1952) conducted
more thorough experimentation and found that not only did ipsilateral DRG increase in
size, but so did the juxtapositioned spinal and sympathetic chain ganglia. They then
placed tumor-containing tissue on the chorioallantoic membrane, such that the only
contact between the tumor and embryo was through the circulatory system of the
embryo. This work yielded comparable results and led to the hypothesis that the
observed phenomena were caused by a soluble, diffusible molecule. In later tissue
culture experiments Levi-Montalcini observed similar, though far less dramatic effects
when normal mouse tissue was used instead of sarcoma. Although at the time Levi-
Montalcini and coworkers failed to identify this soluble factor as a potentially beneficial
molecule, they continued to study its chemical nature. In the mid to late 1950s, S. Cohen
used snake venom to degrade the growth-inducing factor, but instead of resulting in a
negative control these tissue culture experiments showed neurite outgrowth even greater
than that effected by the tumor alone. Further, the addition of snake venom to chicken
ganglia in vitro in the absence of tumor tissue, mirrored the tumor-engendered effect
(Cohen and Levi-Montalcini, 1956). These findings prompted the examination of the
nerve-growth promoting abilities of an extract from mouse submandibular gland, a
homologue of the gland producing snake venom; the resulting neurite extension was
greater than that observed for any of the previous culture conditions. The growth-
inducing molecule was subsequently named NGF; the protein was purified, and its
biological activity was, and continues to be, screened (reviewed in: Greene and Shooter,
1980; Thoenen and Barde, 1980; Johnson et al., 1986; Levi-Montalcini, 1987a, 1987b;
Levi-Montalcini et al., 1996). It was not until approximately 20 years later that BDNF
was identified (Barde et al., 1982). The cloning of this molecule, the identification of a
shared partial amino acid sequence homology with NGF (Leibrock et al., 1989), and the
use of this sequence region as a probe under low stringency conditions soon led to the
discovery of NT-3 (Ernfors et al., 1990a; Hohn et al., 1990; Kaisho et al., 1990;
Maisonpierre et al., 1990a; Rosenthal et al., 1990). PCR (polymerase chain reaction)
analyses, exploiting the sequence similarities between these three neurotrophins, rapidly
allowed for the identification ofNT-4/5 (Berkemeier et al., 1991; Hallbook et al., 1991;
Ip et al., 1992a) and NT-6 (Gotz et al., 1994). Although NGF is still the best
characterized neurotrophin, the roles of the other family members are being rapidly
elucidated.
The neurotrophins have been shown to effect both pre- and postsynaptic
modulation (Berninger et al., 1993; Lohof et al., 1993; Kang and Schuman, 1995; Lesser
2
and Lo, 1995; Levine et al., 1995; Kang et al., 1996; Blochl and Sirrenberg, 1996;
D'Arcangelo et al., 1993), through influencing synaptic density (Causing et al., 1997),
neurotransmitter production and/or release (Kang and Schuman, 1995; Takei et al.,
1997; Fernandes et al., 1998; Sala et al., 1998; Blochl and Sirrenberg, 1996; Chang and
Popov, 1999; Ry1ett et al., 1993; Helke and Verdier-Pinard, 2000), intracellular calcium
levels (Berninger et al., 1993; Jiang et al., 1997), neurotransmitter receptor efficacy
(Mande1zys et al., 1990; Jarvis et al., 1997; Oyelese et al., 1997; Suen et al., 1997;
Levine et al., 1998), and neuronal electrophysiology (Fjell et al., 1999). Further,
neurotrophins can affect gene regulation through the alteration of mRNA stability
(Nishizawa, 1994) and via transcription factors (reviewed in: Bonni and Greenberg,
1997; Segal and Greenberg, 1996; Impey et al., 1999). Through such actions they
modulate the seemingly diverse phenomena of neuronal survival and proliferation
(Cordon-Cardo et al., 1991; Hory-Lee et al., 1993; Memberg and Hall, 1995; Yao and
Cooper, 1995; EIShamy and Ernfors, 1996; Bradbury et al., 1998; reviewed in:
Henderson, 1996; Snider and Silos-Santiago, 1996), neurite outgrowth and
differentiation (Gundersen and Barret, 1979; Connolly et al., 1981; Richardson and
Ebendal, 1982; Wright et al., 1992; Morfini et al., 1994; Ghosh and Greenberg, 1995b;
Edstrom et al., 1996; Gallo et al., 1997; Grabham and Goldberg, 1997; Tuttle and
O'Leary, 1998; Bradbury et al., 1999; reviewed in: Campenot, 1994; Clark and Brugge,
1995), embryonic and adult neuronal phenotype (Lindsay and Harmar, 1989; Ma et al.,
1992; Verge et al., 1995; Friedel et al., 1997; Miller et al., 1991; reviewed in: Lewin,
1996), neuronal regeneration (Yip and Grafstein, 1982; Zhang et al., 1998; Oudega and
Hagg; 1999; reviewed in: Richardson, 1991), pain perception (reviewed in: Lewin and
Mendell, 1993; McMahon, 1996; Woolf, 1996; McMahon et al., 1997; Millan, 1999;
Stucky, 2001) and antinociceptive effects (Siuciak et al., 1994), free radical scavenging
(Olanow, 1993; Goss et al., 1997; Sampath and Perez-Polo, 1997), food uptake
(Lapchak and Hefti, 1992), and memory and learning (Koh et al., 1989; Patterson et al.,
1992; Kang and Schuman, 1995; Korte et al., 1995; Markowska et al., 1994). Moreover,
it appears that neurotrophins are also important in nonneuronal cells, with the potential
to act as bridging molecules between the nervous and immune systems (Besser and
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Wank, 1999; Reinshagen et al., 2000; reviewed in: Scully and Otten, 1995). In addition,
there is evidence that NT-3 plays a critical role in normal cardiac system development
(Donovan et al., 1996; Tessarollo et al., 1997; Story et al., 2000).
It was assumed that multiple, but mutually independent, neurotrophic factors
were synthesized in nonoverlapping regions, cell types, and/or developmental stages and
that following release, potentially from vesicles (Blochl, 1998), these molecules were
retrogradely transported to their target cells (reviewed in: Ebendal, 1992; Korsching,
1993). Currently, considerable evidence points towards more complex interactions;
ultimately, the downstream effects elicited through the binding of neurotrophins to their
receptors (reviewed in:. Ebendal, 1992; Raffioni and Bradshaw, 1993; Davies, 1994;
Lindsay et al., 1994; Frade and Barde, 1998a) may be determined through both temporal
and spatial specificity (reviewed in: Korsching, 1993; Berninger and Poo, 1996). Spatial
specificity occurs through restricted sites of neurotrophin production/release or of
neurotrophin receptor localization; temporal specificity is effected by way of the
activity-dependent release of neurotrophins, the rate of neurotrophin degeneration or its
uptake by nonneuronal cells, or through receptor desensitization.
The neurotrophins and their receptors show both distinct and overlapping
patterns of distribution. Developmentally, in the rat central nervous system (CNS) NT-3
is at its highest levels at the earliest stages and BDNF is at its lowest; NT-3 levels
decrease during development, with BDNF levels increasing concurrently; CNS levels of
NGF mRNA vary as the embryo matures (Maisonpierre et al., 1990b). The levels of
expression of the neurotrophin receptors, trks [trkA (Trk), trkB, trkC], also differ during
development (Martin-Zanca et al., 1990; Ernfors et al., 1993; Tessarollo et al., 1993). In
adult animals NGF, NT-3, and BDNF mRNA are all present in the hippocampus, and
while NGF and BDNF may colocalize in a subset of these neurons, NT-3 does not
(Ernfors et al., 1990b; Kokaia et al., 1993). Additionally, the neurotrophins may be
found in unique structures. For example: unlike NGF and NT-3, BDNF is rarely detected
in peripheral tissues but is strongly expressed in DRG (Emfors et al., 1990b; Wetmore
and Olson, 1995; Yamamoto et al., 1996), while transcripts of all three of these
neurotrophins are present in heart, spleen, and muscle (Yamamoto et al., 1996). The
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expression of trk mRNAs tend to be more restricted to neuronal tissues (Klein et al.,
1990a; Yamamoto et al., 1996); the brain and spinal cord show high mRNA levels of
trkB and trkC (Yamamoto et al., 1996) and DRG exhibit transcripts of all three trk
species. Also of interest is the potential for colocalization or trilocalization of the trks
(McMahon et al., 1994; Williams and Ebendal, 1995; Wright and Snider, 1995; Farinas
et al., 1998; Karchewski et al., 1999) or of the neurotrophins themselves (Miranda et al.,
1993).
Further, the action of one neurotrophin may depend upon the concomitant
presence or interaction with another neurotrophin or trophic factor (reviewed in:
Korsching, 1993; Berninger and Poo, 1996; Sieber-Blum, 1998). For example, in
pheochromocytoma cell line (PCI2) cells both exogenous NGF and BDNF induce the
secretion ofNT-3 (Kruttgen et al., 1998). In addition, NGF has been shown to increase
BDNF mRNA and protein levels (Apfel et al., 1996; Robinson et al., 1996; Michael et
al., 1997), while BDNF can induce NT-3 expression in cerebellar granule neurons
(Leingartner et al., 1994) and act synergistically with NT-3 to influence the survival of
spiral ganglion neurons (Mou et al., 1997). Also, even though NT-3 supports the
survival of a subset of developing sensory neurons in vitro and transforming growth
factor-beta (TGF-J3) does not, in combination NT-3 and TGF-J3 result in significantly
greater numbers of surviving neurons compared to cultures exposed only to NT-3
(Krieglstein and Unsicker, 1996). Moreover, NGF can collaborate with ciliary
neurotrophic factor (CNTF) and fibroblast growth factor (FGF) to promote cellular
differentiation (Ip et al., 1994); both acidic FGF (aFGF) and basic FGF (bFGF) can
induce NGF expression (Figueiredo et al., 1995; Ferhat et al., 1997); CNTF and BDNF
can act synergistically to arrest the development of motor neuron disease (Mitsumoto et
al., 1994); and NT-3 can collaborate with platelet-derived growth factor (PDGF) to
stimulate oligodendrocyte precursor cell proliferation (Barres et al., 1994).
1.1.2 The Neurotrophin Receptors
1.1.2.1 The trks
1.1.2.1.1 trk Structure
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Tropomyosin receptor kinases (trks) are members of a
class of transmembrane receptors categorized as receptor tyrosine kinases - a group
that also includes the receptors for epidermal growth factor (EGF), FGF, insulin, and
PDGF. All receptor tyrosine kinases are composed of an extracellular domain connected
by a single membrane-spanning region to a cytoplasmic domain (reviewed in: Ullrich
and Schlessinger, 1990; Schlessinger and Ullrich, 1992; Segal and Greenberg, 1996).
The extracellular region functions in ligand binding and the intracellular portion
possesses a tyrosine kinase domain that, upon ligand-induced activation, results in the
initiation of signal transduction pathways through which the biological effects of the
trophic factors are mediated. In addition, a highly conserved region of secondary protein
structure has been identified in the cytoplasmic domain ofmany of these receptors which
purportedly facilitates interactions with downstream signaling proteins (Feinstein and
Larhammar, 1990).
All of the trks identified to date [trkA (Martin-Zanca et al., 1989), trkB (Klein et
al., 1989), and trkC (Lamballe et al., 1991)] exhibit ligand-disassociation constants of '"
10-11 M (Sutter et al., 1979; Sonnenfeld and Ishii, 1985; Rodriguez-Tebar and Barde,
1988; Rodriguez-Tebar et al., 1990, 1992; reviewed in: Meakin and Shooter, 1992). The
kinase domains of the trks share'" 85% sequence homology, while there is roughly 50%
homology among the extracellular regions (Lamballe et al., 1991) and a comparable
degree of likeness exists between their ligands (reviewed in: Chao, 1992). However, in
spite of these similarities, members of the NGF family show specificity of binding to
these receptors at picomolar concentrations of ligand; NGF binds to trkA, BDNF and
NT-4/5 to trkB, and NT-3 binds preferentially to trkC (Cordon-Cardo et al., 1991;
Lamballe et al., 1991; Soppet et al., 1991; Ip et al., 1993a). NT-3 has also been reported
to bind to trkA and trkB (Cordon-Cardo et al., 1991; Lamballe et al., 1991; Soppet et al.,
1991; Squinto et al., 1991), but was generally believed to do so at above physiologically
relevant concentrations of ligand (Lamballe et al., 1991; Ip et al., 1993a; reviewed in:
Davies, 1994), since neurotrophins are not found in excess quantities in vivo (reviewed
in: Thoenen, 1991). Recently there have been a number of observations that contradict
this belief (Davies et al., 1995; Belliveau et al., 1997; Fundin et al., 1997b; Maroneyet
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al., 1997; Farifias et al., 1998; Nakatani et al., 1998; Huang et al., 1999): The ability of
biologically relevant levels of NT-3 to support the in vitro survival of trkA- and trkB-
positive embryonic neurons from transgenic mice that lack trkC upholds the view that
NT-3 can activate these receptors, although the ability of NT-3 to influence these
neurons appears to be restricted to certain developmental stages (Davies et al., 1995).
Further, reduced numbers oftrkB-positive sensory neurons in embryos ofNT-3 deficient
mice as compared to wild-type, implies that these neurons may have been dependent on
NT-3/trkB interactions for survival (Farifias et al., 1998). In addition, since transgenic
mice lacking NT-3 show deficits in the numbers of trkA- and trkB-positive prenatal
trigeminal ganglion neurons, it has been proposed that this neurotrophin must promote
their in vivo survival through the activation of these receptors (Huang et al., 1999). More
direct evidence comes from experiments involving neonatal sympathetic neurons, where
NT-3 has been shown to bind to trkA, and even though its capacity to influence neuronal
survival is poor when compared to that ofNGF, its ability to promote neurite outgrowth
and the expression of growth-associated genes are as effective (Belliveau et al., 1997).
These results may reflect a general ability of NT-3 to bind to trkA, or may be because
the trkA present on sympathetic neurons is an isoform with an extracellular insert that
confers preferential binding ofNT-3 (Barker et al., 1993; Clary and Reichardt, 1994).
Isoforms of the various trk genes have been reported; trkA (Barker et al., 1993;
Clary and Reichardt, 1994), trkB (Klein et al., 1990b; Merlio et al., 1992; Ernfors et al.,
1993; Eide et al., 1996; Strohmaier et al., 1996), and trkC (Lamballe et al., 1993;
Tsoulfas et al., 1993, 1996; Valenzuela et al., 1993; Garner and Large, 1994; Shelton et
al., 1995) are known to exist not only as full-length receptor proteins, but also as
truncated receptors, lacking at least a portion of the intracellular catalytic domain, or
with extracellular or cytoplasmic structural insertions. Numerous forms of the truncated
receptors have been identified (Klein et al., 1990b; Merlio et al., 1992; Valenzuela et al.,
1993). They show patterns of distribution both similar and dissimilar to that of the
corresponding full-length receptors (Klein et al., 1990a, 1990b; Beck et al., 1993;
Deckner et al., 1993; Valenzuela et al., 1993; Karchewski et al., 1999), although the
truncated forms appear to be primarily (Klein et al., 1990b; Merlio et al., 1992, 1993;
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Ernfors et al., 1993; Funacoshi et al., 1993; Valenzuela et al., 1993; Wetmore and
Olson, 1995), but not always (Zirrgiebel et al., 1995; Karchewski et al., 1999), localized
to glia. The functional significance of these isoforms is unclear, but because they lack
portions of the tyrosine kinase catalytic domain they are presumed to play a specialized
role, distinct from that of full-length trks (Klein et al., 1990b; Chao, 1992; Valenzuela et
al., 1993; reviewed in: Davies, 1994). Truncated receptors may serve to buffer the
concentration of ligand by maintaining or prolonging higher local levels of bioavailable
neurotrophin, or to reduce the concentration of neurotrophin through direct competition
for ligand with full-length trks (Klein et al., 1990b; Beck et al., 1993; Kokaia et al.,
1993; Merlio et al., 1993; Valenzuela et al., 1993; Kniisel et al., 1994; Palko et al.,
1999). Alternatively, the activity of the full-length receptor may be modulated through
the formation of inactive heterodimers with truncated receptors (Valenzuela et al., 1993;
Kniisel et al., 1994; Eide et al., 1996). Further, differential expression of full-length and
truncated isoforms of trkC may serve to fine-tune neurite outgrowth during development
because overexpression of the former results in increased, and the latter results in
decreased, axonal process formation (Ichinose and Snider, 2000). Another proposed role
for truncated trks may be to transport neurotrophins across the blood-brain barrier, since
trkB transcripts have been localized to the choroid plexus and ependymal cells (Klein et
al., 1990b). Isoforms with extracellular or cytoplasmic domain inserts may show
differing effects. Most importantly, in vitro experiments involving cell lines transfected
to express mammalian and avian trkC isoforms containing amino acid insertions within
their tyrosine kinase or extracellular domains show that these receptors retain their
ability to autophosphorylate in response to exogenous NT-3 (Tsoulfas et al., 1993, 1996;
Valenzuela et al., 1993; Gamer and Large, 1994) and thus, unlike truncated receptors,
have the potential to participate in signal transduction. In spite of these findings,
receptors with intracellular domain inclusions may differ from the non-insert form in
their capacity to function, which suggests that alternative splicing may play an important
role in regulating trk signaling (Tsoulfas et al., 1993, 1996; Gamer and Large, 1994;
Guiton et al., 1995; Meakin et al., 1997; Fernandes et al., 1998). In a fibroblast cell line
that does not normally exhibit trk, cells transfected to express trkC or either of the
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known trkC kinase insert isoforms show that the isoforms have a reduced ability to
participate in at least one aspect of NT-3 induced signal transduction (Guiton et al.,
1995). Moreover, NT-3 effects neurite outgrowth in PC12 cells via trkC, but not through
a mammalian isoform of trkC that contains a 14 amino acid insertion in the tyrosine
kinase domain (trkCki14) (Tsoulfas et al., 1993, 1996; Valenzuela et al., 1993). Further,
although the kinase insertion in an avian trkC isoform (Gamer and Large, 1994) occurs
at the same position in the kinase domain as that of the mammalian insert (Tsoulfas et
al., 1993; Valenzuela et al., 1993), the amino acid sequence of the avian insert is
markedly different. This difference in molecular structure may be reflected in the ability
of the receptors to function, since unlike the mammalian form (Tsoulfas et al., 1993;
Valenzuela et al., 1993) the avian isoform has been shown to mediate process outgrowth
in transfected PC12 cells (Gamer and Large, 1994). In addition, trk species with
extracellular domain additions or deletions may show altered ligand/receptor
interactions: Isoforms of trkB with a deletion in the extracellular domain show
contrasting responses to the ligands, BDNF and NT-4/5 (Strohmaier et al., 1996).
Similarly, a 6 amino acid insertion in the extracellular domain of trkA (trkAei6) endows
the receptor with a heightened responsiveness to NT-3, without apparent alteration in the
ability of trkAei6 to bind or respond to NGF (Barker et al., 1993; Clary and Reichardt,
1994), although the biological responses elicited by NT-3 through this isoform differ
from those effected by NGF (Belliveau et al., 1997). Interestingly, it appears that in
adult rat lumbar DRG neurons the insert-containing isoforms oftrkA and trkC colocalize
with their respective non-insert-containing receptor subtypes (Karchewski et al., 1999).
1.1.2.1.2 trk Signal Transduction
Tyrosine autophosphorylation is necessary for the catalytic
and signaling actions of trk (Cordon-Cardo et al., 1991; Soltoff et al., 1992; Obermeier
et al., 1993, 1994; Kniisel et al., 1994; Stephens et al., 1994), and although the
phosphorylation of tyrosine represents less than 1% of all cellular protein
phosphorylation events, it is crucial to many pathways involving cell growth and
differentiation (reviewed in: Russell, 1995). That the tyrosine kinase domain is the most
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highly conserved portion of all receptor tyrosine molecules underscores the importance
of this region to the functioning of these receptors (Ullrich and Schlessinger, 1990). The
onset of neurotrophin-induced trk tyrosine phosphorylation is rapid (Kaplan et al.,
1991a, 1991b; Ip et al., 1993b; Volonte et al., 1993b; Kniisel et al., 1996), although the
duration of the influence of neurotrophins on trk tyrosine phosphorylation levels appears
to be variable. In PC12 cells, in vitro trkA tyrosine phosphorylation occurs within 1
minute of treatment with physiologically relevant concentrations of NGF, reaching
maximal levels after 5 minutes, and decreasing thereafter (Kaplan et al., 1991a, 1991b).
In vivo injection of NGF into rat brain also results in immediate trk tyrosine
phosphorylation, but phosphorylation levels remain elevated for 1-3 days after NGF
injection, with levels lessening but still detectable 5 days after NGF treatment (Kniisel et
al., 1996).
It has been documented that both the neurotrophins (Hendry et al., 1974; Rohrer
et al., 1982; Richardson and Riopelle, 1984; DiStefano et al., 1992; Fang and Luo, 1996;
Grimes et al., 1997; Matheson et al., 1997; Curtis et al., 1998) and trks (Loy et al., 1994;
Ehlers et al., 1995; von Bartheld et al., 1996b; Bhattacharyya et al., 1997; Grimes et al.,
1997) are retrogradely transported to the perikarya, potentially within vesicles (Rohrer et
al., 1982; Bhattacharyya et al., 1997; Grimes et al., 1997). Although the transport of
neurotrophins alone does not appear to be adequate for trophic signaling at the cell body
(von Bartheld et al., 1996b; Riccio et al., 1997), it seems critical to signal propagation
that the NGF/trkA complexes are internalized and retrogradely transported from distal
processes and that trkA tyrosine phosphorylation is maintained during transit (Riccio et
al., 1997). There is also evidence that distal application of neurotrophin rapidly results in
increased internal levels of phosphorylated trk proximal to the site of ligand/receptor
interactions (Bhattacharyya et al., 1997; Senger and Campenot, 1997). This appears to
occur at a more rapid rate than that reported for the retrograde transport of neurotrophins
(Richardson and Riopelle, 1984). Because of this, these findings suggest that
neurotrophin-induced signal transduction also involves the propagation of signal that is
dependent on the initial ligand-induced activation of trk, but independent of the
internalization and transport of neurotrophin/trk complexes (Bhattacharyya et al., 1997;
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Senger and Campenot, 1997; MacInnis and Campenot, 2002). In addition, neurotrophins
may be transported anterogradely (von Bartheld et al., 1996a; Zhou and Rush, 1996b;
reviewed in: Altar and DiStefano, 1998). For example, it has been shown that ocular
injection of radioiodinated NT-3 results in the apparent anterograde accumulation of the
neurotrophin in presynaptic vesicles of the optic tectum and in postsynaptic dendrites
and perikarya (von Bartheld et al., 1996a). Neurotrophins thus conveyed may then be
released at synapses, potentially affecting postsynaptic targets (Levine et al., 1995; von
Bartheld et al., 1996a) or subserving autocrine functions (Acheson et al., 1995; reviewed
in: Davis and Wright, 1995; Acheson and Lindsay, 1996).
Neurotrophin homodimers, the bioactive form of these molecules (McDonald et
al., 1991; Radziejewski et al., 1992; reviewed in: Thoenen and Barde, 1980; Ebendal,
1992), bind to trk through interactions between specific residues of individual
neurotrophin species and the corresponding receptor (Kullander et al., 1997a; 1997b).
Although neurotrophin heterodimers have not been identified under physiologically
relevant conditions, they may be synthesized (Radziejewski and Robinson, 1993;
Jungbluth et al., 1994; Robinson et al., 1995) and even though they can bind to trk they
show reduced biological activity (Jungbluth et al., 1994; Robinson et al., 1995). Ligand
binding activates the receptor, inducing or stabilizing receptor homodimerization (Jing et
al., 1992; reviewed in: Kaplan and Stephens, 1994; Segal and Greenberg, 1996). This
permits a conformational change in the receptors that allows for the juxtaposition of the
respective tyrosine kinases, which then rapidly results in the activation of the tyrosine
kinase domains and subsequent trans-autophosphorylation of a number of tyrosine
residues on each receptor (Ip et al., 1993a; reviewed in: Kaplan and Stephens, 1994;
Greene and Kaplan, 1995; Bonni and Greenberg, 1997; Kaplan and Miller, 1997). Three
tyrosines have been identified as being phosphorylated within the trkA catalytic domain:
Tyr670, Tyr674, and Tyr675 (Stephens et al., 1994; Segal et al., 1996). Additional
tyrosine phosphorylation sites are found outside this region: Tyr490, located in the
juxtamembrane region of the cytoplasmic domain of trkA, plus Tyr785 and Tyr794,
situated in the carboxyl-terminal intracellular tail oftrkA (Loeb et al., 1994; Stephens et
al., 1994; Segal et al., 1996; MacDonald et al., 2000). Individual tyrosines are not
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coordinately phosphorylated, rather the phosphorylation of these tyrosine residues is
sequential; Tyr674 is completely phosphorylated in vivo before other sites are fully
phosphorylated (Segal et al., 1996). In addition, catalytic domain sites undergo rapid
dephosphorylation, while phosphorylation at the other receptor sites endures for longer
periods (Segal et al., 1996). These phosphotyrosine residues can serve as docking sites
for downstream effector substrates through specific binding with a non-catalytic region
of 100-110 amino acid residues of some intracellular signaling proteins, termed the src
(sarcoma) homology 2 (SH2) domain (reviewed in: Schlessinger and Ullrich, 1992),
although these are not the only molecules to interact with activated trkA (MacDonald et
al., 1999). The majority of SH2 domain-containing proteins are expressed in a wide
range of cell types, while others are presumed to have a restricted distribution; the tissue-
specific SH2 domain proteins are believed to serve a more specialized role in receptor
tyrosine kinase-mediated signal transmission pathways (reviewed in: Schlessinger and
Ullrich, 1992). A number of intracellular SH2 domain-containing proteins are known to
bind to activated trkA - including Shc, phospholipase-C-y (PLCy), and
phosphatidylinositol-3-kinase (PI-3-K) (Ohmichi et al., 1991a, 1991b; Obermeier et al.,
1993; Loeb et al., 1994; Stephens et al., 1994; Baxter et al., 1995; Zirrgiebel et al.,
1995; Segal et al., 1996; Bhattacharyya et al., 1997; Iwasaki et al., 1998). The binding
of these substrates to trk enhances their specific activity, either through receptor-induced
tyrosine phosphorylation or alterations in protein conformation, therein launching signal
transduction cascades (Vetter et al., 1991; Soltoff et al., 1992; Loeb et al., 1992). This
allows for signal amplification, a phenomenon important when a signal threshold must
be reached in order to effect the appropriate cellular response, especially since there may
be degradation of the signal as it travels to the nucleus (Segal et al., 1996). The effects of
neurotrophinltrk interactions have been shown to be local, in the immediate vicinity of
the receptors in situ, and to involve the induction of signal cascades that may ultimately
result in the transmission of an intracellular signal along the length of the axon. They can
also effect rapid and/or long-term cellular reactions. To be considered a "fast action" the
response should occur within one to tens of minutes, before new gene expression and
protein synthesis are possible (Berninger and Poo, 1996). Such actions may affect the
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physiology and morphology of neurons, serving roles in both pre- and postsynaptic
plasticity and neuronal growth (Berninger et al., 1993; Bhattacharyya et al., 1997; Roche
et al., 1994; Siegelbaum, 1994; Kang and Schuman, 1995; Suen et al., 1997; Blochl and
Sirrenberg, 1996; reviewed in: Berninger and Poo, 1996), and may be necessary before
more long-term potentiation is possible (Berninger and Poo, 1996). Neurotrophins have
been shown to rapidly potentiate synaptic transmission and neurotransmitter release
(Kang and Schuman, 1995; Blochl and Sirrenberg, 1996; reviewed in: Berninger and
Poo, 1996), which may result from a neurotrophin-induced elevation in calcium levels at
the presynaptic terminal (Berninger et al., 1993). Neurotrophins may also modulate
synaptic efficacy through changing postsynaptic responses to the released
neurotransmitter (Levine et al., 1995; reviewed in: Berninger and Poo, 1996). The
mechanism underlying both pre- and postsynaptic alterations may be through
neurotrophin-induced serine/threonine and tyrosine phosphorylation modulations of
transmitter receptors and ion channels (Roche et al., 1994; Siegelbaum, 1994). Rapid
alterations in neurite outgrowth have been attributed to neurotrophins: Growth cones
tum toward a source ofNGF within 10-20 minutes (Gundersen and Barret, 1979; Gallo
et al., 1997); removal of NGF causes the loss of filopodial and lamellar extensions,
while the re-addition of NGF induces growth cone spreading and the formation of new
extensions within several minutes (Connolly et al., 1981). Such changes may be due, at
least in part, to the neurotrophin-induced phosphorylation of growth-associated protein
(GAP-43) (Aigner and Caroni, 1995). Additional changes in outgrowth patterns may be
attributed to NGF, since ~1 integrins, receptors of extracellular matrix proteins and
important directors of neuronal migration, form aggregates at the tips of neuronal
filopodia within 10 minutes of exposure to the trophic factor (Grabham and Goldberg,
1997). Neurotrophin-influenced transcriptional regulation takes more time: In vitro,
exogenous NGF upregulates p75, Tal a-tubulin, and tyrosine hydroxylase mRNAs in
sympathetic neurons within 12 hours (Ma et al., 1992).
Shc, an adaptor signaling protein containing an SH2 domain, has been shown to
bind to Tyr490 (Stephens et al., 1994; Segal et al., 1996; Bhattacharyya et al., 1997).
Tyrosine phosphorylated Shc binds to Grb2, an adaptor protein that bridges Shc to Sos
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(Laszlo and Downward, 1993), although there is recent evidence that Grb2 can also bind
to activated trkA independently of Shc (MacDonald et al., 2000). Sos is a guanine
nucleotide releasing protein that activates Ras, enhancing the rate of GDP-GTP
(guanosine diphosphate-guanosine triphosphate) exchange on members of this small
family of GTP-binding proteins (Boriack-Sjodin et al., 1998). In the resting state Ras
proteins bind GDP; upon stimulation they release GDP and bind GTP (Carter et al.
1995; reviewed in: Segal and Greenberg, 1996; Wittinghofer, 1998). Following trkA
activation, the complexes composed of tyrosine phosphorylated Shc-Grb2-Sos do not
appear to stably associate with the receptor; the complex is free from trkA during Ras
activation (Basu et al., 1994). Activated Ras binds to Raf, a serine/threonine protein
kinase, that then phosphorylates, and consequently activates, mitogen-activated protein
kinase kinases (MAPKKs) (Lange-Carter and Johnson, 1994; Vaillancourt et al., 1994).
Activated MAPKK phosphorylates mitogen-activated protein kinases (MAPKs) on
tyrosine and threonine residues, initiating their activation; MAPK phosphorylates and
activates the serine/threonine protein kinase, Rsk, and both enzymes translocate to the
nucleus (Chen et al., 1992; Qiu and Green, 1992). The resulting activation of
transcription factors, including CREB (cyclic adenosine monophosphate response
element-binding protein), regulate the expression of NGF-inducib1e genes (reviewed in:
Bonni and Greenberg, 1997; Segal and Greenberg, 1996; Impey et al., 1999). The
MAPKK-MAPK phosphorylation cascade serves to amplify the signal from the
relatively scarce trks to the plentiful MAPKs, with further augmentation possible due to
the presence of isoforms of both MAPKKs and MAPKs (reviewed in: Russell, 1995;
Impey et al., 1999). Activation of the Ras pathway is required for NGF-mediated
outgrowth, in at least PC12 cells and chicken sensory neurons (reviewed in: Greene and
Kaplan, 1995), and is purported to play a role in learning and memory (Impey et al.,
1999), but its activation appears insufficient to support the survival of hippocampal
neurons (Marsh and Palfrey, 1996).
PI-3-K, another SH2 domain-containing protein, binds to NGF-activated trkA at
or near the Shc binding site (Baxter et al., 1995). The binding of the regulatory subunit
of PI-3-K to the autophosphorylated receptor activates the catalytic subunit and,
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although the exact pathway of this signaling cascade is unclear, data suggest PI-3-K may
initiate a Ras-dependent pathway separate from that of Shc (reviewed in: Russell, 1995;
Greene and Kaplan, 1995; Segal and Greenberg, 1996). The protein has also been shown
to be activated by both NT-3 and BDNF (Widmer et al., 1992; Righi et al., 2000).
Neurotrophin-induced PI-3-K activation has been implicated in neuronal survival (Yao
and Cooper, 1995; Dudek et al., 1997), neurite outgrowth (Kimura et al., 1994), and
neuronal differentiation (Soltoff et al., 1992).
The SH2 domain-containing enzyme, PLCy has been shown to become tyrosine
phosphorylated upon binding to Tyr785 of ligand-activated trkA (Ohmichi et al., 1991a,
1991b; Obermeier et al., 1993; Loeb et al., 1994) and to activated trkB (Zirrgiebel et al.,
1995), although the role of this phosphorylation is not clear (Vetter et al., 1991). PLCy
cleaves membrane phosphatidylinositol-bis-phosphate into diacylglycerol (DAG) and
inositol-triphosphate (IP-3); DAG activates protein kinase C (PKC), while IP-3 induces
the release of stored calcium. Calcium is required for the activation of many PKCs and
also activates calcium-calmodulin-dependent protein kinases. Both of these types of
kinases have been implicated in promoting neuronal survival (Zirrgiebel et al., 1995)
and as mediators of neuronal plasticity (Loeb et al., 1994; reviewed in: Russell, 1995;
Segal and Greenberg, 1996).
A fourth SH2 domain-containing protein, Fyn tyrosine kinase, has been reported
to bind to the intracellular region of trkB upon BDNF activation and, because of this, is
presumed to function in neurotrophin signal transduction pathways (Iwasaki et al.,
1998). In addition, rAPS and SH2-B, two molecules closely related to SH2 domain-
containing effectors, have been implicated in trk signaling in developing neurons (Qian
et al., 1998).
Another neurotrophin-mediated signal transduction pathway involves the protein
SNT (sue-associated neurotrophic factor-induced tyrosine-phosphorylated target) (Rabin
et al., 1993; Meakin et al., 1999). SNT binds to trkA at the same place as Shc (Meakin et
al., 1999), undergoes rapid NGF-induced tyrosine phosphorylation (Rabin et al., 1993),
and appears to function independently of any other known signaling cascades initiated
by trk (Rabin et al., 1993). Interestingly, in embryonic tissues BDNF and NT-3, but not
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NGF, induce the tyrosine phosphorylation of SNT (Kniise! et al., 1994). Activation of
the SNT signaling pathway appears to result in neurite outgrowth and differentiation, but
not neuronal proliferation (Rabin et al., 1993; Peng et al., 1995; Meakin et al., 1999;
reviewed in: Bonni and Greenberg, 1997).
Although aspects of specific neurotrophin/trk signal transduction cascades may
be unique, redundancy and/or cooperation may also exist within these pathways. Both
NGF and BDNF induce neuritogenesis in PC12 cells that coexpress trkA and trkB, but
the phenotypic changes appear to be neurotrophin-specific, with exogenous BDNF
inducing the formation of thicker, longer neurites and larger, more flattened perikarya
(Iwasaki et al., 1997). These results suggest that although each of these neurotrophins
effect neurite outgrowth, the specific downstream signal transduction molecules that are
activated differ. Contrasting with these observations, MAPK 1 can be activated via trkA
through either Shc- or PLCy-dependent signaling pathways (Stephens et al., 1994) and
both the Shc/trkA and PLCy/trkA cascades have been shown to induce PC12 cell
differentiation (Obermeier et al., 1994). Further, PI-3-K may initiate a Ras-dependent
pathway that is independent of the Shc/Ras cascade (reviewed in: Russell, 1995; Greene
and Kaplan, 1995; Segal and Greenberg, 1996). In addition, there is potential for
redundancy or overlap in signaling pathway activation through different, although
specific, ligand/receptor interactions. The activation of the Ras pathway through the
interaction of NGF/trkA, and also by BDNF/trkB (Zirrgiebel et al., 1995), provides
evidence for this theory. Moreover, because NGF, BDNF, and NT-3 can all initiate the
PI-3-K signaling pathway (Widmer et al., 1992; Righi et al., 2000), and since neurons
can coexpress trks (Karchewski et al., 1999), there is the potential for multiple
neurotrophins to initiate parallel signal transduction cascades within an individual cell.
There is also the possibility that two neurotrophins can interact with a single receptor
type, but with each exerting different effects on an individual cell. For instance, mice
with a mutation in the Shc binding site show differing effects in response to BDNF and
NT-4/5; few NT-4/5 dependent sensory neurons survive, while the BDNF-dependent
subpopulation is little affected (Minichiello et al., 1998). Further, the trophic factors
EGF and insulin can also activate Ras and MAPKs, although it appears that the specific
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ligand/receptor interactions may result in variable downstream effects: NGF induces an
extended activation of Ras and MAPKs, while responses to EGF are less strong and of
shorter duration (Qiu and Green, 1992; Traverse et al., 1992). Moreover, because NGF,
but not EGF or insulin, has been shown to effect neurite outgrowth through the
activation of Ras (reviewed in: Greene and Kaplan, 1995), it has been proposed that the
distinction between strong/prolonged and weak/transient Ras pathway activation may
ultimately be evidenced in the difference between neuronal proliferation and
differentiation (Greene and Kaplan, 1995; Marshall, 1995). Another signal transduction
cascade that shows overlap between trophic factors is that involving SNT. Both NGF
and FGF, but not EGF, induce the phosphorylation of this protein, although potential
similarities and differences in their activation of this pathway have not yet been
identified (Rabin et al., 1993).
1.1.2.2 p75
All members of the NGF family bind to an additional receptor
known as p75, or the low-affinity NGF receptor (Chao et al., 1986; Radeke et al., 1987;
Squinto et al., 1991; reviewed in: Chao, 1994). Unrelated to the trks, p75 is a
transmembrane glycoprotein composed of an extracellular domain with a short
cytoplasmic region. The extracellular portion contains four cysteine-rich repeats
(reviewed in: Chao and Hempstead, 1995) and is involved in neurotrophin binding
(Welcher et al., 1991; Yan and Chao, 1991). Individual neurotrophins exhibit similar
binding affinities with this receptor, but each shows variation in the rate of dissociation,
with NGF dissociating from p75 more rapidly than NT-3, and both dissociating more
quickly than BDNF (Rodriguez-Tebar et al., 1990, 1992). Further, upon binding, all of
the known neurotrophins effect similar, but not identical conformational changes to the
binding site of p75 (Shamovsky et al., 1999). Although the intracellular region lacks
inherent kinase activity and was initially believed incapable of signal transduction
(reviewed in: Meakin and Shooter, 1992; Davis, 1994; Greene and Kaplan, 1995), there
is growing evidence that a number of signaling molecules are associated with p75
(Ohmichi et al., 1991c; Volonte et al., 1993a, 1993c; Dobrowsky et al., 1994; Canossa
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et al., 1996; Yamashita et al., 1999). Like the trks, p75 is internalized and retrogradely
conveyed, and while this may have consequences in neurotrophinJp75 signal
transduction, the significance of p75 transport is unclear (Johnson et al., 1987; Raivich
et al., 1991; Curtis et al., 1995; von Bartheld et al., 1996b).
Due to similarities in molecular structure, especially in the highly conserved
cytoplasmic domain, p75 is classified as a member of the tumour necrosis factor (TNF)
receptor superfamily (Smith et al., 1990, 1994; Liepinsh et al., 1997; reviewed in:
Bothwell, 1996). TNF receptor family members are known to be involved in
programmed cell death (apoptosis) (reviewed in: Nagata and Goldstein, 1995; Fraser et
al., 1996; Martinou and Sadoul, 1996) and, because of this, it is not surprising that p75
has been shown to promote this cellular phenomenon (Rabizadeh et al., 1993; Bamji et
al., 1998; Frade and Barde, 1998b; reviewed in: Carter and Lewin, 1997; Chao et al.,
1998) through its cytoplasmic domain (Majdan et al., 1997). p75 is not necessary for
viability since mice with nonfunctional receptors survive (Lee et at., 1992), and although
the phenotype of these animals generally resembles that of the wild-type, p75 must
function in roles besides apoptosis because these mice exhibit sensory (Lee et al., 1994b;
Curtis et al., 1998) and sympathetic (Lee et al., 1994a, 1994b) deficits. In fact, p75 has
also been shown to be involved in neuronal sprouting (Kuchel et al., 1992), neurite
outgrowth (Dostaler et at., 1996; Yamashita et al., 1999), and Schwann cell migration
during development and after injury (Anton et al., 1994; You et at., 1997). There is
additional evidence that p75 directly, or indirectly, influences trks and may be a
necessary component in trk/neurotrophin signal transduction (reviewed in: Meakin and
Shooter, 1992; Chao, 1992; Barker and Shooter, 1994; Hantzopoulos et at., 1994; Chao
and Hempstead, 1995).
1.1.2.2.1 Role ofp75 in Apoptosis
In the nervous system, apoptosis occurs during
development (reviewed in: Raff et al., 1993; Raft: 1998) and following ischemic injury
(reviewed in: Thompson, 1995; Choi, 1996), traumatic spinal cord injury (Liu et al.,
1997), epilepsy (Roux et al., 1999), and neurodegenerative disorders such as
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Alzheimer's disease (reviewed in: Thompson et al., 1995). There is evidence that p75
plays a role in programmed cell death (reviewed in: Bothwell, 1996; Bredesen and
Rabizadeh, 1997; Carter and Lewin, 1997; Chao et al., 1998), although current results
seem to conflict, with the neurotrophin receptor potentially functioning in both an
apoptotic and an antiapoptotic capacity. Application of p75 antisense oligonucleotides to
the proximal end of transected sciatic nerve shows that these molecules are retrogradely
transported and result in decreased p75 protein levels and a reduction in the axotomy-
induced loss of sensory neurons (Cheema et al., 1996). In neuronal-based cell lines death
appears to be invoked through p75 in the absence of ligand binding, while the binding of
NGF or NT-3 to p75 seems to inhibit apoptosis (Rabizadeh et al., 1993; Cortazzo et al.,
1996; Longo et al., 1997; E1Shamy et al., 1998). Further, although p75 has been shown
to mediate both survival and apoptosis in developing sensory neurons, depending on the
developmental stage, the former response has been attributed to the interaction of p75
with trkA, while apoptosis was deemed to involve p75 alone (Barrett and Bartlett, 1994).
Conversely, in glia it appears that the binding ofNGF to p75 induces apoptosis (Frade et
al., 1996; Soilu-Hanninen et al., 1999).
In two glial cell lines, all of the neurotrophins, through binding to p75, have been
shown to activate the sphingomyelin cycle and to subsequently generate the second
messenger ceramide (Dobrowsky et al., 1994, 1995), an inducer of apoptosis (Obeid et
al., 1993; Verheij et al., 1996). Similar results have been reported for postnatal rat
oligodendrocytes, where NGF, but not BDNF or NT-3, invokes apoptosis via p75 and a
subsequent increase in intracellular ceramide (Casaccia-Bonnefil et al., 1996).
Interestingly, the ability ofNGF/ceramide to induce apoptosis may be dependent on the
developmental stage of the cell since NGF exposure does not result in the death of adult
human oligodendrocytes (Ladiwala et al., 1998). Ceramide initiates apoptosis through a
stress-activated protein kinase (Verheij et al., 1996) which phosphorylates Raf,
potentially effecting a link between ceramide activation and the MAPK pathway that is
also activated by the trks (Yao and Cooper, 1995).
The role of ceramide is complex, as there is evidence for a second
NGF/p75/ceramide signaling pathway. The effect of ceramide appears to be
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concentration dependent, with low levels mediating neurite outgrowth and higher
ceramide levels inducing apoptosis (Schwarz and Futerman, 1997; Brann et al., 1999).
Further, coexpression of trkA in p75-positive cells blocks ligand-mediated ceramide
production (Dobrowsky et al., 1995), supporting the hypothesis that p75 alone is
responsible for apoptosis induction and that the presence of trkA impedes p75-induced
cell death (Barrett and Bartlett, 1994). In postnatal rat oligodendrocyte cultures,
activation of introduced trkA negates p75-induced apoptosis through MAPK activation,
and this phenomenon appears to involve both the induction of survival signals and the
concomitant repression of p75-induced death signal (Yoon et al., 1998). This may
involve the production of sphingosine-I-phosphate, a second messenger and downstream
product in the ceramide pathway, which has mitogenic properties (Edsall et al., 1997).
Ceramide may also induce the activation of the transcription factor, nuclear
factor kappa B (NF-KB) (Quillet-Mary et al., 1997). This protein connects early trophic
factor signaling events and downstream changes in gene expression primarily through
the regulation of genes involved in immunity and inflammation, although it may also
induce genes regulating neuronal development, plasticity, and neurodegeneration
(reviewed in: O'Neill and Kaltschmidt, 1997). In rat Schwann cells NGF, but neither
BDNF nor NT-3, activates NF-KB upon binding to p75 (Carter et al., 1996), but this
apparently occurs only under stress conditions (Bhakar et al., 1999). The interaction of
ligand-bound p75 with TRAF6 (tumour necrosis factor receptor-associated factor-6)
mediates the nuclear translocation ofNF-KB (Khursigara et al., 1999), which allows the
transcription factor to modulate gene expression. The inhibition of NF-KB results in
apoptosis of PC12 cells and does not permit NGF-mediated rescue (Taglialatela et al.,
1997), supporting an additional role for the ceramide pathway in survival.
1.1.2.2.2 Interactions betweenp75 and trk
Although glial p75 may serve to present neurotrophins to
trks on adjacent neurons (Johnson et al., 1988), there is evidence that p75 can act more
directly to influence trks and trkJneurotrophin signal transduction; p75 may interact with
trkA to form high-affinity binding sites and, seemingly conversely, may also reduce the
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ability of trkA to interact with NGF (reviewed in: Meakin and Shooter, 1992; Chao,
1992; Barker and Shooter, 1994; Hantzopoulos et al., 1994; Chao and Hempstead, 1995;
Greene and Kaplan, 1995). There is additional evidence that p75 alone, without
interaction with trk, may bind NT-3 with high affinity on sympathetic neurons (Dechant
et al., 1993, 1997).
Concomitant interaction between p75 and trkA appears necessary for optimal
trkA signal transduction, since suboptimal signals are produced when trkA, in the
absence ofp75, is activated (Battleman et al., 1993; Mahadeo et al., 1994; Maliartchouk
and Saragovi, 1997). And while the coexpression of these receptors increases ligand-
induced trkA tyrosine phosphorylation (Verdi et al., 1994), there is conflicting evidence
as to whether the cytoplasmic domain ofp75 is necessary (Battleman et al., 1993; Wolf
et al., 1995; Wang et al., 1998) or not (Hantzopoulos et al., 1994) for effective trkA
interaction. A specific ratio of p75 to trkA seems to be required to create high-affinity
NGF binding sites (Benedetti et al., 1993; Mahedeo et al., 1994), although this may only
occur when there are high levels of both receptor species (Huber and Chao, 1995). In
p75-deficient mice, primary sensory neurons exhibit a two to three fold decrease in
sensitivity to NGF (Lee et al., 1994b), and although sensitivity to the other
neurotrophins remains unchanged in these animals, other data indicate that p75 may
influence the activation oftrkB and trkC (Hantzopoulos et al., 1994).
The ability of trkA to bind and respond to NGF may be controlled by p75,
depending on NGF concentration and/or duration of ligand exposure (Barker and
Shooter, 1994; Kahle et al., 1994; Twiss et al., 1998; Wang et al., 1998). When high
levels of the neurotrophin are present, p75 may decrease NGF-induced trkA signal by
sequestering NGF from trkA (Kahle et al., 1994). Conversely, at low ligand levels p75
appears to pool NGF, elevating levels of the neurotrophin available to interact with trkA
(Barker and Shooter, 1994) and amplifying ligand-induced trkA phosphorylation (Wang
et al., 1998). Further, under short-term NGF exposure p75 appears to enhance ligand-
induced trkA activation, while long-term NGF exposure lessens the signal response
(Twiss et al., 1998). Interestingly, other data indicate that in the absence of bound ligand
p75 confers high-affinity binding properties on trkA, while NGF-activated p75 appears
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to reduce the ability of trkA to bind NGF with high affinity (Ross et al., 1998). In
addition, in PC12 cells, BDNF effects a notable reduction in trkA tyrosine
phosphorylation with a concomitant increase in serine phosphorylation in the
cytoplasmic domain of the receptor (MacPhee and Barker, 1997). These findings appear
to result from an interaction between that neurotrophin and p75, and can be mimicked by
exposure to a ceramide analogue in lieu of BDNF (MacPhee and Barker, 1997).
Affinity-crosslinking and immunoprecipitation experiments show that trkA and
p75 may physically interact (Huber and Chao, 1995). This interaction may be facilitated
through the juxtapositioning of the two receptor types, and although direct contact
appears nonessential for interplay between the two (Kalhe et al., 1994), there is evidence
for direct interaction through the possible formation of p75 and trkA heterodimers,
resulting from NGF-induced conformational changes in the receptors (Ross et al., 1998).
Further, supporting data indicate that a physical interaction between p75 and trkA results
in p75 immobilization; the effect oftrkB on p75 is more modest (Wolf et al., 1995).
1.2 Primary Sensory Neurons
1.2.1 Introduction to Primary Sensory Neurons
DRG neurons are sensory in function - innervating skin, muscle, joints,
or viscera. Information detected by the sensory receptor is transmitted along the afferent
fiber of the peripheral nerve and, bypassing the cell body, moves along the central fiber
of the dorsal root to synapse in the spinal cord grey matter or the brain stem. The cell
bodies, perikarya, of these pseudo-unipolar neurons function primarily in cell
maintenance, are located within the DRG, and are surrounded by glial satellite cells.
Historically, DRG neurons have been described as a homogenous population because
they are all derived from the neural crest, their processes and perikarya are organized in
a similar fashion, and they have a common sensory function (reviewed in: Perl, 1992). In
spite of this, these neurons represent a diverse group - mirrored through differences in
size, cytology, physiology, biochemical markers, and responsiveness to neurotrophic
factors (reviewed in: Hunt et al., 1992; Lawson, 1992).
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These neurons may be classified according to afferent fiber diameter, sensory
receptor type, and cell body morphology. Large, medium, and small diameter myelinated
afferent fibers are termed Au, A~, and AD, respectively; small unmyelinated fibers are
designated as C fibers. A second classification system, with the same defining
characteristics but specific for muscle afferents, has labeled these fibers Type I, II, III,
and IV, respectively. Conduction velocity correlates with afferent axon diameter; Au,
A~, AD, and C fibers conduct impulses at 80-120, 35-75, 5-30, and 0.5-2 mis,
respectively (reviewed in: Kandel et al., 1991). Large diameter fibers that innervate
muscle project to the spinal cord ventral hom, while in general those that innervate skin
project to laminae III and IV of the dorsal hom (Shortland et al., 1989; reviewed in:
Fyffe, 1992; Hunt et al., 1992). Of the small diameter afferents, AD fibers project to
spinal cord laminae I and V (Light and Perl, 1979; reviewed in: Fyffe, 1992; Hunt et al.,
1992) with C fibers predominately projecting to dorsal hom laminae I and II (Sugiura et
al., 1986; reviewed in: Fyffe, 1992; Hunt et al., 1992).
The peripheral termini of primary afferent fibers are specialized sensory
receptors that are individually sensitive to specific stimuli. These receptors have been
variously classified based on the type of sensation to which they respond and may be
further subdivided according to histological characteristics (reviewed in: Perl, 1992).
Nociceptors discriminate the sensation of pain in response to mechanical, thermal, or
chemical stimuli, and are typically free nerve endings. Most mechanoreceptors are
comprised of specialized end organs that surround the axon terminals, and mediate the
sensations of touch (i.e. Merkel cells and Meissner's, Ruffini's, and Pacinian corpuscles)
and proprioception, the sense of limb positioning and movement (i.e. muscle spindles
and Golgi tendon organs). Virtually all mechanoreceptor subtypes, including
proprioceptors, are classed as Au or A~ fibers, while nociceptors belong to the AD and C
fiber groups. Somatosensory information is relayed to the thalamus via two primary
ascending routes, the posterior column-medial lemniscus pathway and the spinothalamic
tract. The former system is important in carrying proprioceptive and tactile information
and the latter transmits principally pain and temperature information.
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Based on their appearance under light microscopy, DRG cell bodies may be
broadly divided into two categories: "large light" and "small dark" neurons and, with few
exceptions, DRG cell body size correlates with the corresponding afferent fiber diameter
(reviewed in: Lawson, 1992; Perl, 1992). Large light-type neurons are neurofilament
(NF)-rich and have large to small sized cell bodies with myelinated fibers, most are
presumed to be Au and Ap mechanoreceptor neurons; small dark-type neurons have
small sized, NF-poor perikarya with A8 and unmyelinated C fibers (reviewed in:
Lawson, 1992). This classification does not reflect the phenotypic complexities of the
subpopulations DRG neurons. Through the use of techniques such as
immunohistochemistry and in situ hybridization, researchers are currently characterizing
numerous distinct subgroups of sensory neurons based on their expression of one or
more biochemical markers - including trophic factors and their receptors,
neuropeptides, cytoskeletal elements, enzymes, and other proteins (reviewed in: Hunt et
al., 1992; Lawson, 1992).
The neuronal diversity seen in DRG populations and the relative accessibility of
these cells makes them ideal models for studying sensory neurons and for determining
potential roles of trophic factors within specific subpopulations. Once unique subgroups
of DRG neurons have been identified based on their responsiveness to neurotrophic
factors, including the neurotrophins, they may be manipulated; such studies will yield
valuable information that could lead to advances in the treatment of neurological
diseases or trauma (Maeda et al., 1996; reviewed in: Eddington, 1993; Barinaga, 1994;
McMahon and Priestly, 1995; Schatzl, 1995; Anand, 1996; Tomlinson et al., 1996,
1997; Mufson et al., 1999).
1.2.2 Characterization of DRG Neurons with Respect to Neurotrophin
Responsiveness
Three distinct, but potentially overlapping, DRG neuronal subpopulations
have been identified through micro-injections of iodinated NGF, BDNF, and NT-3 into
sciatic nerve (DiStefano et al., 1992). One of these subsets, representing 40-45% of the
total (Richardson et al., 1986; Verge et al., 1989a, 1989b, 1990a, 1990b, 1992a; Mu et
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al., 1993; McMahon et al., 1994; Wetmore and Olson, 1995; Wright and Snider, 1995;
Bennett et al., 1996a; Kashiba et al., 1996, 1997a; Karchewski et al., 1999), has been
characterized based on its ability to respond to the neurotrophin, NGF. These neurons
display high-affinity NGF binding sites and express p75 and trkA mRNA (Richardson et
al., 1986; Verge et al., 1989a, 1989b, 1990b, 1992a). The group includes virtually all
substance P- (SP) and most calcitonin gene-related peptide- (CGRP), but not
somatostatin- (SOM), expressing DRG neurons (Verge et al., 1989a; Kashiba et al.,
1996); all members express GAP-43 mRNA (Verge et al., 1990a). They are mainly
small to medium in size (Richardson et al., 1986; Verge et al., 1989a, 1989b, 1990a,
1990b, 1992a, 1992b; Mu et al., 1993; McMahon et al., 1994; Wetmore and Olson,
1995; Kashiba et al., 1996, 1997a; Karchewski et al., 1999) and are presumed to be
nociceptive in function (Crowley et al., 1994; Smeyne et al., 1994). The subsets ofDRG
neurons expressing other trks are poorly characterized, even though subpopulations of
predominantly medium to large sized cells expressing trkB and trkC have been reported
(McMahon et al., 1994; Wetmore and Olson, 1995; Wright and Snider, 1995; Kashiba et
al., 1996, 1997a; Karchewski et al., 1999; reviewed in: Phillips and Armanini, 1996;
Lindsay, 1996; Snider and Silos-Santiago, 1996). Several research groups indicate that
for adult rat DRG 27%\ 260/02, or 5%3 of neurons express trkB mRNA, while 17%1,
21 %2, or 15-20%3 are trkC-positive CMcMahon et al., 1994; 2Wetmore and Olson, 1995;
3Kashiba et al., 1996, 1997a). In this laboratory, we find that'" 33% of DRG neurons
exhibit detectable levels of trkB transcripts, with 30-35% of the total population being
strongly trkC-positive and an additional 10% weakly expressing the signal (Karchewski
et al., 1999). Although the subpopulations of neurons expressing trkA, trkB, or trkC are
for the most part unique, these receptors may also colocalize, although reported
percentages vary (Mu et al., 1993; McMahon et al., 1994; Wright and Snider, 1995;
Karchewski et al., 1999). In addition, between 20-34% of DRG neurons do not appear to
exhibit detectable levels for any of the trks (McMahon et al., 1994; Wright and Snider,
1995; Karchewski et al., 1999).
1.2.3 Effects of Peripheral Injury on Primary Sensory Neurons
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1.2.3.1 Response of Primary Sensory Neuron Perikarya to Injury
Following peripheral nerve injury, the surviving DRG neurons
undergo structural, physiological, and biochemical changes; they may lose their ability
to respond to various types of stimuli or may gain new reactivity (reviewed in:
Lieberman, 1971, 1974; Grafstein and McQuarrie, 1978; Aldskogius et al., 1985, 1992;
Titmus and Faber, 1990). A detailed analysis of these changes is necessary to understand
disturbances in sensory function after peripheral nerve damage and to understand how
these conditions may be prevented, compensated for, or treated. Much of the information
concerning the effect of peripheral trauma on these neurons has come from studies
involving changes observed within their cell bodies.
Studies involving peripheral nerve injury conclude that there is a significant loss
(15-30%) of sensory ganglion neurons (Tessler et al., 1985; Arvidsson et al. 1986),
although it is unclear if there is a selective loss of any specific subpopulation (reviewed
in: Aldskogius et al., 1992). There is a more extensive loss of DRG neurons after a nerve
transection as compared to a crush lesion, after proximal compared to distal nerve
transection, and in injured immature animals compared to adults (Aldskogius et al.,
1985; Redshaw and Bisby, 1985; Navarro et al., 1994). DRG neurons that survive the
axonal injury undergo characteristic alterations in morphology (Greenberg and Lasek,
1988; Moskowitz et al., 1993; reviewed in: Lieberman, 1971). Within 1 day, and for at
least several weeks following the insult, there is a disintegration and redistribution of the
basophilic Nissl substance (chromatolysis), a migration of the nucleus to the periphery of
the soma, and changes in the sizes of the nucleolus, nucleus, and perikaryon (reviewed
in: Lieberman, 1971, 1974; Grafstein and McQuarrie, 1978; Wells and Vaidya, 1989).
These morphological changes reflect significant parallel alterations in the metabolism
and cytoplasmic makeup of the neuron, alterations that may play a key role in
determining successful axonal regeneration (Wells, 1984, 1987; Wells and Vaidya,
1989; reviewed in: Lieberman, 1971, 1974; Grafstein and McQuarrie, 1978).
Chromatolysis has been revealed by electron microscopy studies to be due to a
disorganization of the structure of rough endoplasmic reticulum, with a subsequent
increase in the proportion of free polyribosomes (reviewed in: Lieberman, 1971). Free
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polyribosomes are generally thought to be responsible for the production of cytoplasmic
proteins, whereas membrane-bound ribosomes are responsible for the production of
cellular membranes and secretion products and may reflect a shift from normal
functioning to a survival response (Palade, 1975). Other indications of changes in RNA
metabolism are the observed enlargement of the nucleus and nucleolus, which reflect
increased capacity for RNA, and subsequent protein, synthesis (reviewed in: Lieberman,
1971, 1974; Grafstein and McQuarrie, 1978; Hall, 1982). RNA synthesis in injured DRG
neurons is biphasic, consisting of two major increases about 7 days apart (Wells, 1984,
1987). The significance of this two-phased increase in RNA synthesis after axonal injury
is unclear, but the first phase may be due to an "injury program" that is separated by a
period of reorganization from the second, potentially regenerative, phase (Wells and
Vaidya, 1989). Although an increase of -- 300/0 in total protein synthesis has been noted
in DRG neurons following sciatic nerve axotomy (Hall, 1982), there is a reduction in the
synthesis of proteins associated with synaptic transmitter metabolism (reviewed in:
Grafstein and McQuarrie, 1978), reflecting the finding that transmitting and receiving
functions of the neuron may be partially, or wholly, interrupted after axotomy (reviewed
in: Lieberman, 1971).
NF protein and mRNA levels in DRG neurons decrease following axotomy
(Greenberg and Lasek, 1988; Oblinger and Lasek, 1988; Verge et al., 1990b; Wong and
Oblinger, 1987, 1990, 1991; Emfors et al., 1993; Hoffman et al., 1993), and since
neurofilaments function mainly as architectural elements, the observed decrease in somal
size may be due to a reduction in NF synthesis (Verge et al., 1990b; Hoffman et al.,
1993). Other cytoskeletal components, the microtubule-associated proteins, actins and
Classes II and III ~-tubulins, increase in proportion to neurofilament levels; these
increases reflect an upregulation in intracellular transport levels and axonal regeneration
(Oblinger and Lasek, 1988; Skene, 1989; Hoffman et al., 1993; Moskowitz et al., 1993).
Additional axotomy-induced biochemical changes within DRG neurons include
the regulation of neuropeptides (reviewed in: Hokfelt et al., 1994a, 1994b). Sciatic nerve
transection causes a significant decrease in the levels of a- and ~-CGRP (Shehab and
Atkinson, 1986; Noguchi et al., 1990b, 1993; Klein et al., 1991; Verge et al., 1995), SP
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(Jessell et ai., 1979; Tessler et ai., 1985; Villar et ai., 1989; Klein et ai., 1991; Hokfelt et
ai., 1993; Noguchi et ai., 1994, 1995; Verge et ai., 1995) and SOM (Noguchi et al.,
1993; Verge et ai., 1995). Under similar conditions a dramatic upregulation of the
following peptides occurs: neuropeptide tyrosine (NPY) (Wakisaka et ai., 1991, 1992;
Frisen et ai., 1992; Noguchi et ai., 1993; Zhang et ai., 1994c; Ohara et ai., 1994, 1995;
Verge et ai., 1995; Comess et ai., 1996), galanin (Hokfelt et ai., 1987, 1993; Villar et
ai., 1989; Klein et ai., 1991; Noguchi et ai., 1993; Verge et ai., 1993b, 1995; Comess et
ai., 1996), vasoactive intestinal peptide (VIP) (Villar et ai., 1989; Klein et ai., 1991;
Noguchi et ai., 1993; Verge et ai., 1995), and cholecystokinin (CCK) (Klein et ai., 1991;
Verge et ai., 1993a, 1995; Zhang et ai., 1993b). Although the exact physiological import
of these neuropeptides are not known, some putative roles have been described
(reviewed in: Hunt et ai., 1992; Lawson, 1992; Hokfelt et ai., 1993; Iversen, 1995). Of
the peptides that decrease with injury CGRP and SP may function as an excitatory
molecule, having algesic effects, and may also function as a vasodilator, while SOM
may be involved in thermoception and also act to reduce the intensity of the immune
response. Of the neuropeptides whose expression is upregulated after axotomy VIP is
algesic and has been implicated in the modulation of the immune response, NPY may
play a role in pain pathways through the inhibition of neurotransmitter release, galanin
appears to be important in suppressing states of hyperexcitation after injury; and CCK
may be involved in antagonizing analgesic effects.
In adult rat DRG neurons, upregulation of GAP-43 mRNA and protein levels
have been shown to increase in some neurons 1-2 days after injury (Skene, 1989;
Schreyer and Skene, 1991, 1993; Wiese et ai., 1992), and within 1 week almost all of the
neurons express GAP-43 transcripts (Skene, 1989; Verge et ai., 1990b; Wiese et ai.,
1992). Putative roles for GAP-43 are in axonal elongation and in the growth and
remodeling of synaptic connections (reviewed in: De Graan et ai., 1986; Skene, 1989).
Another protein that is strongly upregulated in sensory neurons following axotomy is the
transcription factor cJUN, encoded by an immediate early gene, cjun, which is rapidly
induced in many tissues in response to a variety of stimuli (Gold et al., 1993a, 1994). It
has been proposed that cJUN may serve to transcriptionally regulate galanin expression
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due to the parallel post-traumatic increase in levels of these two substances in the same
neurons (Herdegen et al., 1993).
In normal rat DRG there is a heterogeneous distribution of neurons with high-
affinity NGF binding sites, representing,..., 40% of the total lumbar DRG population, but
following peripheral nerve injury 125I_NGF binding decreases (Raivich and Kreutzberg,
1987; Verge et al., 1989b), with the number ofNGF binding sites falling by more than
800/0 2 weeks post-injury (Verge et al., 1989b). Moreover, neurotrophin receptor mRNA
expression in DRG neurons for both p75 and the trks decreases post-axotomy (Johnson
et al., 1987; Verge et al., 1989b, 1992a; Emfors et al., 1993; Funakoshi et al., 1993;
Sebert and Shooter, 1993; Zhou et al., 1996; Kashiba et al., 1998).
1.2.3.2 Reversal of Injury-Induced Changes
It is not known what factor(s) causes the alterations in neurons
following peripheral axotomy, but it has been demonstrated that if regeneration is
successful (i.e. neurons reinnervate their targets), many of these changes reverse
(Lieberman, 1971, 1974; Hoffman et al., 1993). Several lines of evidence support the
current view that retrograde transport of a trophic factor(s) from the peripheral target
and/or cells along the distal nerve tract maintain the neuron in its normal biological state;
disruption of this retrograde flow triggers the injury-induced state (Lieberman, 1971,
1974; Grafstein and McQuarrie, 1978; Redshaw and Bisby, 1985; Verge et al., 1992a,
1992b, 1995; Mudge, 1993). This theory is supported by the finding that the appearance
of chromatolytic changes is correlated with the time period necessary for retrograde
axonal transport from the injury site to the soma (Kristensson and Olsson, 1975). Also,
damage to the central axon of the dorsal root does not appear to cause cell death,
chromatolysis, or changes in protein levels (Lieberman, 1971; Oblinger and Lasek,
1988); such a lesion would not affect retrograde flow from the periphery to the cell body.
Additionally, many of the peripheral nerve injury-induced changes can be mimicked by
the application of colchicine or vinblastine, inhibitors of microtubule formation, and,
therefore, of retrograde transport (Woolf et al., 1990; Kashiba et al., 1992a).
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Convincing evidence to support the retrograde-transport theory comes from
experiments where exogenous NGF is infused at a point in time after the neuron has
responded to peripheral axotomy. Since NGF is produced in limited quantities by target
tissue and is moved by retrograde transport to the cell body, where it can exert trophic
effects (reviewed in: Korsching and Thoenen, 1985; Ebendal, 1992; Korsching, 1993),
and because peripheral nerve injury reduces levels of receptor-mediated NGF uptake and
its retrograde transport (Raivich et al., 1991), the axotomy-induced changes may be
attributed to the injury-reduced availability of NGF to this neuronal subpopulation
responsive to this neurotrophin (Verge et al., 1989b, 1992a). Trauma-induced decreases
in neuronal size, NF, u- and p-CGRP, SP, p75, and trkA are counteracted, at least in
part, with NGF infusion (Fitzgerald et ai., 1985; Rich et ai., 1987; Verge et ai., 1989a,
1989b, 1990a, 1990b, 1992a, 1992b, 1995; Gold et ai., 1991; Wong and Oblinger, 1991;
Tetzlaff et ai., 1992), while the trauma-induced increases in GAP-43, cjun, VIP, CCK,
NPY, and galanin are, at least partially, mitigated (Verge et al., 1990b, 1995; Tetzlaff et
ai., 1992; Gold et ai., 1993a). Further, that exogenous NGF does not appear to influence
the injury-induced decrease in SOM expression (Verge et ai., 1992b; Verge et ai., 1995),
is most likely due to a lack of detectable trkA mRNA in the SOM-positive population
(Verge et ai., 1989b). In addition, intraperitoneal injection ofNGF antiserum mimics the
axotomy-mediated alterations in neuropeptide expression, resulting in elevated levels of
galanin and VIP, and reduced levels of SP and CGRP, mRNA and protein (Shadiack et
ai., 2001)
Those trk-positive DRG neurons that are not NGF-responsive (McMahon et ai.,
1994; Wetmore and Olson, 1995; Wright and Snider, 1995; Kashiba et al., 1996, 1997a;
Karchewski et ai., 1999) presumably respond to other molecules (Verge et ai., 1990a,
1995) and, because an individual neuron may possess more than one trk species (Mu et
al., 1993; McMahon et al., 1994; Wright and Snider, 1995; Karchewski et al., 1999),
one can expect to encounter both unique and overlapping forms of the regulation of
cellular phenotype by the various neurotrophins.
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1.3 Objectives
I hypothesize that other members of the NGF family of neurotrophic factors,
specifically NT-3, also playa major role in modulating or maintaining the differentiated
phenotype of adult primary sensory neurons, and that since NT-3 is retrogradely
transported in sciatic nerve (Nitta et al., 1999), that it is part of the signal that allows at
least a subpopulation of these axotomized neurons to return to normal following axonal
regeneration. Therefore, my objective is to obtain a better understanding, at the cellular
level, of the role ofNT-3 in the maintenance of adult primary sensory neuron phenotype.
This will be accomplished through isotopic in situ hybridization processing of intact and
peripherally axotomized adult rat DRG neurons from control and NT-3 infused animals.
Computer-assisted image analysis of serial DRG sections will be used to identify and
characterize the NT-3 responsive subpopulation and to determine and compare relative
levels of mRNA expression for selected neurotrophin receptors, neuropeptides,
cytoskeletal elements, injury- and regeneration-associated molecules, and other markers
in individual neurons under the conditions stated above. This information will be
important in furthering the understanding of the biological role of NT-3 and in the
planning of clinical studies involving neuronal degeneration, regeneration, and the
restoration ofnormal neuronal function following nerve injury.
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2. LITERATURE REVIEW
2.1 Neurotrophin-3 Receptors
2.1.1 trkC
2.1.1.1 trkC in Developing Primary Sensory Neurons
During embryonic development, the neuroepithelium gives rise to
a specialized group of migratory, multipotent cells termed the neural crest. These
progenitors disperse dorso- and ventrolaterally from their dorsal positions along the
neural tube to follow distinct developmental pathways, ultimately establishing a wide
range ofdifferentiated cell types including glia, me1anocytes, and sensory and autonomic
neurons (reviewed in: Kalcheim, 1996). In vivo and in vitro experiments have shown that
trophic factors, including NT-3, are important in supporting the survival and
proliferation of neural crest progenitor cells (reviewed in: Kalcheim, 1996), and although
during migration they have been reported to express trkC mRNA (Tessarollo et al.,
1993), trkC protein is not detectable in these cells (Farifias et al., 1998). This apparent
discrepancy may be because trkC protein has not yet reached detectable levels, or may
be due to a repression of the translation of trkC transcripts during this developmental
stage (Farifias et al., 1998). Later in development, the nascent DRG are composed of a
mixed population of committed and multipotent precursor/progenitor cells and
postmitotic neurons (reviewed in: Kalcheim, 1996). In Ell/1l.S mouse lumbar DRG,
where greater than 60% of cells are precursors (Farifias et al., 1996); virtually all
postmitotic, differentiated neurons exhibit high levels of trkC transcripts (Lamballe et
al., 1994; Phillips and Armanini, 1996; White et al., 1996) and '" 70% display trkC-like
immunoreactivity (-ir) (Farifias et al., 1996). At later developmental stages, the number
of DRG neurons expressing this receptor rapidly decreases (Lamballe et al., 1994;
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Farifias et al., 1996; Phillips and Annanini, 1996; White et al., 1996); by E13 less than
10% of neurons exhibit trkC-ir (Farifias et al., 1996) and although between E15 and
E17.5 trkC mRNA levels remain high, receptor expression continues to be limited to a
subset ofDRG neurons (Lamballe et al., 1994; Phillips and Annanini, 1996). Data from
studies on rat (Ernfors et al., 1993; Mu et al., 1993; Elkabes et al., 1994) and chicken
(Williams and Ebendal, 1995) indicate that trkC expression follows a similar pattern in
DRG neurons of these species. Further, percentages of trkC-positive neurons, as well as
size frequency histograms, indicate that thoracic and lumbar DRG populations are
comparable in rat (Mu et al., 1993). Data regarding the developmental expression of
isofonns of the receptor are limited, but in chicken it has been reported that trkC fu 11 h1- engt
transcripts are detectable prior to those of the truncated fonn (Escandon et al., 1994). At
later stages in development, trkC is primarily localized to neurons with large diameter
perikarya (Mu et al., 1993; Oakley et al., 1995; Williams and Ebendal, 1995; Lefcort et
al., 1996), although an additional subset of neurons with small soma and low levels of
trkC mRNA has also been identified (Lefcort et al., 1996). Together these data indicate
that trkC is differentially expressed in sensory neuron precursors and differentiated DRG
neurons during development, with the number of trkC-positive cells restricted to a subset
of the population in maturing embryos.
2.1.1.2 trkC in Adult Primary Sensory Neurons
A subpopulation of adult murine DRG neurons express trkC
mRNA (Ernfors et al., 1993; Mu et al., 1993; McMahon et al., 1994; Wetmore and
Olson, 1995; Wright and Snider, 1995; Kashiba et al., 1996, 1997a; Helgren et al., 1997;
Karchewski et al., 1999), although reports differ as to the percentages of neurons that
exhibit the receptor. As few as 10%(Mu et al., 1993), and from 17%2, 21 %3, or 15-20%
(McMahon et al., 1994; Wetmore and Olson, 1995; Kashiba et al., 1996, 1997a) of adult
rat lumbar DRG neurons have been identified as being trkC-positive. In this laboratory,
we find that 30-35% of the total Ls DRG population exhibit high levels of trkC
hybridization signal, with up to 10% of additional neurons displaying lower signal levels
(Karchewski et al., 1999). These numbers correspond to the'"'""' 40% of lumbar DRG
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neurons labeled with antiserum to NT-3 (Zhou and Rush, 1995), '" 95% of which also
display trkC-ir (Chen et al., 1996). The apparent discrepancies in the number of trkC-
positive neurons reported by the different research groups may be attributed to several
factors. Even though all of these results were based on in situ hybridization studies, the
protocols followed vary, with some processing methods more sensitive in the detection
of mRNA than others (Tecott et al., 1987). In addition, the duration of exposure of
radioautographs prior to the developing of the emulsion is also important in
distinguishing between neurons with low levels of trkC transcripts and nonspecific,
background labeling. That a number of these researchers have indicated that trkC-
positive neurons display relatively uniform labeling intensities (Wetmore and Olson,
1995; Wright and Snider, 1995) implies that the subset with lower levels of labeling
(Karchewski et al., 1999) may not have been identified in these studies. Despite the
disparity in reported percentages of trkC-positive DRG neurons, all groups concur that
these cells are primarily large in size (Mu et al., 1993; McMahon et al., 1994; Wetmore
and Olson, 1995; Wright and Snider, 1995; Helgren et al., 1997; Karchewski et al.,
1999), with", 85% of trkC-expressing neurons possessing medium to large diameter
perikarya (Karchewski et al., 1999). Hybridization signal for trkC mRNA tends to be of
higher density over medium and large soma; small neurons typically display lower
signal levels (Karchewski et al., 1999). The percentages of rat Ls DRG neurons
expressing two kinase insert isoforms of trkC (trkCkil4 and trkCki39) have also been
determined, with 42%, 35%, and 27% of neurons displaying detectable levels of trkCno
insert' trkCkil4, and trkCki39 mRNAs, respectively (Karchewski et al., 1999). Transcripts of
all three isoforms are primarily detected in medium and large diameter cell bodies, and
expression of trkCki14 or trkCki39 almost always colocalizes with the noninsert isoform
(Karchewski et al., 1999). In rat, all neural tissues appear to possess mRNAs of both the
full-length and truncated trkC isoforms with the potential exception of sciatic nerve, in
which only the latter type has been detected (Valenzuela et al., 1993). In human DRG,
trkC mRNA is expressed at moderate levels, with a relatively high ratio of trkCfull-length to
trkCtruncated transcripts (Yamamoto et al., 1996).
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2.1.1.3 trkC in the Spinal Cord
Northern blot analyses reveal that trkC mRNA is present in rat
spinal cord at differing levels during embryonic development: At E13 and E14 trkC is
expressed at low levels, message levels increase over time, peaking at PI where levels
are 12 fold higher than at E14 (Ernfors et al., 1993). In adult rat, trkC transcripts are
detectable in spinal cord (Ernfors et al., 1993; Funakoshi et al., 1993), but levels are
comparable to those of E13/E14 (Emfors et al., 1993). In the dorsal hom of adult
monkey trkC-ir is detectable in nerve terminals (Arvidsson et al., 1994), while in human
spinal cord trkC message is reported to be strongly expressed, with the majority of
transcripts believed to encode the truncated isoform of the receptor (Yamamoto et al.,
1996).
2.1.2 Coexpression oftrks in Adult Primary Sensory Neurons
Although micro-injection of radioiodinated neurotrophins into adult rat
sciatic nerve retrogradely labels three distinct subpopulations of DRG neurons in a
receptor-mediated fashion - with 12sI_NT_3 and 12sI_NGF primarily localized to large-
and small-sized soma, respectively, and 12sI-BDNF labeling perikarya of varying
diameters (DiStefano et al., 1992) - the somal size distributions of the labeled
populations allow for potential overlap between the expression of the corresponding
neurotrophin receptors.
Numerical analyses by McMahon and colleagues (1994) of radioautographs of
DRG sections processed for in situ hybridization indicate that 44%, 27%, and 17% of
LiLs neurons exhibit transcripts for trkA, trkB, and trkC, respectively. Repeating the
experiment, but with a cocktail containing probes for all three trks, they show that 34%
of these neurons do not express mRNA for any of the receptors. From these findings
they conclude that because 88% of neurons express trks (trkA + trkB + trkC), and since
34% do not exhibit detectable trk transcripts, some neurons must express more than one
trk species. They further suggest that trkB would be most likely to colocalize with trkA
or trkC, since trkB transcripts are present in cells of varying somal diameters, while the
other trks show more restricted size distributions.
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Direct evidence for the coexpression of trks is provided through the work of two
research groups (Wright and Snider, 1995; Karchewski et al., 1999). Using isotopic and
nonisotopic in situ hybridization protocols to detect two different trk species mRNAs in
individual thoracic DRG neurons, Wright and Snider (1995) show that while the
majority of trkA-positive cells lack detectable levels of trkC transcripts, coexpression of
the receptors occurs in a subset of larger diameter neurons that represents -- 6% of the
trkA-positive, and -- 150/0 of the trkC-positive, subpopulations. Surprisingly, given the
somal size frequency distributions ofDRG neurons that express each of the trks, they did
not identify any neurons in which trkB colocalized with either trkA or trkC. More
recently, this laboratory (Karchewski et al., 1999) used 5 /-lm thick serial sections
processed for radioisotopic in situ hybridization to indicate the subgroups of Ls DRG
neurons expressing trks. Individual neurons were identified in each series of sections and
the relative levels of hybridization signal for the trks expressed by these neurons were
quantified. Results show that -- 40%, 30%, and 40% of neurons exhibit transcripts for
trkA, trkB, and trkC, respectively, with size distributions corresponding to previous
reports (DiStefano et al., 1992; McMahon et al., 1994; Wetmore and Olson, 1995;
Wright and Snider, 1995; Kashiba et al., 1996, 1997a, 1998). In addition, coexpression
of trkA and trkB, trkA and trkC, and trkB and trkC occurs in -- 10%, 20%, and 20% of
neurons respectively, with transcripts for all three of the trks detectable in 3-4% of the
total DRG population. These data indicate that the colocalization of trk mRNAs is more
common than the expression of a single trk species in adult rat DRG neurons.
While there is general agreement that 40-45% of DRG neurons display high-
affinity NGF binding sites and trkA mRNA (Verge et al., 1990a, 1990b, 1992a; Mu et
al., 1993; McMahon et al., 1994; Wetmore and Olson, 1995; Wright and Snider, 1995;
Bennett et al., 1996a; Kashiba et al., 1996, 1997a, 1998; Karchewski et al., 1999), there
are considerable discrepancies in the reported percentages of neurons expressing, or
coexpressing, the other trks. These differences may be attributed to factors that limit the
sensitivity of the in situ hybridization protocol; low levels of transcripts are more apt to
be detected when tissue is fresh-frozen rather than fixed and if radioisotopic, instead of
nonisotopic, probes are used. Moreover, disparities may be magnified because unlike
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trkA, where message levels tend to be homogeneously expressed, greater numbers of
trkB- and trkC-positive DRG neurons exhibit variable levels of hybridization signal for
the respective trks (Karchewski et al., 1999) and, therefore, in some cells transcript
levels may be below the level ofdetection of some protocols.
2.1.3 p75 in Primary Sensory Neurons
The neurotrophin receptor, p75 is detectable in migrating mouse neural
crest cells (Farinas et al., 1998), and hybridization signal levels are high in DRG
between E11.5 and PI (Schecterson and Bothwell, 1992). Transcripts are also present in
adult rat DRG (Verge et al., 1992a; Sebert and Shooter, 1993; Wetmore and Olson,
1995; Wright and Snider, 1995; Zhou et al., 1996; Karchewski et al., 1999), and p75
mRNA is widely distributed in human PNS (Yamamoto et al., 1996). Message and
protein are expressed heterogenously, both in the level of labeling intensities and in the
size range of neurons exhibiting the marker (Verge et al., 1992a; Zhou et al., 1993,
1996; Wetmore and Olson, 1995; Wright and Snider, 1995; Karchewski et al., 1999),
with reported percentages of p75-positive cells for L/Ls adult rat DRG neurons ranging
from 602_80%1,3 CWetmore and Olson, 1995; 2Zhou et al., 1993, 1996; 3Karchewski et
al., 1999). Further, the distribution of p75 appears to closely correlate with trk
expression; few neurons express one type of neurotrophin receptor and lack the other
(Wright and Snider, 1995; Karchewski et al., 1999).
2.2 Neurotrophin-3
2.2.1 Sources ofNeurotrophin-3 for Primary Sensory Neurons
2.2.1.1 Neurotrophin-3 in Developing Primary Sensory Neurons
That NT-3 is expressed in early developing CNS (Maisonpierre et
al., 1990a) is consistent with studies illustrating the presence of trophic factors in the
neural tube, necessary to the survival of migrating neural crest cells (reviewed in:
Kalcheim, 1996). Following migration and early in DRG fonnation, NT-3 has been
identified in target tissues (Emfors and Persson, 1991; Schecterson and Bothwell, 1992;
Copray and Brouwer, 1994; White et al., 1996), but at this developmental time point
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trkC-positive DRG cells (Ernfors et al., 1993; Mu et al., 1993; Elkabes et al., 1994;
Lamballe et al., 1994; Williams and Ebendal, 1995; Farifias et al., 1996) do not have
contact with target tissues, and therefore, cannot access NT-3 from these sources.
Although reports vary as to the initial developmental stage at which NT-3 mRNA is
detectable in mouse (Schecterson and Bothwell, 1992; Ernfors et al., 1993; EIShamy and
Emfors, 1996; Tojo et al., 1996), the neurotrophin has been shown to be present at low
levels as early as Ell using an RNase protection assay (EIShamy and Ernfors, 1996). By
E15.5, 10-15% of mouse primary sensory neurons display low levels of hybridization
signal for NT-3 (Schecterson and Bothwell, 1992), but by E17.5 the marker is no longer
detectable in DRG using in situ hybridization (Schecterson and Bothwell, 1992).
Further, by P15, levels of NT-3 mRNA expression are below the detection limit of
RNase protection assays (EIShamy and Ernfors, 1996). Similar developmental patterns
of expression have been reported in embryonic rat DRG (Ernfors and Persson, 1991;
Elkabes et al., 1994). These data suggest that during development NT-3 is produced
within DRG and consequently may act locally on DRG neurons, although such
interactions may be more important in early DRG since levels of the neurotrophin
decrease postnatally.
2.2.1.2 Neurotrophin-3 in Adult Primary Sensory Neurons
Even though NT-3 mRNA has been identified in regions of adult
CNS (Ernfors et al., 1990b; Maisonpierre et al., 1990a; Kokaia et al., 1993), there are
conflicting reports as to the presence of the neurotrophin in adult DRG. Using in situ
hybridization, three research groups were unable to detect NT-3 mRNA in adult murine
lumbar DRG (Ernfors et al., 1990b; Wetmore and Olson, 1995; Mearow, 1998), nor was
message for the neurotrophin detected in similar tissue in either RNase or ribonuclease
protection assay studies (ElShamy and Ernfors, 1996; Shen et al., 1999). In contrast, one
laboratory has shown the presence ofboth NT-3 transcripts and protein in adult rat DRG,
although the mRNA and protein appear to label two different subsets of neurons (Zhou
and Rush, 1995; Chen et al., 1996; Zhou et al., 1999a). In lumbar DRG many large, and
some small, neurons exhibit low levels of in situ hybridization signal for NT-3 (Zhou et
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al., 1999a); whereas NT-3-ir is localized to --.J 40% of DRG neurons, primarily those with
large perikarya (Zhou and Rush, 1995; Chen et at., 1996). There is a positive correlation
between NT-3-ir and the trkC-positive subpopulation, with trkC-ir colocalizing in 940/0
ofNT-3-ir neurons, implying that the presence ofNT-3-ir is due to internalization of the
neurotrophin after trkC activation (Chen et at., 1996). Further, this group has shown that
even though satellite cells do not normally express NT-3 mRNA, 48 hours after sciatic
nerve transection, and for at least 2 weeks after, NT-3 message levels are upregulated
within cells surrounding a subset of large, and some small, neuronal soma in ipsilateral
DRG (Zhou et at., 1999a). Moreover, a second group has used reverse transcriptase-
polymerase chain reaction (RT-PCR) to demonstrate the presence of low levels ofNT-3
mRNA in human DRG (Yamamoto et al., 1996). The localization ofNT-3 transcripts to
mature DRG neurons and satellite cells suggests potential autocrine and/or paracrine
roles for the neurotrophin.
2.2.1.3 Neurotrophin-3 in Target Tissues
Although transcripts for NT-3 have been identified in mature
DRG (Yamamoto et at., 1996; Zhou et al., 1999a), the primary source of NT-3 for
primary sensory neurons may be target-derived. In adult rats, within 1 day of sciatic
nerve transection NT-3 protein accumulates inside axons of the distal stump; levels
return to normal values by 3 days post-surgery (Nitta et at., 1999). For both the proximal
and distal nerve segments, axotomy does not appear to alter NT-3 message levels, nor is
there an injury-induced change in the preexisting low NT-3 protein levels in Schwann
cells (Nitta et at., 1999). These findings indicate that in the intact state, although NT-3
mRNA is present in sciatic nerve, significant levels of NT-3 protein appear to be
retrogradely transported in many peripheral nerve axons, and thus may function in
sensory neuron maintenance.
An in situ hybridization study involving developing mouse embryos shows that
NT-3 mRNA is present in skin dermal mesenchyme at moderate to high levels between
E1l.5 and E15.5; by E17.5 signal levels are weak and fall to below detectable values by
PI (Schecterson and Bothwell, 1992). NT-3 is not detectable in hair follicles between
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E11.5 and E12.5, but by E14.5 levels are strong; transcripts decline to moderate levels
by E15.5, decrease further by E17.5, and fall below the limits of detection by PI
(Schecterson and Bothwell, 1992). In skeletal muscle NT-3 mRNA is present at
moderate to high levels between E11.5 and E15.5 (Schecterson and Bothwell, 1992;
Griesbeck et al., 1995), but message expression rapidly falls below detectable values by
E17.5 (Schecterson and Bothwell, 1992). Transcripts of the neurotrophin are evidenced
in the spinal cord ventral hom at high levels in mouse motoneurons from E11.5 to PI
(Schecterson and Bothwell, 1992) and in rat at E13/13.5 (Emfors and Persson, 1991;
Elkabes et al., 1994).
In adult chicken a range of peripheral tissues exhibit NT-3 mRNA, including
skin, muscle, intestine, heart, liver, thymus, and lung; the highest message levels are
present in kidney and spleen (Maisonpierre et al., 1990a). Similarly, in adult murine
tissues, NT-3 transcripts are abundantly expressed in skeletal muscle, kidney glomeruli,
submandibular gland, and ovary (Emfors et al., 1990b; Funakoshi et al., 1993;
Griesbeck et al., 1995); lower levels of transcripts of the neurotrophin have been
localized to sciatic nerve and spinal cord (Funakoshi et al., 1993; Nitta et al., 1999). In
humans, NT-3 mRNA distribution and expression is also comparable to that observed in
other organisms, with transcripts present at high levels in nonneuronal tissues of liver,
spleen, muscle and at low levels in sciatic nerve (Yamamoto et al., 1996). The presence
of the neurotrophin in these tissues supports a role for target-derived NT-3 in the
maintenance of adult primary sensory neurons.
2.2.2 Roles ofNeurotrophin-3 in Primary Sensory Neurons
2.2.2.1 Neurotrophin and Neurotrophin Receptor Mutants
2.2.2.1.1 Neurotrophin-3 Mutants
In an attempt to better understand the biological role of
NT-3, studies were conducted on mice with a targeted mutation of the NT-3 gene,
engineered such that these animals lack functional neurotrophin (NT-3-1-). At birth these
animals appear normal, but show abnormal limb movements and positioning, decreased
activity, no evidence of food uptake, and typically die within 24 hours (Emfors et al.,
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1994b; Farifias et al., 1994; Tessarollo et al., 1994). Histological examinations indicate
that NT-3-1- mice exhibit a substantial loss of peripheral sensory neurons (Emfors et al.,
1994b; Farifias et al., 1994, 1998; Tojo et al., 1995; EIShamy and Emfors, 1996; Liebl et
al., 1997), with a 70-80% reduction in the number of lumbar DRG neurons over wild-
type (Farifias et al., 1994; Liebl et al., 1997; Tessarollo et al., 1997). Not only are limb
proprioceptive afferent fibers missing in NT-3 deficient animals (Emfors et al., 1994b;
Kucera et al., 1995b), they also lack the corresponding peripheral sensory receptors,
muscle spindles (Emfors et al., 1994b; Farifias et al., 1994; Kucera et al., 1998; Matsuo
et al., 2000), Golgi tendon organs (Emfors et al., 1994b), and Ia fiber projections to the
spinal cord ventral hom (Farifias et al., 1994; Tessarollo et al., 1994). Further, although
present during early development, two subtypes of mechanoreceptors, Merkel cells and
D-hair receptors, are essentially lacking in P14 NT-3-1- mice; other kinds of cutaneous
sensory receptors appear normal (Airaksinen et al., 1996). In addition, while there are no
obvious alterations in the proportions of trkA- and trkB-expressing neurons in DRG
(Tessarollo et al., 1994), there are reported reductions in (Tojo et al., 1995), or loss of
(Tessarollo et al., 1994), the trkC-positive subpopulation. Even though there is
conspicuous limb proprioceptive dysfunction, NT-3-1- mice are capable of responding to
tail pinch stimuli, implying normal nociceptive innervation (Tessarollo et al., 1994).
Moreover, there are no gross deficits in Pacinian corpuscles (Emfors et al., 1994b;
Airaksinen et al., 1996), deep nerve fibers to joint capsules and tendons (Emfors et al.,
1994b), cutaneous afferents (Tessarollo et al., 1994), or in the number and phenotype of
motoneurons (Emfors et al., 1994b; Farifias et al., 1994; Tessarollo et al., 1994; Kucera
et al., 1995a; Tojo et al., 1995). NT-3-1- mice further genetically altered to express NT-3
only in muscle cells exhibited normal development of Ia afferents, which underscores
the importance of target-derived NT-3 to these neurons (Wright et al., 1997).
Interestingly, in contrast to the reported complete loss of limb proprioceptive
afferents and muscle spindles in NT-3-1- mice (Emfors et al., 1994b; Farifias et al., 1994;
Kucera et al., 1998; Matsuo et al., 2000), cranial proprioceptive neurons of the
trigeminal mesencephalic nucleus and corresponding sensory receptors are present,
although numbers are reduced by -- 600/0 over wild-type (Fan et al., 2000); similar but
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less dramatic results have been reported for trkC-I- mice (Matsuo et al., 2000). The
presence of trigeminal mesencephalic nucleus proprioceptive neurons in NT-3-1- and
trkC-I- mice may be attributed to the coexpression of trkB and trkC in wild-type animals,
thereby allowing these cells to respond to multiple neurotrophins (Fan et al., 2000;
Matsuo et al., 2000).
Mice with heterozygous expression of the mutant NT-3 gene (NT-3+/-) do not
exhibit any obvious morphological or behavioral abnormalities (Farinas et al., 1994), but
microscopic examination reveals a loss ofDRG neurons intermediate between wild-type
and NT-3-1- animals (Airaksinen and Meyer, 1996; Krimm et al., 2000) and an '" 50%
loss of muscle spindles (Emfors et al., 1994b). These data suggest that there is a gene-
dose effect for NT-3, such that the number of nonmutated alleles reflects the severity of
phenotypic alterations.
Similar to NT-3-1- animals, transgenic mice that overexpress NT-3 through the
nestin gene, which encodes an intermediate filament widely expressed in the developing
nervous system, show a severe inability to coordinate limb movement (Ringsted et al.,
1997). Histologically, although there is no apparent loss of DRG neurons, with both the
number of trkC-positive neurons and the proportion of SP- and CGRP-positive cells
consistent with wild-type, these animals lack peripheral and centralIa projections and
muscle spindles (Ringsted et al., 1997). That the overexpression ofNT-3 results in some
alterations in sensory phenotype similar to those ofNT-3-/- mice is surprising, and may in
part result from placing the control of NT-3 expression under the widely expressed
nestin gene, but these results underscore the importance ofNT-3 in the differentiation of
proprioceptive neurons and the formation of Ia projections and their sensory receptors.
Using another transgenic model of NT-3 overexpression, in which epidermal
keratinocytes have been genetically engineered to heterozygously express the
neurotrophin, a second research group has demonstrated that this manipulation results in
a greater than 40% increase in the number ofDRG neurons compared to control (Albers
et al., 1996). In addition, this paradigm shows that overexpression ofNT-3 increases the
density of both dermal and epidermal innervation, notably in association with hair
follicles and touch dome mechanoreceptors (Albers et al., 1996). The latter receptors are
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also enlarged and have greater numbers of associated Merkel cells compared to those of
control animals (Albers et al., 1996). Further, these researchers have shown that
overexpression of NT-3 in the skin of NT-3+1- mice prevents the'" 30% loss of LiLs
DRG neurons evidenced in NT-3 deficient heterozygous animals (Krimm et al., 2000).
Moreover, the reduction in numbers of Merkel cells associated with touch domes and the
loss of associated sensory innervation witnessed in NT-3+1- mice are restored to values
similar to those ofanimals modified only to overexpress NT-3 (Krimm et al., 2000).
2.2.2.1.2 trkC Mutants
Mice genetically engineered to lack trkC, either through a
targeted mutation in the tyrosine kinase domain of the receptor (trkCkinase-I-) (Klein et al.,
1994) or altered to be devoid of both the functional kinase-containing and truncated
isoforms (trkCa1t) (Liebl et al., 1997; Tessarollo et al., 1997), have been generated to
gain insights into the biological role of this NT-3 receptor. The resulting mutant animals
appear normal at birth, but are smaller than wild-type at P4, and most do not survive past
P21 (Klein et al., 1994; Liebl et al., 1997; Tessarollo et al., 1997). In addition, they
show the abnormal limb movement and positioning indicative of proprioceptive deficits
(Klein et al., 1994; Liebl et al., 1997; Tessarollo et al., 1997). More specifically, as for
the NT-3 mutants (see Section 2.2.2.1.1), trkC-I- mice lack muscle spindles (Kucera et
al., 1998), do not possess proprioceptive muscle afferents (Klein et al., 1994; Matsuo et
al., 2000), and have fewer large diameter myelinated axons in the dorsal roots and
posterior columns of the spinal cord (Klein et al., 1994). Numbers of lumbar DRG
neurons from both trkCkinase-l- and trkCan-l- animals show a 19% (Klein et al., 1994) and a
33-380/0 (Liebl et al., 1997; Tessarollo et al., 1997) reduction over wild-type,
respectively; that trkCan-l- mice appear to exhibit a greater loss of DRG neurons may
indicate an important role in sensory neuron development for the truncated isoform,
different from that oftrkCfull_length (Tessarollo et al., 1997).
2.2.2.1.3 Other Neurotrophin and Neurotrophin Receptor Mutants
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Mice exhibiting a disrupted region in the tyrosine kinase
domain oftrkA (trkA-1-), appear normal at birth, but by PI0 are substantially smaller than
their littermates and at P20 only about half are still surviving, with none living past P55
(Smeyne et al., 1994). trkA-1- animals exhibit a number of sensory deficits: These
mutants fail to respond to nociceptive stimuli (Smeyne et al., 1994) and show extensive
reductions in numbers of thoracic and lumbar DRG neurons, a 70-90% loss compared to
wild-type, with a preferential loss of small cells (Smeyne et al., 1994; Minichiello et al.,
1995; Silos-Santiago et al., 1995). In addition, 3-4 weeks postnatally trkA-1- mice begin
to develop skin abnormalities and ulcerations, the pathology of which intensifies with
age (Smeyne et al., 1994). Similar to trkA-1- animals, NGF-1- mice fail to survive neonatal
stages, show an inability to respond to noxious mechanical stimuli, and exhibit an ,...., 70%
loss of primarily small-sized peptidergic DRG neurons (Crowley et al., 1994). Mice
heterogeneous for NGF (NGF+1-) are capable of responding to painful stimuli, although
they are not as sensitive to nociceptive stimuli as wild-type animals (Crowley et al.,
1994).
As is the case for trkC-I- and trkA-1- mutants, mice with a targeted mutation in the
tyrosine kinase domain of trkB (trkBkinase-I-) initially appear normal, but die soon after
birth (Klein et al., 1993). The death of the trkB deficient animals may be exacerbated by
their apparent inability to intake food (Klein et al., 1993). In addition, their DRG (T12-
L3) are reduced in size and exhibit a 20-30% neuronal loss compared to wild-type (Klein
et al., 1993; Minichiello et al., 1995), and these mice do not respond to mechanical
stimulation (Klein et al., 1993). At birth, BDNF-1- mice are smaller in size than wild-
type, exhibit abnormal coordination of movement and balance, and most die within 2
weeks (Emfors et al., 1994a; Jones et al., 1994; Conover et al., 1995). DRG from BDNF
deficient animals are also smaller than normal and, as for trkB-1- mice, there is a loss of ,....,
30% of neurons over wild-type numbers (Emfors et al., 1994a; Jones et al., 1994). In
contrast, the appearance and gross behavior of NT-4-1- mice are similar to those of wild-
type at birth and, interestingly, these animals continue to survive and can produce viable
offspring (Conover et al., 1995; Liu et al., 1995; Erickson et al., 1996). Although at 2
months after birth there is no apparent difference in the number of trkB-positive neurons
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between NT-4-1- mutants and control animals, the former exhibit an '" 14% loss of L4
DRG neurons (Liu et al., 1995).
Double trk mutants generated through the intercrossing of single trk-I- mice also
show distinctive patterns of neuronal loss compared to wild-type, with the effect of the
double mutations apparently additive - roughly analogous to the combined neuronal
loss of the corresponding single trk mutants (Minichiello et al., 1995). The double
mutants trkA-1-/trkC-I-, trkA-1-/trkB-1-, and trkB-1-/trkC-I- exhibit 93% , 78%, and 41 % loss of
PI L4 DRG neurons, while the losses from trkA-1-, trkB-1-, and trkC-I- animals are 73%,
200/0, and 17%, respectively (Minichiello et al., 1995).
Mice with a targeted mutation in the ligand binding region ofp75 (p75-1-), and are
therefore presumed to lack functional receptors (Lee et al., 1992), allow for further
investigation into the biological role of neurotrophins in sensory neurons. The p75-1-
embryos are normal in appearance, and in contrast to the homozygous neurotrophin- and
trk-knockout mice (with the exception ofNT-4-1- animals), the mutation does not result
in neonatal lethality (Lee et al., 1992). Histological examination indicates that p75-1-
mice exhibit diminished sensory fiber innervation to skin; the reduction appears to
involve small diameter afferents, with fewer SP- and CGRP-positive fibers present in
mutant animals than in wild-type (Lee et al., 1992). In addition, these animals show
marked deficits in their ability to respond to noxious heat stimuli (Lee et al., 1992).
Also, the majority of p75-1- animals develop severe skin edemas and ulcerations; these
initially form in the extremities, progressing to more proximal regions, and ultimately
result in secondary infections and the loss of epidermis in the areas involved (Lee et al.,
1992).
2.2.2.1.4 Summary of Neurotrophin and Neurotrophin Receptor
Mutant Data
Germline-targeted mice, generated through rendering a
specific gene nonfunctional by targeted mutagenesis, provide the opportunity to identify
the biological roles of specific molecules in vivo (Gerlai, 1996), and studies of
neurotrophin- and neurotrophin receptor-knockout mutant animals have yielded
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interesting results (reviewed in: Klein, 1994; Snider, 1994; Conover and Yancopoulos,
1997).
All of the neurotrophin- and trk-knockout mice show an important similarity in
that all display neuronal abnormalities that tend to occur within definable subpopulations
of sensory neurons. NT-3-1-, NGF-1-, and BDNF-1- mice all exhibit specific severe
neurological deficits and early postnatal death (Crowley et al., 1994; Emfors et al.,
1994a, 1994b; Farinas et al., 1994, 1998; Jones et al., 1994; Tessarollo et al., 1994,
1997; Conover et al., 1995; Kucera et al., 1995b, 1998; Tojo et al., 1995; EIShamy and
Emfors, 1996; Liebl et al., 1997; Matsuo et al., 2000); NT-4/S-I- mutants do not die early
in development and although they have some neurological defects, these do not appear
to be as compromising as those of the other neurotrophin-knockout animals (Conover et
al., 1995; Liu et al., 1995; Erickson et al., 1996). Further, the data support unique roles
for the trks, since distinct from trkB-1- mutants (Klein et al., 1993; Minichiello et al.,
1995), trkC-I-- and trkA-1--knockout mice are able to feed normally; while unlike trkA-1-
animals (Smeyne et al., 1994; Minichiello et al., 1995; Silos-Santiago et al., 1995), trkC-
1- mutants are responsive to painful stimuli (Klein et al., 1994; Liebl et al., 1997;
Tessarollo et al., 1997). The data also demonstrate a relationship between the number of
surviving DRG neurons and the level of neurotrophin available, with numbers for NT-
3+1- (Emfors et al., 1994b; Airaksinen and Meyer, 1996; Krimm et al., 2000) and NGF+1-
(Crowley et al., 1994) animals intermediate between those of the homozygous mutant
counterparts and wild-type. In addition, experiments comparing numbers of DRG
neurons between double trk mutants and the corresponding single trk/-animals show that
the loss is roughly additive (Minichiello et al., 1995).
Despite the knowledge gained from these studies, there are negative aspects in
using knockout mice: Firstly, germline-targeted studies reflect the developmental
importance of the gene of interest and this may obscure its role in the adult animal.
Secondly, the alteration of one gene may result in the downstream alteration of a number
of other gene products in an attempt to compensate for the direct effect of the mutation
- these changes may ultimately be reflected in complex phenotypic modifications that
are unlike wild-type, and not related to the functioning of the selected mutant gene.
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Additionally, these studies do not allow for potential interactions between neurotrophin
species or between these molecules and other trophic factors (i.e. FGF, PDGF, CNTF;
see Section 1.1.1). Moreover, the use of knockout models that alter the tyrosine kinase
portion of trk, but retain the ligand-binding domain, still allows for a potentially
functional receptor, similar to a truncated isoform (see Section 1.1.2.1.1).
To more fully understand the biological role of the neurotrophins and their
receptors, data from the· knockout studies must be combined with that gleaned through
other means. This could include data from inducible gene targeting experiments wherein
the gene of interest may be switched on or off at defined stages during development or in
specific tissues; as well as from studies concerning the spatial and temporal expression
patterns of both the ligands and their receptors, from tissue culture experiments
characterizing the biological activities of the neurotrophins, and from the in vivo use of
neutralizing antibodies or other means to deplete and augment neurotrophin availability.
2.2.2.2 Biological Functions of Neurotrophin-3 in Primary Sensory
Neurons
NT-3 is an important neurotrophin during sensory neuron
development, as evidenced through targeted mutation studies (see Section 2.2.2.1).
While early in embryogenesis NT-3 and other trophic molecules have been shown to
promote the in vitro proliferation of neural crest cells, the progenitors of sensory neurons
(Kalcheim et al., 1992; reviewed in: Kalcheim, 1996) (see Section 2.1.1.1), it is during
gangliogenesis, at two distinct time points, that the presence of NT-3 appears critical to
normal development (Wright et al., 1992; Gaese et al., 1994; Tessarollo et al., 1994;
Oakley et al., 1995, 1997; EIShamy and Emfors, 1996; Farifias et al., 1996; Lefcort et
al., 1996; EIShamy et al., 1998; Zhou et al., 1998).
In E11111.5 mouse lumbar DRG, prior to the onset of target-dependent cell
death, practically all cells, including differentiated neurons express abundant trkC
mRNA (Lamballe et al., 1994; Phillips and Armanini, 1996; White et al., 1996) and
have the potential to access local sources of NT-3 (Schecterson and Bothwell, 1992;
Emfors et al., 1993; EIShamy and Emfors, 1996; Farifias et al., 1996; Tojo et al., 1996).
47
At this stage, NT-3 appears to increase the number of neurons, possibly through the
stimulation of progenitor cell differentiation (Wright et al., 1992; ElShamy and Emfors,
1996; Farinas et al., 1996; Lefcort et al., 1996; E1Shamy et al., 1998). Two approaches,
based on the use ofNT-3-1- mice and antiserum to trkC, have been employed to identify
the role of the neurotrophin at this stage of DRG development. The reported 70-80% loss
(see Section 2.2.2.1.1) of surviving primary sensory neurons in neonatal NT-3-1- mice
compared to wild-type animals (Farinas et al., 1994; Liebl et al., 1997; Tessarollo et al.,
1997) prompted several research groups to closely examine neuronal loss in these
animals at specific developmental time points. In DRG of NT-3-1- mice, the loss appears
to be due to an overall increase in neuronal apoptosis and an increase in neurogenesis
that results in the depletion of the precursor pool, and ultimately in reduced
differentiation of postmitotic neurons (E1Shamy and Emfors, 1996; Farinas et al., 1996;
E1Shamy et al., 1998). These observations suggest that in the early stages of DRG
formation NT-3 is a critical factor in precursor cell differentiation: the neurotrophin
promotes the formation of mature, postmitotic primary sensory neurons, with its absence
leading to precursor cell apoptosis (E1Shamy et al., 1998). In a second experimental
paradigm adapted to understand the role of NT-3 in DRG development, daily in ovo
injections of trkC antiserum were used to neutralize the receptor in situ. Beginning at the
time when neural crest cell migration was complete, the injections resulted in an almost
50% depletion in numbers of neurons compared to control (Lefcort et al., 1996). The
deficit was attributed to either a loss of neuronal precursors or of postmitotic neurons
(Lefcort et al., 1996), and the work serves to further underscore the importance ofNT-3
early in DRG development. In a seemingly contradictory study, early treatment of
chicken embryos with NT-3 resulted in a substantial decrease in the number of DRG
neurons compared to control (Ockel et al., 1996a, 1996b). The loss was not restricted to
any neuronal subtype and appeared to be due to a decrease in the number of proliferating
neuroblasts in treated embryos (Ockel et al., 1996a, 1996b). The reported neuronal loss
following NT-3 treatment may be attributed to the premature differentiation of neuronal
precursors which resulted in the inability of these cells to proliferate, hence a depleted
precursor pool, and, therefore, ultimately in reduced numbers ofneurons.
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Later in DRG development, during apoptosis and continuing postnatally, trkC
mRNA expression is limited to a subset ofneurons (Lamballe et al., 1994; Fariiias et al.,
1996; Phillips and Armanini, 1996; White et al., 1996), and it is during this period of
cell death that the influence of NT-3 appears to be restricted to the trkC-positive
subpopulation (Gaese et al., 1994; Tessarollo et al., 1994; Oakley et al., 1995, 1997;
Zhou et al., 1998). These neurons may have access to ganglion-derived NT-3
(Yamamoto et al., 1996; Zhou et al., 1999a), but the principal source seems to be
provided by target tissues (see Section 2.2.1). The use of a monoclonal antibody to block
the biological activity ofNT-3 during the completion of gangliogenesis in quail sensory
DRG has been shown to result in an '" 30% reduction in the number of neurons (Gaese et
al., 1994). Likewise, in neonatal rat, administration of anti-NT-3 for 2 weeks effected the
loss of a subset of large diameter DRG neurons, representing '" 20% of the total
population (Zhou et al., 1998). Interestingly, also in neonatal animals, when the majority
of primary sensory neurons have made contact with target tissues, the role of NT-3 is
further limited, with this neurotrophin no longer being necessary for their survival
(Memberg and Hall, 1995).
Experiments involving the use of NT-3, anti-NT-3, and NT-3-1- mice have
identified the functional subset of neurons most affected by the neurotrophin prior to
target innervation (Tessarollo et al., 1994; Oakley et al., 1995, 1997; Zhou et al., 1998).
For example, injection of anti-NT-3, to deplete the neurotrophin from peripheral tissues
during apoptosis in embryonic chicken DRG, resulted in decreased numbers of muscle
spindle afferents; the survival of cutaneous sensory neurons and motoneurons did not
seem to be affected (Oakley et al., 1995). In addition, the use of a fluorescent marker to
retrogradely label sensory and motor neurons of skin and axial muscle in wild-type and
NT-3-1- mice showed that, unlike wild-type, mutant animals lack demonstrable muscle
spindle (Ia) afferents (Tessarollo et al., 1994). That cutaneous afferents appeared normal
is indicative of a selective loss of proprioceptive neurons in NT-3-1- mice (Tessarollo et
al., 1994). Further, the removal of a limb bud early in chicken development, which
eliminates'" 90% of ipsilateral trkC-positive DRG neurons, followed by daily treatments
of the embryo with NT-3 late in apoptosis, resulted in the rescue of Ia afferents despite
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the lack of other limb-derived signals (Oakley et al., 1997). The NT-3 induced effect
appeared to be specific, since treatment with the neurotrophin reestablished the normal
number of trkC-expressing neurons, whereas there was no difference in the number of
trkA- or trkB-positive cells between experimental and control animals (Oakley et al.,
1997). These findings, in conjunction with data from gene-target based experiments (see
Section 2.2.2.1), point towards the importance of NT-3 in supporting proprioception.
Further, in experiments that utilized two different fluorescent markers to label neurons
innervating chick skin and muscle, and where these cells were subsequently cultured,
NT-3 was found to promote the survival of almost twice as many muscle sensory
afferents than NGF (Hory-Lee et al., 1993). Conversely, NGF supported double the
number of cutaneous sensory neurons (Hory-Lee et al., 1993). Interestingly, even though
these data indicate a bias towards the ability of specific neurotrophins to effect the
viability of specific neuronal populations as defined by target tissues, the work also
shows that exogenous NT-3 is able to sustain a subset of cutaneous sensory neurons
(Hory-Lee et al., 1993). An in vivo study yielded similar findings (Oakley et al., 2000).
Moreover, in adult rat, although trkC mRNA was detected in 73% of DRG neurons
projecting to gastrocnemius muscle, 17% of cutaneous afferents (saphenous nerve) and a
small subgroup of visceral afferents expressed transcripts for the receptor (McMahon et
al., 1994). In another study on adult rat, while 30% of DRG neurons projecting to tibial
muscle were shown to exhibit NT-3-ir, additional sensory neurons displaying NT-3-ir
projected to tendon, whisker hair follicles, subdermis/epidermis, and kidney (39%, 50%,
17%, and 1%, respectively) (Zhou and Rush, 1995). NT-3 is also critical to the normal
development of at least two mechanoreceptor subtypes - D-hair receptors and Merkel
cell touch domes (Airaksinen et al., 1996; Fundin et al., 1997b; Rice et al., 1998; Zhou
et al., 1998). Thus, although many NT-3 responsive DRG neurons subserve
proprioception, there are also cutaneous afferents, specifically subtypes of
mechanoceptors, that depend on the neurotrophin.
In addition to supporting the survival of proprioceptive neurons and the
development of at least two mechanoceptor subtypes, NT-3 has been shown to modulate
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aspects of sensory neuron phenotype, affect neurite outgrowth/regeneration, and to have
the potential to influence sensory neuropathies.
Several studies have examined the role of NT-3 in regulating neuropeptide
expression in DRG neurons. In one experiment on adult rats, a silicone reservoir
containing saline or NT-3 was attached for 3 weeks to the proximal transected sciatic
nerve stump and the level of NPY in DRG neurons was compared between the two
treatments (Ohara et al., 1995). Exposure to the neurotrophin resulted in a reduction in
the number of NPY-ir neurons and decreased staining intensities for the neuropeptide
(Ohara et al., 1995). Further, radioimmumoassays demonstrated that there was a 36%
reduction in NPY protein levels (Ohara et al., 1995). Similarly, animals with
entubulated, NT-3 impregnated fibronectin mats grafted between the proximal and distal
ends oftransected and resected sciatic nerve showed an'" 45% decrease in the number of
NPY-ir LiLs DRG neurons compared to control (fibronectin mats not exposed to NT-3)
30 days post-injury (Sterne et al., 1998). This treatment with NT-3 did not appear to
alter SP, CGRP, or VIP levels (Sterne et al., 1998). Nor was SP expression in DRG
neurons affected after direct application ofNT-3 to axotomized sciatic nerve, although a
combined exposure to NT-3 and BDNF counteracted the injury-induced reduction in SP
(Zhang et al., 1995a). Moreover, neither SP, CGRP, VIP, nor SOM protein levels were
found to be significantly changed following the treatment of adult rat DRG cultures with
NT-3 (Mulderry, 1994). In general, given the size ranges ofDRG neurons in which these
neuropeptides are principally expressed compared to that of the trkC-positive
subpopulation, these results are not necessarily unexpected.
SP and CGRP are normally associated with nociception (Klein et al., 1992;
Mense et al., 1994; Wiesenfeld-Hallin et al., 1994; Neumann et al., 1996; Cao et al.,
1998; De Felipe et al., 1998; Parker and Grillner, 1998; Nichols et al., 1999; Bennett et
al., 2000a; Zhang et al., 2001) and both are expressed in normal adult animals. Between
17-30% of DRG neurons are reported to exhibit SP transcripts and/or protein (Boehmer
et al., 1989; Bergman et al., 1996; Ji et al., 1996; Hall et al., 1997; Ma and Bisby,
1998b); their perikarya are primarily small in size (Wiesenfeld-Hallin et al., 1984;
Dalsgaard et al., 1985; Skofitsch and Jacobowitz, 1985; Ju et al., 1987; Boehmer et al.,
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1989; McCarthy and Lawson, 1989; Anand et al., 1991; Villar et al., 1991; Noguchi et
al., 1994; 1995; Verge et al., 1995; Bergman et al., 1996). CGRP mRNA and protein
have been identified in neurons of all sizes (Rosenfeld et al., 1983; Ju et al., 1987;
Noguchi et al., 1990a, 1990b; Nothias et al., 1993; Verge et al., 1995), representing 35-
500/0 of the total DRG population (Ju et al., 1987; McCarthy and Lawson, 1989; Nothias
et al., 1993; Zhou et al., 1993; Minichiello et al., 1995; Bergman et al., 1996; Groves et
al., 1996; Kashiba et al., 1997a). The two peptides colocalize in a large subset of adult
rat DRG neurons (Wiesenfeld-Hallin et al., 1984; Skofitsch and Jacobowitz, 1985;
Gibbins et al., 1987; Ju et al., 1987; Villar et al., 1989), and virtually all SP- and most
CGRP-positive cells also display high-affinity NGF binding sites (Verge et al., 1989a).
NGF has been shown to upregu1ate protein and message levels of both peptides (Kessler
and Black, 1980; Otten et al., 1980; Otten and Lorez, 1982; Fitzgerald et al., 1985;
Lindsay and Harmer, 1989; Inaishi et al., 1992; Verge et al., 1995; Ji et al., 1996) and,
because r-J 50% of trkA-positive neurons also coexpress trkC (Karchewski et al., 1999),
one might have expected NT-3 to have the potential to modulate SP and/or CGRP levels.
Moreover, even though protein and mRNA levels of both markers decrease after nerve
injury (Jessell et al., 1979; Tessler et al., 1985; Shehab and Atkinson, 1986; Villar et al.,
1989, 1991; Noguchi et al., 1990b, 1993, 1994, 1995; Klein et al., 1991; Inaishi et al.,
1992; Hokfe1t et al., 1993; Verge et al., 1995; Groves et al., 1996; Ji et al., 1996; Ma
and Bisby, 1998a, 1998b), SP expression appears to be induced in a relatively small
subpopu1ation of medium to large diameter neurons (Noguchi et al., 1994, 1995; Ji et
al., 1996; Ma and Bisby, 1998b). These cells project to the gracile nucleus (Noguchi et
al., 1995), part of the posterior column-medial lemniscus pathway, the principal
ascending tract conveying proprioceptive information, and therefore may be responsive
to NT-3 (see Section 2.2.2.1). In addition, while the majority of SP-positive DRG
neurons are lacking in trkA-1- mice, a subset of SP-expressing, apparently trkA-
independent neurons is present (Minichiello et al., 1995). At least a portion of this group
of neurons appear to be trkC-dependent, since there are fewer of them in trkA-1-/trkC-I-
mice than in trkA-1., trkC-I-, trkA-1-/trkB-1-, trkB-1-/trkC-I-, or wild-type animals (Minichiello
et al., 1995). CGRP does not appear to be dependent on trkC, as the expression of this
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neuropeptide is identical in wild-type and trkC-I- mice (Minichiello et al., 1995). On the
other hand, CGRP is not present in trkA-l - animals, or in trkA-1-/trkB-l - and trkA-I-/trkC-I-
mice (Minichiello et al., 1995). VIP and NPY are rarely expressed in DRG neurons of
normal animals (Ju et al., 1987; Noguchi et al., 1993; Zhang et al., 1993a; Ohara et al.,
1994; Verge et al., 1995; Comess et al., 1996; Ji et al., 1996; Thompson et al., 1998b; Li
et al., 1999b; Landry et ai., 2000), but after nerve injury VIP is detectable in many
small- to medium-sized cells (Ju et al., 1987; Noguchi et al., 1993; Zhang et al., 1993a;
Ohara et al., 1994; Verge et al., 1995) while many large and some medium diameter
neurons exhibit NPY mRNA and protein (Wakisaka et al., 1991, 1992; Noguchi et al.,
1993; Zhang et al., 1993a; Ohara et al., 1994; Verge et al., 1995; Comess et al., 1996;
Thompson et al., 1998b; Cougnon-Aptel et al., 1999; Li et al., 1999b; Shi et al., 1999;
Landry et al., 2000). Again, given the predominant somal size distributions of neurons
expressing these neuropeptides, the NPY-positive subpopulation would be the most
likely to be responsive to NT-3.
Another regulatory peptide, pituitary adenylate cyclase-activating polypeptide
(PACAP), believed to function in neuronal survival, regeneration, and nociception
(Morio et al., 1996; Campard et al., 1997; Lioudyno et al., 1998), is also influenced by
NT-3 (Jongsma Wallin et al., 2001). In adult rat, under normal conditions, 25-30% of
L4- L6 DRG neurons display PACAP-ir (Zhang et al., 1996; Jongsma et al., 2000), while
~ 50% of neurons express detectable PACAP mRNA (Jongsma Wallin et al., 2001). The
soma of the majority of PACAP-positive neurons are of small diameter and are heavily
labeled for the neuropeptide (Zhang et al., 1996; Jongsma et al., 2000; Jongsma Wallin
et al., 2001). Sciatic nerve transection results in increased numbers of neurons exhibiting
PACAP mRNA (- 85%) (Jongsma Wallin et al., 2001) and protein (50-60%) (Zhang et
al., 1996; Jongsma et al., 2000). This subset now includes many medium and some large
diameter cells (Zhang et al., 1996; Jongsma et al., 2000; Jongsma Wallin et al., 2001),
although the small PACAP-positive perikarya display reduced levels of hybridization
signal compared to uninjured neurons (Jongsma Wallin et al., 2001). A 1 week
intrathecal infusion of NT-3, 2 weeks after axotomy resulted in lowered levels of
PACAP hybridization signal, and an ~ 20% reduction in the total number of PACAP-
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positive neurons compared to DRG from axotomized, non-infused animals (Jongsma
Wallin et aI., 2001). These results are not necessarily surprising since ---- 25% of DRG
neurons, representing ---- 500/0 of trkC-positive cells, were shown to coexpress PACAP
and trkC mRNAs; these cells rarely exhibited the neuropeptide at moderate or high
levels (Jongsma Wallin et aI., 2001). Post-axotomy, levels of trkC mRNA decreased,
although the proportion of trkC-positive neurons remained similar to control values;
conversely, PACAP mRNA levels were elevated following injury, and the neuropeptide
was detected in most trkC-expressing neurons (Jongsma Wallin et aI., 2001). What is
surprising is that the infusion of NT-3 reversed injury-induced message levels of the
neuropeptide in both the trkC-positive and trkC-negative subpopulations, albeit most
strongly in the former group (Jongsma Wallin et al., 2001). Also of note, NT-3 infusion
in normal, non-axotomized animals resulted in both decreased levels of PACAP mRNA
and in an ---- 400/0 loss ofPACAP-expressing neurons (Jongsma Wallin et aI., 2001). This
NT-3 effected depression ofPACAP signal levels appeared to occur in both neurons that
expressed trkC and in those that lacked detectable trkC transcripts, but was most evident
in the subset of trkA-positive/trkC-negative cells - those that normally express the
highest levels of the neuropeptide (Jongsma Wallin et al., 2001).
NT-3 has also been shown to be a potential regulator of calcium-binding
proteins, including parvalbumin, calbindin, and calretinin (Copray et al., 1994; Friedel et
al., 1997; Zhou et al., 1998), which serve to restrict, redistribute, and reestablish
physiological intracellular calcium levels (reviewed in: Miller, 1991, 1992; Bainbridge
et al., 1992). These proteins are expressed by subsets of DRG neurons (Carr et al.,
1989a, 1989b; Rogers, 1989; Antal et al., 1990; Celio et al., 1990; Zhang et al., 1990;
Duc et al., 1993b, 1994; Ichikawa et al., 1993, 1994, 1999, 2000; Kiraly et al., 1993;
Copray et al., 1994; Ambrus et al., 1998; !ino et al., 1998) and are efficient regulators of
calcium-dependent activity within these subpopulations (Chard et al., 1993). Calbindin-,
parvalbumin-, and calretinin-ir are present in 22% (Carr et al., 1989b), ---- 15% (Carr et
al., 1989b), and less than 8% (Ambrus et al., 1998) of rat DRG neurons respectively, and
all of these markers predominately label large diameter perikarya (Carr et al., 1989b;
Antal et al., 1990; Duc et al., 1993b, 1994; Ichikawa et al., 1993, 1994; Kiraly et al.,
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1993). These three calcium-binding proteins exhibit distinct and overlapping
distributions among DRG neurons (Carr et al., 1989b; Rogers, 1989; Duc et al., 1993b,
1994; Copray et al., 1994; Ichikawa et al., 1994): calbindin-ir and calretinin-ir
frequently colocalize in large diameter cells (Rogers, 1989; Duc et al., 1994), and,
similarly, virtually all neurons that display parvalbumin-ir are also calbindin-positive
(Carr et al., 1989b; Ichikawa et al., 1994). Only -- 30% of parvalbumin-ir neurons also
coexpress calretinin-ir, but -- 70% of calretinin-positive cells exhibit parvalbumin-ir; the
soma of the former subgroup are large in size, while small calretinin-ir neurons are
parvalbumin-negative (Ichikawa et al., 1994). Further, most calretinin-positive neurons
are also calbindin-positive (Duc et al., 1993b, 1994). All three markers have putative
roles in mechanoeceptors, including proprioceptors (Duc et al., 1993a, 1994; Ichikawa et
al., 1999). Several lines of evidence point to the ability of NT-3 to regulate levels of
calcium-binding proteins. In one experiment, the injection of anti-NT-3 for 2 weeks in
postnatal rats, to neutralize endogenous NT-3 late in sensory development, resulted in
decreased levels of calbindin- and calretinin-ir and reduced numbers of parvalbumin-ir
DRG neurons compared to control (Zhou et al., 1998). In another study, where
dissociated E16 rat DRG neurons were cultured in the presence ofneurotrophins, -- 750/0
of cells displayed parvalbumin-ir following NT-3 treatment, while less than 10% were
positive for parvalbumin after exposure to NGF or BDNF (Copray et al., 1994). In
addition, embryonic DRG explants exposed to exogenous NT-3 showed significantly
higher levels of parvalbumin and calretinin transcripts compared to those treated with
NGF (Friedel et al., 1997). The importance ofNT-3 to parvalbumin expression is further
demonstrated by the lack of detectable immunoreactivity for this marker in DRG of NT-
3-1- mice (Emfors et al., 1994b). In contrast, the expression of the others may be
independent, or less dependent on NT-3, given the presence of calretinin-ir in primary
sensory neurons of NT-3-1- animals (Airaksinen and Meyer, 1996). Moreover, in
dissociated embryonic DRG cultures treated with NGF, BDNF, or NT-3, all three
neurotrophins supported survival and neurite outgrowth in similar percentages (10-170/0)
of calretinin- and calbindin-ir neurons (Copray et al., 1994). That calbindin,
parvalbumin, and calretinin are at least somewhat influenced by NT-3 is not surprising,
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given that these markers label subsets of neurons similar in perikaryal size and in
sensory function to the trkC-positive subpopulation.
The expression of two other markers, GAP-43 and Tal a-tubulin, have been
shown to be modulated by NT-3 (Mohiuddin et al., 1995). GAP-43 (B-50, FI, pp46,
pp57, neuromodulin), a protein associated with axonal growth and regeneration
(reviewed in: De Graan et al., 1986; Basi et al., 1987; Benowitz and Routtenberg, 1987;
Skene, 1989), is abundantly expressed during development (Jacobson et al., 1986; Basi
et al., 1987; Karns et al., 1987); levels decline postnatally (Hoffman, 1989), but are
upregulated after injury and remain high during regeneration (Skene and Willard, 1981;
Hoffman, 1989; Tetzlaff et al., 1989; Verge et al., 1990b; Wiese et al., 1992; Schreyer
and Skene, 1993; Groves et al., 1996; Verkade et al., 1996). In adult rat lumbar DRG,
under normal conditions, a subset of primarily small neurons exhibit GAP-43 mRNA
and/or protein, representing 40-70% of the total population (Verge et al., 1990b;
Schreyer and Skene, 1993; Liabotis and Schreyer, 1995; Groves et al., 1996; Andersen
and Schreyer, 1999). Axotomy results in a dramatic upregulation of GAP-43, with
virtually all axotomized neurons now exhibiting it at detectable levels (Hoffman, 1989;
Verge et al., 1990b; Tetzlaff et al., 1992; Wiese et al., 1992; Schreyer and Skene, 1993;
Liabotis and Schreyer, 1995; Andersen and Schreyer, 1999). Like GAP-43, Tal a-
tubulin, a tubulin isotype, is also expressed in rat at high levels during growth and
following injury in developing and mature neurons (Miller et al., 1987, 1989, 1991;
Mathew and Miller, 1990, 1993; Ma et al., 1992; Wu et al., 1993). In an in vitro study
on dissociated cultures of adult rat DRG neurons, NT-3 (10 ng/ml) treatment increased
message levels for GAP-43 by over 2 fold and Tal a-tubulin by over 3 fold (Mohiuddin
et al., 1995). Interestingly, exposing the neurons to higher concentrations of NT-3 (50
ng/ml) resulted in mRNA levels for these markers being only slightly higher than those
seen in untreated cultures (Mohiuddin et al., 1995).
The ability of the neurotrophin to modulate GAP-43 and Tal a-tubulin suggests
that NT-3 may not only be important in maintaining or regulating aspects of neuronal
phenotype, but that it may also playa significant role in axonal growth and regeneration.
Indeed, in the study described above, exogenous NT-3 was shown to enhance neurite
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outgrowth in a subset of neurons with large diameter soma, although the degree of NT-3
induced outgrowth was greater at 10 ng/ml than at 50 ng/ml (Mohiuddin et al., 1995).
Similarly, exogenous NT-3 has been demonstrated to increase neurite outgrowth in
cultures of developing sensory neurons (Maisonpierre et al., 1990a; Lentz et al., 1999).
Despite these findings, the role of NT-3 in promoting neurite extension, as in its
regulation of GAP-43 and Tal a-tubulin levels (Mohiuddin et al., 1995), seems to be
more complex. In utero injection of rat embryos with NT-3 appeared to either have no
influence on or to inhibit axonal growth, depending on the developmental stage of the
animal (Zhang et al., 1994a). The degree ofprojection of Ia afferent axons into the spinal
cord of embryos injected with NT-3 at E14 and E15, and then sacrificed at E16, was --
50% less than that of control animals (Zhang et al., 1994a). In animals treated with the
neurotrophin at E15 and E17, and then sacrificed at E19, NT-3 did not appear to
influence Ia axonal projections into the spinal cord (Zhang et al., 1994a). A significant
difference between the two developmental stages may be that in the rat at E14, unlike
E15, the Ia afferent axons have not yet penetrated the spinal cord grey matter (Snider et
al., 1992; Zhang et al., 1994a), although the potential importance of this to the ability of
NT-3 to modulate axonal growth is unclear. Exogenous NT-3 (50 ng/ml) also supported
increased axonal growth in adult mouse LiL5 DRG explant cultures (Edstrom et al.,
1996), but the addition of NT-3 (1, 10, or 100 ng/ml) to the distal portion of
compartmentalized cultures of adult rat DRG neurons failed to induce neurite outgrowth
(Kimpinski et al., 1997). Neither did the treatment of parallel cultures with both NT-3
and NGF alter the growth-inducing effects of NGF alone (Kimpinski et al., 1997).
Likewise, NT-3 treatment of cultures of dissociated adult rat lumbar DRG neurons did
not appear to influence axonal growth, although this research group found that
cotreatment with NT-3 and NGF partially blocked NGF-enhanced neurite outgrowth
(Gavazzi et al., 1999). Together, these data indicate that although NT-3 can influence
axonal growth - in a positive or negative manner, or not at all - the effect may be
influenced by the concentration of the neurotrophin, the means ofneurotrophin delivery,
the presence of additional neurotrophic factors, and/or the level ofmaturity of the neuron
at the time ofneurotrophin exposure.
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An increasing number of studies provide evidence for a role for NT-3 following
injury of sensory neurons. In adult rat, spinal nerve transection results in the death of a
significant number of DRG neurons, but treatment with NT-3 post-axotomy, whether
through intrathecal infusion (Ljunberg et al., 1999) or a reservoir attached to the
proximal nerve stump (Groves et al., 1999), dramatically reduced neuron loss. Similarly,
delivery of NT-3 to lesioned spinal cord reversed injury-induced cell atrophy and
substantially increased the number of surviving neurons compared to control (Bradbury
et al., 1998). Moreover, NT-3 appears to support peripheral nerve regeneration. In adult
rats, entubulated fibronectin mats impregnated with NT-3 (500 ng/ml) grafted to
resected sciatic nerve supported the regeneration of significantly more myelinated axons
than control, nonimpregnated mat grafts, even after 8 months post-insertion (Sterne et
al., 1997a).
Peripheral axotomy also alters the conduction velocities of injured neurons;
transection of the tibial nerve resulted in a progressive reduction in axonal conduction
velocities at 1, 3, and 5 weeks post-injury (Munson et al., 1997). Delayed infusion of
NT-3 to the proximal nerve stump mitigated axotomy-induced changes in conduction
velocities, but the effect was dose dependent (Munson et al., 1997). A 2 week infusion
of 6 Jlg/day 3 weeks post-transection had no significant consequence, whereas similar
treatment with 60 Jlg/day reestablished conduction velocity values intermediate between
those of uninjured and 5 week axotomized axons (Munson et al., 1997). Moreover,
conduction velocities in axons of animals treated with NT-3 for 4 weeks (60 Jlg/d), 1
week after nerve injury were similar to, or higher than, those recorded 1 week post-
transection in untreated animals (Munson et al., 1997). In addition, a 2 week infusion of
trkC-IgG (60 Jlg/d) into muscle, to sequester endogenous NT-3 in target tissue, reflected
the axotomy-induced effect of lowering axonal conduction velocities of sensory neurons
(Munson et al., 1997).
Another injury-induced change following peripheral axotomy is the sprouting of
at least a subset ofA~ sensory fibers into laminae I and II of the spinal cord dorsal hom
(Woolf et al., 1992a; Shortland and Woolf, 1993; Bennett et al., 1996b, 1998; Eriksson
et al., 1997; White, 1997b, 1998, 2000). In uninjured animals, the central axons of A~
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neurons project to laminae III and IV (Shortland et al., 1989), whereas nociceptive
neurons normally terminate in lamina II (Sugiura et al., 1986). The post-trauma
sprouting of the Ap fibers is important since if they can form functional synapses in
lamina II then these neurons might playa role in nerve injury-induced hyperalgesia
(Woolf et at., 1992a). Because Ap fibers are potentially responsive to NT-3 (see above
and Sections 2.1.1.2, 2.2.2.1.1, 2.2.2.1.2) several research groups investigated whether
exogenous NT-3 could prevent their sprouting (Bennett et al., 1996b; Eriksson et al.,
1997; White, 1997b, 1998). Neither a capsule containing NT-3 (27 f.lg) implanted in
juxtaposition to the transected sciatic nerve (Eriksson et al., 1997) nor intrathecal
infusion of the neurotrophin (1 mg/ml, 14 d) (Bennett et al., 1996b) prevented or
reduced the trauma-induced sprouting. In contrast, intrathecal infusion ofNT-3 antisense
oligonucleotide appeared to attenuate the Ap fiber sprouting (White, 2000). Moreover,
intrathecal infusion of NT-3 (200 ngjd, 14 d) in normal, uninjured rats mirrored the
Ap fiber trauma-induced sprouting into lamina II, albeit to a lesser degree (White,
1997b, 1998). Further, NT-3 infusion also decreased the mechanical nociceptive
threshold in uninjured animals (White, 1997b, 1998), whereas the infusion of NT-3
antisense oligonucleotide had an analgesic effect (White, 2000). Both of these NT-3
effected changes in uninjured animals might occur through NPY, because the
neuropeptide induces neurite outgrowth in vitro (White and Mansfield, 1996; White,
1997b, 1998) which is attenuated by anti-NT-3 (White, 1997b, 1998) and because
treatment with exogenous NPY exacerbates injury-induced mechanical hyperalgesia
(White, 1997a). These data are not supported by the reports that exogenous NT-3
downregulates NPY mRNA and protein in vivo (see above) (Ohara et al., 1995; Sterne et
al., 1998). Interestingly, unlike after NT-3 treatment, aberrant Ap fiber sprouting was
significantly reduced by NGF (Bennett et at., 1996b; Eriksson et al., 1997). However the
effect appeared to be both dose dependent and to decrease over time: 8 days post-injury
the level of sprouting was greatly reduced with both 6 f.lg and 24 Jlg encapsulated NGF,
but by day 16, sprouting in animals with lower dose NGF appeared similar to control
(cytochrome C) and 33 days after capsule implantation, Ap fiber sprouting under both
NGF treatments was indistinguishable from control (Eriksson et at., 1997). If the
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Af3 sprouting into laminae I and II is induced by NPY (White and Mansfield, 1996;
White, 1997b, 1998), then the capacity ofNGF to reduce the injury-associated sprouting
(Bennett et al., 1996b; Eriksson et al., 1997) may be due to the ability of NGF to
mitigate axotomy-induced levels of the neuropeptide (Verge et al., 1995). On the other
hand, collateral sprouting of nociceptive DRG neurons requires NGF; removal of the
neurotrophin stops both collateral sprouting and axonal elongation (Diamond et al.,
1992a; Mearow and Kril, 1995). Also of interest is that glial cell line-derived
neurotrophic factor (GDNF) (Lin et al., 1993, 1994) has been shown to prevent the
injury-induced Af3 fiber sprouting into lamina II (Bennett et al., 1998).
The CNS, unlike the PNS, appears to be an unfavorable environment for axonal
regeneration but, in spite of this, the difficulties may be overcome, at least to some
degree, under certain experimental conditions (McQuarrie, 1973; McQuarrie et al., 1977,
1978; Oblinger and Lasek, 1984; Richardson and Issa, 1984; Bunge et al., 1986, 1989;
Richardson and Verge, 1987; Schnell and Schwab, 1990, 1993; Lu and Richardson,
1991; Bajrovic et al., 1994; Midha et al., 1994; Tuszynski and Gage, 1995; Cheng et al.,
1996; Torigoe et al., 1996; Bradbury et al., 1999; Neumann and Woolf, 1999; Oudega
and Hagg, 1999; Ramer et al., 2000; reviewed in: Fawcett and Keynes, 1990; Schwab,
1990; Richardson, 1991; Schwab and Bartholdi, 1996; Young, 1996). Of relevance here,
is the recent finding that NT-3 can support the regrowth of injured dorsal root axons into
the spinal cord of adult rats (Zhang et al., 1998; Ramer et al., 2000). Delayed injection
of adenoviral vectors containing the genes for NT-3 or LacZ (control) into the spinal
cord ventral hom of animals with axotomized dorsal roots resulted in a significant
increase in the number ofaxons that regenerated into the spinal cord, but only in those
with the introduced NT-3 gene (Zhang et al., 1998). Similarly, but in a different
experimental model, immediate intrathecal infusion of NT-3 (500 ng/h, 7 d) promoted
the regrowth of injured dorsal root axons into the spinal cord (Ramer et al., 2000). The
effect was selective, with NT-3 favoring regeneration of large diameter sensory fibers
and a subset of small, non-peptidergic neurons (Ramer et al., 2000). Significantly, in this
study, 4 weeks after axotomy of the central axons of these neurons and the initiation of
NT-3 infusion, experimental animals exhibited some functional recovery, since
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peripheral nerve stimulation evoked a modest postsynaptic potential, although NT-3
treatment did not influence the responsiveness of these animals to noxious mechanical
and thermal stimuli (Ramer et al., 2000). Further, NT-3 treatment also promoted sensory
axon regeneration within ascending pathways after spinal cord injury, but again
apparently in only a subset of injured neurons (Bradbury et al., 1999; Oudega and Hagg,
1999).
In order to determine potential clinical relevance of the neurotrophins, their
efficacy has been tested in several laboratory animal models of sensory neuropathies
(reviewed in: McMahon and Priestly, 1995; Anand, 1996; McMahon, 1996; Tomlinson
et al., 1996; Woolf, 1996). Given the reported size distribution of trkC-positive DRG
neurons (see Section 2.1.1.2), the functional population responsive to NT-3 (see above
and Sections 2.2.2.1.1, 2.2.2.1.2), and the ability ofNT-3 to partially reverse axotomy-
induced changes in injured primary sensory neurons (see above), one might expect NT-3
to have clinical applications. Recently, a number of studies have shown this to be the
case (Gao et al., 1995; Rodriguez-Pena et al., 1995; Tomlinson et al., 1996, 1997;
Helgren et al., 1997; Femyhough et al., 1998; Mizisin et al., 1998). Experimentally-
induced large fiber sensory neuropathy is evidenced by the degeneration of large
diameter DRG neurons, decreased axonal conduction velocities, and a concomitant
deficit in proprioception and the capacity to detect vibration. Treatment with NT-3
appears to prevent or reverse nerve fiber degeneration, restore axonal conduction
velocities, and attenuate the behavioral deficits (Gao et al., 1995; Helgren et al., 1997;
Mizisin et al., 1998). NT-3 has also been shown to be influential in treating
experimentally-induced diabetes (Rodriguez-Pena et al., 1995; Tomlinson et al., 1996,
1997; Femyhough et al., 1998). Although NGF is the principal neurotrophin used to
treat induced diabetes, one component of diabetic neuropathy appears to involve the NT-
3 responsive subpopulation of primary sensory neurons (reviewed in: Anand, 1996;
Tomlinson et al., 1996). Induction of diabetes significantly reduces NT-3 mRNA levels
in nerve (Rodriguez-Pena et al., 1995), as well as in muscle, the primary target of many
large fiber DRG neurons (Tomlinson et al., 1996, 1997; Femyhough et al., 1998), but
administration of insulin restores NT-3 mRNA levels (Tomlinson et al., 1996, 1997;
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Femyhough et al., 1998) and treatment with NT-3 counteracts the diabetic-induced
reduction in axonal conduction velocities (Tomlinson et al., 1997).
In summary, although NT-3 responsive DRG neurons project primarily to
muscle, they also innervate skin and viscera, and the neurotrophin appears critical to the
survival and/or normal development of proprioceptors and several other subtypes of
mechanoceptors. Further, the apparent ability of NT-3 after injury to increase neuronal
survival, effect regeneration, restore reduced conduction velocities, and to mitigate
axotomy-induced NPY and PACAP levels points to an important role for the
neurotrophin in the maintenance of normal neuronal phenotype and as a potential
therapeutic molecule, for at least a subpopulation ofDRG neurons.
62
3. MATERIALS AND METHODS
3.1 Surgery
All surgical procedures, with the exception of perfusions, were perfonned by Dr.
V. M. K. Verge and were conducted in accordance with the animal care guidelines of the
University of Saskatchewan under protocol number 9200164. Over the course of this
project, 112 animals were sacrificed.
3.1.1 Axotomy
Adult Wistar rats (150-200 g) were anesthetized by intraperitoneal
injection of sodium pentobarbital (50 mg/kg). The analgesic buprenorphine (0.1-0.2
mg/kg) was injected just prior to surgery, and then every 12 hours for 2-3 days. The right
leg, from pelvis to knee joint, of each animal was shaved and the area wiped with 700/0
(v/v) ethanol. An incision was made lateral to the midline of the vertebral column, 5 mm
caudal and 15 mm rostral to the right iliac crest, and a portion of the crest was rongeured
to expose the sciatic nerve. The nerve was then transected with microscissors at its origin
from the L4 and Ls spinal nerves; a 5 mm segment was resected to prevent nerve
regeneration. Transections at this level should result in the axotomy of greater than 95%
of Ls DRG neurons (Swett et al., 1991). Axotomies were perfonned on a total of 76
animals.
3.1.2 Mini-Osmotic Pumps
3.1.2.1 Pump Preparation and Assembly
3.1.2.1.1 Preparation of Pump Catheters
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Two sizes of silicone tubing were used to make pump
catheters: 0.635 mm inner diameter X 1.194 mm outer diameter and 0.305 rom inner
diameter X 0.635 mm outer diameter (Silastic brand medical grade silicone tubing; Dow
Coming Corp., Midland, MI). A razor blade was used to cut the larger diameter tubing
into 0.8 cm lengths and the smaller diameter tubing into 3 cm segments. For each
catheter unit, one end of the smaller diameter tubing was beveled. This end was inserted
into a length of the larger diameter tubing, such that the lumen of the smaller was fully
ensheathed within the larger. Silicone glue (non-sterile Silastic brand medical adhesive,
silicone type A; Dow Coming Corp.) was applied around this joint and the unit was left
to dry. The catheters were then placed between two pieces of thin cardboard, wrapped in
foil, and autoclaved prior to pump assembly.
3.1.2.1.2 Pump Filling and Assembly
Mini-osmotic pumps (Alzat model 2001; output of 1
Jlllhour for 7 days; Alza Pharmaceuticals, Palo Alto, CA) were filled and assembled
under aseptic conditions 12-18 hours prior to implantation. Initial experiments were
conducted by Regeneron Pharmaceuticals (Tarrytown, NY), and then by this laboratory,
using 300 ng NT-3/JlI of vehicle. These experiments involved a total of29 animals (16:
Regeneron Pharmaceuticals; 13: Univ. Saskatchewan) and showed that to achieve
consistent results a higher concentration of the neurotrophin was needed. It was decided
that the pumps should contain a working concentration of600 ng NT-3IJlI ofvehicle.
Stock recombinant methionyl human NT-3 (1.1 ml aliquots of 1 mglml in sterile
distilled water, stored at -70°C; Regeneron Pharmaceuticals) was thawed on ice; the
required volume was removed and diluted with sterile 2X vehicle (see below) to a
working concentration of 600 ng/Jll. The volume ofNT-3 needed was calculated based
on using 300 Jll of diluted solution for each pump. Any remaining NT-3 stock was
returned to the freezer, but on each occasion that pumps were prepared, a fresh aliquot of
stock was used. To prepare 2X vehicle, 2 mg/ml rat serum albumin (Fraction V; Sigma
Chemical Co., St. Louis, MO) and 20 Jlllmi penicillin/streptomycin (103 U/ml penicillin
G sodium with 103 Jlg/ml streptomycin sulfate; Gibco BRL, Grand Island, NY) were
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added to sterile 0.1 M phosphate buffered saline (PBS) (Appendix). The solution was
then transferred to a syringe and sterilized by passing through a 0.2 f.lm pore low-protein
binding syringe filter (Acrodisc, Gelman Sciences Inc., Ann Arbor, MI). The fluid for
filling the control pumps was made by adding the appropriate volume of 2X vehicle to
an equal volume of sterile 0.1M PBS. NT-3 working solution was prepared by adding
the calculated volume ofNT-3 stock to the appropriate volume of sterile 2X vehicle and
then passing this through a syringe and syringe filter that had been preconditioned with
sterile vehicle.
Each pump was assembled from three parts: The pump body, the flow moderator,
and the catheter. The flow moderator was removed from the sterile packet and the plastic
end-cap was removed to reveal a short stainless steel tube. Sterile forceps were used to
gently pull a sterile catheter down the length of the metal shaft and this arrangement was
secured with sterile suture. The packet containing the sterilized pump body was then
carefully opened to expose the top of the pump; the pump was left enclosed within the
package. A 1 cc syringe (preconditioned with sterile vehicle) was filled with sterile
solution and the sterile blunt-tipped filling tube (supplied with the pumps) was attached.
Then, while holding the packet containing the pump body in an upright position, the
body was filled with --.; 280 f.ll of solution and the long metal shaft of the flow moderator
was fully inserted into the pump. In a properly assembled pump, the fluid was visible
within the catheter after the flow moderator was in place. The assembled pump was
placed in a sterile 50 cc polypropylene tube of PBS such that the body of the pump was
submerged and the open end of the catheter was above the level of the buffer.
Experimental and control pumps were placed in separate tubes and the tubes were stored
at 4 °C until the pumps were implanted.
Pumps were filled with either vehicle alone (control) or vehicle plus NT-3
(experimental). For each run, control pumps were prepared first and then the same sterile
syringe and pump needle were used to fill the experimental pumps.
3.1.2.2 Pump Implantation
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Mini-osmotic pumps were implanted two weeks after axotomy
(38 experimental, 2 control). Additional experimental pumps were implanted in animals
that had not undergone sciatic nerve transection - when infused, but non-axotomized
tissue, was desired (18 experimental, 2 control).
Rats were anesthetized by an intraperitoneal injection of sodium pentobarbital
(50 mg/kg) and the analgesic buprenorphine (0.1-0.2 mg/kg) was injected just prior to
surgery, and then every 12 hours for 2-3 days. The back of each animal was shaved and
the area wiped with 70% ethanol. An incision was made along the midline of the
lumbosacral region and blunt tipped scissors were used to separate the skin from the
muscle layer to create a pocket for the pump. A scalpel was used to cut through the back
muscles on either side of the vertebral column and then, using the sacrum as a landmark,
a laminectomy was performed at sacra12• A cavity, 2-3 mm in diameter, was rongeured
through the vertebra at the midline to expose the dura and a small slit was made through
it with fine forceps. Prior to pump implantation, a sterile towel (with a central 10 cm X 3
cm hole) was placed over the animal, with the opening centered over the incision. A
pump was then placed on the aseptic towel, caudal to the incision, and the catheter
inserted through the opening in the dura so that a 1.5 cm portion was positioned in the
subarachnoid space. While maintaining the placement of the catheter, the pump was
carefully flipped laterally, positioned, and secured to the back muscles with two sutures
around the pump body and one around the tubing-enclosed shaft of the flow moderator.
Finally, the incision over the pump was sutured closed. Pumps were left in place for one
week. At the time of sacrifice, animals were checked to ensure the correct positioning of
the catheter and for visible signs of infection or inflammation; these animals were not
included in further analysis.
3.1.3 Surgery Controls
Radioautographs of tissue processed for in situ hybridization (see Section
3.2) were qualitatively examined under dark-field illumination and it was determined
that for the biochemical markers examined here, ganglia contralateral to the axotomy
were comparable to DRG from non-operated animals. Therefore, in this work, unless
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otherwise noted, DRG contralateral to the axotomized sciatic nerve were considered to
represent "normal" or "intact" tissue.
The efficacy of the sciatic nerve transection was indicated by elevated levels of
cjun, GAP-43, VIP, and/or NPY mRNAs in the injured DRG, over that of the uninjured,
control tissue. It was more difficult to ascertain the efficacy of the transection in NT-3
infused animals because of potential alterations in message levels following infusion;
although since SOM and VIP mRNA levels were apparently not affected by NT-3, the
lack of SOM, and the presence of VIP, expression indicated that the axotomy was
successful. The results from 1 animal (out of76) were rejected from further analysis, due
to an apparently poor transection.
To determine whether potential effects seen with the infusion of NT-3 were due
to the vehicle components or to pump installation, radioautographs of DRG processed
for in situ hybridization were compared between animals infused with vehicle alone or
with NT-3 (Figure 3.1).
3.2 In Situ Hybridization
The technique of radioisotopic in situ hybridization, combined with
radioautography, results in the formation of silver grains over tissues in which specific
radioactive probes have bound to the target mRNA. Here, processing of semi-thin tissue
sections allowed for the visualization of the resulting silver grains over individual cells,
and computer-assisted image analyses of such tissues were used to determine the relative
level of specific mRNAs for individual neurons.
3.2.1 Tissue Preparation
At the appropriate time after axotomy (3 weeks) or osmotic pump
implantation (1 week), deeply anesthetized animals were perfused through the aorta in
the following manner. The chest area of each animal was shaved and the area wiped with
70% ethanol. Blunt tipped scissors were used to open the chest cavity just below the rib
cage and to cut along the ribs on one side; the resulting flap of tissue was clamped with a
heavy pair of forceps and the area was then flipped away from the chest cavity. A hole
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Figure 3.1 Comparison of the effect of intrathecal infusion ofNT-3 plus vehicle to that of vehicle alone on mRNA levels in adult rat
DRG neurons.
Scanned darkfield photomicrographs of6 J,lm thick adult rat Ls DRG sections processed for in situ hybridization, compare the effect
of a 7 day intrathecal infusion of vehicle alone (control pump) and of vehicle plus NT-3 (NT-3 pump, 600 ng/J,ll/h) under normal
conditions (intact) and 3 weeks following sciatic nerve transection (cut) on NFM and galanin mRNA expression. Scale bar = 200 J,lm.
was made in the pericardium using fine-tipped forceps and the pericardium was gently
pulled away to free the heart. The heart was pushed to one side to expose the aorta,
which was then clamped with a hemostat. Fatty tissue and mesentery were removed
from an area ,..... 3 cm from where aorta entered the heart, so that the forceps could be
inserted beneath the aorta. With the forceps in position, one end of a 14 cm length of
suture was grasped and pulled under the aorta. Microscissors were then used to make a
small slit in the aorta in this area. A catheter, made from a 20 G needle inserted into a 13
cm length of polyethylene tubing with a beveled tip (0.86 mm inner diameter X 1.27 mm
outer diameter; Intramedic PE-90, Clay Adams, Division of Becton Dickinson and Co.,
Parsippany, NJ), was then inserted into the aorta and tightly secured in place with the
suture. A syringe containing 60 cc of cold 0.1 M PBS was attached to the catheter, a hole
was cut in the right atrium, and the cold PBS was slowly pushed through the circulatory
system over a 5 minute period. The ipsilateral and contralateral L4 and Ls DRG, which
contain neurons that contribute to the sciatic nerve (Molander and Grant, 1986), were
then sequentially removed. For each pair, care was taken to place the right and left
ganglia in the appropriate positions in a prelabeled cryomold (Tissue Tek, Miles Labs.,
Elkhart, IN). The mold was then filled with OCT compound (Tissue Tek) and the tissue
rapidly frozen in a beaker of isopentane cooled in a slurry of acetone and dry ice. The
molds containing the frozen tissue were wrapped in aluminum foil, placed in freezer-safe
storage bags, and stored at -70 °C. Prior to sectioning, blocks containing the right and
left ganglia from the same lumbar region (i.e. L4 or Ls) for both a control and an
experimental animal were removed from the cryomolds and fused with OCT compound,
so that further processing of that tissue would occur under identical conditions and to
allow the comparison of relative levels ofhybridization signal between experimental and
control conditions. It was necessary to fuse OCT blocks containing control and
experimental tissue, instead ofplacing the four ganglia into one cryomold, because RNA
and protein degradation would have occurred during the time needed to dissect the DRG
from the two animals. The resulting block was allowed to come to -20 to -22 °C, before
being serially sectioned at 6 Ilm thickness at the same temperature in a cryostat (Microm
HM500; Carl Zeiss Canada, Don Mills, ON). Cutting tissue at this thickness allows the
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perikarya of even small diameter neurons to be present and identifiable in at least three
consecutive sections. Additionally, the thinner the section the greater the probability that
silver grains visualized over an individual perikaryon resulted from the probe binding to
mRNA within that neuron (Salpeter et al., 1969, 1978). Sections were manipulated onto
cold (-22°C) Probe-on slides (Fisher Scientific, Pittsburgh, PA) that had been previously
labeled in 4H pencil, and were thaw-mounted, by briefly touching a gloved fingertip to
the underside of the slide until the OCT compound around the sections visibly thawed.
Care was taken to obtain serial sections and to record the beginning and end of each
series for each block of tissue. While keeping the sectioned tissue in the cryostat, the
slides were placed in cold desiccant-containing slide boxes, and when filled, the boxes
were stored at -20°C until tissue was processed for in situ hybridization. Tissue and
tissue sections were subsequently stored at -70 °C and -20°C, respectively, for up to 5
years.
3.2.2 Oligonucleotide Probes
3.2.2.1 Probes
The following oligonucleotide probes were used for in situ
hybridization studies (synthesized by VCDA, Vniv. Calgary, Calgary, AB): rat a-CGRP
- bases 664-698 (Amara et al., 1985), cjun - bases 778-825 (Ryseck et al., 1988), rat
galanin - bases 152-199 (Vrontakis et al., 1987), rat GAP-43 - bases 70-117 (Karns et
al., 1987), rat NFM - bases 1222-1270 (Napolitano et al., 1987), rat NPY - bases
1671-1714 (Larhammar et al., 1987), rat p75 - bases 873-920 (Radeke et al., 1987), rat
SP - bases 145-192 (Krause et al., 1987), chicken SNAP-25 - bases 133-179
(Catsicas et al., 1991), rat SOM - nucleotides encoding amino acids 97-107 (Goodman
et al., 1983), rat trkA which is the counterpart of bases 1198-1245 of the human trkA
sequence (Medio et al., 1992; Meakin et al., 1992), rat trkC - bases 1189-1236
all
(Medio et al., 1992), rat trkC - bases 1654-1701 (Medio et al., 1992), rat trkCnofull-length
insert - bases 2107-2154 (Valenzuela et al., 1993), rat Tal a-tubulin - bases 1548-1594
(Lemischka et al., 1981), and rat VIP - bases 347-394 (Nishizawa et al., 1985). The
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probes are anti-sense and, therefore, complementary to the mRNAs for which they are
specific.
The probes were shipped dry and desalted and were resuspended, under RNase-
free conditions, in sterile distilled water so that stock solution concentration was 400
ng/ml and the working concentration was 40 ng/ml. Probe stock solutions were stored at
-20 DC indefinitely with the solution being thawed, the necessary volume removed, and
the remaining fluid returned to the freezer. Diluted probes were stored at 4 DC for up to 6
months.
3.2.2.2 Three Prime-End Labeling of Probe
The following method was based on that described by Dagerlind
and colleagues (1992). All equipment used was RNase-free and gloves were worn at all
times during the following procedure to avoid RNase and radioactive contamination.
Recipes for the solutions listed are presented in the Appendix.
The following were added in the order listed to a 10 Jll aliquot of a-[35S]dATP
(Dupont New England Nuclear, Boston, MA) with gentle, but thorough, mixing between
each: 2.5 JllI0X cobalt chloride reaction buffer (supplied with the terminal transferase),
8 Jll of sterile distilled water, 2 Jll of 40 ng/ml oligonucleotide probe, and 3 Jll of
terminal deoxynucIeotidyl transferase (----24 U; Amersham Corp., Arlington Heights, IL).
The vial containing terminal transferase was removed from the -20 DC freezer
immediately prior to use, but was kept in a labtop cooler (Nalge Nunc International
Corp., Naperville, IL) in order to avoid enzyme inactivation. After all ingredients were
added, the tube was placed in a 37 DC water bath for 1.5-2 hours. The reaction was
stopped by adding 500 Jll 0.1 M Tris-HCl (pH 8); the solution was then vortexed and
stored at 4 DC until it was purified. For each probe to be purified, an NENSORB 20
column (Dupont New England Nuclear) was prepared by holding the column upright
and gently tapping it three times on the counter. The column was then clamped into a
stand, a disposable beaker was positioned below, and the protective cap was removed
and replaced with a syringe adapter that was supplied with the columns. The column was
rinsed by adding 3 ml HPLC grade methanol and then, using constant and gentle
71
pressure on an air-filled 50 cc syringe, the methanol was pushed through the column
bed. Throughout this, and all further steps, column flow rates were not allowed to exceed
1 drop every 2 seconds and the resin bed was not allowed to dry. Next, 3 ml of 0.1 M
Tris-HCI (pH 8) was added and subsequently pushed through the column. This step was
repeated with the unpurified 35S-labeled probe. After the probe was loaded onto the
column, the column bed was washed with 1.5 ml of 0.1 M Tris-HCI (pH 8) as before.
The purified probe was eluted by loading 500 fll of freshly prepared 30% (v/v) ethanol
onto the column. Pressure was then applied to the air-filled syringe; the initial drop was
discarded and the following 12 drops were collected in a sterile 1.5 ml microcentrifuge
tube. Dithiothetol (DTT; 1 M stock, stored at -20°C) was added to the purified probe for
a final concentration of 10 mM. After vortexing, a 2 fll sample of the probe was removed
and placed in a scintillation vial. Scintillation fluid was then added, and the radioactivity
of the sample was determined in order to ascertain the incorporation of 35S-label (LS
6500 Liquid Scintillation System; Beckman Instruments, Inc., Fullerton, CA). The
radioactivity of labeled probes used for in situ hybridization experiments generally
ranged between 350,000 and 500,000 CPm/fll. The labeled purified probes were stored at
4 °C until they were no longer considered to generate strong signal to noise ratios.
Probes under 250,000 cPm/fll were not used for in situ hybridization studies.
3.2.2.3 Probe Controls
The specificity of the hybridization signal for each probe was
determined by hybridizing adjacent sections under the following conditions. A 400-1000
fold excess of a dissimilar unlabeled probe, of the same length and of similar guanine
and cytosine content, was combined with the 107 cpm/ml hybridization solution of
labeled experimental probe (Figure 3.2). For each probe used, no change in the
hybridization pattern was observed between that of the experimental probe alone and
when an excess of unlabeled dissimilar probe was used in competition. Signal was
depleted when tissue was hybridized with solution containing a 400-1000 fold excess of
unlabeled probe and 107 cpm/ml of the same 35S-labeled probe.
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Figure 3.2 Oligonucleotide probe controls.
Scanned darkfield photomicrographs of6 11m thick adult rat LsDRG sections proc-
essed for in situ hybridization to detect trkC, Tal a-tubulin, and GAP-43 mRNA plus
either a 400-1000 fold excess ofthe same, but unlabeled, probe or a 400-1000 fold excess
of a dissimilar unlabeled probe, of the same length and of similar guanine and cytosine
content. Scale bar = 200 Ilm. Asterisks identify artifacts on the slide.
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Also, the sequences of all probes were checked against Genbank entries (website:
www.ncbi.nlm.nih.gov/BLAST)priortouse.andagainpriortothesispreparation.to
verify no greater than 65% homology with any other known mRNA sequences.
In addition, the stringency used for the in situ experiments (e.g. wash
temperature, salt concentration) was such that greater than 90% identity was required for
the probe to remain hybridized to the mRNA transcript (Dagerlind et al., 1992).
3.2.3 Hybridization
The following method was based on that described by Dagerlind and
colleagues (1992). All equipment used was RNase-free and gloves were worn at all
times during the following procedures to avoid RNase and radioactive contamination.
Glassware was pretreated with diethyl-pyrocarbonate (DEPC, Appendix) and equipment
was treated with RNase ZAP according to manufacturer's directions (Sigma). Recipes
for the solutions listed below are presented in the Appendix.
For each probe, the necessary volume of hybridization solution containing 35S_
labeled probe was calculated based on 200 JlI for each slide pair. At least one slide was
included in each run as a hybridization control for each probe used. For each milliliter of
solution, 900 JlI of hybridization cocktail (43°C), 50 Jllof 10 mg/ml denatured salmon
sperm DNA stock (prior to use the vial of frozen stock was placed in boiling water and
then submerged in ice water, for 5 minutes each), 107 cpm of labeled probe, and 40 JlI of
5 M DTT were added in the order as listed and the solution was vortexed between each
addition. The hybridization solution was then placed in a 43°C water bath.
Hybridization trays were lined with blotting paper and the paper was then saturated with
IX SSC. Slide boxes containing tissue sections were removed from the freezer, placed in
a cold cryostat (-20 to -22°C), and the desired slides were removed and allowed to
equilibrate to room temperature ('" 20 minutes). In a laminar flow hood, and working on
a raised surface, 180 JlI of hybridization solution was pipetted near the tissue on one
slide. A second slide was then gently layered on top of the first so that the DRG sections
on each slide were exposed to an even layer of the hybridization solution; the paint on
the comers of the Probe-on slides permitted two slides to be "sandwiched" together
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during in situ hybridization processing. This technique minimized probe usage and
evaporation and did not result in tissue damage. When all slides were paired, or the
hybridization tray was full, the lid was placed in position and sealed tightly with tape to
construct a humidified chamber. The tray was then placed into a 43°C oven for 16-18
hours. Following hybridization, spatula-tipped forceps were used to transfer a slide pair
to a 250 ml beaker of 55°C IX SSC. The slides were gently separated and transferred to
a glass slide rack submerged in a glass staining dish filled with 55°C IX SSC. This
procedure was repeated, and when the rack was full it was transferred to another staining
dish containing fresh hot (55°C) IX SSC and then placed in a 55°C water bath. The
fluid from the original staining dish and beaker was discarded as radioactive waste and
the vessels were refilled with hot IX SSC. This process was continued until all slides
were submerged in SSC. Slides were incubated in the water bath for 15 minutes and then
the slide racks were transferred to staining dishes containing fresh hot IX SSC and the
dishes replaced in the 55°C water bath. After four 15 minute incubations in IX sse at
55 °c, the dishes containing the slides were removed from the water bath and left at
room temperature for an additional 15 minutes. Racks containing slides were then
dipped into two staining dishes filled with triple distilled water four times (no longer
than 4 seconds in total), followed by nine dips over 9 seconds in 60% ethanol, and then
twelve dips over 12 seconds in 95% ethanol. Slides were air-dried for 1-2 hours and then
placed in slide boxes containing packets of desiccant. Slides were not overcrowded; one
box or more was used for each probe and at least one box was used for each radiography
development time point for the hybridization control slides. The slide boxes were stored
at room temperature overnight, prior to coating in radiosensitive emulsion.
3.2.4 Radioautography
In a light-tight darkroom and under sodium vapour lamp illumination
(Thomas Duplex Super Safelight; Thomas Instruments Co., Inc., Charlottesville, VA),
slides processed for in situ hybridization were coated with radiosensitive emulsion
(Kodak NTB2, Eastman Kodak Co., Rochester, NY; diluted I: 1 with triple distilled
water) in the following manner. The emulsion was melted in a 43 °e water bath, gently
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mixed, poured into a dipping container, and returned to the water bath. Control slides
and identical probe-labeled slides were processed in consecutive series. In a smooth and
steady movement, each slide was dipped into the emulsion and then placed to dry on a
rack. After all slides were coated with emulsion, racks were covered to avoid dust
contamination and slides were left to dry for 2.5-3 hours. The slides were then replaced
in the desiccant-containing slide boxes and the boxes inserted into pre-labeled light-tight
bags, which were sealed and incubated at 4 °C for 15 hours to 7-30 days, depending on
the probe.
In order to determine the optimal degree of exposure for the radioautography,
control slides for each probe were developed at 1, 3, or 7 days; the duration of incubation
having been predetermined for each probe. Microscopic examination of the developed
control slides for each run of each probe was conducted to determine the time point for
the development of the corresponding experimental slides. Development times were
chosen to maximize silver grain densities, while allowing for minimal grain overlap, and
to permit the identification of those neuronal populations exhibiting low levels of
labeling. To develop the radioautography, the emulsion-coated slides were allowed to
come to room temperature (20-30 minutes). In a darkroom, under sodium vapour lamp
illumination, slide boxes were removed from the light-tight bags and the slides were
loaded into glass slide carriers. The carriers were then placed in staining dishes ofcooled
(18-20 °C), filtered D-19 developer (Eastman Kodak Co.) for 3 minutes, dipped several
times in 20°C running tap water, fixed for 5-6 minutes in filtered Rapid Fixer (Eastman
Kodak Co.), and left to rinse for 20 minutes in a basin of20 °C running tap water. When
rinsing was complete, the basin containing the submerged slides was removed from the
darkroom. Individual slides were removed from the water, the emulsion scraped from the
, back of the slide with a single edged razor blade, and the slide placed to dry in a dust-
free environment. Dried slides were stored at room temperature. For dark-field
photomicroscopy (dark-field stage adapter; Micro Video Instruments, Inc., Avon, MA)
sections were mounted in glycerine. If rephotographed under bright-field conditions, the
coverslip was removed and tissue was lightly stained with 0.5 (w/v) toluidine blue,
dehydrated, cleared in xylene, and mounted with permount and a coverslip.
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Alternatively, digital images of the stained ganglia were obtained (Northern Eclipse,
Version 2.0; Empix Imaging, Inc., Mississauga, ON). Radioautographs of ganglia on
individual slides were qualitatively examined under dark- and/or bright-field
illumination for relative differences in silver grain density levels.
3.2.5 Quantification of Relative Levels ofmRNA
Radioautographs were examined under dark-field illumination to
qualitatively determine potential differences or similarities in relative mRNA levels of a
number of proteins between control and experimental conditions. For each probe or
series of probes under deliberation, a minimum of 2 representative slides, or consecutive
slide series (if colocalization or trilocalization was to be undertaken), were chosen for
quantification of relative neuronal grain densities. Care was taken to choose
radioautographs that exhibited a compromise between minimizing grain overlap over
those neurons with high silver grain densities and maximizing the positive-label to
background ratio for neurons expressing low levels of hybridization signal. Care was
also taken to choose ganglia with a similar plane of section, so that there was a
comparable distribution of neurons throughout each of the sections that were to be
compared, in order to minimize potential differences in the topography of
subpopulations ofDRG neurons.
Photomicrographs (25X, bright-field) of lightly stained DRG sections were taken
in series and the resulting enlarged prints were compiled to create montages. For each
serial set of montages, those neurons present in all sections were identified and
consecutively numbered (on average 229 per ganglion section). Then, as described by
Richardson and coworkers (1989), a computer-assisted image analysis system, with a
software program developed by W. G. Tatton (Department of Neurology, Mt. Sinai
School of Medicine, New York, NY), and modified by P. M. Richardson (Division of
Neurosurgery, Montreal General Hospital and McGill Univ., Montreal, PQ), was used to
determine relative silver grain densities for the probes under consideration. A digital
camera, connected to a microscope and a computer monitor, was used to obtain black
and white images of each of the identified neurons under 63X oil immersion
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microscopy. If the staining of the tissue was sufficiently dark as to interfere with silver
grain visualization, the coverslip was removed after soaking the slide in xylene and
sections were then destained in a downgraded ethanol series (100-75%). When the
desired staining intensity was reached, sections were dehydrated and coversliped as
before. As each neuronal image was obtained, background light was subtracted and the
image was "stretched" to maximize the grey scale value range. Then the perikaryal area
covered by silver grains for each of the identified cells was determined. To do this, a
grain overlay was created for each neuron. Since under bright-field illumination silver
grains appear as dark spots, it was necessary to select a minimal grey-shade pixel value
so that the resulting grain overlay fitted the majority of grains over an individual neuron.
The differential cytoplasmic staining intensity of neurons was the most important factor
in determining the need for this adjustment. Although it was necessary to adjust the
grain overlay threshold value for each neuron, it was critical that the degree of grain
overlay was consistent for all neurons in all of the DRG sections in which relative levels
of hybridization signal were to be compared. After the grain overlay threshold was
adjusted, the periphery of the neuron, and then the nucleus, were traced and the software
program determined the percentage of these areas covered by silver grains. When
individual neurons were identified in adjacent sections, the largest perikaryal area was
used to determine the diameter of the cell body; calculations were based on the
presumption that the perikaryon was spherical. Background labeling was determined by
averaging grain counts over 5 areas of neuropil lacking positive-labeled cell bodies. Data
files were edited using WordStar 5.5 (MicroPro International, San Rafael, CA) and were
later transferred to Microsoft Excel (Microsoft Excel 97 SR-l; Microsoft Corp., 1985-
1997) to allow for further analyses. To determine the density of silver grains over
perikaryal cytoplasm, "f', the area of the nucleus multiplied by the density of silver
grains over the nucleus was subtracted from the area of the cell body multiplied by the
density of silver grains over the cell body. The resulting number was then divided by the
area of the nucleus subtracted from the area of the cell body. Since the image analysis
program calculated grain coverage, a grain overlap correction factor, f/(1 - f), was
included in the analysis (Richardson et al., 1989). The corrected parameter, termed
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labeling density, reflects the relative level of target mRNA. To avoid negative numbers,
total labeling was used without the subtraction of background labeling. Instead, the
corrected labeling density was divided by the corrected background density and this
value was termed the labeling index of the neuron. Cells with labeling indices of greater
than three to ten times background levels were said to be positive for the marker under
consideration; for each probe and for each set of ganglia this "cut off' value was chosen
to reflect both the level of positive hybridization signal and the degree of nonspecific
binding. Scatterplots of labeling indices of the identified neurons were constructed
(SPSS for Windows, Release 6.1; SPSS Inc., 1989-1994) to depict the relationship
between perikaryal diameter and probe labeling density, or between the labeling indices
of two probes, for the entire identified DRG population or for defined subpopulations.
For each probe, neuronal labeling indices were compared only between ganglia situated
on the same slide because, with the exception of the time taken for dissection and
freezing, any further processing of these tissues would have been under identical
conditions. For individual slides, differences such as the thickness of the radiosensitive
emulsion, or the temperature and/or duration of the post-hybridization washes, result in
different densities of silver grains (Verge et al., 1990b; Tetzlaff et al., 1992). No attempt
was made to convert individual neuronal labeling indices to actual cellular mRNA
levels. This conversion would have necessitated the inclusion of variables that were not
considered in this work, such as the degree of message degradation during tissue
processing, the ability of the probe to access cellular mRNA, and the standardization of
the hybridizations with known amounts of the appropriate mRNA (Verge et al., 1990b;
Tetzlaff et al., 1992).
3.2.5.1 Statistical Analyses
While in situ hybridization allows for the localization ofmRNA at
the cellular level, there are certain disadvantages to the technique. Aspects of the
protocol, including radioisotopic labeling of the probe, hybridization and wash
conditions, and emulsion thickness, are likely to result in different silver grain densities,
making the comparison between grain labeling indices, and therefore relative mRNA
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levels of tissues processed separately, inadvisable. To highlight the trends in changes of
relative message levels seen following NT-3 infusion, and to combine the data from
replicate analyses for each marker, summary graphs were constructed (SPSS). Since
labeling index values for specific markers in the Ls DRG neuronal population could not
be assumed to be normally distributed, median, not mean, values were used as a measure
of central tendency. The median of a set of measurements is defined as the midpoint
value when the measurements are arranged in order of magnitude. In addition, the
median, unlike the mean, is a resistant measure of center; that is to say that the median is
not sensitive to the influence of extreme values and it does not respond strongly to
changes in a few observations, no matter how large those changes may be. These
qualities are important here, because the intuitive component of the data collection
methodology (see Section 3.2.5) may have increased the possibility of the inclusion of
occasional outlier values. To depict the variability of the data, the 25th and 75th percentile
values were also plotted for each treatment. The 25th percentile is the labeling index
value such that 25% of the measurements are less than, and 75% are greater than, that
value; while the 75th percentile is the labeling index value such that 75% of the
measurements are less than, and 25% are greater than, that value. Hence, labeling index
values falling between the 25th and 75th percentiles encompass 50% of the measurements
and the median labeling index value.
In order to be consistent in statistical analyses, and since it could not be assumed
that the population distribution of the labeling indices for the various biochemical
markers examined were normally distributed, nonparametric analyses were conducted.
Within each replicate, and to determine if the population distribution of labeling indices
between axotomized and axotomized/NT-3 infused or between normal and normal/NT-3
infused treatments were identical, a Mann-Whitney U Test was performed. The
threshold probability value (a) was set at 0.05. Therefore if the calculated probability
value (P) was less than 0.05, the null hypothesis was rejected and the difference in
labeling indices between the two populations was deemed statistically significant.
Statistical analyses, including calculation of medians and of statistical
significance, were performed in SPSS.
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3.3 Detection of High-Affinity NGF Binding Sites
In order to determine the effect of NT-3 infusion on the density of high-affinity
NGF binding sites, 40 pM radiolabe1ed NGF was employed in binding experiments on
DRG tissue sections using a modification of the technique described by Richardson and
colleagues (1989). Iodination was achieved by the lactoperoxidase method, originally
described by Sutter and coworkers (1979), which allows the 1251_NGF to maintain
essentially the same biological activity as unlabeled NGF (Richardson et al., 1993).
Recipes are presented in the Appendix.
3.3.1 Tissue Preparation
L4 and L5 DRG were obtained and processed for cryostat sectioning as
described in Section 3.2.1. Serial sections (6 J..lm thick) were thaw-mounted onto cold
gelatin-subbed glass microscope slides for 125I_NGF binding. Additional sections were
mounted onto cold Probe-on slides; these sections were reserved for trkA in situ
hybridization and were consecutive in series to tissue processed for 1251_NGF binding.
Since both techniques were isotopic, it was necessary to use adjacent DRG sections to
coloca1ize 1251_NGF binding sites and trkA message expression in individual neurons
(Verge et al., 1992a). Only freshly cut, frozen tissue was used in binding experiments.
3.3.2 Iodination ofNGF
In an iodination hood, and with the appropriate precautions (i.e. double
gloved, masked, behind a lead brick wall), the following ingredients were added in the
order listed to 20 J..lI of 2 mCi 1251 (Amersham): 20 J..lI 0.1 M phosphate buffer (PB) (pH
7.4), 10 III NGF stock [15 mg in 0.2 (v/v) acetic acid, pH 5; gift ofW. Mobe1y, UCSF],
10 III lactoperoxidase stock (0.5 mg in 0.1 M PB), and 10 J..lI of 0.003% (v/v) hydrogen
peroxide (in 0.1 M PB). The ingredients were added to the 1251 in the radioisotope
shipping vial and mixed thoroughly via trituration between each addition. After 30
minutes, an additional 10 III of 0.0030/0 hydrogen peroxide was added and the mixture
incubated for an extra 30 minutes. Prior to the next step, but before the end of the final
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incubation period, a Sep-Pak Waters Accell CM cation-exchange cartridge (Waters, a
division of Millipore Corp., Milford, MA) was equilibrated with 5 cc of 0.05 M sodium
acetate (pH 4.0,4 °C). When the final incubation was finished, a 10 III aliquot of the 1251_
NGF was removed, added to 3 ml of 0.1 M PB (pH 7.4) with 1 mg/ml bovine serum
albumin (BSA, Fraction V; Sigma), and placed on ice. This sample was for
trichloroacetic acid (TCA) precipitation. In order to separate 125I_NGF from free 1251, the
remaining iodination mixture was applied to the equilibriated cartridge and then loaded
by pushing the fluid through the cartridge with an air-filled syringe. A 1 cc syringe
containing 0.05 M sodium acetate buffer (pH 4.0) was then attached to one end of the
cartridge and an empty syringe to the other. The cartridge was washed by drawing the
sodium acetate solution back and forth five times through the cartridge. The syringes
were removed, and one containing 20 cc of 0.05 M Tris-HCI (pH 7.6) was attached to
the cartridge and the buffer was pushed through into a waste container. Finally, 10 cc of
0.05 M Tris-HCl (pH 9.0) with 1 M sodium chloride and 0.5 mg/ml BSA was used to
elute the 125I_NGF into six microcentrifuge tubes; the first aliquot was 0.5 ml and the
remaining aliquots were 1 ml each. Aliquots were stored on ice, or at 4°C. To determine
radioactivity, each aliquot was vortexed and a 10 III subsample was removed and
analyzed with a scintillation counter as described in Section 3.2.2.2. The 125I_NGF was
used within 24 hours ofpreparation.
3.3.2.1 TCA Precipitation
The tube containing the 10 III aliquot of 125I_NGF in the 3 ml of
0.1 M PB (pH 7.4) with 1 mg/ml BSA was vortexed, a 10 Jll sample removed, and the
radioactivity of the sample was determined as described in Section 3.2.2.2. This value
was designated "C" and used in the calculation of percentage of isotope incorporation. A
200 III sample was then removed, added to 400 III of freshly prepared 20% (w/v) TCA
solution, vortexed, and subdivided into equal subsamples in four 1.5 ml microcentrifuge
tubes. These subsamples were vortexed and then incubated at 4 °C for 2 hours.
Following incubation, the subsamples were centrifuged (10,000 g, 10 minutes, 4°C) and
then, avoiding the precipitate, 10 III was removed from each tube, and the radioactivity
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of each determined. The counts for the four 10 ~l subsamples were averaged to obtain
the value "T", which represented free 1251; the pellet contained iodinated and non-
iodinated NGF.
3.3.2.2 Calculation of Available 125I_NGF
The percentage of 1251 incorporation was calculated as follows:
1000/0 - T (cpm/10 ~l) * 300 I C (cpm/10 ~l). Incorporation for the two binding
experiments undertaken was 60%. The total counts of bound 1251 (cpm/Jlg) was
calculated using the following equation: C (cpm/10 ~l) * 300 * v * i I total NGF; where
"v" was the volume of the iodination mixture prior to removal of samples and "i"
represented the incorporation of 1251, expressed as a decimal. Specific activity was 31.7
~Ci/~g. Of the 6 microcentrifuge tubes of 1251_NGF, the sample with the highest level of
radioactivity was selected as the source of 1251_NGF for binding experiments. The
amount of available 125I_NGF (ng/~l) was calculated by dividing the total cpm/~l of the
chosen sample by total counts ofbound 1251.
3.3.3 125I_NGF Binding
Immediately prior to use, the necessary volume of radioligand solution
was prepared by adding 1.5 mg/ml cytochrome C (Sigma), 0.083 mg/ml phenylmethyl-
sulphonyl fluoride solution (solid dissolved in 500 ~l 100% ethanol; Sigma), 4.0 ~g/ml
leupeptin (Sigma), 0.5 mM magnesium chloride, and 40 pM 125I_NGF (molecular weight
of NGF dimer is 26,000 gil). This concentration of NGF had been previously shown to
provide the best ratio ofneuronal to background labeling (Richardson et al., 1986; Verge
et al., 1989a). For each run, it was necessary to prepare controls to distinguish between
specific and nonspecific binding. To accomplish this, slides were incubated in a Coplin
jar of radioligand solution containing 40 pM 125I_NGF to which excess non-iodinated
NGF (2560 pM) had been added.
After preparation of the radioligand solution, the slides were removed from the -
20°C freezer or cryostat and allowed to come to room temperature (20-30 minutes).
Slides were incubated in Coplin jars containing radio1igand solution for 90 minutes; jars
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were placed on a rocker table for the duration of the incubation period. Slides were then
rinsed in six changes over 3 minutes of cold 0.1 M PBS. Sections were fixed for 10
minutes in cold 2% (w/v) formaldehyde with 2% (v/v) glutaraldehyde in 0.1 M PBS (pH
7.4), rinsed in two changes over 1 minute in PBS, 30 seconds in distilled water, 1 minute
in 60% ethanol, 2 minutes in 95% ethanol, and 1 minute in 100% ethanol. Slides were
air-dried, placed in slide boxes containing packets of desiccant, stored overnight at 4°C,
and then dipped in radiosensitive emulsion (see Section 3.2.4). Radioautographs were
tested for degree of 1251 exposure 2 days after dipping. Optimal emulsion exposure time
was chosen to maximize the ratio of specific 1251_NGF to nonspecific (background)
binding. Two runs of 1251_NGF binding were undertaken.
3.3.4 Quantification of 1251_NGF Binding
In order to quantify the density of NGF binding sites and trkA message
levels, serial sections of tissue processed for 1251_NGF binding, 1251_NGF plus 2560 pM
non-iodinated NGF binding, and trkA in situ hybridization were examined following the
method described in Section 3.2.5. The corrected grain densities, labeling indices, were
linearly related to the concentration ofbound 1251_NGF (Richardson et al., 1989; Verge et
al., 1992a). Scatterplots of labeling indices of the 191-276 identified neurons in each
ganglion were constructed to depict the relationship between perikaryal diameter and
labeling index or between the labeling indices of 1251_NGF binding and trkA in situ
hybridization or 1251_NGF and 1251_NGF plus excess cold NGF binding. To highlight the
trends seen following NT-3 infusion, and to combine the data from replicate analyses,
summary graphs were constructed as described in Section 3.2.5.1.
3.4 Preparation of Photo-plates
Darkfield and brightfield photomicrographs were prepared using standard
darkroom techniques. These were later scanned (Hewlett-Packard ScanJet 6100 CIT,
Hewlett-Packard Co., Palo Alto, CA); the resulting images were then appropriately
sized, compiled to form a plate, and contrast-adjusted as necessary for best output in
Adobe Photoshop Version 5.5 (Adobe Systems Inc., San Jose, CA). Contrast adjustment
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at this time did not interfere with the determination of neuron labeling indices, but was
for photo-plate preparation only. Finally, plate text and figure headings were added in
Adobe Pagemaker Version 6.5.
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4. THE ROLE OF NT-3 IN THE MAINTENANCE OF PHENOTYPE OF ADULT
PRIMARY SENSORY NEURONS: CHARACTERIZATION OF THE trkC-POSITIVE
SUBPOPULATION
4.1 Introduction
DRG neurons innervate skin, muscle, joints, or VIscera and serve in a
somatosensory capacity as nociceptors, mechanoreceptors, or proprioceptors. Mirroring
the diversity of function, this heterogeneous population may also be differentiated
according to perikaryal and axon fiber diameter and physiology. Moreover, these
neurons may be divided into a number of subpopulations based on their expression of
the neurotrophin receptors trkA, trkB, and trkC and then further characterized vis-a-vis
the expression of biochemical markers - including neuropeptides, cytoskeletal
elements, enzymes, and other proteins.
As many as 10,500-17,900 neuronal perikarya are estimated to be housed in
individual adult rat L4 or Ls DRG (Schmalbruch, 1987; Klein et al., 1991; Swett et al.,
1991; Tandrup, 1993). The best characterized subgroup of these neurons is that
responsive to NGF, which represents 40-45% of the total neuronal population
(Richardson et al., 1986; Verge et al., 1989a, 1990a, 1990b, 1992a; Mu et al., 1993;
McMahon et al., 1994; Wetmore and Olson, 1995; Wright and Snider, 1995; Bennett et
al., 1996a; Kashiba et al., 1996, 1997a, 1998; Karchewski et al., 1999), and displays
high affinity NGF binding sites and expresses both p75 and trkA mRNAs (Richardson et
al., 1986; Verge et al., 1989a, 1989b, 1990a, 1990b, 1992a). The group includes
virtually all SP- and most CGRP-, but not SOM-, expressing DRG neurons (Verge et al.,
1989a; Kashiba et al., 1996); all express GAP-43 mRNA (Verge et al., 1990a). They are
predominately small to medium in size (Richardson et al., 1986; Verge et al., 1989a,
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1989b, 1992a, 1992b; Mu et al., 1993; McMahon et al., 1994; Wetmore and Olson,
1995; Kashiba et al., 1996; Karchewski et al., 1999) and are thought to function in
nociception (Crowley et al., 1994; Smeyne et al., 1994). While the NGF-responsive
subpopulation is well characterized, the same cannot be said for the subsets of DRG
neurons capable of responding to the other neurotrophins.
Micro-injection of sciatic nerve with iodinated NT-3 labels a subset of
principally large-sized DRG neurons in a receptor-mediated fashion (DiStefano et al.,
1992; Helgren et al., 1997), and NT-3 is potentially bioavailable to these cells from
target (Emfors et al., 1990b; Maisonpierre et al., 1990a; Funakoshi et al., 1993;
Griesbeck et al., 1995; Yamamoto et al., 1996), nerve (Funakoshi et al., 1993;
Yamamoto et al., 1996; Nitta et al., 1999), spinal cord (Funakoshi et al., 1993; Nitta et
al., 1999), and local autocrine/paracrine (Zhou et al., 1999a) sources. Since among the
trks, NT-3 preferentially binds to trkC (Lamballe et al., 1991; Ip et al., 1993a),
characterization of the trkC-positive population is critical to discerning the role(s) of this
neurotrophin in maintaining the phenotype of adult primary sensory neurons. Although
the majority of DRG neurons that express trkC mRNA are reported to be medium to
large in size (Mu et al., 1993; McMahon et al., 1994; Wetmore and Olson, 1995; Wright
and Snider, 1995; Kashiba et al., 1996, 1997a; Helgren et al., 1997; Karchewski et al.,
1999) and are believed to be proprioceptive in function (Emfors et ai., 1994b; Farifias et
al., 1994; Klein et ai., 1994; Tessarollo et ai., 1994; Kucera et ai., 1998; Matsuo et ai.,
2000), there is disagreement as to the number of trkC-positive cells. Several research
groups have indicated that for adult rat DRG between 10-20°tlo of DRG neurons display
trkC transcripts (Mu et al., 1993; McMahon et al., 1994; Wetmore and Olson, 1995;
Kashiba et al., 1996, 1997a). However, in this laboratory, in situ hybridization
experiments with an oligonucleotide probe for trkC mRNA demonstrate that 30-35% of
the total population are strongly trkC-positive, with an additional 10% exhibiting low
levels of signal (Karchewski et ai., 1999). Moreover, '" 50% of the trkC-positive subset
coexpress trkA mRNA (Karchewski et al., 1999).
Peripheral nerve injury may result in loss ofDRG neurons, but those that survive
undergo characteristic alterations in response to the insult and in preparation for axonal
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regeneration (see Section 1.2.3.1). Included among these changes are the upregulation of
microtubule-associated proteins (Oblinger and Lasek, 1988; Skene, 1989; Hoffman et
al., 1993; Moskowitz et al., 1993); GAP-43 (Skene, 1989; Schreyer and Skene, 1991,
1993; Verge et al., 1990b; Wiese et al., 1992), and the transcription factor cJUN (Gold
et al., 1993a, 1994). Further, additional axotomy-induced biochemical changes within
DRG neurons include the differential regulation of neuropeptides: with levels of a- and
~-CGRP (Shehab and Atkinson, 1986; Noguchi et al., 1990b, 1993; Klein et al., 1991),
SP (Jessell et al., 1979; Tessler et al., 1985; Villar et al., 1989; Klein et al., 1991;
Hokfelt et al., 1993; Noguchi et al., 1994, 1995) and SOM (Noguchi et al., 1993)
decreasing; while NPY (Wakisaka et al., 1991, 1992; Frisen et al., 1992; Noguchi et al.,
1993; Zhang et al., 1994c; Ohara et al., 1994, 1995), galanin (Hokfelt et al., 1987, 1993;
Villar et al., 1989; Klein et al., 1991; Noguchi et al., 1993; Verge et al., 1993b), and VIP
(Villar et al., 1989; Klein et al., 1991; Noguchi et al., 1993) are upregulated.
Upon gaining a better understanding of the phenotype(s) of normal and injured
DRG neurons that may be responsive to NT-3, unique subgroups may be identified. This
knowledge can be used to manipulate specific neuronal populations, through the
introduction of exogenous trophic factor, and ultimately such studies will yield valuable
information that could lead to advances in the treatment of neurological diseases or
trauma.
Here, the subpopulation of DRG neurons potentially responsive to NT-3 is
characterized using serial adult rat DRG sections processed for in situ hybridization to
allow for the colocalization or trilocalization of the following mRNAs with trkC: the
neurotrophin receptors trkA and p75; the cytoskeletal elements NF medium (160 kDa)
subunit (NFM) and Tal a-tubulin; the neuropeptides SP, a-CGRP, SOM, galanin,
NPY, and VIP; the injury/regeneration-associated markers GAP-43 and cJUN; and the
synaptosomal-associated protein SNAP-25. Computer-assisted image analysis of
radioautographs has been used to determine the relative transcript levels for trkC and the
preceding markers coexpressed by individual neurons, both under normal conditions and
following sciatic nerve transection for injury-induced markers.
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4.2 Results
4.2.1 Technical Considerations
Labeling index, detennined through computer-assisted image analysis of
radioautographs, refers to the ratio of silver grain density over neuropil devoid of
positive hybridization signal (background) and reflects the relative level of the target
mRNA (see Section 3.2.5). Labeling index values between the probe-positive "cut off'
value and fifteen times background are considered to represent low levels of
hybridization signal, while those above fifteen times background denote moderate to
heavy signal levels. To allow for the quantification of relative mRNA levels following
radioisotopic in situ hybridization, radioautographs must be developed so that silver
grain overlap is minimized. In order to achieve this result, but at the same time pennit
the identification of neuronal populations with low transcript levels, development times
were chosen to maximize silver grain densities and minimize grain overlap. Because of
this, in cases where there is heterogeneous mRNA expression for specific markers, there
may be instances where neurons with low transcript levels are not considered to exhibit
detectable message for that marker. Another consideration that must be taken into
account when analyzing radioautographs is the inability to compare actual labeling index
values for individual probes between slides; for each marker, neuronal labeling indices
may only be compared between ganglia present on the same slide (see Section 3.2.5).
This is due to constraints inherent to the technique that affect the fonnation of silver
grains. Only relative labeling indices, not the actual values, are meaningful.
To ascertain neuronal size, the image analysis software program (see Section
3.2.5) uses the largest perikaryal area of each individual neuron identified in serial
sections to detennine the diameter of the cell body; calculations are based on the
presumption that the perikaryon is spherical; diameters less than 30 flm, between 30-45
flm, and greater than 45 flm represent small-, medium-, and large-sized neurons,
respectively. Since some of the image analyses presented here involve the trilocalization
of specific markers, there may be a bias against small diameter neurons because of the
difficulty in identifying perikarya of this size in all three of the serial 6 J.!m thick DRG
sections.
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4.2.2 Neurotrophin Receptors
4.2.2.1 The Expression of trkC mRNA in the Intact State and Following
Axotomy
Qualitative assessment of radioautographs of 6 Jlm thick sections
of adult rat L5 DRG processed for in situ hybridization to detect transcripts of either the
full-length (trkCfull-Iength), or both the full-length and truncated (trkCall), forms of the trkC
receptor shows that the two probes exhibit virtually identical patterns of neuronal
expression (Figure 4.1). In some cases, a trkCno insert probe (see Section 3.2.2.1) was used
instead of the trkCfull_length probe to identify transcripts of the full-length trkC receptor.
DRG sections processed with these probes show similar patterns of labeling and
percentages of probe-positive neurons (Karchewski et al., 1999), therefore from this
point in this work, the term "trkC" is used to represent in situ hybridization results
obtained by using either the trkCfull_length or the trkCno insert probe.
In intact DRG, trkC mRNA is detectable in many neurons and these trkC-
positive perikarya are distributed throughout the ganglion (Figure 4.2). The majority of
trkC-expressing neurons are medium to large in size, exhibiting moderate to high levels
of hybridization signal. Radioautographs from intact animals compared to those from
animals sacrificed 3 weeks after sciatic nerve transection, show a perceptible axotomy-
induced decrease in trkC hybridization signal levels (Figure 4.2).
Scatterplots (e.g. Figure 4.3) constructed from data obtained through quantitative
analysis of labeling indices and perikaryal diameter of individual neurons identified in
sections of adult rat L5 DRG (18 DRG sections/treatment, average 227 neurons/section)
processed for in situ hybridization, and subsequent radioautography, to detect trkC
transcripts show that in the intact state trkC mRNA is expressed by -- 40% of neurons,
with -- 30% of the total DRG population exhibiting moderate to high levels of
hybridization signal compared to the remaining -- 10% (see Section 4.2.1). Further, these
analyses show that -- 85% of trkC-positive neurons possess medium and large diameter
perikarya. Small cells tend to express low levels of hybridization signal for trkC, while
larger diameter neurons exhibit the full range of labeling indices. Those neurons with the
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Figure 4.1 Comparison between the expression oftrkCfuJl_length and trkCau transcripts
in adult rat DRG neurons.
Scanned brightfield photomicrographs of serial 6 !lm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect mRNA transcripts of the full-length
(trkCfull_length)' and both the full-length and the truncated (trkCall), forms ofthe trkC receptor.
Arrows indicate that both probes hybridize to transcripts in the same neurons. Scale bar =
30 !lm.
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Figure 4.2 Expression of trkC mRNA under normal and axotomized conditions.
Scanned darkfie1d photomicrographs of 6 Jlm thick sections of adult rat Ls DRG
processed for in situ hybridization to detect trkC mRNA, under normal conditions (intact)
and 3 weeks following sciatic nerve transection (cut). Scale bar = 200 Jlm.
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Figure 4.3 Relationship between perikaryal diameter and the relative level of trkC mRNA under normal and axotomized
conditions.
Scatterplots of labeling indices of 283-291 individual neurons identified in 6 Ilm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect trkC mRNA, depict the relationship between perikaryal diameter (x
axis) and trkC labeling indices (y axis) under normal (intact) and 3 week axotomized (cut) conditions. Labeling index refers to the ratio
of silver grain density over neuropil devoid ofpositive hybridization signal (background) and reflects the relative level of trkC mRNA.
Neuronal profiles above the dashed horizontal line are considered positive for trkC mRNA.
highest level of trkC mRNA are of larger diameter. The majority of small-sized neurons,
and a subpopulation of medium to large diameter cells, do not express detectable levels
of trkC mRNA. Three weeks following sciatic nerve transection trkC mRNA levels
decrease, although axotomy does not appear to greatly affect the proportion of trkC-
positive cells within the population of surviving neurons. However, there may be a
reduced ability, in the axotomized verses the intact state, to detect trkC mRNA in
neurons with low trkC levels.
4.2.2.2 The Expression oftrkA mRNA in the Intact State
Microscopic analysis of serial Ls DRG sections processed for in
situ hybridization to detect trkC or trkA mRNA show that the mRNAs for the two
neurotrophin receptors are abundantly and heterogenously expressed in DRG neurons
(Figure 4.4). Message for trkA is primarily localized to small and medium diameter
perikarya and may colocalize with trkC mRNA; there are also neurons in which only
trkA or trkC transcripts are detectable.
Scatterplots (e.g. Figure 4.5), comparing the relationship between trkA and trkC
mRNA expression for individual neurons (6 DRG sections/probe, 265 neurons/section),
demonstrate that while -- 400/0 of neurons express trkA transcripts, there is a
subpopulation of cells in which the message for both of these high-affinity neurotrophin
receptors is coexpressed. This trkA/trkC-positive subset represents -- 10% of the total
DRG neuronal population, and approximately one quarter oftrkC- or oftrkA-expressing
neurons. They tend to exhibit moderate levels ofhybridization signal for trkA and low to
moderate signal levels for trkC mRNA, but there are also small subpopulations of these
neurons with either high trkA/low trkC or low trkA/high trkC labeling indices.
Scatterplots (e.g. Figure 4.6), depicting the relationship between perikaryal
diameter and trkA or trkC mRNA expression for individual neurons (10 DRG
sections/probe, average 250 neurons/section), indicate that trkA-positive neurons are
primarily small in size, although there are a number with medium, and fewer with large,
diameter perikarya. The level of hybridization signal for trkA ranges from low to high,
with smaller neurons expressing all ranges of labeling, while larger diameter neurons
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Figure 4.4 Colocalization of trkA and trkC mRNA under normal conditions.
Scanned brightfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect trkA (upper panel) and trkC (lower
panel) mRNA under normal conditions. Arrows indicate neurons positive for both mark-
ers. Scale bar = 30 Jlm.
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Figure 4.5 Relationship between relative levels of trkC and trkA mRNA under
normal conditions.
Scatterplot demonstrates the relationship between trkC and trkA labeling indices
for 252 neurons identified in adjacent 6 I..lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect trkC (x axis) or trkA
(y axis) mRNA under normal (intact) conditions. Labeling index refers to the ratio of
silver grain density over neuropil devoid of positive hybridization signal (background)
and reflects the relative level of indicated mRNA. Neuronal profiles to the right of the
dashed vertical line, and above the dashed horizontal line, are considered positive for
trkC and trkA mRNA, respectively. The upper right quadrant encompasses neurons
labeled for both markers.
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Figure 4.6 Relationship between perikaryal diameter and the relative level of trkA mRNA under normal conditions for the
total DRG and for the trkC-positive subpopulation.
Scatterplots of labeling indices of 210 individual neurons (of which 87/210 are trkC-positive) identified in adjacent 6 /-lm thick
sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkA and trkC mRNA.
Graphs depict the relationship between perikaryal diameter (x axis) and trkA labeling indices (y axis), for the total population and for
the trkC-positive subpopulation under normal conditions (intact). Labeling index refers to the ratio of silver grain density over neuropil
devoid of positive hybridization signal (background) and reflects the relative level of trkA mRNA. For each plot, neuronal profiles
above the dashed horizontal line are considered positive for trkA mRNA.
exhibit moderate levels of trkA labeling. Neurons lacking detectable levels of trkA
mRNA do not fit any specific size distribution, but represent all size classes; those
coexpressing trkA and trkC message are primarily of medium size, yet include some
large neurons.
4.2.2.3 The Expression ofp75 mRNA in the Intact State
Serial Ls DRG sections, processed for in situ hybridization to
detect trkC or p75 mRNA, show that there is colocalization of the mRNA for the two
neurotrophin receptors (Figure 4.7). All, or virtually all, trkC-positive neurons appear to
also express p75, although there are many p75-positive neurons that do not express trkC
mRNA and a subpopulation that do not express detectable p75 or trkC hybridization
signal.
Scatterplots (e.g. Figure 4.8), illustrating the relationship between trkC and p75
mRNA expression for individual neurons (4 DRG sections/probe, average 255
neurons/section), demonstrate that virtually all trkC-positive cells exhibit detectable
levels of p75 transcripts. Although p75 mRNA is heterogenously expressed throughout
the trkC-positive subpopulation, neurons with the highest levels of trkC mRNA tend to
possess lower p75 message levels. Additionally, '" 20% of DRG neurons do not exhibit
detectable p75 mRNA.
Scatterplots (e.g. Figure 4.9), comparing the relationship between perikaryal
diameter and p75 mRNA expression for individual neurons (4 DRG sections/probe,
average 255 neurons/section) in the total DRG and for the trkC-positive subpopulation,
indicate that there is no obvious correlation between p75 mRNA levels, neuronal size,
and trkC expression - although a subgroup of medium-sized cells that exhibit the
highest levels of p75 transcripts and do not appear to express detectable levels of trkC
mRNA. Further, neurons lacking detectable p75 transcripts tend to have small diameter
perikarya.
Scatterplots (e.g. Figure 4.10), demonstrating the relationship between p75, trkC,
and trkA mRNA expression for individual neurons (4 DRG sections/probe, average 255
neurons/section), show that there is a tendency for trkC/trkA-positive cells to display
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Figure 4.7 Colocalization ofp75 and trkC mRNA under normal conditions.
Scanned brightfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect p75 (upper panel) and trkC (lower panel)
mRNA under normal conditions. Arrows indicate neurons positive for both markers. Scale
bar = 30 Jlm.
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Figure 4.8 Relationship between relative levels of trkC and p75 mRNA under
normal conditions.
Scatterplot demonstrates the relationship between trkC and p75 labeling indices
for 296 neurons identified in adjacent 6 Jlm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect trkC (x axis) or p75
(y axis) mRNA under normal (intact) conditions. Labeling index refers to the ratio of
silver grain density over neuropil devoid of positive hybridization signal (background)
and reflects the relative level of indicated mRNA. Neuronal profiles to the right of the
dashed vertical line, and above the dashed horizontal line, are considered positive for
trkC and p75 mRNA, respectively. The upper right quadrant encompasses neurons
labeled for both markers.
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Figure 4.9 Relationship between perikaryal diameter and the relative level of p75 mRNA under normal conditions for the total
DRG and for the trkC-positive subpopulation.
Scatterplots of labeling indices of296 individual neurons (of which 133/296 are trkC-positive) identified in adjacent 6 J-lm thick
sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect p75 and trkC mRNA.
Graphs depict the relationship between perikaryal diameter (x axis) and p75 labeling indices (y axis), for the total population and for
the trkC-positive subpopulation under normal conditions (intact). Labeling index refers to the ratio of silver grain density over neuropil
devoid of positive hybridization signal (background) and reflects the relative level of p75 mRNA. For each plot, neuronal profiles
above the dashed horizontal line are considered positive for p75 mRNA.
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Figure 4.10 Relationship between relative levels of trkA and p75 mRNA under
normal conditions in the trkC-positive subpopulation.
Scatterplot demonstrates the relationship between trkA and p75 labeling indices
for 87/210 neurons identified in adjacent 6 Jlm thick sections of adult rat Ls DRG
processed for in situ hybridization, and subsequent radioautography, to detect trkA (x
axis), p75 (y axis), or trkC mRNA under normal (intact) conditions in the subpopulation
of neurons coexpressing trkC. Labeling index refers to the ratio of silver grain density
over neuropil devoid of positive hybridization signal (background) and reflects the
relative level of indicated mRNA. Neuronal profiles to the right of the dashed vertical
line, and above the dashed horizontal line, are considered positive for trkA and p75
mRNA, respectively. The upper right quadrant encompasses neurons labeled for all three
markers.
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higher p75 labeling indices than the low to moderate levels of hybridization signal for
p75 exhibited by trkC-positive neurons that do not coexpress trkA.
4.2.3 Cytoskeletal Elements
4.2.3.1 The Expression ofNFM mRNA in the Intact State
NFM mRNA is detectable in virtually all normal DRG neurons
(Figure 4.11) and those cells that express trkC tend to exhibit high levels of NFM
message.
Scatterplots (e.g. Figure 4.12), comparing the relationship between NFM and
trkC mRNA expression for individual neurons (2 DRG sections/probe, 333
neurons/section), demonstrate that virtually all trkC-positive neurons also exhibit
detectable NFM transcripts. Neurons with high levels of hybridization signal for trkC
tend to express high signal levels for NFM, and while there is a group of cells with low
trkC/high NFM labeling indices, there is also a subset with low levels of trkC, and low
to moderate levels of NFM, hybridization signal. The largest proportion of neurons that
do not express detectable trkC mRNA, exhibit low to moderate levels of hybridization
signal for NFM.
Scatterplots (e.g. Figure 4.13), depicting the relationship between perikaryal
diameter and NFM mRNA expression for individual neurons (2 DRG sections/probe,
average 333 neurons/section) in the total DRG and for the trkC-positive subpopulation,
indicate that there appears to be a positive correlation between perikaryal size and NFM
transcript level, with larger diameter cells expressing higher levels of hybridization
signal for NFM. This correlation is maintained within the subset of neurons expressing
trkC message.
4.2.3.2 The Expression of Tal a-tubulin mRNA in the Intact State and
Following Axotomy
Under normal conditions, hybridization signal for Tal a-tubulin
is exhibited by almost all DRG neurons at moderate to high levels; axotomy results in
increased message levels (Figure 4.14).
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Figure 4.11 Colocalization ofNFM and trkC mRNA under normal conditions.
Scanned brightfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect NFM (upper panel) and trkC (lower
panel) mRNA under normal conditions. Arrows indicate neurons positive for both mark-
ers. Scale bar = 30 Jlm.
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Figure 4.12 Relationship between relative levels of trkC and NFM mRNA under
normal conditions.
Scatterplot demonstrates the relationship between trkC and NFM labeling indices
for 373 neurons identified in adjacent 6 J.lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect trkC (x axis) or NFM
(y axis) mRNA under normal conditions (intact). Labeling index refers to the ratio of
silver grain density over neuropil devoid of positive hybridization signal (background)
and reflects the relative level of indicated mRNA. Neuronal profiles to the right of the
dashed vertical line, and above the dashed horizontal line, are considered positive for
trkC and NFM mRNA, respectively. The upper right quadrant encompasses neurons
labeled for both markers.
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Figure 4.13 Relationship between perikaryal diameter and the relative level of NFM mRNA under normal conditions for the
total DRG and for the trkC-positive subpopulation.
Scatterplots of labeling indices of 373 individual neurons (of which 165/373 are trkC-positive) identified in adjacent 6 Jlrn
thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect NFM and trkC
mRNA. Graphs depict the relationship between perikaryal diameter (x axis) and NFM labeling indices (y axis), for the total population
and for the trkC-positive subpopulation under normal conditions (intact). Labeling index refers to the ratio of silver grain density over
neuropil devoid of positive hybridization signal (background) and reflects the relative level of NFM mRNA. For each plot, neuronal
profiles above the dashed horizontal line are considered positive for NFM mRNA.
Figure 4.14 Colocalization of Tal a-tubulin and trkC mRNA under normal and
axotomized states.
Scanned brightfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect Tal a-tubulin (upper panel) and trkC
(lower panel) mRNA under normal conditions (intact) and 3 weeks following sciatic
nerve transection (cut). Arrows indicate neurons positive for both markers. Scale bar = 30
Jlm.
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Scatterplots (e.g. Figure 4.15), illustrating the relationship between trkC and Tal
a-tubulin mRNA expression for individual neurons (2 DRG sections/treatment/probe,
average 257 neurons/section), demonstrate that under normal conditions all DRG
neurons exhibit detectable message levels of Tal a-tubulin. Although trkC transcripts
are heterogenously expressed, this subpopulation tends to display moderate labeling
indices for Tal a-tubulin, with the exception of a small subgroup that exhibits low
levels of trkC, and high levels of Tal a-tubulin, hybridization signal. The highest basal
levels of message for Tal a-tubulin are expressed in a subset of neurons that do not
exhibit detectable levels of trkC mRNA. Three weeks post-axotomy, message levels of
Tal a-tubulin increase, seemingly in all DRG neurons, although the subpopulation
possessing the highest levels of Tal a-tubulin mRNA is still represented by neurons
lacking detectable levels of trkC message.
Scatterplots (e.g. Figure 4.16), comparing the relationship between perikaryal
diameter and Tal a-tubulin mRNA expression for individual neurons (2 DRG
sections/treatment/probe, average 257 neurons/section) in the total DRG and for the
trkC-positive subpopulation, indicate that under normal conditions there is a loose
negative correlation between Tal a-tubulin labeling indices and perikaryal size, with
small diameter cells exhibiting the highest levels of hybridization signal for Tal a-
tubulin. This correlation is upheld in the trkC-positive subpopulation. Axotomy results
in increased Tal a-tubulin message levels throughout the neuronal population.
4.2.4 Neuropeptides
4.2.4.1 The Expression of a-CGRP mRNA in the Intact State
In intact DRG, a-CGRP mRNA is detectable in many small and
medium diameter neurons and, in some cases, transcripts for this neuropeptide colocalize
with those for trkC (Figure 4.17).
Scatterplots (e.g. Figure 4.18), depicting the relationship between perikaryal
diameter and a-CGRP mRNA expression for individual neurons (2 DRG sections/probe,
average 200 neurons/section), indicate that'" 55% of DRG neurons express detectable 0.-
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Figure 4.15 Relationship between relative levels of trkC and Tal a-tubulin mRNA under normal and axotomized states.
Scatterplots demonstrate the relationship between trkC and Tal a-tubulin labeling indices for 262-283 neurons identified in
adjacent 6 f..lm thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x
axis) or Tal a-tubulin (y axis) mRNA under normal (intact) and 3 week axotomized (cut) conditions. Labeling index refers to the
ratio of silver grain density over neuropil devoid of positive hybridization signal (background) and reflects the relative level of
indicated mRNA. For each plot, neuronal profiles to the right of the short-dashed vertical line, and above the short-dashed horizontal
line, are considered positive for trkC and Tal a-tubulin mRNA, respectively. The long-dashed lines serve as references to facilitate
data interpretation.
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Figure 4.16 Relationship between perikaryal diameter and the relative level of Tal
a-tubulin mRNA under normal and axotomized conditions for the total DRG and
for the trkC-positive subpopulation.
Scatterplots of labeling indices of 262 (intact) and 283 (cut) individual neurons
(of which 112/262 and 126/283 are trkC-positive) identified in adjacent 6 f.!m thick
sections of adult rat Ls DRG processed for in situ hybridization, and subsequent
radioautography, to detect Tal a-tubulin and trkC mRNA. Graphs depict the
relationship between perikaryal diameter (x axis) and Tal a-tubulin labeling indices (y
axis), for the total population and for the trkC-positive subpopulation. Panels show a
comparison of data under normal conditions (intact) and 3 week axotomized (cut).
Labeling index refers to the ratio of silver grain density over neuropil devoid of positive
hybridization signal (background) and reflects the relative level of Tal a-tubulin
mRNA, For each plot, neuronal profiles above the dashed horizontal line are considered
positive for Tal a-tubulin mRNA,
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Figure 4.17 Colocalization of a-CGRP and trkC mRNA under normal conditions.
Scanned stained darkfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG
sections processed for in situ hybridization to detect a-CGRP (upper panel) and trkC
(lower panel) mRNA under normal conditions. Arrows indicate neurons positive for both
markers. Scale bar = 40 Jlm.
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Figure 4.18 Relationship between perikaryal diameter and the relative level of a-CGRP mRNA under normal conditions for
the total DRG and for the trkC-positive subpopulation.
Scatterplots of labeling indices of 200 individual neurons (of which 78/200 are trkC-positive) identified in adjacent 6 J-lm thick
sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect a-CGRP and trkC mRNA.
Graphs depict the relationship between perikaryal diameter (x axis) and a-CGRP labeling indices (y axis), for the total population and
for the trkC-positive subpopulation under normal conditions (intact). Labeling index refers to the ratio of silver grain density over
neuropil devoid of positive hybridization signal (background) and reflects the relative level of a-CGRP mRNA. For each plot,
neuronal profiles above the dashed horizontal line are considered positive for a-CGRP mRNA.
CGRP message. Within the a-CGRP positive population, there is a subset of small
diameter cells that tend to express low to moderate levels of hybridization signal for the
peptide and a group of predominately medium-sized neurons that exhibit high signal
levels for a-CGRP. The trkC-positive population includes a small group of a-CGRP
positive cells, which represent'" 8% of DRG, '" 16% of a-CGRP, and'" 22% of trkC-
expressing neurons. The a-CGRP/trkC-positive neurons range in size from small to
large and tend to express moderately high levels ofhybridization signal for a-CGRP.
Scatterplots (e.g. Figures 4.19 and 4.20), comparing the relationship between a-
CGRP, trkA, and trkC mRNA expression for individual neurons (2 DRG sections/probe,
200 neurons/section), demonstrate that the majority of cells that express a-CGRP
mRNA are trkA-positive and that this subgroup represents'" 63% of a-CGRP and '"
900/0 of trkA-positive cells. Neurons with higher levels of hybridization signal for trkA
typically exhibit higher levels of a-CGRP signal and those with low trkA hybridization
signal levels tend to express moderate levels of a-CGRP signal. For the most part, the a-
CGRP/trkC-positive subpopulation ('" 8% of DRG neurons) show low trkC, and
moderately high a-CGRP, labeling indices. The subset in which all three markers are
detectable represents'" 6% of DRG neurons; '" 11 % of a-CORP, '" 160/0 of trkA-, '" 15%
of trkC-positive cells; and", 17% of a-CORP/trkA- and'" 70% of a-CGRP/trkC-
expressing neurons. They exhibit moderate to moderately high a-CGRP and trkA, and
low trkC, hybridization signal levels.
4.2.4.2 The Expression of SP mRNA in the Intact State and Following
Axotomy
Under normal conditions, many small diameter perikarya exhibit
medium to high hybridization signal levels for SP and although SP and trkC transcripts
colocalize, these occurrences are limited (Figure 4.21). Following axotomy, there is a
substantial reduction in levels of hybridization signal for SP; low levels of hybridization
signal for the peptide are now detectable in a subpopulation of medium-sized, trkC-
positive neurons.
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Figure 4.19 Relationship between relative levels of trkC and a-CGRP mRNA in the total DRG population and in the trkA-
positive subpopulation.
Left scatterplot demonstrates the relationship between trkC and a-CGRP labeling indices for 200 neurons identified in
adjacent 6 Jlm thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x
axis) or a-CGRP (y axis), or trkA mRNA under normal (intact) conditions, The right scatterplot demonstrates the same relationship
between trkC and a-CGRP, in the same section, but is specific for those neurons identified as expressing trkA mRNA (76/200).
Labeling index refers to the ratio of silver grain density over neuropil devoid ofpositive hybridization signal (background) and reflects
the relative level of indicated mRNA. Neuronal profiles to the right of the dashed vertical line, and above the dashed horizontal line,
are considered positive for trkC and a-CGRP mRNA, respectively.
INTACT
TOTAL POPULATION trkC-POSITIVE SUBPOPULATION
350J : I
o,..: -------.1 - - ~ - - - - ; - - - - - - - • - - - - - - - - - - . - . - - - .... - . - - - - - - - .. - - - - I
o . 20 . 40 . 60 . 80 . 100 . 120.......
.......
VI
~
~
~
tiS'~ §
~ 0~ 6h~~~2
~0
c.:I
u
b
350
300
250
200
150
100
I'
~SOl:" .
o.~ ~ ~. ~'. ::.. ,:.~ -.'-~ ;---.---.---------.---.-----------------.---
o . 20 . 40 . 60 . 80 . 100 . do
3001
250-1
200,
150
1100
50
00
trkA LABELING INDEX (X background)
Figure 4.20 Relationship between relative levels of trkA and a-CGRP mRNA in the total DRG population and in the trkC-
positive subpopulation.
Left scatterplot demonstrates the relationship between trkA and a-CORP labeling indices for 200 neurons identified in
adjacent 6 J.1m thick sections of adult rat Ls DRO processed for in situ hybridization, and subsequent radioautography, to detect trkA
(x axis) or a-CORP (y axis), or trkC mRNA under normal (intact) conditions. The right scatterplot demonstrates the same relationship
between trkA and a-CORP, in the same section, but is specific for those neurons identified as expressing trkC mRNA (78/200).
Labeling index refers to the ratio of silver grain density over neuropil devoid ofpositive hybridization signal (background) and reflects
the relative level of indicated mRNA. Neuronal profiles to the right of the dashed vertical line, and above the dashed horizontal line,
are considered positive for trkA and a-CORP mRNA, respectively.
Figure 4.21 Colocalization of SP and trkC mRNA under normal and axotomized
states.
Scanned brightfield photomicrographs of serial 6 ~m thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect SP (upper panel) and trkC (lower panel)
mRNA under normal conditions (intact) and 3 weeks following sciatic nerve transection
(cut). Asterisks indicate neurons positive for both markers. Scale bar = 40 f.lm.
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Scatterplots (e.g. Figure 4.22), illustrating the relationship between SP and trkC
mRNA expression for individual neurons (2 DRG sections/treatment/probe, average 215
neurons/section) under normal conditions and 3 weeks post-axotomy, demonstrate that
while'" 20% of DRG neurons heterogenously express SP message in the intact state,
only'" 4% of these cells coexpress trkC mRNA. Cells in which SP and trkC transcripts
colocalize represent'" 20% of SP-positive, and", 12% of trkC-positive, neurons; the
group includes a small subpopulation with moderate trkC, and low to moderate SP,
hybridization signal levels and a subset of cells with low trkC, and moderate to high SP,
signal levels. Following sciatic nerve transection SP transcript levels decrease, with the
majority of SP-positive neurons now exhibiting only low levels of hybridization signal.
Interestingly, although the percentage of SP-expressing cells remains the same ('" 20%),
there is a trauma-induced shift in the character of the subpopulations of SP-positive
neurons. Although SP mRNA is coexpressed in a group of trkC-positive neurons in the
intact state ('" 20% of SP-positive neurons), axotomy appears to trigger the induction of
detectable message levels of SP in a second subset of trkC-expressing neurons; SP and
trkC mRNA now colocalize in '" 150/0 of the surviving cells, representing", 78% of the
SP-positive, and", 28% of the trkC-positive, subpopulations. In addition to exhibiting
low levels of hybridization signal for SP, the post-transection SP/trkC population
expresses low levels of signal for trkC.
Scatterplots (e.g. Figure 4.23), comparing the relationship between perikaryal
diameter and SP mRNA expression for individual neurons (2 DRG
sections/treatment/probe, average 215 neurons/section) in the total DRG and for the
trkC-expressing subpopulation, indicate that in the intact state the majority of SP-
positive neurons are small in size ('" 720/0) and only a subset of these small cells
coexhibit trkC mRNA ('" 12%). There is also a group of medium and large diameter
trkC-positive cells that coexpress low levels of SP hybridization signal ('" 10% of SP-
positive neurons). Axotomy appears to result in a substantial reduction in the number of
small neurons exhibiting detectable SP message and in the induction of low levels of
hybridization signal for SP in a subpopulation of larger diameter neurons; following
transection'" 88 % of the cells with detectable SP mRNA are medium to large in size.
117
INTACT CUT
trkC LABELING INDEX (X background)
. ..
~::-.~.-;.~.~~;'n··: --.- - 0 -: - _ •• - - - 0 - -: •• - ~ - - -- - - ~. - - ~ - - -- - - -. - - 0 ~ - - -- - - -1
o 15 30 45 60 75 90~
~
00
&3
~]
d g
~~~ 0~ ro~~~C
~
CZl
140~ , -q----------------,
120 :
100 :'
80·· :.
...:.
60··· :
.. ,
40 :
.. ,
2°L: .o.~,:---0 - - - - - ~ -. i·O - -.i·' - • - - - .. - 0 - - o· 0 0 ~ - - - • - - - - 0 - - - - _ - • - - - - 0 _
o ' · IS"' 3"0·· 45 60'· '15 .
Figure 4.22 Relationship between relative levels of trkC and SP mRNA under normal and axotomized states.
Scatterplots demonstrate the relationship between trkC and SP labeling indices for 192-283 neurons identified in adjacent 6 Jlm
thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x axis) or SP (y
axis) mRNA under normal (intact) and 3 week axotomized (cut) conditions. Labeling index refers to the ratio of silver grain density
over neuropil devoid of positive hybridization signal (background) and reflects the relative level of indicated mRNA. For each plot,
neuronal profiles to the right of the dashed vertical line, and above the dashed horizontal line, are considered positive for trkC and SP
mRNA, respectively. The upper right quadrant of each plot encompasses neurons labeled for both markers.
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Figure 4.23 Relationship between perikaryal diameter and the relative level of SP
mRNA under normal and axotomized conditions for the total DRG and for the
trkC-positive subpopulation.
Scatterplots of labeling indices of 283 (intact) and 192 (cut) individual neurons
(of which 107/283 and 99/192 are trkC-positive) identified in adjacent 6 Jlm thick
sections of adult rat Ls DRG processed for in situ hybridization, and subsequent
radioautography, to detect SP and trkC mRNA. Graphs depict the relationship between
perikaryal diameter (x axis) and SP labeling indices (y axis), for the total population and
for the trkC-positive subpopulation. Panels show a comparison of data under normal
conditions (intact) and 3 week axotomized (cut). Labeling index refers to the ratio of
silver grain density over neuropil devoid of positive hybridization signal (background)
and reflects the relative level of SP mRNA. For each plot, neuronal profiles above the
dashed horizontal line are considered positive for SP mRNA.
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The post-trauma SP-positive population is principally composed of cells expressing trkC
message, representing -- 78% of SP-expressing neurons.
Scatterplots (e.g. Figure 4.24), comparing the relationship between SP and trkA
mRNA expression for individual neurons (2 DRG sections/treatment/probe, average 192
neurons/section) in the total DRG and for the trkC-positive subpopulation, indicate that
in the intact state -- 75% of SP-positive neurons coexpress trkA, with only -- 120/0 of the
SP population exhibiting detectable levels of both trkAand trkC transcripts. This group,
in which all of the markers trilocalize, expresses variable trkC, and moderate to high SP
and trkA, hybridization signal levels. Following axotomy, only -- 10% of the neurons
that display SP mRNA coexpress trkA, with the majority of SP-positive neurons now
exhibiting trkC message (-- 78%); -- 6% of the SP population express all three markers.
4.2.4.3 The Expression of SOM mRNA in the Intact State
High levels of hybridization signal for SOM are exhibited by a
small subpopulation of small- to medium-sized DRG neurons (Figure 4.25). There
appears to be limited, if any, colocalization between this neuropeptide and trkC mRNA.
4.2.4.4 The Expression of Galanin mRNA in the Intact State and
Following Axotomy
In the intact state, galanin mRNA is detectable in only a small
number of small-sized DRG neurons (Figure 4.26). Sciatic nerve transection results in a
dramatic increase in both the number of galanin-positive neurons and the level of
hybridization signal. Three weeks post-axotomy, neurons of all sizes now express the
peptide and there is significant overlap between these cells and the trkC-positive
subpopulation.
4.2.4.5 The Expression ofNPY mRNA in the Intact State and Following
Axotomy
Normal DRG neurons do not exhibit detectable NPY mRNA
(Figure 4.27). Three weeks following sciatic nerve transection, hybridization signal for
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Figure 4.24 Relationship between the relative levels of trkA and SP mRNA under
normal and axotomized conditions for the total DRG and for the trkC-positive
subpopulation.
Scatterplots of labeling indices of 228 (intact) and 156 (cut) individual neurons
(of which 79/228 and 82/156 are trkC-positive) identified in adjacent 6 Jlm thick
sections of adult rat Ls DRG processed for in situ hybridization, and subsequent
radioautography, to detect trkA, SP, and trkC mRNA. Graphs depict the relationship
between trkA (x axis) and SP labeling indices (y axis), for the total population and for
the trkC-positive subpopulation. Panels show a comparison of data under normal
conditions (intact) and 3 week axotomized (cut). Labeling index refers to the ratio of
silver grain density over neuropil devoid of positive hybridization signal (background)
and reflects the relative level of indicated mRNA. For each plot, neuronal profiles to the
right of the the dashed vertical line and above the dashed horizontal line are considered
positive for trkA and SP mRNA, respectively.
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Figure 4.25 Colocalization of 80M and trkC mRNA under normal conditions.
Scanned brightfield photomicrographs of serial 6 11m thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect SOM (upper panel) and trkC (lower
panel) mRNA under normal conditions. Scale bar = 30 11m.
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Figure 4.26 Colocalization of galanin and trkC mRNA under normal and axotomized
states.
Scanned brightfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect galanin (upper panel) and trkC (lower
panel) mRNA under normal conditions (intact) and 3 weeks following sciatic nerve transec-
tion (cut). Stars indicate neurons positive for both markers. Scale bar = 20 flm.
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Figure 4.27 Colocalization of NPY and trkC mRNA under normal and axotomized
states.
Scanned brightfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect NPY (upper panel) and trkC (lower
panel) mRNA under normal conditions (intact) and 3 weeks following sciatic nerve transec-
tion (cut). Arrows indicate neurons positive for both markers. Scale bar = 30 ~m.
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NPY is evident at moderate to high levels in a subpopulation of medium and large
neurons, many of which also coexpress trkC mRNA.
4.2.4.6 The Expression of VIP mRNA in the Intact State and Following
Axotomy
In the intact state, VIP mRNA is not detectable in DRG neurons
(Figure 4.28). Even though 3 weeks post-axotomy many neurons, representing all size
classes, exhibit moderate to high levels of hybridization signal for this peptide there is
no apparent overlap with the trkC-positive subpopulation.
4.2.5 Injury and Regeneration Associated Markers
4.2.5.1 The Expression of GAP-43 mRNA in the Intact State and
Following Axotomy
Hybridization signal detecting GAP-43 mRNA is present at
moderate to high levels in many intact DRG neurons and there is a limited overlap
between the GAP-43 positive and trkC-positive subpopulations (Figure 4.29). Following
axotomy message levels appear to increase dramatically, with virtually all neurons
expressing detectable levels of this marker.
Scatterplots (e.g. Figure 4.30), illustrating the relationship between trkC and
GAP-43 mRNA expression for individual neurons (2 DRG sections/treatment/probe,
average 243 neurons/section), demonstrate that under normal conditions,...., 600/0 of DRG
neurons exhibit detectable GAP-43 transcripts and that,...., 15% of neurons coexpress
GAP-43 and trkC mRNA. The GAP-43/trkC-positive subpopulation represents,...., 250/0 of
GAP-43 expressing, and ,....,35% of trkC-expressing, cells: There is no apparent
correlation between labeling index values for the two markers. There is also a subset of
neurons that do not exhibit detectable levels of either marker. Three weeks post-
axotomy, there is a notable increase in both the levels of GAP-43 hybridization signal
and in the number of neurons expressing GAP-43; transcripts are detectable in virtually
all neurons. The highest GAP-43 message levels are present in a subset of cells in which
trkC transcripts are not detectable and in a subset of cells with low levels of
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Figure 4.28 Colocalization of VIP and trkC mRNA under normal and axotomized
states.
Scanned brightfield photomicrographs of serial 6 /lm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect VIP (upper panel) and trkC (lower
panel) mRNA under normal conditions (intact) and 3 weeks following sciatic nerve transec-
tion (cut). Scale bar = 30 /lm.
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Figure 4.29 Colocalization ofGAP-43 and trkC mRNA under normal and axotomized
states
Scanned brightfield photomicrographs of serial 6 }lm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect GAP-43 (upper panel) and trkC (lower
panel) mRNA under normal conditions (intact) and 3 weeks following sciatic nerve transec-
tion (cut). Arrows indicate neurons positive for both markers. Scale bar = 30 }lrn.
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Figure 4.30 Relationship between relative levels of trkC and GAP-43 mRNA under normal and axotomized states.
Scatterplots demonstrate the relationship between trkC and GAP-43 labeling indices for 233-246 neurons identified in adjacent
6 Jlm thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x axis) or
GAP-43 (y axis) mRNA under normal (intact) and axotomized (cut) conditions. Labeling index refers to the ratio of silver grain
density over neuropil devoid of positive hybridization signal (background) and reflects the relative level of indicated mRNA. For each
plot, neuronal profiles to the right of the short-dashed vertical line, and above the short-dashed horizontal line, are considered positive
for trkC and GAP-43 mRNA, respectively. The long-dashed lines serve as references to facilitate data interpretation.
hybridization signal for trkC.
Scatterplots (e.g. Figure 4.31), comparing the relationship between perikaryal
diameter and GAP-43 mRNA expression for individual neurons (2 DRG
sections/treatment/probe, average 243 neurons/section) in the total DRG and for the
trkC-positive subpopulation, indicate that in the intact state the majority of small, a
subset of medium, and fewer large diameter neurons express GAP-43 mRNA. Three
weeks following sciatic nerve transection GAP-43 transcripts are detectable in almost all
neurons and although the mRNA is heterogenously expressed, a subset of small cells
display the highest levels of hybridization signal. GAP-43 mRNA levels in the trkC-
positive subpopulation, under both normal conditions and post-axotomy, reflect the
range of levels present in the DRG population as a whole.
4.2.5.2 The Expression of cjun mRNA in the Intact State and Following
Axotomy
Qualitative assessment of serial DRG sections show that in the
intact state the majority of neurons exhibit low levels of hybridization signal for cjun
(Figure 4.32). Following axotomy, there is a substantial increase in cjun mRNA levels.
Scatterplots (e.g. Figure 4.33), illustrating the relationship between trkC and cjun
mRNA expression for individual neurons (3 DRG sections/treatment/probe, average 206
neurons/section), demonstrate that under normal conditions,...., 55% of neurons possess
detectable levels of cjun transcripts and message expression is homogenous.
Approximately 30% of the DRG population coexpress cjun and trkC mRNA; this
subpopulation represents ,...., 53% of cjun-positive, and ,...., 72% of trkC-positive, cells.
Since there is little variation in cjun labeling index values within the trkC-positive
subset, there is no apparent correlation between levels of cjun and trkC transcripts. Three
weeks following axotomy, there is a substantial upregulation of basal cjun message
levels and virtually all neurons now express mRNA for the marker. Although the post-
trauma message levels of cjun are elevated compared to those of the intact state, labeling
index values remain more or less homogenous - except for a subset of cells lacking
detectable trkC transcripts that exhibits higher levels of cjun hybridization signal.
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Figure 4.31 Relationship between perikaryal diameter and the relative level of
GAP-43 mRNA under normal and axotomized conditions for the total DRG and
for the trkC-positive subpopulation.
Scatterplots of labeling indices of 246 (intact) and 233 (cut) individual neurons
(of which 116/246 and 147/233 are trkC-positive) identified in adjacent 6 j.lm thick
sections of adult rat Ls DRG processed for in situ hybridization, and subsequent
radioautography, to detect GAP-43 and trkC mRNA. Graphs depict the relationship
between perikaryal diameter (x axis) and GAP-43 labeling indices (y axis), for the total
population and for the trkC-positive subpopulation. Panels show a comparison of data
under normal conditions (intact) and 3 week axotomized (cut). Labeling index refers to
the ratio of silver grain density over neuropil devoid of positive hybridization signal
(background) and reflects the relative level of GAP-43 mRNA. For each plot, neuronal
profiles above the dashed horizontal line are considered positive for GAP-43 mRNA.
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Figure 4.32 Colocalization of cjun and trkC mRNA under normal and axotomized
states.
Scanned brightfield photomicrographs of serial 6 /lm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect cjun (upper panel) and trkC (lower
panel) mRNA under normal conditions (intact) and 3 weeks following sciatic nerve transec-
tion (cut). Arrowheads indicate neurons positive for both markers. Scale bar = 30 11m.
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Figure 4.33 Relationship between relative levels of trkC and cjun mRNA under normal and axotomized states.
Scatterplots demonstrate the relationship between trkC and cjun labeling indices for 156-188 neurons identified in adjacent 6
J.!m thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x axis) or
cjun (y axis) mRNA under normal (intact) and 3 week axotomized (cut) conditions. Labeling index refers to the ratio of silver grain
density over neuropil devoid of positive hybridization signal (background) and reflects the relative level of indicated mRNA. For each
plot, neuronal profiles to the right of the dashed vertical line, and above the dashed horizontal line, are considered positive for trkC
and cjun mRNA, respectively. The upper right quadrant of each plot encompasses neurons labeled for both markers.
Scatterplots (e.g. Figure 4.34), comparing the relationship between perikaryal
diameter and cJun mRNA expreSSIon for individual neurons (3 DRG
sections/treatment/probe, average 206 neurons/section) in the total DRG and for the
trkC-positive subpopulation, indicate that in the intact state cells exhibiting cjun
transcripts represent all sizes of neurons and that there are more small-sized than large
diameter perikarya that lack detectable cjun mRNA. After axotomy, virtually all DRG
neurons display moderate to high levels of hybridization signal for cjun. Within each
perikaryal size range neurons express a range of cjun hybridization signal levels,
although a greater number of small diameter, non-trkC-expressing cells appear to display
higher labeling indices for cjun. Within the trkC-positive subpopulation, cjun labeling
index values are representative of those exhibited by the DRG population as a whole.
4.2.6 The Expression of SNAP-25 mRNA in the Intact State
SNAP-25 transcripts are abundantly expressed in most DRG neurons,
although some neurons exhibit higher levels of hybridization signal than others - these
cells tend to coexpress trkC mRNA (Figure 4.35).
Scatterplots (e.g. Figure 4.36), delineating the relationship between trkC and
SNAP-25 mRNA expression for individual neurons (2 DRG sections/probe, average 208
neurons/section), demonstrate that under normal conditions all, or virtually all, neurons
exhibit detectable, though variable, levels of SNAP-25 hybridization signal. While trkC-
positive neurons display high levels of SNAP-25 hybridization signal, regardless of trkC
mRNA levels, a subset of these cells display SNAP-25 labeling indices higher than those
of the general DRG population. In contrast, a subgroup of neurons that lack detectable
trkC mRNA exhibit the lowest relative levels ofSNAP-25 hybridization signal.
Scatterplots (e.g. Figure 4.37), depicting the relationship between perikaryal
diameter and SNAP-25 mRNA expression for individual neurons (2 DRG
sections/probe, average 208 neurons/section), show that small diameter cells, typically
lacking detectable trkC mRNA, tend to express low SNAP-25 labeling indices; medium
and large neurons principally exhibit higher levels of SNAP-25 hybridization signal.
There is no apparent correlation between perikaryal diameter and SNAP-25 message
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Figure 4.34 Relationship between perikaryal diameter and the relative level of cjun
mRNA under normal and axotomized conditions for the total DRG and for the
trkC-positive subpopulation.
Scatterplots of labeling indices of 246 (intact) and 198 (cut) individual neurons
(of which 112/246 and 99/198 are trkC-positive) identified in adjacent 6 /-lm thick
sections of adult rat Ls DRG processed for in situ hybridization, and subsequent
radioautography, to detect cjun and trkC mRNA. Graphs depict the relationship between
perikaryal diameter (x axis) and cjun labeling indices (y axis), for the total population
and for the trkC-positive subpopulation. Panels show a comparison ofdata under normal
conditions (intact) and 3 week axotomized (cut). Labeling index refers to the ratio of
silver grain density over neuropil devoid of positive hybridization signal (background)
and reflects the relative level of cjun mRNA. For each plot, neuronal profiles above the
dashed horizontal line are considered positive for cjun mRNA.
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Figure 4.35 Colocalization of SNAP-25 and trkC mRNA under normal conditions.
Scanned brightfield photomicrographs of serial 6 J.lm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect SNAP-25 (upper panel) and trkC (lower
panel) mRNA under normal conditions. Stars indicate neurons positive for both markers.
Scale bar = 10 J.lm.
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Figure 4.36 Relationship between relative levels of trkC and SNAP-25 mRNA
under normal conditions.
Scatterplot demonstrates the relationship between trkC and SNAP-25 labeling
indices for 165 neurons identified in adjacent 6 flm thick sections of adult rat Ls DRG
processed for in situ hybridization, and subsequent radioautography, to detect trkC (x
axis) or SNAP-25 (y axis) mRNA under normal (intact) conditions. Labeling index
refers to the ratio of silver grain density over neuropil devoid of positive hybridization
signal (background) and reflects the relative level of indicated mRNA. Neuronal profiles
to the right of the dashed vertical line, and above the dashed horizontal line, are
considered positive for trkC and SNAP-25 mRNA, respectively, with the upper right
quadrant encompassing neurons labeled for both markers.
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Figure 4.37 Relationship between perikaryal diameter and the relative level of SNAP-25 mRNA under normal conditions for
the total DRG and for the trkC-positive subpopulation.
Scatterplots of labeling indices of 165 individual neurons (of which 72/165 are trkC-positive) identified in adjacent 6 /-lm thick
sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect SNAP-25 and trkC mRNA.
Graphs depict the relationship between perikaryal diameter (x axis) and SNAP-25 labeling indices (y axis), for the total population and
for the trkC-positive subpopulation under normal conditions (intact). Labeling index refers to the ratio of silver grain density over
neuropil devoid of positive hybridization signal (background) and reflects the relative level of SNAP-25 mRNA. For each plot,
neuronal profiles above the dashed horizontal line are considered positive for SNAP-25 mRNA.
levels in the trkC-positive subpopulation, with the majority of these cells expressing
high labeling index values for SNAP-25.
4.3 Discussion
4.3.1 trkC mRNA Expression In Adult Rat Lumbar DRG Neurons
Although transcripts of the NT-3 receptor, trkC, have been identified in a
subset of adult rat lumbar DRG neurons, reported percentages differ greatly, with from
10% (Mu et al., 1993), to 15-20% (McMahon et al., 1994; Wetmore and Olson, 1995;
Kashiba et al., 1996, 1997a), and up to 45% (Karchewski et al., 1999) of the total
population deemed to express this marker. Results here, indicating that,...., 400/0 of adult
rat lumbar DRG neurons exhibit detectable trkC mRNA, correspond most closely with
the latter findings (Karchewski et al., 1999), not a surprising observation since the same
animal Strain (Wistar), protocol, materials, and modes of analyses were used in both
cases. These findings are also supported by a study that indicates that of the,...., 40% of
lumbar DRG neurons that display NT-3-ir (Zhou and Rush, 1995; Chen et al., 1996),
trkC-ir colocalizes in,...., 95% of these cells (Chen et al., 1996).
The apparent discrepancies in the percentages of trkC-positive DRG neurons
identified by different research groups may be due to a number of factors. Most
importantly, even though all data were obtained through in situ hybridization studies
(Mu et al., 1993; McMahon et al., 1994; Wetmore and Olson, 1995; Kashiba et al.,
1996, 1997a; Karchewski et al., 1999), the protocols followed may have differed, with
some processing methods more sensitive to the detection of mRNA than others (Tecott
et al., 1987). Furthermore, when radioisotopic probes are used the length of time that the
radioautographs are exposed to emulsion before developing is also important in
distinguishing between cells with low levels of trkC transcripts and nonspecific,
background labeling. Several groups have reported uniformity of labeling intensities
among the trkC-positive subpopulation (Wetmore and Olson, 1995; Wright and Snider,
1995), which may reflect a technical limitation in their abilities to identify neurons with
low to near background levels of hybridization signal. Here, as for the findings of
Karchewski and coworkers (1999), ,...., 10% of trkC-expressing Ls DRG neurons are
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shown to exhibit relatively low signal levels for the receptor - a factor that may account
for the apparent inability of some researchers to detect trkC transcripts within these cells.
The small disparity between the number of trkC-positive neurons identified here
compared to that reported by Karchewski and colleagues (1999) (40% versus 450/0,
respectively) may be attributed to the need in this work to colocalize transcripts of one or
more markers with trkC mRNA in consecutive sections and to select DRG with a similar
plane of section for all experimental treatments examined in order to ensure comparable
ganglionic topography. In some instances, these considerations may have necessitated
the use of tissue with suboptimal radioautograph exposure to preserve the series, which
may have resulted in slightly reduced numbers of neurons exhibiting trkC hybridization
signal above detectable levels.
In spite of the interstudy variability in the reported percentages of trkC-positive
DRG neurons, all groups concur that the perikarya of these cells are primarily large-
sized (Mu et at., 1993; McMahon et at., 1994; Wetmore and Olson, 1995; Wright and
Snider, 1995; Kashiba et at., 1996, 1997a; Helgren et at., 1997; Karchewski et aI.,
1999). Here, in agreement with the observations of Karchewski and coworkers (1999), ,.....,
850/0 oftrkC-expressing cells possess medium to large diameter soma. Further, there is a
tendency for small neurons to exhibit relatively low levels of hybridization signal for
trkC mRNA and, although larger perikarya display variable labeling intensities, those
with the highest levels of labeling are of large diameter. These data parallel the findings
of a study wherein large diameter soma were moderately to heavily labeled with
radioiodinated NT-3 that had been injected into sciatic nerve, but small diameter
perikarya exhibited only moderate levels of labeling (Helgren et at., 1997). Also, I have
shown that three weeks following sciatic nerve transection levels of trkC hybridization
signal decrease, but the proportion of surviving neurons that are trkC-positive remains
comparable to that of the intact state, inferring a lack of bias for the loss or survival of
trkC-positive neurons. Similar data have been reported for the same and earlier post-
axotomy time points (McMahon et at., 1994; Jongsma Wallin et at., 2001).
These results, together with the data reported by Karchewski and colleagues
(1999), indicate that a far greater proportion (40-45%) of adult rat lumbar DRG neurons
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are trkC-positive than had been previously believed, and that these cells express a range
of in situ hybridization labeling intensities and include neurons of all sizes. Moreover,
while axotomy results in reduced levels of trkC expression in individual neurons, it does
not appear to alter the percentage of cells that exhibit transcripts for the receptor.
4.3.2 Colocalization oftrkC with trkA and p75
In this work'" 40% of adult rat Ls DRG neurons are shown to exhibit
detectable trkA mRNA - a finding supported by the literature, wherein 40-45% of
lumbar neurons are reported to possess high-affinity NGF binding sites (Richardson et
al., 1986; Verge et al., 1989a, 1989b, 1990b, 1992a) or to express trkA message (Verge
et al., 1992a, 1995; McMahon et al., 1994; Wetmore and Olson, 1995; Karchewski et
al., 1999). Further, as also shown here, there is consensus that the perikarya of these
cells are primarily small to medium in size (Richardson et al., 1986; Verge et al., 1989a,
1992a, 1992b; Mu et al., 1993; McMahon et al., 1994; Wetmore and Olson, 1995;
Kashiba et al., 1996; Karchewski et al., 1999).
There are a limited number of studies that concern the coexpression of trks in
adult DRG neurons. One experiment (DiStefano et al., 1992) demonstrated that although
retrogradely transported iodinated NT-3, NGF, and BDNF labeled neurotrophin-specific
subsets of neurons, the range of perikaryal sizes that each identified raises the possibility
of trk species colocalization. Similarly, in a study comparing the number of trk-positive
neurons in adult rat DRG sections hybridized with a cocktail containing probes for all
three known trks (66%) to the cumulative number of neurons labeled with the same
probes but for the individual trks (% trkA + % trkB + % trkC = 880/0), the greater
number of neurons identified in the latter analysis implies that overlapping expression of
the trks exists (McMahon et al., 1994). Moreover, two research groups have directly
demonstrated that a subset of primary sensory neurons coexpress trkA and trkC. Wright
and Snider (1995) describe a small subgroup of thoracic DRG neurons in which mRNAs
for the two receptor species colocalize. In a more detailed study, Karchewski et al.
(1999) showed that in adult rat L/Ls DRG '" 200/0 of neurons are trkA/trkC-positive;
these cells represent '" 50% of both the trkA- and trkC-expressing subpopulations.
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Further, they showed that within the trkA/trkC-positive subset, mRNAs for both markers
were expressed at variable levels, although many exhibited low levels of trkC
hybridization signal. Here, ""' 10% of Ls DRG neurons, representing""' 25% of the trkA-
and trkC-positive subpopulations, are shown to coexpress variable levels of trkA and
trkC transcripts. That a lower percentage of trkA/trkC-positive neurons has been
reported in this work is most likely a reflection of a failure to detect at least some cells
with low message levels of either marker (see Section 4.3.1). This is especially relevant
in the case of neurons that coexpress trkA and trkC, since a subset appear to exhibit
relatively low levels of hybridization signal for the latter receptor (Karchewski et al.,
1999). In agreement with the findings of Wright and Snider (1995), trkA/trkC-
expressing neurons are primarily medium-sized, with larger perikarya than most other
trkA-positive cells.
In addition to the trkA/trkC-expressing subset, trkC/trkB- and trkA/trkB-positive
subpopulations have been identified and represent ""' 18% and ""' 10% of LiLs DRG
neurons, respectively (Karchewski et al., 1999). In fact, their data indicate that the
colocalization of trks occurs more often than the expression of individual trk species in
adult rat lumbar DRG neurons (Karchewski et al., 1999). Moreover, the three trk species
trilocalize in 3-4% of these cells (Karchewski et al., 1999). These observations may
represent important phenomena in defining the NT-3 responsive subpopulation of DRG
neurons, given the reports of that neurotrophin binding to trkA and/or trkB under certain
conditions (Cordon-Cardo et al., 1991; Lamballe et al., 1991; Soppet et al., 1991;
Squinto et al., 1991) (see Section 1.1.2.1.1).
Also of interest is the report that an isofonn of trkA (trkAinserJ that appears to
bind NT-3 with high affinity in sympathetic neurons (Barker et al., 1993; Clary and
Reichardt, 1994) (see Section 1.1.2.1.1), is present in at least 90% of lumbar DRG
neurons that express trkA; relative levels of expression of both isofonns seem to be
positively correlated (Karchewski et al., 1999). These findings further increase the
potential that NT-3 can directly influence all, or most, trkA-positive neurons.
Here, in agreement with previous findings (Wetmore and Olson, 1995;
Karchewski et al., 1999), p75 mRNA is shown to be heterogenous1y expressed in ""' 80%
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of adult rat lumbar DRG neurons. Moreover, the reported tight correlation between trk
and p75 mRNA expression (Verge et al., 1992a; Wright and Snider, 1995; Karchewski
et al., 1999) appears to be maintained for trkC and p75, with the colocalization of p75
transcripts in virtually all trkC-positive neurons. These findings conflict with those of
Wright and Snider (1995), wherein only 50% oftrkC-expressing neurons were shown to
coexhibit p75 mRNA in adult rat thoracic DRG. Their use of a combination of isotopic
and nonisotopic probes to colocalize the two receptor species may have resulted in a
reduced ability to detect low levels of transcripts. Results here (e.g. Figure 4.8) show
that many trkC-positive cells, especially those with the highest levels of trkC
hybridization signal, exhibit relatively low labeling indices for p75 - these neurons
may therefore possess message levels below the detection limit of the digoxigenin-
labeled p75 probe used by Wright and Snider (1995). Their report that the majority of
trkA- or trkB-positive thoracic DRG neurons coexpress p75 does not contradict this
observation, since data here indicate that trkC/trkA-expressing cells tend to exhibit
higher levels of p75 hybridization signal than trkC-positive neurons that do not
coexpress trkA. Additionally, because in situ hybridization studies demonstrate p75
transcripts in '" 80% of DRG neurons (Wetmore and Olson, 1995; Karchewski et al.,
1999), while only", 60% of neurons have been shown to display detectable p75-ir in less
sensitive immunohistochemical analyses (Zhou et al., 1993, 1996a), indicates that some
neurons express relatively low levels ofp75.
The colocalization of trkC and p75 transcripts and the heterogeneous expression
of mRNA for these receptors in subsets of adult rat lumbar DRG neurons allow for the
possibility that individual neurons, or at least specific subpopulations of these cells
characterized on the presence and level of the receptors, may uniquely respond to NT-3.
Moreover, the potential for the coexistence of trkC, p75, trkA, and trkAinsert transcripts
further subdivides DRG neurons, creating micropopulations that potentially permit
population-specific responses to the neurotrophins; presumably the same would hold
true for the trkC/p75/trkB- and trkC/p75/trkB/trkA-positive subsets identified by
Karchewski and colleagues (1999). Such responses could be attributed to a number of
factors: The presence of p75 may influence the ability of ligand to bind to trk (Barker
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and Shooter, 1994; Kahle et al., 1994; Twiss et al., 1998; Wang et al., 1998) in either a
positive or negative manner, depending on neurotrophin concentration and the duration
of ligand availability (see Section 1.1.2.2.2). Further, at least for trkA and potentially for
the other trks, the ratio between trk and p75 appears to be important to establishing the
efficacy of the former receptor (see Section 1.1.2.2.2). Also, the presence in individual
neurons of multiple neurotrophin receptors that can bind NT-3 may allow for parallel
and/or synergistic downstream signal transduction pathways and effects or, conversely,
the NT-3 induced activation of multiple trk species may be redundant (see Section
1.1.2.1.2).
4.3.3 Characterization of the trkC-Positive Subpopulation with Respect to the
Expression of the Cytoskeletal Elements NFM and Tal a-tubulin
Neurofilaments are a class of intermediate filaments specific to neurons
and are an important component of the neuronal cytoskeleton (reviewed in: Fliegner and
Liem, 1991). They are assembled from three polypeptide subunits, defined according to
molecular weight and designated NF low/light (NFL), NF middle/medium (NFM), and
NF high/heavy (NFH), although the actual molecular weight of each varies between
species. In mammals, the molecular weights for NFL, NFM, and NFH range from 60-70
kDa, 130-170 kDa, and 180-200 kDa, respectively (reviewed in: Fliegner and Liem,
1991). A positive correlation has been demonstrated to exist between NF level and
perikaryal size (Sharp et al., 1982; Verge et al., 1990a; Tetzlaff et al., 1992), with even
the smallest diameter DRG neurons expressing low, but detectable levels of NFM
transcripts (Verge et al., 1990a). Similar observations are reported in this study. Further,
although there does not appear to be a correlation between the numbers of high-affinity
NGF-binding sites and NFM levels in primary sensory neurons (Verge et al., 1990a;
Tetzlaff et al., 1992), there is some degree of correlation between trkC and NFM
message levels. Here, small trkC-positive neurons are shown to express low levels of
trkC and NFM mRNAs, and although larger diameter neurons exhibit a range of trkC
labeling indices, those with the highest levels of hybridization signal for trkC tend to
have larger soma and higher NFM labeling indices. Moreover, because there is a tight
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correlation between NF level and axonal diameter (Friede and Samorajski, 1970; Weiss
and Mayr, 1971; Hoffman et al., 1987) and between perikaryal volume and fiber
conduction velocity (Harper and Lawson, 1985a, 1985b; Lee et al., 1986), these data
support the role of large diameter, high NFM- and trkC-expressing neurons as
mechanoceptors, and more specifically as proprioceptors (see Sections 2.2.2.1, 2.2.2.2).
Tubulin, which polymerizes to form microtubules, is itself formed from chains of
heterodimers of a- and p-tubulin (reviewed in: Baas, 1997). Neurons constitutively
express two isotypes of a-tubulin, T26 and Tal, although levels of the former remain
unchanged throughout development and during regeneration (Miller et al., 1987, 1989),
while those of the latter are upregulated under such circumstances (Miller et al., 1987,
1989, 1991; Mathew and Miller, 1990, 1993; Ma et al., 1992; Wu et al., 1993). p-tubulin
has also been shown to be upregulated in neurons following peripheral nerve injury
(Hoffinan et al., 1987, 1993; Hoffinan, 1989; Oblinger et al., 1989; Wong and Oblinger,
1990; Moskowitz et al., 1993). In this work, all Ls DRG neurons are shown to express
Tal a-tubulin mRNA in the intact state. This corresponds to a report indicating that
100% of DRG neurons, at all spinal levels, express a-tubulin (Boehmer et al., 1989),
and to the important role of microtubules in intracellular transport, axonal growth, and in
the neuronal cytoskeleton (reviewed in: Baas, 1997). Moreover, in this study the trkC-
positive subpopulation has been characterized as to Tal a-tubulin expression: Even
though in normal animals trkC transcripts are heterogenously expressed, Tal a-tubulin
mRNA expression in trkC-positive cells tends to be relatively homogenous, exhibiting
moderate labeling index values. A small subset of neurons, with relatively low levels of
hybridization signal for trkC and high levels of Tal a-tubulin message, is a notable
exception to this observation. Neurons with the highest Tal a-tubulin transcript levels
lack detectable trkC mRNA. Two weeks after sciatic nerve transection, Tal a-tubulin
message levels increase in all Ls DRG neurons, although smaller, trkC-negative neurons
still tend to exhibit the highest labeling indices for Tal a-tubulin.
4.3.4 Characterization of the trkC-Positive Subpopulation with Respect to
Neuropeptide Expression
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Although it is often thought that large diameter, potentially trkC-positive
primary sensory neurons do not tend to express neuropeptides, this study examined the
potential colocalization between several of these markers and trkC.
The neuropeptides CGRP and SP exhibit both a commonality of function and a
high degree of colocalization. Including a putative role in nociception (Wiesenfeld-
Hallin et al., 1994; Bennett et al., 2000a; Zhang et al., 2001) shared with SP (Klein et
al., 1992; Mense et al., 1994; Neumann et al., 1996; Cao et al., 1998; De Filipe et a!.,
1998; Parker and Grillner, 1998; Nichols et al., 1999), CGRP can also potentiate the
algesic actions of SP (Wiesenfeld-Hallin et al., 1994). In addition, the neuropeptide has
been shown to inhibit bone resorption (Valentijn et al., 1997; Ballica et al., 1999) and to
stimulate endothelial cell proliferation (Haegerstrand et ai., 1990), two processes
potentially important in recovering from injury. Under normal conditions, 35-50% of
DRG neurons have been shown to express CGRP transcripts and/or protein (Ju et al.,
1987; McCarthy and Lawson, 1989; Nothias et ai., 1993; Zhou et al., 1993; Minichiello
et a!., 1995; Bergman et a!., 1996; Groves et al., 1996; Kashiba et al., 1997a; Bennett et
al., 1998), and this subset includes neurons of all sizes (Rosenfeld et al., 1983; Ju et al.,
1987; Noguchi et al., 1990a, 1990b; Nothias et al., 1993; Verge et al., 1995). Moreover,
depending upon the probe used, these observations may represent two distinct
subpopulations of neurons, since through alternative processing the gene encodes two
forms of the neuropeptide, a- and ~-CGRP (Amara et al., 1985). The two are
differentially expressed in adult rat (Noguchi et al., 1990a, 1990b; Verge et al., 1995),
with a-CGRP labeling,..., 36% of Ls DRG neurons of all sizes and ,..., 30% of primarily
small- and medium-sized cells exhibiting ~-CGRP mRNA (Noguchi et al., 1990a,
1990b). Here, ,..., 550/0 of adult rat Ls DRG neurons were found to possess transcripts
specific for a-CGRP; the greater number of labeled neurons in this study may be due to
increased sensitivity of the in situ hybridization technique (see Section 2.1.1.2). The
population includes many small and medium diameter neurons, with small cells
expressing low to moderate labeling indices and medium-sized neurons displaying
higher levels of hybridization signal for the neuropeptide. Further, trkC and a-CGRP
were shown to colocalize in a subset of neurons with small to large diameter perikarya,
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representing r-.; 8% of DRG, r-.; 16% of a-CGRP, and r-.; 22% of trkC-positive neurons.
These cells tended to exhibit low levels of hybridization signal for trkC and moderate
levels for a-CGRP.
SP functions as an excitatory neuropeptide in nociception (Klein et al., 1992;
Mense et al., 1994; Neumann et al., 1996; Cao et al., 1998; De Felipe et al., 1998;
Parker and Grillner, 1998; Nichols et al., 1999), but may also play a role in wound
healing since the neuropeptide has been shown to stimulate the proliferation of arterial
smooth muscle cells and skin fibroblasts in vitro (Nilsson et al., 1985). SP, and the
preprotachykinin gene that encodes it (Krause et al., 1987), have been detected in 20-
25% of DRG neurons (Boehmer et al., 1989; Bergman et al., 1996; Ji et al., 1996; Hall
et al., 1997; Ma and Bisby, 1998b); their perikarya are predominately small-sized
(Wiesenfeld-Hallin et al., 1984; Dalsgaard et al., 1985; Skofitsch and Jacobowitz, 1985;
Ju et al., 1987; Boehmer et aI., 1989; McCarthy and Lawson, 1989; Anand et al., 1991;
Villar et al., 1991; Noguchi et al., 1994; 1995; Verge et al., 1995; Bergman et al., 1996).
These observations on the SP-positive subset ofDRG neurons correspond to the findings
reported in this study. Further, r-.J 4% of Ls DRG neurons coexpress SP and trkC, which
represents r-.; 20% of the SP-positive and r-.J 12% of the trkC-positive subpopulations.
These neurons tend to have small soma and fall into two major groups - those with
moderate trkC and low to moderate SP labeling indices, and those with low trkC and
moderate to high SP labeling indices.
Virtually all SP-and most CGRP-positive cells have also been shown to display
high-affinity NGF binding sites (Verge et al., 1989a). Here, r-.J 63% of a-CGRP- and r-.J
75% of SP-positive neurons coexpress trkA mRNA, and trkC and trkA transcripts
colocalize in r-.; 11% of a-CGRP- and r-.; 12% of SP-expressing neurons. Although no
attempt was made to identify SP/a-CGRP/trkC-positive neurons, SP and a-CGRP may
coexist in at least a subset of these cells because the neuropeptides have been shown to
colocalize in many adult rat primary sensory neurons (Wiesenfeld-Hallin et al., 1984;
Skofitsch and Jacobowitz, 1985; Gibbins et al., 1987; Ju et al., 1987; Villar et al., 1989).
Moreover, there appears to be a few SP/trkC-positive, trkA-negative neurons (see Figure
4.24). These cells could represent the subset of SP-expressing neurons that appear to be
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trkC-dependent, but trkA-independent, described from experiments on trk/- and double
trk/- mice (Minichiello et al., 1995). Interestingly, even though a few a-CGRP/trkC-
positive, trkA-negative neurons were identified here (see Figure 4.20), a-CGRP
transcripts were not detected in trkA-1., trkA-1-/trkC-1-, or trkA-1-/trkB-1- animals and a-
CGRP expression in both trkC-I- and trkB-1- mice resembled that of wild-type
(Minichiello et al., 1995).
Following peripheral nerve injury, levels of SP and CGRP protein and mRNA
have been shown to decrease (Jessell et al., 1979; Tessler et al., 1985; Shehab and
Atkinson, 1986; Villar et al., 1989, 1991; Noguchi et al., 1990b, 1993, 1994, 1995;
Klein et a!., 1991; Inaishi et al., 1992; Hokfelt et al., 1993; Verge et al., 1995; Groves et
al., 1996; Ji et a!', 1996; Ma and Bisby, 1998a, 1998b). Contrary to, but concomitant
with this phenomenon, SP expression appears to be induced, albeit at low levels, in a
relatively small subpopulation of medium to large diameter neurons (Noguchi et al.,
1994, 1995; Ji et a!., 1996; Ma and Bisby, 1998a). In this study, the subset of neurons
that appear to exhibit injury-induced SP coexpress trkC mRNA, but seem to lack
detectable trkA transcripts. That such cells have been shown to project to the gracile
nucleus (Noguchi et al., 1995), part of the posterior column-medial lemniscus pathway,
further supports the identification of these neurons as part of the trkC-positive
subpopulation and their role in proprioception under normal conditions. Recently,
similar observations were made for a subset of medium to large diameter DRG neurons
in which CGRP mRNA is upregulated after sciatic nerve transection (Miki et al., 1998).
I failed to detect such a subpopulation in this study (data not shown). This is most likely
because under normal conditions many neurons that express a-CGRP exhibit very high
levels ofhybridization signal for the neuropeptide, and in this project it was necessary to
strike a compromise between minimizing silver grain overlap and detecting cells with
low levels of a-CGRP transcripts in order to allow for the calculation of labeling indices
(see Section 4.2.1). Presumably in having the injured ganglion section on the same slide,
and therefore exposed to the emulsion for the same length of time as normal tissue, very
low message levels of a-CGRP were not discernible from background, and the subset of
a-CGRP positive neurons was overlooked.
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Other neuropeptides are expressed by DRG neurons: A subset of mainly small
neurons display SOM protein and/or transcripts (Hokfelt et al., 1976; Price, 1985;
Tuchscherer and Seybold, 1985; Ju et al., 1987) and represent between 5-10% of lumbar
DRG neurons in nonnal animals (Boehmer et al., 1989; Verge et al., 1995; Bergman et
al., 1996; Kashiba et al., 1997a; Bennett et al., 1998). This study yielded similar results,
but as appears to be the case for trkA (Verge et al., 1995), I was unable to colocalize
trkC and SOM mRNAs. Somatostatinergic neurons have recently been shown to
coexpress receptor components for a trophic factor unrelated to the neurotrophins,
GDNF (Bennett et al., 1998).
In nonnallumbar DRG, galanin mRNA and/or protein has been detected in 3-7%
of neurons (Hokfelt et al., 1987; Bergman et al., 1996; Ji et al., 1996; Thompson et al.,
1998b), primarily with small soma (Hokfelt et a!., 1987; Zhang et al., 1993a;
Wiesenfeld-Hallin et al., 1994; Verge et al., 1995; Ji et al., 1996; Thompson et al.,
1998b; Hao et al., 1999; Landry et al., 2000). Results presented here are in accord with
those described above, with the additional observation that there is no apparent overlap
between the trkC- and galanin-expressing subpopulations. Peripheral nerve injury effects
an upregulation in galanin (Hokfelt et al., 1987; Villar et al., 1989, 1991; Anand et al.,
1991; Noguchi et al., 1993; Wiesenfeld-Hallin et al., 1994; Comess et al., 1996;
Thompson et al., 1998b; Shi et al., 1999; Landry et al., 2000), such that signal levels are
increased and the neuropeptide is expressed in many neurons, of all sizes (Noguchi et
al., 1993; Zhang et al., 1993a; Verge et al., 1995; Comess et al., 1996; Ji et al., 1996;
Hao et al., 1999). The number of galanin-positive DRG neurons increases over time
post-trauma; 3 days following sciatic nerve transection'" 25% of cells have been shown
to express galanin (Ji et al., 1996), by day 7 '" 35% exhibit galanin mRNA (Noguchi et
al., 1993), but 2 weeks after axotomy galanin message has been detected in '" 800/0 of
neurons (Verge et al., 1995). Again, results from this study concur with previous reports.
Further, unlike in nonnal animals, 3 weeks post-axotomy galanin and trkC transcripts
are shown here to frequently colocalize. The principal role for galanin appears to be in
inhibiting nociception and preventing allodynia (Villar et al., 1989; Wiesenfeld-Hallin et
al., 1994; Hao et al., 1999; Shi et al., 1999; Xu et al., 2000; reviewed in: Bartfai et al.,
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1992, 1993; Wiesenfeld-Hallin et al., 1992; Bedecs et al., 1995). In addition, the
neuropeptide also has been shown to function in learning and memory (Ogren et al.,
1992).
NPY is rarely detected in DRG neurons of normal animals (Zhang et al., 1993a;
Ohara et al., 1994; Verge et al., 1995; Corness et al., 1996; Ji et al., 1996; Thompson et
al., 1998b; Li et al., 1999b; Landry et al., 2000). But following peripheral axotomy,
many large and some medium diameter neurons exhibit NPY mRNA and protein
(Wakisaka et al., 1991, 1992; Frisen et al., 1992; Noguchi et al., 1993; Zhang et al.,
1993a; Ohara et al., 1994; Verge et al., 1995; Corness et al., 1996; Ji et al., 1996;
Thompson et al., 1998b; Cougnon-Aptel et al., 1999; Li et al., 1999b; Marchand et al.,
1999; Shi et al., 1999; Landry et al., 2000); 25-50% of DRG neurons have been shown
to express NPY message 3 days to 2 weeks post-injury (Noguchi et al., 1993; Verge et
al., 1995; Corness et al., 1996; Ji et al., 1996). Here, similar findings are reported, with
the additional observation that 3 weeks after sciatic nerve transection many NPY-
positive neurons now are labeled for trkC mRNA. NPY appears to act as an analgesic
(Walker et al., 1988; Duggan et al., 1991; Hua et al., 1991; Mantyh et al., 1994;
Naveilhan et al., 2001), potentially through the inhibition of SP release (Walker et al.,
1988; Duggan et al., 1991). Moreover, the neuropeptide may be important to neuronal
regeneration (White and Mansfield, 1996).
Like NPY, VIP mRNA and protein have been detected in a minimal number of
DRG neurons in normal animals (Ju et al., 1987; Noguchi et al., 1993; Zhang et al.,
1993a; Wiesenfeld-Hallin et aL, 1994; Verge et al., 1995), but as early as 3 days post-
axotomy many small and medium diameter perikarya now exhibit VIP (1u et al., 1987;
Noguchi et al., 1993; Zhang et al., 1993a; Wiesenfeld-Hallin et al., 1994; Verge et al.,
1995) and by 2 weeks post-injury they represent 20-35% of the total DRG population
(Noguchi et al., 1993; Verge et al., 1995). Data from this study support the previous
reports but, in addition, indicate that VIP and trkC mRNAs do not appear to be
coexpressed in injured DRG n(;mrons. VIP has been identified as having roles in such
varied processes as nociception (Wiesenfeld-Hallin et al., 1994; Dickinson et al., 1999),
stimulation of neuronal regeneration (Shehab and Atkinson, 1986; White and Mansfield,
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1996), and memory and learning (Magistretti et al., 1998; Blondel et al., 2000).
As is the case for SP and CGRP (see above and Section 2.2.2.2), other
neuropeptides are expressed in both overlapping and unique subpopulations of sensory
neurons (Hokfelt et al., 1976, 1994b; Dalsgaard et al., 1982; Leah et al., 1985a, 1985b;
Gibbins et al., 1987; Ju et al., 1987; Villar et al., 1989; Kashiba et al., 1992b, 1994;
Zhang et al., 1993a; Heppelmann et al., 1994; Wiesenfeld-Hallin et al., 1994; Verge et
al., 1995; Landry et al., 2000). In adult rat DRG neurons, SP and CGRP have been
reported to colocalize with each other, and with galanin and VIP (Ju et al., 1987; Villar
et al., 1989; Verge et al., 1995). Furthermore, CGRP- and SOM-ir have been identified
in the same neuron (Ju et al., 1987), but there are conflicting reports as to whether SOM
colocalizes with SP (Ju et al., 1987) or not (Hokfelt et al., 1976; Verge et al., 1995).
SOM has also been shown to be coexpressed with VIP (Verge et al., 1995), but not with
galanin (Ju et al., 1987). In addition, although galanin colocalizes with CGRP (Ju et al.,
1987; Villar et al., 1989), SP (Ju et al., 1987), VIP (Kashiba et al., 1992b; Wiesenfeld-
Hallin et al., 1994), and NPY (Zhang et al., 1993a; Hokfelt et al., 1994b; Kashiba et al.,
1994; Landry et al., 2000); NPY has only been shown to be coexpressed with galanin
(Zhang et al., 1993a; Hokfelt et al., 1994b; Kashiba et al., 1994; Landry et al., 2000). In
spite of the putative roles of many of these neuropeptides in nociception, there does not
appear to be a clear relationship between sensory function and peptide expression, but
subsets of neurons, defined according to peptide content, can be linked to target
projection fields. A study comparing the expression patterns of four peptides associated
with nociceptive pathways (SP, CGRP, CCK, dynorphin) in DRG of guinea-pig showed
that subpopulations of neurons exhibiting various combinations of these markers
projected to specific peripheral targets (Gibbins et al., 1987): For the most part,
SP/CGRP/CCKldynorphin-positive cells projected to skin; SP/CGRP/CCK-positive,
dynorphin-negative neurons to small blood vessels of skeletal muscle;
SP/CGRP/dynorphin-positive, CCK-negative neurons to pelvic viscera and airways; and
SP/CGRP-positive, CCKldynorphin-negative cells innervating the heart and blood
vessels to viscera and sympathetic ganglia. Small subpopulations of neurons that
expressed only SP, CGRP, or CCK were also identified (Gibbins et al., 1987).
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Neuropeptides may also colocalize with neuropeptide receptors in sensory neurons
(Zhang et al., 1994b, 1995b, 1997; Xu et al., 1996; Landry et al., 2000, Naveilhan et al.,
2001). For example, of two major receptors for NPY (reviewed in: Wahlestedt and Reis,
1993; Blomqvist and Hertzog, 1997), Yl and Y2 are primarily expressed in small- and
medium-sized (Naveilhan et al., 1998, 2001; Landry et al., 2000) and medium to large
diameter (Zhang et al., 1997; Landry et al., 2000) neurons, respectively. Yl and SP
frequently colocalize (Naveilhan et al., 2001), and both Yl and Y2 are often expressed
by CGRP-, galanin-, and NPY-positive neurons (Zhang et al., 1994b, 1995b, 1997;
Landry et al., 2000). Further, transcripts for one type of galanin receptor, gal-Rl, are
found in '" 60% of neurons that exhibit CGRP message and the two markers colocalize
in over 95% of the gal-Rl expressing subpopulation (Xu et al., 1996). Moreover, since
trkC has been shown here to colocalize with SP, CGRP, galanin, and NPY there is the
potential for multiple neuropeptides and/or neuropeptide receptors to be coexpressed by
individual trkC-positive cells, with the variable peptide expression within the NT-3
responsive population possibly reflecting differences in sensory function between
subsets of these neurons.
4.3.5 Characterization of the trkC-Positive Subpopulation with Respect to the
Expression of the Injury and Regeneration Associated Markers GAP-43 and cjun
GAP-43 (B-50, Fl, pp46, pp57, neuromodulin) is an intracellular protein
with a distribution restricted to the nervous system (Basi et al., 1987; Karns et al., 1987;
Benowitz et al., 1988; Meiri et al., 1988), expressed not only in neurons, but also in
CNS and PNS glia (Deloulme et al., 1990; da Cunha and Vitkovic, 1990; Curtis et al.,
1992; Woolf et al., 1992b; Scherer et al., 1994). The marker is linked to axonal growth
and regeneration (reviewed in: De Graan et al., 1986; Basi et al., 1987; Benowitz and
Routtenberg, 1987; Skene, 1989). It is abundantly expressed during development
(Jacobson et al., 1986; Basi et al., 1987; Karns et al., 1987); levels decrease postnatally
(Hoffman, 1989), but are upregulated after peripheral nerve injury and remain high
during regeneration (Skene and Willard, 1981; Hoffman, 1989; Tetzlaff et al., 1989;
Verge et al., 1990b; Wiese et al., 1992; Schreyer and Skene, 1993; Groves et al., 1996;
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Verkade et aI., 1996; Andersen and Schreyer, 1999). Although GAP-43-ir is distributed
throughout the neuron, the highest levels are in growth cones (Meiri et aI., 1988;
Coggeshall et aI., 1991), where it appears to be associated with the cell membrane, not
the cytoskeleton (Skene and Virag, 1989; Meiri and Gordon-Weeks, 1990). GAP-43 is
important in neurite outgrowth: in vitro it has been shown to play roles in growth cone
formation (Aigner and Caroni, 1993), promoting neurite and growth cone adhesion
(Aigner and Caroni, 1995), potentiating the growth cone response to extrinsic signals
(Igarashi et al., 1995), and in the regulation of Go, a GTP-binding protein and major
growth cone component (Strittmatter et al., 1990). It has also been implicated in the
regulation of neurotransmitter release (Dekker et al., 1989), endocytosis and synaptic
vesicle recycling (Neve et aI., 1998), and in influencing neuronal survival (Gagliardini et
aI., 2000).
In normal rat lumbar DRG, 40-700/0 of neurons, primarily with small diameter
perikarya, exhibit detectable levels of GAP-43 (Verge et aI., 1990b; Schreyer and Skene,
1993; Liabotis and Schreyer, 1995; Groves et aI., 1996; Andersen and Schreyer, 1999),
but following peripheral axotomy all injured neurons express the marker (Hoffman,
1989; Verge et aI., 1990b; Tetzlaff et aI., 1992; Wiese et al., 1992; Schreyer and Skene,
1993; Liabotis and Schreyer, 1995; Andersen and Schreyer, 1999). Results presented in
this work are in agreement with these observations. Moreover, findings reported here
indicate that in the intact state, trkC colocalizes with GAP-43 in - 15% of Ls DRG
neurons, many of which exhibit low trkC and high GAP-43 labeling indices. At least a
portion of this subset may also coexpress trkA, since the majority of neurons expressing
high GAP-43 mRNA levels exhibit high-affinity NGF binding sites (Verge et al., 1990b;
Tetzlaff et aI., 1992), and because the two trks colocalize in 25-500/0 of trkA- and/or
trkC-positive neurons (see Section 4.3.2). Others have shown the population of intact
sensory neurons expressing NGF receptors to be highly plastic, readily undergoing
collateral sprouting in response to NGF (Diamond et aI., 1992a); the observation here
that - 85% of uninjured trkC-positive DRG neurons lack detectable GAP-43 transcripts
may reflect an apparent inability of NT-3 to influence neurite outgrowth (Kimpinski et
al., 1997).
152
Some immediate early genes (lEGs) encode transcription factors that upon site-
specific binding to target gene DNA, can activate or repress gene expression, and
although lEG transcription is induced both rapidly and transiently after noxious cellular
stimulation, their effects may contribute to long-term changes within the cell (reviewed
in: Sheng and Greenberg, 1990; Herdegen and Zimmermann, 1994b; Morgan and
Curran, 1995; Herdegen et al., 1997). One such lEG is cjun, which upon activation by
ATF-2 encodes the protein, cJUN, that serves in the regulation of apoptosis and cellular
differentiation, and is the primary transcription factor expressed following
neurodegenerative disorders - including multiple sclerosis, Alzheimer's disease,
ischemic insult, and nerve injury (reviewed in: Herdegen et al., 1997). Following the
activation of cJUN through cJUN NH2-terminal kinases (JNKs) (Hibi et al., 1993;
reviewed in: Kyriakis et al., 1994; Herdegen et al., 1997), the protein forms a
heterodimeric complex with one of several other lEG products, creating the transcription
factor, AP-l (activator protein-I) (Curran and Franza, 1988; reviewed in: Herdegen et
al., 1997). This complex binds to the AP-l DNA consensus element in the promoter
region of a target gene, therein regulating its transcription; the functional specificity of
the complex - including DNA binding affinity, stability of AP-l, and whether
positively or negatively regulating transcription - is dependent on the specific
combination of the components (Hai and Curran, 1991; Kerppola and Curran, 1994;
reviewed in: Herdegen and Zimmermann, 1994a; Herdegen et al., 1997).
Low basal levels of cjun mRNA and protein have been detected in normal adult
rat LiLs DRG (De Leon et al., 1995). Here, over half were found to exhibit transcripts
for the marker, with over half of these coexpressing trkC, and with no apparent
difference in cjun levels between the two populations. This number corresponds to the '"
600/0 of mouse L4 DRG neurons reported to exhibit cJUN-ir (Gold et al., 1994).
Following peripheral nerve injury, as described in the literature (Jenkins and Hunt, 1991;
Herdegen et al., 1992; De Leon et al., 1995) and demonstrated in this study, there is a
dramatic upregulation in cjun expression, notable as early as 2 hours post-axotomy
(Herdegen et al., 1992). Here, 3 weeks after sciatic nerve transection cjun transcripts are
detectable in all DRG neurons, with no apparent overall difference in levels of the
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marker between those that coexpress trkC and the majority of cells that lack the receptor.
The presence of a small subset of trkC-negative neurons that exhibit the highest cjun
labeling index values (see Figure 4.32) suggests that these cells are more susceptible to
stress (reviewed in: Herdegen et al., 1997) than the others, including those that express
trkC.
4.3.6 Characterization of the trkC-Positive Subpopulation with Respect to
SNAP-25 Expression
SNAP-25 (synaptosomal-associated protein, 25 kDa) (reviewed in:
Hodel, 1998), is an integral membrane protein that is widely, but differentially,
expressed by diverse subpopulations of mammalian neurons (Oyler et al., 1989).
Although its distribution is almost exclusively neural, SNAP-25 is also present in some
endocrine cells, including neutrophils and pinealocytes (Redecker et al., 1996, 1997;
Yamada et al., 1996; Nabokina et al., 1997). The protein plays a key role in vesicle-
membrane fusion and exocytosis as part of the SNARE [soluble NSF (N-
ethylmaleimide-sensitive fusion protein) attachment protein receptor] complex in
conjunction with syntaxin 1 and VAMP-2 (vesicle-associated membrane protein) (Hao
et ai., 1997; O'Conner et al., 1997; reviewed in: Sollner and Rothman, 1994; Emr and
Malhotra, 1997; Burgoyne and Morgan, 1998; Robinson and Martin, 1998). The
presence of highly concentrated SNAP-25-ir at nerve terminals (Catsicas et al., 1991; Li
et al., 1996), presumably mirrors, through its participation in the SNARE complex, its
critical role in the release of neurotransmitters (O'Conner et al., 1997; reviewed in:
Mochida, 2000), neuropeptides (Banetjee et al., 1996; Purkiss et al., 2000), and
neurotrophins (Blochl, 1998). SNAP-25 also appears to be important in membrane
expansion, and therefore in axonal elongation and potentially synaptic plasticity
(Catsicas et al., 1991; Gsen-Sand et al., 1993; Haruta et al., 1997; Igarashi et al., 1997;
Roberts et al., 1998). Its biological importance is underscored by the high degree of
sequence conservation between species (Catsicas et al., 1991), and the presence of
several SNAP-25 homologues. SNAP-23, and its murine equivalent syndet, performs a
role similar to that of SNAP-25, but is expressed by lymphocytes, fibroblasts, muscle,
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and adipocytes (Wang et al., 1997; Wong et al., 1997; Guo et al., 1998; Leung et al.,
1998; Rea et al., 1998); Vam7p is associated with vacuolar membranes and participates
in the vacuolar SNARE complex (Sato et al., 1998; Ungermann and Wiclmer, 1998).
In this study, SNAP-25 is shown to be heterogeneously expressed and detectable
in virtually all Ls DRG neurons. Further, while all trkC-positive neurons exhibit high
mRNA levels for the marker, a subset of medium to large diameter cells have the highest
SNAP-25 labeling index values; neurons that lack trkC transcripts express the lowest
message levels for SNAP-25. The presence of high levels of SNAP-25 mRNA in a
subset of trkC neurons may be a reflection of their sensory function. Rapidly adapting
mechanoceptors, including those that innervate muscle spindles, discharge rapidly and/or
frequently (Carr et al., 1989a), and because of this would presumably require high levels
of SNAP-25 for neurotransmitter release. Moreover, at least some of these neurons are
responsive to NT-3 (see Sections 2.2.2.1.1, 2.2.2.1.2, 2.2.2.2). Further to this, since
calcium plays an important role in vesicle release (Sollner and Rothman, 1994; Sheng
and Kim, 1996; Biirgoyne and Morgan, 1998), this subset of trkC-positive neurons
might represent the NT-3 responsive subpopulation that expresses one or more of the
calcium-binding proteins parvalbumin, calbindin, and calretinin (see Section 2.2.2.2).
4.3.7 Summary
Determining the role of NT-3 in adult primary sensory neurons
necessitates an understanding of the phenotype of the putative NT-3 responsive
population - the trkC-positive subset, which represents""" 40% of DRG neurons. Of the
thirteen markers examined in this study, eleven colocalized, at least in part, with
transcripts for trkC (Table 4.1). Coexpression ranged from including virtually all trkC-
positive cells (i.e. for p75, NFM, and Tal a-tubulin) to less than 15% oftrkC-expressing
neurons (i.e. for a-CGRP and SP), but even a small percentage equates to a significant
population, since it is estimated that 10,500-17,900 neuronal perikarya are housed in
individual adult rat LiLs DRG (Schmalbruch, 1987; Klein et al., 1991; Swett et al.,
1991; Tandrup, 1993). Together, these results indicate that whether under normal or
axotomized conditions, beyond the presence of trkC transcripts, no single marker can be
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Table 4.1 Summary of selected phenotypic markers expressed by DRG neurons with and without detectable levels of trkC mRNA in the adult rat.
INTACT AXOTOMIZED
MARK.ER % total DRG neurons % total DRG neurons coexpressing trkC % total DRG neurons % total DRG neurons coexpressing trkC
trkA ~40% (40-45%)1 ~1O% (~20%i ND ND
p75 ~80% (~80%)3 ~100% ND ND
NFM ~100% (~100%)4 ~100% ND ND
Tal a-tubulin ~100% (~100%)5 ~100% ~100% ~100%
a-CGRP ~55% (35-50%)6 ~8% ND ND
SP ~20% (20-25%)7 ~4% ~20% ~15%
SOM #, % ND (5-10%)8 *,%ND ND ND
galanin #, % ND (3-7%)9 *,%ND #, % ND (~80%)10 #,%ND
.....
NPY *, % ND (*)11 *,%ND #, % ND (25_50%)12 #,%ND
Vl VIP *, % ND (*)13 *,%ND #, % ND (20_35%)14 *,%ND0\
GAP-43 ~60% (40_70%)15 ~15% ~100% (~100%)16 ~100%
cjun ~55% (~60%)17 ~30% ~100% ~100%
SNAP-25 ~100% ~100% ND ND
Table illustrates the percentages of primary sensory neurons expressing selected phenotypic markers and the percentage of neurons in which that
marker colocalizes with trkC, under both normal (intact) and axotomized conditions. The first number or symbol in each cell represents findings of
this project (rat Ls DRG) and the second, enclosed in parentheses, those reported in the literature (murine DRG). "#" indicates that at least some
neurons express that marker; "*,, indicates that neurons rarely exhibit message for that marker or that transcripts were not detected; "ND"
indicates that data was not determined. I Verge et al., 1992a, 1995; McMahon et al., 1994; Wetmore and Olson, 1995; Karchewski et al., 1999. 2 Karchewski et al., 1999. 3 Wetmore
and Olson, 1995; Karchewskietal., 1999. 4Vergeetal., 1990a;Tetzlaffetal., 1992. 5 Boehmeretal., 1989. 6Juetal., 1987; McCarthy and Lawson, 1989; Nothiasetal., 1993;Zhouetal., 1993;
Minichiello et al., 1995; Bergman et al., 1996; Groves et aI., 1996; Kashiba et al., 1997a; Bennett et al., 1998. 7 Boehmer et al., 1989; Bergman et al., 1996; Ji et al., 1996; Hall et al., 1997; Ma and
Bisby, 1998b. 8 Boehmer et aI., 1989; Verge et al., 1995; Bergman et al., 1996; Kashiba et al., 1997a; Bennett et al., 1998. 9 Hokfelt et aI., 1987; Bergman et al., 1996; Ji et al., 1996; Thompson et
al., 1998b.Boehmer. 10 Verge et aI., 1995. II Zhang et al., 1993a; Ohara et al., 1994; Verge et al., 1995; Comess et aI., 1996; Ji et al., 1996; Thompson et al., 1998b; Li et al., 1999b; Landry et aI.,
2000. 12 Noguchi et aI., 1993; Verge et al., 1995; Comess et al., 1996; Ji et aI., 1996. 13 Ju et al., 1987; Noguchi et al., 1993; Zhang et al., 1993a; Wiesenfeld-Hallin et aI., 1994; Verge et al., 1995. 14
Noguchi et al., 1993; Verge et aI., 1995. 15 Verge et al., 1990b; Schreyer and Skene, 1993; Liabotis and Schreyer, 1995; Groves et al., 1996; Andersen and Schreyer, 1999. 16 Hoffman, 1989; Verge et
al., 1990b; Tetzlaff et al., 1992; Wiese et al., 1992; Schreyer and Skene, 1993; Liabotis and Schreyer, 1995; Andersen and Schreyer, 1999. 17 Gold et al., 1994.
used to define the subgroup of primary sensory neurons responsive to NT-3. Rather, the
trkC-positive subset is made up of phenotypically unique micropopulations. Moreover,
understanding the importance of "NT-3 to mature DRO neurons is even more complex
because of its promiscuous nature - that of potentially binding to receptors other than
trkC (see Section 1.1.2.1.1). But do these subsets reflect functionally unique groups of
neurons? Even though trkC has classically been only associated with proprioception,
several other mechanoreceptor subtypes have been shown to be dependent upon NT-3
for normal formation (see Sections 2.2.2.1.1, 2.2.2.1.2, 2.2.2.2) and these sensory
neurons have been reported to exhibit complex phenotypes (Fundin et al.,1997a; Rice et
al.,1997). Although much has been accomplished here in gaining insight into the
phenotypic makeup of trkC-positive DRO neurons, further studies might involve
refining the definition of the micropopulations, that is to say examining potential overlap
between the markers and attempting to define their functional significance. A technical
advance in data analysis developed after the completion of this project, and therefore
used infrequently here, allows fi)r the direct comparison of markers X, Y, and Z in
individual cells, instead of the previous limitation of comparing X to Y, X to Z, and Y to
Z, which can obscure important data. For example, Figure 4.19 compares a-CORP and
trkC labeling indices for individual neurons in the total DRO and for the trkA-positive
subset. These two graphs demonstrate that virtually all of those neurons that coexpress
a-CORP and trkC also express trkA, and that trkC/trkA/ a-CORP-positive cells exhibit
low to moderate trkC, and high a-CORP, mRNA levels. Moreover, they indicate that the
highest levels of a-CORP transcripts are present in trkA-positive/trkC-negative neurons,
and that while there are trkA-positive/trkC-negative cells with a-CORP levels
comparable to those of trkA/trkC- positive neurons, the lowest levels of a-CGRP are
localized to a subset of trkA-positive cells that lack detectable trkC transcripts. Similar
trilocalization analyses should be performed for all markers of trkC-positive neurons in
order to better phenotypically define the different micropopulations that express trkC.
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5. THE EFFECT OF NT-3 INFUSION ON INJURED DRG NEURONS
5.1 Introduction
As demonstrated in this thesis (see Sections 4.2, 4.3), the subset of trkC-positive
DRG neurons may be divided into micropopulations, defined through the variable
expression ofphenotypic markers. However, although the data provide a characterization
of trkC-expressing neurons, there is limited published information concerning the in vivo
functioning of its ligand, NT-3, in adult primary sensory neurons (see Section 2.2.2.2).
One way to gain insight into the biological roles of the neurotrophins is to deprive DRG
neurons of their principal source of endogenous trophic factors via peripheral axotomy
and to then supply specific exogenous neurotrophin, comparing alterations in phenotypic
markers between the two conditions, and with uninjured tissue. Following peripheral
nerve transection, the surviving neurons undergo a series of predictable structural,
physiological, and biochemical changes (see Section 1.2.3.1), while successful
regeneration results in a complete to partial return towards the normal state, purportedly
due to a successful re-establishment of the retrograde transport of target-derived trophic
molecules (see Section 1.2.3.2). There is abundant experimental evidence that
reintroduction of NGF to axotomized DRG neurons mitigates many of the trauma-
induced alterations, in at least some cells (see Section 1.2.3.2). But, since NGF high-
affinity binding sites or trkA are present in only", 400/0 of adult DRG neurons
(Richardson et al., 1986; Verge et al., 1989a, 1989b, 1990a, 1990b, 1992a; Mu et al.,
1993; McMahon et al., 1994; Wetmore and Olson, 1995; Wright and Snider, 1995;
Bennett et al., 1996a; Kashiba et al., 1996, 1997a; Karchewski et al., 1999), those non-
trkA-expressing/trk-positive cells (McMahon et al., 1994; Wetmore and Olson, 1995;
Wright and Snider, 1995; Kashiba et al., 1996, 1997a; Karchewski et al., 1999)
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presumably respond to other molecules and, because an individual neuron may possess
more than one trk species (Mu et al., 1993; McMahon et al., 1994; Wright and Snider,
1995; Karchewski et al., 1999), one can expect to encounter both unique and
overlapping fonns ofcellular phenotype regulation by the various neurotrophins. Indeed,
it has been shown that a number of unidentified genes are differentially regulated by
NGF and NT-3 (Friedel et al., 1997). Here, a similar experimental paradigm, a 2 week
peripheral axotomy followed by a 1 week intrathecal infusion ofNT-3, will be employed
in order to examine the role of this neurotrophin in the maintenance of adult primary
sensory neuron phenotype.
5.2 Results
5.2.1 Technical Considerations
See Section 4.2.1.
5.2.2 Neurotrophin Receptors
5.2.2.1 The Effect ofAxotomy and Subsequent Delayed Intrathecal
Infusion ofNT-3 on trkC mRNA Levels
Qualitative assessment of radioautographs of 6 Ilm thick sections
of adult rat Ls DRG processed for in situ hybridization to detect trkC mRNA show that
while hybridization signal intensity decreases 3 weeks following sciatic nerve
transection, a delayed 7 day 600 ng/J-tllh intrathecal infusion ofNT-3 is at least partially
effective in counteracting the reduction in neuronal expression oftrkC (Figure 5.1).
Scatterplots (e.g. Figure 5.2) constructed from data obtained through quantitative
analysis of labeling indices of individual neurons identified in 6 Ilm thick DRG sections
(16 DRG sections/treatment, average 218 neurons/section) processed for in situ
hybridization, and subsequent radioautography, illustrate the relationship between
perikaryal diameter and trkC mRNA expression in the intact state and under axotomized
and axotomizedlNT-3 infused conditions. These graphs show that while levels of
hybridization signal for trkC range from low to high in the intact state, 3 weeks
following sciatic nerve transection trkC signal levels decrease. A 7 day intrathecal
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Figure 5.1. Expression oftrkC mRNA under normal and axotomized conditions and following intrathecal infusion ofNT-3.
Scanned darkfield photomicrographs of 6 Ilm thick sections of adult rat Ls DRG processed for in situ hybridization to detect trkC
mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng/Illih intrathecal
infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 200 Ilm.
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Figure 5.2 Relationship between perikaryal diameter and the relative level of trkC mRNA under the following conditions:
normal, axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots of labeling indices of 186-246 individual neurons identified in 6 f.lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect trkC mRNA, depict the relationship between perikaryal diameter
(x axis) and trkC labeling indices (y axis). Panels show a comparison of data under normal conditions (intact), 3 week axotomized
(cut), and 3 week axotomized with intrathecal infusion of 600 ng/JlI/h NT-3 for the final 7 days (cut + NT-3). Labeling index refers to
the ratio of silver grain density over neuropil devoid of positive hybridization signal (background) and reflects the relative level of
indicated mRNA. For each plot, neuronal profiles above the short-dashed horizontal line are considered positive for trkC mRNA. The
long-dashed lines serve as references to facilitate data interpretation.
infusion of NT-3, 2 weeks following axotomy, appears to mitigate the injury-reduced
levels of trkC mRNA, although message levels for this receptor do not reach those
observed in the intact state.
Figure 5.3 highlights the trend in changes in levels of trkC mRNA expression
following axotomy and the effect of a post-trauma, 7 day intrathecal infusion of NT-3
for six replicate data sets. Whereas properties inherent to the technique of in situ
hybridization do not allow for the comparison of silver grain densities between replicates
(see Section 3.2.5), these graphs provide a summary of the data seen in the panel of
scatterplots for each replicate set (e.g. Figure 5.2). The median and the 25th and 75 th
percentile values for trkC mRNA labeling are plotted for each treatment condition
(intact, cut, cut plus NT-3) for each replicate. Although the return towards normal trkC
mRNA levels is clearly evident in the graph representing trkC labeling indices for all
identified trkC-positive neurons, the effect of NT-3 infusion appears more pronounced
when only those neurons with moderate to heavy levels of hybridization signal for trkC
are considered. In five out of six of cases, the difference in trkC labeling indices between
axotomized and axotomizedlNT-3 infused tissues is statistically significant (Mann-
Whitney U Test, p<0.05). Data from the six replicates represent analyses of tissues from
four different animals; replicates two, four, and six represent analyses of tissue sections
from the same animal.
5.2.2.2 The Effect ofAxotomy and Subsequent Delayed Intrathecal
Infusion ofNT-3 on p75 mRNA Levels
The low-affinity neurotrophin receptor is heterogenously
expressed by a large number ofDRG neurons (Figure 5.4). Axotomy results in decreased
p75 mRNA levels and a delayed 7 day intrathecal infusion ofNT-3 appears to partially
reverse this effect, within at least a subpopulation of neurons.
Scatterplots (e.g. Figure 5.5), illustrating the relationship between perikaryal
diameter and p75 mRNA expression for individual neurons identified in DRG sections
(4 DRG sections/treatment, average 220 neurons/section), show that in the intact state ,...,
80% of DRG neurons exhibit detectable p75 message levels. Although p75 mRNA is
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Figure 5.3 The effect of intrathecal infusion of NT-3 on trauma-reduced trkC mRNA levels.
Left graph depicts the relative differences in trkC labeling indices between normal (intact), 3 week axotomized (cut), and 3
week axotomized with delayed 7 day intrathecal infusion ofNT-3 (cut + NT-3) treatments, for those neurons expressing trkC mRNA.
Right graph shows the relative differences in trkC labeling indices for the same data sets, but only for neurons with moderate to heavy
trkC mRNA levels. Since the data are not normally distributed, median labeling indices are presented instead of means. The error bars
represent the labeling indices of neurons falling between 25% and 75% of the median. In each of the replicates, trkC labeling indices
for individual neurons were determined from image analysis of 6 f.lm thick sections of adult rat Ls DRG processed for in situ
hybridization, and subsequent radioautography, to detect trkC. Labeling index refers to the ratio of silver grain density over neuropil
devoid of positive hybridization signal (background) and reflects the relative level of indicated mRNA. Asterisk indicates significant
difference between axotomized and axotomized plus NT-3 infused treatments (Mann-Whitney U Test, P<0.05). Sample sizes (number
of neurons) for each treatment are indicated below each replicate. Total number of neurons identified and analyzed for replicates 1-6
(intact, cut, cut + NT-3) are as follows: 283, 192,200; 298, 195, 175; 246, 233, 207; 291, 283, 256; 304, 195, 328; 246, 198, 186.
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Figure 5.4 Expression of p75 mRNA under normal and axotomized conditions and following intrathecal infusion of NT-3.
Scanned darkfield photomicrographs of 6 /lm thick sections of adult rat Ls DRG processed for in situ hybridization to detect p75
mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng//lllh intrathecal
infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 200 /lm.
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Figure 5.5 Relationship between perikaryal diameter and the relative level of p75 mRNA under the following conditions:
normal, axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots of labeling indices of 131-210 individual neurons identified in 6 /-lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect p75 mRNA, depict the relationship between perikaryal diameter (x
axis) and p75 labeling indices (y axis). Panels show a comparison of data under normal conditions (intact), 3 week axotomized (cut),
and 3 week axotomized with intrathecal infusion of 600 ng//-ll/h NT-3 for the final 7 days (cut + NT-3). Labeling index refers to the
ratio of silver grain density over neuropil devoid of positive hybridization signal (background) and reflects the relative level of p75
mRNA. For each plot, neuronal profiles above the short-dashed horizontal line are considered positive for p75 mRNA. The long-
dashed lines serve as references to facilitate data interpretation.
heterogenously expressed by neurons of all size ranges, those with the highest level of
hybridization signal tend to be medium-sized, with small and large diameter perikarya
exhibiting lower p75 labeling indices. Three weeks after axotomy p75 mRNA levels
decrease dramatically, with virtually all p75-positive cells now expressing low to
moderate levels of hybridization signal. Additionally, there is a trauma-induced
reduction in the number of neurons with detectable hybridization signal; ,...., 55% of
surviving neurons exhibit p75 mRNA. Following sciatic nerve transection, in addition to
the small-sized cells observed under normal conditions, a subpopulation of medium and
large diameter neurons do not express detectable levels of hybridization signal for p75.
Exogenous NT-3, supplied 2 weeks after injury, appears to result in heightened p75
message levels and this increase is most conspicuous in medium and large diameter
cells. The infusion also seems to increase the percentage of surviving neurons with
detectable p75 hybridization signal (,...., 62%). Neither the labeling indices for p75, nor the
percentage ofp75-positive neurons, return to normal, pre-axotomy values.
Scatterplots (e.g. Figure 5.6), demonstrating the relationship between trkC and
p75 mRNA expression for individual neurons (4 DRG sections/treatment/probe, average
220 neurons/section), indicate that there is a subset of neurons that coexpress the
message for both of these NT-3 receptors. Under normal conditions, the majority of
trkC-positive neurons express detectable p75 mRNA. There is also a subgroup of cells
that exhibit p75 message but do not express hybridization signal for trkC and one that
lacks detectable transcripts for either receptor. Message levels for both markers decrease
following axotomy. A 1 week infusion of NT-3 appears to off set the injury-induced
reduction in p75 and trkC mRNA levels; the increase in p75 message expression seems
to be most evident in the trkC-positive subpopulation.
Figures 5.7 highlights the trend in changes in p75 mRNA expression following
axotomy and the effect of a post-trauma, 7 day intrathecal infusion of NT-3 for the
subpopulation of trkC-positive neurons in 4 replicate data sets. Following sciatic nerve
transection there is a dramatic reduction in the median and 25 th and 75th percentile values
for p75labeling indices. Post-injury, delayed infusion ofNT-3 results in median labeling
index values equal to, or greater than, those recorded for the intact state, in three out of
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Figure 5.6 Relationship between the relative levels of trkC and p75 mRNA under the following conditions: normal,
axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots demonstrate the relationship between trkC and p75 mRNA labeling indices for 195-328 neurons identified in
adjacent 6 f.lm thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x
axis) or p75 (y axis) mRNA under normal conditions (intact), 3 week axotomized (cut), and 3 week axotomized with intrathecal
infusion of 600 ng1f.lI/h NT-3 for the final 7 days (cut + NT-3). Labeling index refers to the ratio of silver grain density over neuropil
devoid of positive hybridization signal (background) and reflects the relative level of indicated mRNA. For each plot, neurons to the
right of the short-dashed vertical line, and those above the short-dashed horizontal line, are considered positive for trkC and p75
mRNA, respectively. The long-dashed lines serve as references to facilitate data interpretation.
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Figure 5.7 The effect of intrathecal infusion of NT-3 on trauma-reduced p75
mRNA levels in neurons expressing trkC mRNA.
Graph depicts the relative differences in p75 mRNA labeling indices between
intact, 3 week axotomized, and 3 week axotomized with delayed 7 day intrathecal
infusion of NT-3 treatments, for those neurons expressing trkC mRNA. Since the data
are not normally distributed, median labeling indices are presented instead of means.
The error bars represent the labeling indices of neurons falling between 25% and 75% of
the median. In each of the replicates, p75 and trkC labeling indices for individual
neurons were determined from inlage analysis of adjacent 6 J-lm thick sections of adult
rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to
detect trkC or p75 mRNA. Labeling index refers to the ratio of silver grain density over
neuropil devoid of positive hybridization signal (background) and reflects the relative
level of indicated mRNA. Asterisk indicates significant difference between axotomized
and axotomized plus NT-3 infused treatments (Mann-Whitney U Test, P<O.OOI). Sample
sizes (number of neurons) for each treatment are indicated below each replicate. Total
number of neurons identified and analyzed for replicates 1-4 (intact, cut, cut + NT-3) are
as follows: 210, 146, 131;304, 195,329;296, 194,233;209, 174, 165.
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four replicates. In all cases, for the trkC-positive subpopulation, the difference in p75
labeling indices between axotomized and axotomizedlNT-3 infused tissues is
statistically significant (Mann-Whitney U Test, p<O.OOI). Data from the four replicates
represent analyses of tissues from four different animals. For the same set of replicates,
but considering the subpopulation of neurons lacking detectable trkC mRNA (Figure
5.8), there is a substantial decrease in p75 transcript levels after axotomy, but median
p75 labeling index values following NT-3 infusion are greater than those of transection
alone in only one of four cases. This is also the only replicate in which the difference in
p75 labeling indices between axotomized and axotomizedlNT-3 infused tissues is
statistically significant (Mann-Whitney U Test, p<0.05).
5.2.3 Cytoskeletal Elements
5.2.3.1 The Effect ofAxotomy and Subsequent Delayed Intrathecal
Infusion ofNT-3 on NFM mRNA Levels
In the intact state, virtually all DRG neurons express moderate to
high levels of hybridization signal for NFM; a dramatic decrease in NFM mRNA
expression is evident 3 weeks following axotomy (Figure 5.9). Delayed NT-3 infusion
appears to counteract this decrease, although normal NFM message levels are not
reestablished.
Scatterplots (e.g. Figure 5.10) are used to illustrate the relationship between
perikaryal diameter and NFM mRNA expression for individual neurons (2 DRG
sections/treatment, average 264 neurons/section) under normal conditions and in
axotomized and axotomizedlNT-3 infused animals. In the intact state, NFM mRNA is
detectable in virtually all DRG neurons. The marker is heterogenously expressed, and
there seems to be a positive correlation between perikaryal diameter and NFM message
level. Three weeks following sciatic nerve transection, there is a notable decrease in
NFM mRNA expression and the number of neurons exhibiting detectable levels ofNFM
transcripts is reduced by '" 10%. Exogenous NT-3 appears to partially counteract the
axotomy-induced reduction in NFM mRNA levels and seem to influence the return in
the number ofcells with detectable NFM message towards normal.
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Figure 5.8 The effect of intrathecal infusion of NT-3 on trauma-reduced p75
mRNA levels in neurons not expressing detectable trkC mRNA.
Graph depicts the relative differences in p75 mRNA labeling indices between
intact, 3 week axotomized, and 3 week axotomized with delayed 7 day intrathecal
infusion of NT-3 treatments, for those neurons with near to below background labeling
for trkC mRNA. Since the data are not normally distributed, median labeling indices are
presented instead of means. The error bars represent the labeling indices of neurons
falling between 25% and 75% of the median. In each of the replicates, p75 and trkC
labeling indices for individual neurons were determined from image analysis of adjacent
6 /lm thick sections of adult rat Ls DRG processed for in situ hybridization, and
subsequent radioautography, to detect p75 or trkC mRNA. Labeling index refers to the
ratio of silver grain density over neuropil devoid of positive hybridization signal
(background) and reflects the relative level of indicated mRNA. Asterisk indicates
significant difference between axotomized and axotomized plus NT-3 infused
treatments (Mann-Whitney U Test, P<0.05). Sample sizes (number of neurons) for each
treatment are indicated below each replicate. Total number of neurons identified and
analyzed for replicates 1-4 (intact, cut, cut + NT-3) are as follows: 210, 146, 131; 304,
195,329;296,194,233;209,174,165.
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Figure 5.9 Expression of NFM mRNA under normal and axotomized conditions and following intrathecal infusion of NT-3.
Scanned darkfield photomicrographs of 6 J.1m thick sections of adult rat Ls DRG processed for in situ hybridization to detect trkC
mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng/J.1l/h intrathecal
infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 200 J.1m.
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Figure 5.10 Relationship between perikaryal diameter and the relative level of NFM mRNA under the following conditions:
normal, axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots of labeling indices of 187-373 individual neurons identified in 6 Ilm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect NFM mRNA, depict the relationship between perikaryal diameter
(x axis) and NFM labeling indices (y axis). Panels show a comparison of data under normal conditions (intact), 3 week axotomized
(cut), and 3 week axotomized with intrathecal infusion of 600 ng/J,!l/h NT-3 for the final 7 days (cut + NT-3). Labeling index refers to
the ratio of silver grain density over neuropil devoid of positive hybridization signal (background) and reflects the relative level of
NFM mRNA. For each plot, neuronal profiles above the short-dashed horizontal line are considered positive for NFM mRNA. The
long-dashed lines serve as references to facilitate data interpretation.
Scatterplots (e.g. Figure 5.11), demonstrating the relationship between trkC and
NFM mRNA expression for individual neurons (2 DRG sections/treatment/probe,
average 264 neurons/section), indicate that in the intact state NFM message is
heterogenously expressed by both neurons lacking detectable trkC mRNA and in the
trkC-positive subpopulation. Axotomy results in a striking reduction in the level ofNFM
transcripts. This loss in NFM mRNA expression can be at least partially reversed by
delayed infusion of NT-3 and this phenomenon appears to occur in both trkC-positive
cells and in at least a subset ofneurons that do not exhibit detectable trkC message.
Figure 5.12 highlights trends in alterations in NFM mRNA expression in the
trkC-positive subpopulation following axotomy and with a post-trauma, 7 day
intrathecal infusion of NT-3 for 2 replicate data sets. Three weeks following sciatic
nerve transection, a dramatic reduction in the median and 75th percentile NFM labeling
index values is evident; exogenous NT-3 effects an increase in both of these values. The
difference in NFM labeling indices between axotomized and axotomizedlNT-3 infused
tissues for neurons expressing detectable levels of trkC mRNA is statistically significant
for both replicates (Mann-Whitney U Test, p<O.OOl). Since in the intact state neurons
lacking detectable trkC transcripts tend to exhibit low to moderate levels of NFM
hybridization signal (Figure 5.11), the post-trauma diminished NFM message levels
appear less conspicuous here than for the cells that express trkC. Data from the two
replicates represent analyses of tissues from two different animals. For the same set of
replicates depicted in Figure 5.12, but considering only neurons that do not exhibit
detectable trkC mRNA, axotomy results in only a relatively modest reduction in median
NFM labeling index values (Figure 5.13). Infusion ofNT-3 appears to influence a return
towards normal median NFM labeling index values. In one of the two cases, the NFM
labeling index 75th percentile value for injuredlNT-3 infused tissues is greater than that
for the intact state, and it is for the same replicate that the difference in NFM labeling
indices between axotomized and axotomizedlNT-3 infused tissues is statistically
significant (Mann-Whitney U Test, p<O.05).
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Figure 5.11 Relationship between the relative levels of trkC and NFM mRNA under the following conditions: normal,
axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots demonstrate the relationship between trkC and NFM mRNA labeling indices for 187-373 neurons identified in
adjacent 6 Ilm thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x
axis) or NFM (y axis) mRNA under normal conditions (intact), 3 week axotomized (cut), and 3 week axotomized with intrathecal
infusion of 600 ng/IlI/h NT-3 for the final 7 days (cut + NT-3). Labeling index refers to the ratio of silver grain density over neuropil
devoid of positive hybridization signal (background) and reflects the relative level of indicated mRNA. For each plot, neurons to the
right of the short-dashed vertical line, and those above the short-dashed horizontal line, are considered positive for trkC and NFM
mRNA, respectively. The long-dashed lines serve as references to facilitate data interpretation.
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Figure 5.12 The effect of intrathecal infusion of NT-3 on trauma-reduced NFM
mRNA levels in neurons expressing trkC mRNA.
Graph depicts the relative differences in NFM mRNA labeling indices between
normal (intact), 3 week axotomized (cut), and 3 week axotomized with delayed 7 day
intrathecal infusion ofNT-3 (cut + NT-3) treatments, for the trkC-positive subpopulation
of neurons. Since the data are not normally distributed, median labeling indices are
presented instead of means. The error bars represent the labeling indices of neurons
falling between 25% and 75% of the median. In each of the replicates, NFM and trkC
labeling indices for individual neurons were determined from image analysis of adjacent
6 J..lm thick sections of adult rat Ls DRG processed for in situ hybridization, and
subsequent radioautography, to detect trkC or NFM mRNA. Labeling index refers to the
ratio of silver grain density over neuropil devoid of positive hybridization signal
(background) and reflects the relative level of indicated mRNA. Asterisk indicates
significant difference between axotomized and axotomized plus NT-3 infused treatments
(Mann-Whitney U Test, P<O.OOI). Sample sizes (number of neurons) for each treatment
are indicated below each replicate. Total number of neurons identified and analyzed for
replicates 1 and 2 (intact, cut, cut + NT-3) are as follows: 373, 195, 187; 291, 283, 256.
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Figure 5.13 The effect of intrathecal infusion of NT-3 on trauma-reduced NFM
mRNA levels in neurons not expressing detectable trkC mRNA.
Graph depicts the relative differences in NFM mRNA labeling indices between
intact, 3 week axotomized, and 3 week axotomized with delayed 7 day intrathecal
infusion of NT-3 treatments, for those neurons with near to below background labeling
for trkC mRNA. Since the data are not nonnally distributed, median labeling indices are
presented instead of means. The error bars represent the labeling indices of neurons
falling between 25% and 75% of the median. In each of the replicates, NFM and trkC
labeling indices for individual neurons were detennined from image analysis of adjacent
6 IJ,m thick sections of adult rat Ls DRG processed for in situ hybridization, and
subsequent radioautography, to detect NFM or trkC mRNA. Labeling index refers to the
ratio of silver grain density over neuropil devoid of positive hybridization signal
(background) and reflects the relative level of indicated mRNA. Asterisk indicates
significant difference between axotomized and axotomized plus NT-3 infused
treatments (Mann-Whitney U Test, P<O.05). Sample sizes (number of neurons) for each
treatment are indicated below each replicate. Total number of neurons identified and
analyzed for replicates 1 and 2 (intact, cut, cut + NT-3) are as follows: 373, 195, 187;
291, 283, 256.
176
5.2.3.2 The Effect ofAxotomy and Subsequent Delayed Intrathecal
Infusion ofNT-3 on Tal a-tubulin mRNA Levels
Although hybridization signal for Ta1 a-tubulin is expressed at
moderate to high levels in most DRG neurons in the intact state, 3 weeks post-axotomy
signal levels increase (Figure 5.14). Delayed intrathecal infusion of NT-3 appears to
result in a decrease in trauma-induced Ta1 a-tubulin message levels.
Scatterplots (e.g. Figure 5.15), depicting the relationship between perikaryal
diameter and Tal a-tubulin mRNA expression for individual neurons (4 DRG
sections/treatment, average 197 neurons/section), indicate that all DRG neurons exhibit
detectable Tal a-tubulin transcripts and that there seems to be a loose negative
correlation between Tal a-tubulin labeling indices and perikaryal diameter. Although
axotomy results in a general increase in Tal a-tubulin mRNA expression, small cells
still tend to possess the highest levels of hybridization signal for Tal a-tubulin, and
there is no change in the percentage of surviving neurons that express Tal a-tubulin
message. Intrathecal infusion ofNT-3 appears to result in a reduction of Tal a-tubulin
mRNA levels in all sizes of cells.
Scatterplots (e.g. Figure 5.16), illustrating the relationship between trkC and Tal
a-tubulin mRNA expression for individual neurons (2 DRG sections/treatment/probe,
average 238 neurons/section), show that under normal conditions the majority of trkC-
positive cells display relatively similar levels of Ta I a-tubulin hybridization signal,
regardless of the trkC message expression, and that the subgroup of neurons with the
highest Tal a-tubulin mRNA levels do not typically exhibit detectable trkC transcripts.
Following axotomy, message levels of Tal a-tubulin appear to increase in all neurons,
although a subpopulation of cells lacking detectable trkC mRNA still expresses the
highest levels of Tal a-tubulin transcripts. Exogenous NT-3 partially mitigates injury-
induced Tal a-tubulin message levels in the trkC-expressing population and also, to
some extent, in neurons that do not exhibit detectable trkC mRNA.
Figure 5.17 highlights the trend in changes in Tal a-tubulin mRNA expression
following axotomy and the effect of a post-trauma, 7 day intrathecal infusion of NT-3
for 4 replicate data sets. Three weeks following sciatic nerve transection, the median and
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Figure 5.14 Expression ofTa1 a-tubulin mRNA under normal and axotomized conditions and following intrathecal infusion of
NT-3.
Scanned darkfield photomicrographs of6 J.1m thick sections ofadult rat Ls DRG processed for in situ hybridization to detect Tal a-
tubulin mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng/J.1l1h
intrathecal infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 100 J.1m.
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Figure 5.15 Relationship between perikaryal diameter and the relative level of Tal a-tubulin mRNA under the following
conditions: normal, axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots of labeling indices of 184-286 individual neurons identified in 6 J-lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect Tal a-tubulin mRNA, depict the relationship between perikaryal
diameter (x axis) and Tal a-tubulin labeling indices (y axis). Panels show a comparison of data under nonnal conditions (intact), 3
week axotomized (cut), and 3 week axotomized with intrathecal infusion of 600 ng/}ll/h NT-3 for the final 7 days (cut + NT-3).
Labeling index refers to the ratio of silver grain density over neuropil devoid of positive hybridization signal (background) and reflects
the relative level of Tal a-tubulin mRNA. For each plot, neuronal profiles above the short-dashed horizontal line are considered
positive for Tal a-tubulin mRNA. The long-dashed lines serve as references to facilitate data interpretation.
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o Figure 5.16 Relationship between the relative levels oftrkC and Tal a-tubulin mRNA under the following conditions: normal,
axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots demonstrate the relationship between trkC and Tal a-tubulin mRNA labeling indices for 213-283 neurons
identified in adjacent 6 Jlm thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to
detect trkC (x axis) or Tal a-tubulin (y axis) mRNA under normal conditions (intact), 3 week axotomized (cut), and 3 week
axotomized with intrathecal infusion of 600 ng/JlI/h NT-3 for the final 7 days (cut + NT-3). Labeling index refers to the ratio of silver
grain density over neuropil devoid of positive hybridization signal (background) and reflects the relative level of Tal a-tubulin
mRNA. For each plot, neurons to the right of the short-dashed vertical line, and those above the short-dashed horizontal line, are
considered positive for trkC and Tal a-tubulin mRNA, respectively. The long-dashed lines serve as references to facilitate data
interpretation.
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Figure 5.17 The effect of intrathecal infusion of NT-3 on trauma-induced Tal
a-tubulin mRNA levels.
Graph depicts the relative differences in Tal a-tubulin mRNA labeling indices
between intact, 3 week axotomized, and 3 week axotomized with delayed 7 day
intrathecal infusion of NT-3 treatments. Since the data are not normally distributed,
median labeling indices are presented instead of means. The error bars represent the
labeling indices of neurons falling between 25% and 75% of the median. In each of the
four replicates, Tal a-tubulin labeling indices for individual neurons were determined
from image analysis of 6 Ilm thick sections of adult rat Ls DRG processed for in situ
hybridization, and subsequent radioautography, to detect Tal a-tubulin mRNA.
Labeling index refers to the ratio of silver grain density over neuropil devoid of positive
hybridization signal (background) and reflects the relative level of indicated mRNA.
Asterisk indicates significant difference between axotomized and axotomized plus NT-3
infused treatments (Mann-Whitney U Test, P<O.OOl). Sample sizes (number of neurons)
for each treatment are indicated below each replicate.
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the 25th and 75th percentile labeling index values for Tal a-tubulin increase over those
observed in the intact state. Delayed infusion of NT-3 partially mitigates the trauma-
induced levels of these values. In all cases, the difference in To.1 a-tubulin labeling
indices between axotomized and axotomized/NT-3 infused tissues is statistically
significant (Mann-Whitney U Test, p<O.OOI). Data from the four replicates represent
analyses of tissues from two different animals; replicates one and three represent
analyses of tissue sections from the same animal. A summary of the effect ofaxotomy
and the post-trauma infusion ofNT-3 on Tal a-tubulin message levels within the trkC-
positive subpopulation (Figure 5.18) shows that these data reflect the findings for the
general population (Figure 5.17). The same may be said for the data when only those
cells lacking detectable trkC hybridization signal are considered (Figure 5.19), although
the ability ofNT-3 to reduce Tal a-tubulin message levels appears to be less dramatic
than that seen in trkC-positive neurons. In both cases, for the subset of neurons
exhibiting trkC mRNA, the difference in Tal a-tubulin labeling indices between
axotomized and axotomized/NT-3 infused tissues is statistically significant (Mann-
Whitney U Test, p<O.OOI), while for neurons not expressing detectable trkC transcripts,
the difference in Tal a-tubulin labeling indices is statistically significant for only one of
the two replicate sets (Mann-Whitney U Test, p<0.05). Data from the two replicates
represent analyses of tissues from two different animals.
5.2.4 Neuropeptides
5.2.4.1 The Effect ofAxotomy and Subsequent Delayed Intrathecal
Infusion ofNT-3 on Galanin mRNA Levels
Only a small number of DRG neurons exhibit detectable levels of
galanin mRNA in the intact state (Figure 5.20) and there does not appear to be overlap
between this subset and the trkC-positive subpopulation (Figure 5.21). Three weeks after
sciatic nerve transection there is a notable increase in both the number of galanin-
positive neurons and the level of galanin message expression; post-axotomy there is
substantial colocalization of galanin and trkC mRNA. NT-3 infusion appears to partially
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Figure 5.18 The effect of intrathecal infusion of NT-3 on trauma-induced Tal a-
tubulin mRNA levels in neurons expressing trkC mRNA.
Graph depicts the relative differences in Tal a-tubulin mRNA labeling indices
between nonnal (intact), 3 week axotomized (cut), and 3 week axotomized with delayed
7 day intrathecal infusion of NT-3 (cut + NT-3) treatments, for those neurons
coexpressing trkC mRNA. Since the data are not nonnally distributed, median labeling
indices are presented instead of means. The error bars represent the labeling indices of
neurons falling between 250/0 and 75% of the median. In each replicate, Ta1 a-tubulin
and trkC labeling indices for individual neurons were detennined from image analysis of
adjacent 6 Jlm thick sections of adult rat Ls DRG processed for in situ hybridization, and
subsequent radioautography, to detect trkC or Tal a-tubulin mRNA. Labeling index
refers to the ratio of silver grain density over neuropil devoid of positive hybridization
signal (background) and reflects the relative level of indicated mRNA. Asterisk indicates
significant difference between axotomized and axotomized plus NT-3 infused treatments
(Mann-Whitney U Test, P<O.OOI). Sample sizes (number of neurons) for each treatment
are indicated below each replicate. Total number of neurons identified and analyzed for
replicates 1-2 (intact, cut, cut + NT-3) are as follows: 262,283,213; 286, 197, 184.
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Figure 5.19 The effect of intrathecal infusion of NT-3 on trauma-induced Tal
a-tubulin mRNA levels in neurons not expressing detectable trkC mRNA.
Graph depicts the relative differences in Tal a-tubulin mRNA labeling
indices between intact, 3 week axotomized, and 3 week axotomized with delayed 7
day intrathecal infusion of NT-3 treatments, for those neurons with near to below
background labeling for trkC mRNA. Since the data are not normally dis,tributed,
median labeling indices are presented instead of means. The error bars represent the
labeling indices of neurons falling between 25% and 75% of the median. In each
replicate, Tal a-tubulin and trkC labeling indices for individual neurons were
determined from image analysis of adjacent 6 J.lm thick sections of adult rat Ls DRG
processed for in situ hybridization, and subsequent radioautography, to detect Tal
a-tubulin or trkC mRNA. Labeling index refers to the ratio of silver grain density
over neuropil devoid of positive hybridization signal (background) and reflects the
relative level of indicated mRNA. Asterisk indicates significant difference between
axotomized and axotomized plus NT-3 infused treatments (Mann-Whitney U Test,
P<O.05). Sample sizes (number of neurons) for each treatment are indicated below
each replicate. Total number of neurons identified and analyzed for replicates 1-2
(intact, cut, cut + NT-3) are as follows: 262, 283, 213; 286, 197, 184.
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Figure 5.20 Expression of galanin mRNA under normal and axotomized conditions and following intrathecal infusion ofNT-3.
Scanned darkfield photomicrographs of6 Jlm thick sections ofadult rat Ls DRG processed for in situ hybridization to detect galanin
mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng/JlI/h intrathecal
infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 200 Jlm.
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Figure 5.21 Colocalization of galanin and trkC mRNA under normal and axotomized conditions and following intrathecal infusion
ofNT-3.
Scanned brightfield photomicrographs of serial 6 /lm thick adult rat Ls DRG sections processed for in situ hybridization to detect
galanin (upper panel) and trkC (lower panel) mRNA under normal conditions (intact), 3 weeks following sciatic nerve transection (cut),
and following a 7 day 600 ng//ll/h intrathecal infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Stars indicate neurons positive for
both markers. Scale bar = 20 /lm.
counteract the axotomy-induced upregulation of this neuropeptide, with the decrease in
galanin transcripts seemingly most dramatic within neurons coexpressing trkC mRNA.
5.2.4.2 The Effect ofAxotomy and Subsequent Delayed Intrathecal
Infusion ofNT-3 on NPY mRNA Levels
Under normal conditions few, if any, DRG neurons express
detectable levels of NPY mRNA (Figure 5.22). Three weeks post-axotomy, NPY
message is upregulated in many medium and large diameter neurons, and mRNA for the
neuropeptide strongly colocalizes with trkC message (Figure 5.23). Delayed intrathecal
infusion ofNT-3 for 7 days, 2 weeks after injury, partially mitigates the trauma-induced
levels of NPY transcripts. The decrease in NPY message seen following NT-3 infusion
in axotomized animals is most apparent in neurons that coexpress trkC mRNA.
5.2.4.3 The Effect ofAxotomy and Subsequent Delayed Intrathecal
Infusion ofNT-3 on VIP mRNA Levels
VIP transcripts are not detectable in normal DRG (Figure 5.24).
After axotomy, many small and medium size neurons exhibit moderate to high levels of
hybridization signal for the peptide, although there is no apparent overlap between VIP
and trkC mRNA expression (Figure 5.25). Exogenous NT-3 does not appear to affect the
injury-induced levels of VIP mRNA.
5.2.4.4 The Effect ofAxotomy and Subsequent Delayed Intrathecal
Infusion ofNT-3 on SOM mRNA Levels
A small number of DRG neurons express detectable SOM mRNA
under normal conditions and axotomy results in reduced message levels (Figure 5.26).
SOM-positive neurons are small to medium in size and transcript colocalization does not
appear to occur between this neuropeptide and trkC (Figure 5.27). NT-3 infusion has no
apparent influence on injury-reduced SOM expression.
5.2.5 Injury and Regeneration Associated Markers
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Figure 5.22 Expression ofNPY mRNA under normal and axotomized conditions and following intrathecal infusion ofNT-3.
Scanned stained darkfield photomicrographs of6 /-lm thick sections ofadult rat Ls DRG processed for in situ hybridization to detect
NPY mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng//-ll/h
intrathecal infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 200 /-lm.
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Figure 5.23 Colocalization ofNPY and trkC mRNA under normal and axotomized conditions and following intrathecal infusion of
NT-3.
Scanned brightfield photomicrographs of serial 6 Ilm thick adult rat Ls DRG sections processed for in situ hybridization to detect
NPY (upper panel) and trkC (lower panel) mRNA under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and
following a 7 day 600 ng/Ill/h intrathecal infusion ofNT-3,2 weeks post-axotomy (cut +NT-3). Arrows indicate neurons positive for both
markers. Scale bar = 30 Ilm.
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Figure 5.24 Expression ofVIP mRNA under normal and axotomized conditions and following intrathecal infusion ofNT-3.
Scanned darkfield photomicrographs of 6 J.lm thick sections of adult rat Ls DRG processed for in situ hybridization to detect VIP
mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng/J.lI/h intrathecal
infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 200 J.lrn.
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Figure 5.25 Colocalization ofVIP and trkC mRNA under normal and axotomized conditions and following intrathecal infusion of
NT-3.
Scanned brightfield photomicrographs of serial 6 ~m thick adult rat Ls DRG sections processed for in situ hybridization to detect
VIP (upper panel) and trkC (lower panel) mRNA under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and
following a 7 day 600 ng/~l/h intrathecal infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 30 ~m.
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Figure 5.26 Expression of 80M mRNA under normal and axotomized conditions and following intrathecal infusion of NT-3.
Scanned darkfield photomicrographs of 6 Ilm thick sections of adult rat Ls DRG processed for in situ hybridization to detect SOM
mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng/Illih intrathecal
infusion of NT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 200 Ilm.
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Figure 5.27 Colocalization ofSOM and trkC mRNA under normal and axotomized conditions and following intrathecal infusion
ofNT-3.
Scanned brightfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG sections processed for in situ hybridization to detect
SOM (upper panel) and trkC (lower panel) mRNA under normal conditions (intact), 3 weeks following sciatic nerve transection (cut),
and following a 7 day 600 ng/JlI/h intrathecal infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 30 Jlm.
5.2.5.1 The Effect ofAxotomy and Subsequent Delayed Intrathecal
Infusion ofNT-3 on GAP-43 mRNA Levels
Although under normal conditions GAP-43 mRNA is detectable
in many neurons, 3 weeks following sciatic nerve transection message levels increase
dramatically, with virtually all neurons now expressing this marker (Figure 5.28). NT-3
infusion, 2 weeks post-axotomy, appears to result in decreased levels of GAP-43
transcripts.
Scatterplots (e.g. Figure 5.29), depicting the relationship between perikaryal
diameter and GAP-43 mRNA expression for individual neurons (2 DRG
sections/treatment, average 226 neurons/section), indicate that'" 60% of DRG neurons
express detectable message levels of GAP-43 in the intact state. The majority of small
diameter cells exhibit GAP-43 transcripts, while a high proportion of large neurons lack
detectable GAP-43 mRNA. Virtually all neurons display GAP-43 hybridization signal
after axotomy. Although the post-trauma infusion ofNT-3 results in a partial reduction
in injury-induced message levels, the proportion of GAP-43 expressing neurons is not
altered. The regulatory influence ofNT-3 on GAP-43 mRNA levels does not appear to
be restricted to any specific neuronal size class.
Scatterplots (e.g. Figure 5.30), illustrating the relationship between trkC and
GAP-43 mRNA expression for individual neurons (2 DRG sections/treatment/probe,
average 226 neurons/section), show that under normal conditions '" 15% of DRG
neurons display detectable levels ofboth trkC and GAP-43 mRNA. These GAP-43/trkC-
expressing neurons tend to exhibit low to moderate levels of GAP-43, and low levels of
trkC, hybridization signa1. Expression of trkC transcripts appears heterogenous in GAP-
43 negative/trkC-positive neurons. Three weeks following sciatic nerve transection,
virtually all surviving neurons express GAP-43 mRNA; a subset of non-trkC expressing
cells tend to display the highest GAP-43 labeling indices. Treatment with NT-3 appears
to allay injury-induced message levels for GAP-43. The effect of NT-3 on GAP-43
mRNA expression is notable in the trkC-positive subpopulation, but the influence of the
neurotrophin is not always evident in neurons that lack detectable trkC transcripts.
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Figure 5.28 Expression ofGAP-43 mRNA under normal and axotomized conditions and following intrathecal infusion ofNT-3.
Scanned darkfield photomicrographs of 6 Jlm thick sections of adult rat Ls DRG processed for in situ hybridization to detect trkC
mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng/Jlllh intrathecal
infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 100 Jlm.
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Figure 5.29 Relationship between perikaryal diameter and the relative level of GAP-43 mRNA under the following conditions:
normal, axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots of labeling indices of 175-298 individual neurons identified in 6 J-lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect GAP-43 mRNA, depict the relationship between perikaryal
diameter (x axis) and GAP-43 labeling indices (y axis). Panels show a comparison of data under normal conditions (intact), 3 week
axotomized (cut), and 3 week axotomized with intrathecal infusion of 600 ng/JlI/h NT-3 for the final 7 days (cut + NT-3). Labeling
index refers to the ratio of silver grain density over neuropil devoid of positive hybridization signal (background) and reflects the
relative level of GAP-43 mRNA. For each plot, neuronal profiles above the short-dashed horizontal line are considered positive for
GAP-43 mRNA. The long-dashed lines serve as references to facilitate data interpretation.
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Figure 5.30 Relationship between the relative levels of trkC and GAP-43 mRNA under the following conditions: normal,
axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots demonstrate the relationship between trkC and GAP-43 mRNA labeling indices for 175-298 neurons identified in
adjacent 6 Ilm thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x
axis) or GAP-43 (y axis) mRNA under nonnal conditions (intact), 3 week axotomized (cut), and 3 week axotomized with intrathecal
infusion of 600 ng/fll/h NT-3 for the final 7 days (cut + NT-3). Labeling index refers to the ratio of silver grain density over neuropil
devoid of positive hybridization signal (background) and reflects the relative level of indicated mRNA. For each plot, neurons to the
right of the short-dashed vertical line, and those above the short-dashed horizontal line, are considered positive for trkC and GAP-43
mRNA, respectively. The long-dashed lines serve as references to facilitate data interpretation.
Figures 5.31 and 5.32 highlight the trend in changes in GAP-43 mRNA
expression following axotomy and the effect of a delayed 7 day intrathecal infusion of
NT-3, in trkC-positive neurons for 2 replicate data sets. The axotomy-induced increase,
and the post-infusion reduction, in median GAP-43 labeling index values is clear,
although the influence of NT-3 on these values appears to be more robust in cells with
moderate to high levels of trkC hybridization signal. The difference in GAP-43 mRNA
labeling indices between axotomized and axotomizedlNT-3 infused tissues is
statistically significant for both replicates for the subset of neurons exhibiting moderate
to heavy levels oftrkC hybridization signal (Mann-Whitney U Test, p<0.005). Data from
the two replicates represent analyses of tissues from two different animals. Figure 5.33
represents the same data, but examines the effect of exogenous NT-3 on those cells
lacking detectable trkC mRNA. The graph mirrors the trkC versus GAP-43 scatterplot
observations, in that the effect ofNT-3 infusion on GAP-43 message expression in this
subpopulation is unclear. NT-3 appears to result in an elevated GAP-43 median labeling
index value in one replicate and a lower value in the second.
5.2.5.2 The Effect ofAxotomy and Subsequent Delayed Intrathecal
Infusion ofNT-3 on cjun mRNA Levels
In the intact state many DRG neurons exhibit low levels
hybridization signal for cjun and levels increase dramatically after axotomy (Figure
5.34). Infusion of NT-3 appears to result in the return towards normal cjun message
levels.
Scatterplots (e.g. Figure 5.35), demonstrating the relationship between perikaryal
diameter and cjun mRNA expression for individual neurons (3 DRG sections/treatment,
average 204 neurons/section), show that in the intact state cjun message is detectable in
,..., 55% ofcells, at more or less homogenous levels. There is no clear correlation between
neuronal size and the level of hybridization signal for cjun. Three weeks following
sciatic nerve transection cjun message increases over basal levels, and now virtually all
neurons display moderate to high levels of cjun hybridization signal. Although the
proportion of cjun-positive cells remains the same, infusion ofNT-3 appears to result in
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Figure 5.31 The effect of intrathecal infusion of NT-3 on trauma-induced GAP-43
mRNA levels in the trkC-positive subpopulation of neurons.
Graph depicts the relative differences in GAP-43 mRNA labeling indices
between normal (intact), 3 week axotomized (cut), and 3 week axotomized with delayed
7 day intrathecal infusion of NT-3 (cut + NT-3) treatments, for those neurons with
positive trkC mRNA labeling. Since the data are not normally distributed, median
labeling indices are presented instead of means. The error bars represent the labeling
indices of neurons falling between 25% and 75% of the median. In each of the
replicates, GAP-43 and trkC labeling indices for individual neurons were determined
from image analysis of adjacent 6 flm thick sections of adult rat Ls DRG processed for
in situ hybridization, and subsequent radioautography, to detect trkC or GAP-43 mRNA.
Labeling index refers to the ratio of silver grain density over neuropil devoid of positive
hybridization signal (background) and reflects the relative level of indicated mRNA.
Asterisk indicates significant difference between axotomized and axotomized plus NT-3
infused treatments (Mann-Whitney U Test, P<0.05). Sample sizes (number of neurons)
for each treatment are indicated below each replicate. Total number of neurons identified
and analyzed for replicates 1 and 2 (intact, cut, cut + NT-3) are as follows: 246, 233,
207; 298, 195, 175.
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Figure 5.32 The effect of intrathecal infusion of NT-3 on trauma-induced GAP-43
mRNA levels in neurons with moderate to heavy trkC mRNA expression.
Graph depicts the relative differences in GAP-43 mRNA labeling indices
between normal (intact), 3 week axotomized (cut), and 3 week axotomized with delayed
7 day intrathecal infusion of NT-3 (cut + NT-3) treatments, for those neurons with
moderate to heavy trkC mRNA labeling. In each replicate, GAP-43 and trkC labeling
indices for individual neurons were determined from image analysis of adjacent 6 flm
thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent
radioautography, to detect trkC or GAP-43 mRNA. Labeling index refers to the ratio of
silver grain density over neuropil devoid of positive hybridization signal (background)
and reflects the relative level of indicated mRNA. Asterisk indicates significant
difference between axotomized and axotomized plus NT-3 infused treatments (Mann-
Whitney U Test, P<0.005). Sample sizes (number of neurons) for each treatment are
indicated below each replicate. Total number of neurons identified and analyzed for
replicates 1 and 2 (intact, cut, cut + NT-3) are as follows: 246, 233, 207; 298,195,175.
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Figure 5.33 The effect of intrathecal infusion of NT-3 on trauma-induced GAP-43
mRNA levels in neurons not expressing detectable trkC.
Graph depicts the relative differences in GAP-43 mRNA labeling indices
between intact, 3 week axotomized, and 3 week axotomized with delayed 7 day
intrathecal infusion of NT-3 treatments, for those neurons with near to below
background labeling for trkC mRNA. Since the data are not normally distributed,
median labeling indices are presented instead of means. The error bars represent the
labeling indices of neurons falling between 25% and 75% of the median. In each of the
replicates, GAP-43 and trkC labeling indices for individual neurons were determined
from image analysis of adjacent 6 Jlm thick sections of adult rat Ls DRG processed for
in situ hybridization, and subsequent radioautography, to detect GAP-43 or trkC mRNA.
Labeling index refers to the ratio of silver grain density over neuropil devoid of positive
hybridization signal (background) and reflects the relative level of indicated mRNA.
Asterisk indicates significant difference between axotomized and axotomized plus NT-3
infused treatments (Mann-Whitney U Test, P<0.05). Sample sizes (number of neurons)
for each treatment are indicated below each replicate. Total number of neurons
identified and analyzed for replicates 1 and 2 (intact, cut, cut + NT-3) are as follows:
246,233,207;298,195,175.
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Figure 5.34 Expression of cjun mRNA under normal and axotomized conditions and following intrathecal infusion of NT-3.
Upper panel: Scanned darkfield photomicrographs of6 /.lm thick sections ofadult rat Ls DRG processed for in situ hybridization to
detect cjun mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng//.ll/
h intrathecal infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 200 /.lm. Lower panel: Corresponding enlarged portion of
upper photomicrograph. Scale bar = 100 /.lm.
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Figure 5.35 Relationship between perikaryal diameter and the relative level of cjun mRNA under the following conditions:
normal, axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots of labeling indices of 186-246 individual neurons identified in 6 f.lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect cjun mRNA, depict the relationship between perikaryal diameter
(x axis) and cjun labeling indices (y axis). Panels show a comparison of data under normal conditions (intact), 3 week axotomized
(cut), and 3 week axotomized with intrathecal infusion of 600 ng/J.llih NT-3 for the final 7 days (cut + NT-3). Labeling index refers to
the ratio of silver grain density over neuropil devoid of positive hybridization signal (background) and reflects the relative level of
cjun mRNA. For each plot, neuronal profiles above the short-dashed horizontal line are considered positive for cjun mRNA. The long-
dashed lines serve as references to facilitate data interpretation.
a decrease in axotomy-induced levels of cjun mRNA. The lessening in cjun message
levels is evident in neurons of all sizes, but the effect may be more conspicuous in large
diameter cells.
Scatterplots (e.g. Figure 5.36), depicting the relationship between trkC and cjun
mRNA expression for individual neurons (3 DRG sections/treatment/probe, average 204
neurons/section), indicate that under nonnal conditions trkC and cjun transcripts
colocalize in""" 30% ofDRG neurons, representing,...., 720/0 oftrkC-positive, and,...., 53% of
cjun-positive, cells. Message expression for cjun is more or less homogenous and this
observation holds true for trkC-expressing neurons, regardless of trkC message level.
After axotomy, the level of cjun hybridization signal increases and now""" 100% Ls DRG
neurons exhibit moderate to high labeling index values for this marker. Infusion of NT-
3, two weeks following the transection, appears to result in decreased cjun message
levels, although ,...., 100% of neurons still express cjun transcripts. The modulation in
trauma-induced cjun mRNA levels seems to be most distinct in the trkC-positive
subpopulation, and there appears to be a negative correlation between the levels of trkC
and cjun hybridization signal; neurons with higher trkC labeling indices tend to exhibit
lower levels of cjun hybridization signal.
Figure 5.37 highlights the trend in changes in cjun mRNA expression following
axotomy and the effect of a delayed 7 day intrathecal infusion of NT-3 in trkC-positive
neurons for 3 replicate data sets. Sciatic nerve transection results in a conspicuous
increase in the median and the 25 th and 75th percentile labeling index values for cjun.
Infusion of NT-3 effects a reduction in these values within the trkC-positive
subpopulation, such that the difference in cjun labeling indices between axotomized and
axotomizedlNT-3 infused tissues is statistically significant for all replicates (Mann-
Whitney U Test, p<0.05). Data from the three replicates represent analyses of tissues
from three different animals. The effect ofaxotomy on the median and the 25 th and 75 th
percentile cjun labeling index values for those neurons that lack detectable trkC mRNA
is similar to that observed in the trkC-positive subpopulation (Figure 5.38), and although
NT-3 induced alterations in these values are less dramatic, the difference in cjun labeling
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Figure 5.36 Relationship between the relative levels of trkC and cjun mRNA under the following conditions: normal,
axotomized, and axotomized with delayed intrathecal infusion of NT-3.
Scatterplots demonstrate the relationship between trkC and cjun mRNA labeling indices for 198-248 neurons identified in
adjacent 6 Jlm thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x
axis) or cjun (y axis) mRNA under normal conditions (intact), 3 week axotomized (cut), and 3 week axotomized with intrathecal
infusion of 600 ng/Jllih NT-3 for the final 7 days (cut + NT-3). Labeling index refers to the ratio of silver grain density over neuropil
devoid of positive hybridization signal (background) and reflects the relative level of indicated mRNA. For each plot, neurons to the
right of the short-dashed vertical line, and those above the short-dashed horizontal line, are considered positive for trkC and cjun
mRNA, respectively. The long-dashed lines serve as references to facilitate data interpretation.
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Figure 5.37 The effect of intrathecal infusion of NT-3 on trauma-induced cjun
mRNA levels in neurons expressing trkC mRNA.
Graph depicts the relative differences in cjun mRNA labeling indices between
normal (intact), 3 week axotomized (cut), and 3 week axotomized with delayed 7 day
intrathecal infusion of NT-3 treatments (cut + NT-3), for those neurons with trkC
mRNA labeling. Since the data are not normally distributed, median labeling indices are
presented instead of means. The error bars represent the labeling indices of neurons
falling between 25% and 75% of the median. In each of the three replicates, cjun and
trkC labeling indices for individual neurons were determined from image analysis of
adjacent 6 Ilm thick sections ofadult rat Ls DRG processed for in situ hybridization, and
subsequent radioautography, to detect trkC or cjun mRNA. Labeling index refers to the
ratio of silver grain density over neuropil devoid of positive hybridization signal
(background) and reflects the relative level of indicated mRNA. Asterisk indicates
significant difference between axotomized and axotomized plus NT-3 infused treatments
(Mann-Whitney U Test, P<O.05). Sample sizes (number of neurons) for each treatment
are indicated below each replicate. Total number of neurons identified and analyzed for
replicates 1-3 (intact, cut, cut + NT-3) are as follows: 246, 198, 186; 248, 198,218; 188,
156, 148.
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Figure 5.38 The effect of intrathecal infusion of NT-3 on trauma-induced cjun
mRNA levels in neurons not expressing detectable trkC mRNA.
Graph depicts the relative differences in cjun mRNA labeling indices
between normal (intact), 3 week axotomized (cut), and 3 week axotomized with
delayed 7 day intrathecal infusion of NT-3 treatments (cut + NT-3), for those
neurons with near to below background labeling for trkC mRNA. Since the data are
not normally distributed, median labeling indices are presented instead of means.
The error bars represent the labeling indices of neurons falling between 250/0 and
75% of the median. In each of the three replicates, cjun and trkC labeling indices for
individual neurons were determined from image analysis of adjacent 6 Jlm thick
sections of adult rat Ls DRG processed for in situ hybridization, and subsequent
radioautography, to detect cjun or trkC mRNA. Labeling index refers to the ratio of
silver grain density over neuropil devoid of positive hybridization signal
(background) and reflects the relative level of indicated mRNA. Asterisk indicates
significant difference between axotomized and axotomized plus NT-3 infused
treatments (Mann-Whitney U Test, P<O.05). Sample sizes (number of neurons) for
each treatment are indicated below each replicate. Total number of neurons
identified and analyzed for replicates 1-3 (intact, cut, cut + NT-3) are as follows:
246, 198, 186; 248, 198,218; 188, 156, 148.
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indices between axotomized and axotomized/NT-3 infused tissues is statistically
significant in two of the three cases (Mann-Whitney U Test, p<O.05).
5.2.6 The Effect ofAxotomy and Subsequent Delayed Intrathecal Infusion of
NT-3 on SNAP-25 mRNA levels.
Under normal conditions, SNAP-25 mRNA is abundantly, although
heterogenously, expressed in all DRG neurons (Figure 5.39); with larger diameter, trkC-
positive cells typically expressing higher levels of hybridization signal for the marker
(Figure 5.40). Three weeks following sciatic nerve transection, SNAP-25 message levels
decrease; a 1 week intrathecal infusion of NT-3 appears to result in the upregulation of
injury-reduced levels of SNAP-25 mRNA towards normal, but this increase appears to
be primarily restricted to a subpopulation of medium and large diameter neurons that
coexpress trkC transcripts.
5.3 Discussion
5.3.1 The Influence of Exogenous NT-3 on Injury-Induced Changes in
Neurotrophin Receptor Expression
Consistent with the literature (Johnson et al., 1987; Raivich and
Kreutzberg, 1987; Verge et al., 1989b, 1992a; Emfors et al., 1993; Funakoshi et al.,
1993; Sebert and Shooter, 1993; McMahon et al., 1994; Zhou et al., 1996; Kashiba et
al., 1998; Jongsma Wallin et al., 2001), results here demonstrate that axotomy induces a
reduction in trk and p75levels in DRG neurons. Despite the loss of peripherally-derived
NT-3 following sciatic nerve transection (see Section 2.2.1.3), primary sensory neurons
may access local sources of the neurotrophin (see Section 2.2.1.2): NT-3 mRNA, present
in satellite cells surrounding some neurons, is upregulated in the ipsilateral ganglion
within 48 hours ofaxotomy and remains so for at least 2 months (Zhou et al., 1999a).
But, even though the neurotrophin is present in DRG after injury, this source is not
sufficient to prevent the trauma-induced alterations in neuronal phenotype. It would
appear that peripherally-sourced neurotrophin is critical to the maintenance of normal
phenotype of primary sensory neurons. Moreover, data presented herein indicate that a 7
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Figure 5.39 Expression of SNAP-25 mRNA under normal and axotomized conditions and following intrathecal infusion of NT-3.
Scanned darkfield photomicrographs of6 Jlm thick sections ofadult rat Ls DRG processed for in situ hybridization to detect SNAP-
25 mRNA, under normal conditions (intact), 3 weeks following sciatic nerve transection (cut), and following a 7 day 600 ng/Jlllh intrath-
ecal infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Scale bar = 100 Jlm.
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Figure 5.40 Colocalization of SNAP-25 and trkC mRNA under normal and axotomized conditions and following intrathecal infu-
sion of NT-3.
Scanned brightfield photomicrographs of serial 6 J!m thick adult rat Ls DRG sections processed for in situ hybridization to detect
SNAP-25 (upper panel) and trkC (lower panel) mRNA under normal conditions (intact), 3 weeks following sciatic nerve transection
(cut), and following a 7 day 600 ng/J!l/h intrathecal infusion ofNT-3, 2 weeks post-axotomy (cut + NT-3). Asterisks indicate neurons
positive for both markers. Scale bar = 10 J!m.
day intrathecal infusion of NT-3 (600 ng//ll/h) 14 days post-injury, is successful in
partially mitigating the trauma-induced reduction in both trkC and p75 mRNA
expression within these cells. These data are not surprising, since NGF has long been
shown to regulate high-affinity NGF binding sites/trkA and p75 in primary sensory
neurons in vivo (Verge et al., 1989b, 1992a; Jongsma Wallin et al., 2001). Furthermore,
a recent study (Wyatt et al., 1999) has reported that NT-3 influences trkC expression in
dissociated and explant cultures of embryonic mouse trigeminal ganglia. It is of interest
to note that because exogenous NT-3 was more effective in upregulating trkC in explant
cultures, the regulation of trkC message levels might involve additional factors present
in the ganglion but not available to neurons in monocultures. This observation is also
important to keep in mind when comparing data between in vivo and in vitro based
experimental paradigms. The same study (Wyatt et al., 1999) also showed that trkC
expression in cultured sympathetic neurons was not altered following NT-3 treatment,
indicating that the ability of the neurotrophin to regulate receptor expression may be
dependent on cell type. This may be due in part to the low level of trkC transcripts in
sympathetic neurons (Belliveau et al., 1997; Dechant et al., 1997), with any NT-3
influenced elevation in trkC levels potentially below the detection limit of the technique
used in that study, or because the degree of change in trkC expression might be
dependent on the initial level of receptor expression. Here (see Section 5.2.2.1, Figure
5.3), although NT-3 is effective in mitigating the injury-induced reduction in trkC levels
in virtually all trkC-positive neurons, the infusion-effect is most pronounced within the
subset of cells with moderate to high trkC labeling indices, further supporting the
concept that the influences of NT-3 on receptor levels may be dependent on receptor
concentration.
In addition to potential dependence on NT-3 effected regulation of receptor
levels, various effects attributed to neurotrophins have been shown to be dose-
dependent. As reported here (see Section 3.1.2.1.2) and in the literature, alterations in
aspects of cellular phenotype vary with neurotrophin concentration (Ma et al., 1992;
Belliveau et al., 1997; Bennett et al., 1998). Similar results have been described for
neurotrophin-influenced regulation of axonal elongation (Lentz et al., 1999), level of trk
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tyrosine phosphorylation (Belliveau et al., 1997; Senger and Campenot, 1997),
neurotransmitter release (Blochl and Sirrenberg, 1996), and degree of neuroprotective
effects (Helgren et al., 1997).
Another important factor to note regarding neurotrophin regulation of receptors
concerns p75. In this study (see Section 5.2.2.2; Figures 5.6, 5.7 5.8), the NT-3 effected
upregulation ofp75 appears to be specific for the subgroup of neurons in which p75 and
trkC transcripts colocalize. Similar parallel results were described for NGF and p75,
wherein post-axotomy infused NGF mitigated the injury-induced decrease in p75 levels
only in trkA/p75-positive sensory neurons (Verge et al., 1992a). These data are
interesting because all of the neurotrophins bind to p75 (see Section 1.1.2.2) and because
up to 80% of lumbar DRG neurons express the receptor (see Sections 2.1.3, 4.2.2.3,
4.3.1), suggesting that p75 mRNA regulation does not occur via the neurotrophin
binding to that receptor, but through binding to the appropriate trk.
5.3.2 The Influence of Exogenous NT-3 on Injury-Induced Changes in
Expression of the Cytoskeletal Elements NFM and Ta 1 a-tubulin
Under normal conditions all, or virtually all, adult rat lumbar DRG
neurons, including the trkC-positive population, express transcripts for the cytoskeletal
elements NFM and Tal a-tubulin (see section 4.3.3), with message levels for the fonner
exhibiting a positive correlation and the latter a loose negative correlation with
perikaryal diameter. Three weeks following sciatic nerve transection NFM message
levels fall, while those for Tal a-tubulin rise (see Sections 4.2.3.1, 4.2.3.2, 4.3.3), but
here a 2 week delayed, 7 day intrathecal infusion of NT-3 partially mitigates the
axotomy-induced changes, bringing transcript levels for both markers towards nonnal
values. With regard to NF expression these results are not surprising, since NGF has
been reported to upregulate the message levels of all three NF subunits in cultured PC12
cells (Lindenbaum et al., 1988) and in adult rat DRG neurons following axotomy (Verge
et al., 1990a; Gold et al., 1991; Tetzlaff et al., 1992). Since there is a positive correlation
between NF levels and perikaryal and fiber diameter (Friede and Samorajski, 1970;
Weiss and Mayr, 1971; Sharp et aI., 1982; Hoffinan et al., 1987; Verge et al., 1990a;
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Tetzlaff et al., 1992) (see Section 4.2.3.1), and since axotomy results in both a reduction
in NF expression (Greenberg and Lasek, 1988; Oblinger and Lasek, 1988; Verge et al.,
1990b; Wong and Oblinger, 1987, 1990, 1991; Emfors et al., 1993; Hoffman et al.,
1993) and somal and fiber size (Gold et al., 1991; Hoffman et al., 1993), one might
expect that reestablishment of NF levels might also restore neuronal volume. Although
investigation of this was not rigorously pursued in this thesis, results here suggest that
exogenous NT-3 successfully restores near-nonnal perikaryal diameter. Similar data,
collected under a variety of experimental conditions, have been reported after treatment
with either NT-3 (Zhang et al, 1994a; Gao et al., 1995; Albers et al., 1996; Belliveau et
al., 1997; Mizisin et al., 1998; Lentz et al., 1999) or NGF (Gold et al., 1991; Belliveau
et al, 1997; Goodness et al., 1997). Moreover, axonal conduction velocity, which
decreases following injury (Munson et al., 1997) and is detennined by axonal caliber
(Harper and Lawson, 1985a, 1985b; Lee et al., 1986), has also been reported to be
restored with NT-3 treatment (Munson et al., 1997) (see Section 2.2.2.2).
NGF has also been shown to regulate Tal a-tubulin expression in pe12 cells
(Miller et al, 1987) and neonatal sympathetic neurons (Matthew and Miller, 1990; Ma et
al., 1992) in vitro, but in all of these cases transcript levels of the marker increased after
exposure to the neurotrophin. In contrast, data from a study involving exposure of the
proximal nerve stump of adult rats to NGF showed that this treatment failed to mitigate
the injury-induced levels of Tal a-tubulin mRNA, although neither was the expression
of NFL reported to be altered (Wong and Oblinger, 1991). As is the case for NGF, in
vitro treatment with NT-3 also appears to result in higher levels of Tal a-tubulin
expression. Two studies, using dissociated cultures of adult rat DRG neurons
(Mohiuddin et al., 1995) or neonatal sympathetic neurons (Belliveau et al., 1997), report
that exogenous NT-3 effected increased levels of Tal a-tubulin mRNA. These results
conflict with my findings; this may be due to a potential dose-dependent effect (see
Section 5.3.1.) or may be a consequence of the mode ofneurotrophin delivery. Support
for the fonner argument comes from a study on adult primary sensory neurons
(Mohiuddin et al., 1995), wherein exposure to higher levels of NT-3 yielded Tal a-
tubu1in message levels only slightly elevated above control values. Support for the latter
213
hypothesis may be derived from experiments involving comparisons between two
treatment methods, including where or how the molecule is delivered. For instance, in
adult rats intrathecal infusion of NGF allowed for more consistent results than did its
infusion into the cut nerve stump (Verge et al., 1990b), while peripheral injection of
chicken embryos with NT-3 specific antiserum resulted in decreased numbers of muscle
spindle afferents, but injection of the same protein into the spinal cord failed to produce
a demonstrable change (Oakley et al., 1995). These data suggest that the differences
between my finding and those of Mohiuddin and colleagues (1995) may be due to the
differences between supplying NT-3 via intrathecal infusion versus bathing the entire
cell in neurotrophin. Further, the rate of delivery appears to be important in delineating
the neuronal response to the neurotrophin: BDNF delivered slowly to hippocampal slices
failed to incite synaptic potentiation, whereas fast delivery was reflected by increased
potentiation rates (Kang et aI., 1996).
Interestingly, in the cases ofNFM and Tal a-tubulin, unlike for p75 (see Section
5.3.1), NT-3 effected alterations in mRNA levels appear to occur throughout the
population of DRG neurons, although changes are most pronounced in those cells that
express detectable levels of trkC. Reexamination of data comparing the ability of NGF
to mitigate the post-axotomy reduction in NFM levels in neurons with or without high-
affinity NGF binding sites (Verge et al., 1990a; Tetzlaff et al., 1992) also appears to
indicate that the NGF-effected increase in NFM mRNA levels is not restricted to
neurons with high densities of NGF binding sites. This suggests that the regulation of
cytoskeletal elements is under a more general control than is p75 - one that is
influenced by the neurotrophin, but ultimately overseen by a more broad-acting factor.
Or, the regulation of NFM and Tal a-tubulin gene expression may be determined
through the activation of different parallel, convergent, or divergent signal transduction
pathways associated with the trks (see Section 1.1.2.1.1). Another possibility is that NT-
3 effects an upregulation in NFM and a concomitant downregulation of Ta1 a-tubulin
levels by binding not only to trkC, but to the other trk species (see Section 1.1.2.1.1).
Moreover, in addition to potentially activating trkA and trkB, NT-3 has been shown to
bind to trkAei6 (see Section 1.1.2.1.1), an isoform of trkA that exhibits heightened
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responsiveness to NT-3 (Barker et al., 1993; Clary and Reichardt, 1994) and which
colocalizes with non-insert trkA in over 900/0 of trkA adult rat lumbar DRG neurons
(Karchewski et al., 1999). But this premise does not explain the ability of NGF to also
regulate NFM mRNA levels in non-trkA expressing neurons, since that ligand, unlike
NT-3, has only been reported to bind specifically to trkA (see Section 1.1.2.1.2).
Alternately, regulation of the expression of the two cytoskeletal markers may be through
the activation of p75, which is expressed in up to 80% of adult primary sensory neurons
(see Sections 4.2.2.3, 4.3.2).
5.3.3 The Influence of Exogenous NT-3 on Injury-Induced Changes in
Neuropeptide Expression
The neuropeptides galanin and SOM are expressed by small subsets of
small diameter DRG neurons, but both the levels and the number of cells exhibiting the
former increase post-axotomy (see Sections 4.2.4.3, 4.2.4.4, 4.3.4), while those of the
latter decrease (Noguchi et at., 1993; Verge et at., 1995). NPY and VIP are rarely
detected in uninjured neurons, but peripheral nerve transection results in the expression
of both markers in many medium to large and small to medium diameter neurons,
respectively (see Sections 4.2.4.5, 4.2.4.6, 4.3.4). My data are consistent with these
findings, but, in addition, demonstrate that there is limited, if any, overlap between trkC
and SOM or VIP and a significant degree ofcoexpression of the receptor with galanin or
NPY post-injury. Further, because of their expression, or lack thereof, of these
neuropeptides in the trkC-positive subpopulation, it is not surprising to note here that
while NT-3 infusion mitigates the axotomy-induced levels of galanin and NPY mRNA,
NT-3 treatment fails to alter SOM and VIP message levels.
Several studies have examined the role of NT-3 in regulating neuropeptide
expression in DRG neurons (see Section 2.2.2.2), and these data support my findings: A
continual 3 week delivery of NT-3 to the proximal transected sciatic nerve stump
resulted in a reduction in the number of NPY-ir neurons and decreased staining
intensities for the neuropeptide, with an overall 36% reduction in NPY protein levels
(Ohara et al., 1995). Similarly, there was", 45% decrease in the number of NPY-ir LiLs
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DRG neurons in animals 30 days after NT-3 impregnated, entubulated fibronectin mats
were grafted between the proximal and distal ends of the transected/resected sciatic
nerve; the presence of exogenous NT-3 did not appear to alter VIP levels (Sterne et al.,
1998). Additionally, neither VIP nor SOM protein levels were found to be significantly
changed following the treatment of adult rat DRG neuron cultures with NT-3 (Mulderry,
1994). Interestingly, the neurotrophin appears to affect these neuropeptides in an
opposite manner in CNS neurons. NT-3 treatment of neonatal rat cortex (Barnea et al.,
1995, 1996) and hippocampal slice (Marty and Onteniente, 1999) cultures resulted in
increased NPY and SOM protein levels. Moreover, culturing vagal/glossopharyngeal
visceral afferent neurons in the presence ofNT-3 effected an upregulation in the number
of VIP-positive cells, whereas anti-NT-3 treatment prevented this increase (Helke and
Verdier-Pinard, 2000).
NT-3 is not the only neurotrophic factor known to influence neuropeptide
expression in primary sensory neurons - in fact, the regulation of neuropeptide levels
appears to be complex. For example, NGF has been shown to modulate levels of SP,
CGRP, NPY, galanin, VIP, and CCK (Kessler and Black, 1980; Otten et at., 1980; Otten
and Lorez, 1982; Lindsay et at., 1989; Verge et at., 1995; Bennett et at., 1998; Corness
et at., 1998; Ramer et at., 1998). In addition, GDNF mitigates the post-axotomy levels of
both SOM and SP (Bennett et at., 1998; Ogun-Muyiwa et at., 1999; Issa et al., 2001), as
does aFGF for galanin and bFGF for SP (Ji et al., 1996).
Besides the negative regulation of galanin levels in injured primary sensory
neurons effected by NT-3 (see Section 5.2.4.1), NGF (Verge et al., 1995; Corness et aI.,
1998; Ramer et at., 1998), and aFGF (Ji et a!., 1996), other trophic factors influence
galanin levels in a positive manner. The injury-induced cytokines, IL-6 (interleukin-6)
and LIF (leukemia inhibitory factor) (Curtis et al., 1994; Murphy et at., 1995, 1999a,
1999b; Kurek et al., 1996a, 1996b; Sun and Zigmond, 1996; Arruda et al., 1998), appear
to be responsible for the upregulation of the neuropeptide after nerve injury (Corness et
al., 1998; Ramer et al., 1998; Thompson et al., 1998b; Kerekes et at., 1999; Murphyet
at., 1999b). Two studies have provided insight into how these molecules may interact in
regulating galanin expression. Cultures of E13 DRG neurons, initially exposed to both
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NGF and LIF, exhibited elevated galanin message levels upon withdrawal of NGF,
while the addition of LIF to the NGF-deprived cultures resulted in even higher levels of
galanin expression; culturing these cells in the presence of both neurotrophic factors did
not result in galanin levels significantly different from control values (Comess et al.,
1998). Moreover, application of LIF directly to intact superior cervical ganglion neurons
did not alter galanin levels, but injection of anti-NGF coupled with LIF treatment
stimulated galanin expression (Shadiack et al., 1998). These observations suggest that
the availability of NGF (or NT-3 or aFGF), is potentially more critical to maintaining
normal galanin levels than is the presence of the cytokine. Similar interactions may
occur in the trophic factor regulation ofthe other neuropeptides.
5.3.4 The Influence of Exogenous NT-3 on Injury-Induced Changes in
Expression of the Injury and Regeneration Associated Markers GAP-43 and cjun
GAP-43 and cjun transcripts are expressed in many DRG neurons,
including some that are trkC-positive, in the intact state, but peripheral axotomy triggers
a dramatic upregulation in both levels of mRNA expression and in the numbers of
neurons exhibiting detectable levels of these the markers (see Sections 4.2, 4.3.5, 5.2.5).
Here, intrathecal infusion ofNT-3 has been shown to effect a reduction in injury-induced
GAP-43 and cjun message levels within trkC-expressing neurons. Downregulation of
GAP-43 mRNA levels appears to be most notable in those neurons with moderate to
high trkC labeling indices; the degree of cjun mRNA regulation appears to be negatively
correlated with trkC expression, with post-infusion cjun levels lowest in cells with the
highest labeling indices for the receptor.
Although to my knowledge there is no published record ofNT-3 modulating cjun
expression in primary sensory neurons, intrathecal infusion of NGF has also been
reported to mitigate injury-induced cJUN-ir levels in adult rat Ls DRG neurons (Gold et
al., 1993a). Further to this, removal of access to target-derived NGF through injection of
antiserum to NGF resulted in elevated cJUN-ir, both in the number of cJUN-positive
neurons and the staining intensity (Gold et al., 1993a). These data suggest a similar
control mechanism for cjun expression in neurotrophin-responsive primary sensory
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neurons. Contrary to these findings, another group found that in cultures of DRG
neurons and glia neither NGF nor BDNF inhibited cjun expression (De Filipe and Hunt,
1994).
In an experiment in which dissociated cultures of adult rat DRG neurons were
treated with 10 ng/ml NT-3, there was a reported 2 fold increase in GAP-43 mRNA
levels (Mohiuddin et al., 1995) (see Section 2.2.2.2). These data contrast sharply with
my results, but the same study also noted that a higher concentration of NT-3 (50 ng/ml)
effected an upregulation in GAP-43 message levels only slightly elevated compared to
those of untreated cultures. This observation suggests that the influence of the
neurotrophin on GAP-43 mRNA regulation is dose-dependent and may also be a
reflection of the method used to deliver the neurotrophin (see Sections 5.3.1, 5.3.2).
Unlike for NT-3, intrathecal infusion ofNGF did not appear to significantly alter injury-
induced GAP-43 mRNA levels, implying that a peripherally-derived signal other than
NGF regulates the post-trauma expression of GAP-43 (Verge et al., 1990b).
Interestingly, the positive correlation that exists between GAP-43 mRNA expression and
the presence of high-affinity NGF binding sites under normal conditions suggests a role
for NGF in maintaining the high GAP-43 message levels within this subpopulation
(Verge et al., 1990b). Moreover, in a different study, in vivo NGF treatment resulted in
elevated GAP-43 mRNA levels compared to control, which was thought to reflect the
role of that neurotrophin in collateral sprouting (Mearow, 1998). Further, exposure of
cultures of adult rat DRG neurons to anti-NGF prevented the normal increased levels of
GAP-43 expression in sprouting neurons (Mearow and Kril, 1995).
Although it is unclear whether NT-3 treatment influences GAP-43 expression in
neurons that lack detectable levels of trkC transcripts, the neurotrophin effects a
downregulation of cjun mRNA levels in this subset, albeit a less notable one than that in
trkC-positive neurons. It may be that at least in the case of cjun, similar to that reported
here for NFM and Tal a-tubulin (see Section 5.3.2), regulation of gene expression is
under a more general control. The source of this regulation could involve retrograde
signals derived from the site of the lesion (Murphy et al., 1999a), or more generally
those derived from immune cells participating in the injury response (Brown et al.,
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1991; Richardson and Lu, 1994; Lu and Richardson, 1995). In this sense the modulation
of GAP-43 and cjun expression by NT-3 would be an indirect one, through influencing
the production of factors in glia and immune cells, which normally positively regulate
the injury phenotype. This, coupled with a direct influence on the trkC subpopulation,
could be responsible for the stronger modulation observed in this subgroup. This could
also account for the in vivo/in vitro differences, since key glia and immune cells would
be missing from these cultures.
The ability of the neurotrophin to modulate GAP-43 and Tal a-tubulin
expression (see Sections 5.2.3.2, 5.3.2) suggests that NT-3 may not only be important in
maintaining or regulating aspects of neuronal phenotype, but that it may also play a
significant role in regulating axonal growth and regeneration. A number of studies have
examined the ability ofNT-3 to influence neurite extension and the resulting data form a
complex picture.
NT-3 was shown to enhance neurite outgrowth in a subset of adult rat DRG
neurons in vitro, although the degree ofNT-3 induced outgrowth was greater at 10 ng/ml
than at 50 ng/ml (Mohiuddin et at., 1995). Exogenous NT-3 (50 ng/ml) also supported
increased axonal growth in adult mouse LiLs DRG explant cultures (Edstrom et at.,
1996), but the addition of NT-3 (1, 10, or 100 ng/ml) to the distal portion of
compartmentalized cultures of adult rat DRG neurons failed to induce neurite outgrowth
(Kimpinski et at., 1997). Neither did the treatment of parallel cultures with both NT-3
and NGF alter the growth-inducing effects of NGF alone (Kimpinski et at., 1997).
Likewise, treatment of cultures of dissociated adult rat lumbar DRG neurons with NT-3
did not appear to influence axonal growth, although cotreatment with NT-3 and NGF
partially blocked NGF-enhanced neurite outgrowth (Gavazzi et at., 1999).
NT-3 has been shown to effect peripheral nerve regeneration in vivo. In adult
rats, entubulated fibronectin mats impregnated with NT-3 (SOD ng/ml) grafted to
resected sciatic nerve supported the regeneration of significantly more myelinated axons
than control, nonimpregnated mat grafts, even at 8 months post-insertion (Sterne et al.,
1997a). In contrast, in utero injection of rat embryos with NT-3 appeared to either have
219
no influence on, or to inhibit, axonal growth, depending on the developmental stage of
the animal (Zhang et al., 1994a).
Together, these data indicate that although NT-3 can influence axonal growth -
in a positive or negative manner, or not at all - the effect may be influenced by the
concentration of the neurotrophin, the means of neurotrophin delivery, the presence of
additional neurotrophic factors, and/or the level of maturity of neurons at the time of
neurotrophin exposure. Since this study shows that three markers of nerve injury and
regeneration (GAP-43, Tal a-tubulin, and cjun) are all downregulated following NT-3
treatment, it would be of interest to examine whether intrathecal infusion ofNT-3 would
affect the regeneration process. In experiments involving the immediate intrathecal
infusion of NGF, that neurotrophin has also been shown to mitigate injury-induced
upregulation of cJUN-ir levels in adult rat L5 DRG neurons (Gold et al., 1993a), but
NGF treatment only delayed the onset of the regeneration process for 2 days; it did not
alter the maximum rate of regeneration (Gold, 1997).
5.3.5 The Influence of Exogenous NT-3 on Injury-Induced Alterations in SNAP-
25 Expression
Here, under nonnal conditions, all Ls DRG neurons are shown to express
detectable levels of SNAP-25 mRNA, with a subset of large diameter trkC-positive
neurons exhibiting the highest SNAP-25 message levels (also see Section 4.2.6). Three
weeks following sciatic nerve transection, there is a downregulation in SNAP-25
transcript levels, but a delayed, 7 day intrathecal infusion results in the mitigation of the
injury-induced changes in SNAP-25 levels. This upregulation of SNAP-25 expression
appears to be primarily restricted to medium and large trkC-expressing neurons.
Although there is limited infonnation available delineating the regulation ofSNAP-25 in
primary sensory neurons, BDNF has been shown to upregulate SNAP-25 levels, as well
as those of other proteins associated with vesicle fusion and exocytosis, in embryonic
cortical neurons in vitro (Takei et al., 1997). The same study (Takei et al., 1997)
demonstrated that exogenous BDNF increased stimulation-evoked release of glutamate
and increased the number ofdense core and clear vesicles in nerve tenninals. These data,
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together with my findings, suggest that neurotrophins are important to neurotransmitter
and neuropeptide release. Also of interest, is a report that prolonged incubation of PC12
cells with NGF resulted in increased SNAP-25 phosphorylation and a concomitant
increase in plasma membrane-localized SNAP-25-ir (Kataoka et al., 2000). This
suggests that the neurotrophins are not only important in the regulation of SNAP-25
mRNA levels, but also in SNAP-25 activation. SNAP-25 has also been shown to be
upregulated by dibutyryl-cAMP in PCl2 cells (Sanna et al., 1991). Similarly, potassium
chloride induced SNAP-25-ir in hippocampal neurons and PC12 cells, but failed to do so
in cerebellar neuron cultures, while arachidonic acid upregulated SNAP-25-ir only in the
fonner cell type (Sepulveda et al., 1998). Conversely, estrogen implants in the pituitary
gland of ovariectomized rats resulted in a downregulation of SNAP-25 mRNA levels,
although message levels of other SNARE components were not affected (Jacobsson et
al., 1998). Taken together, these reports coupled with my findings, indicate that, as for
other markers (see Sections 5.3.2, 5.3.4), the regulation of SNAP-25 is complex,
involving numerous regulatory molecules, and is also dependent on cell type.
5.3.6 Summary
In primary sensory neurons, delayed intrathecal infusion ofNT-3 resulted
in a return towards nonnal, pre-axotomy mRNA levels for all of the phenotypic markers
examined here, but only if at least a subset of the neurons expressing the marker also
expressed trkC (Table 5.1): NT-3 treatment effected an upregulation in injury-reduced
message levels oftrkC, p75, NFM, and SNAP-25; with a concomitant downregulation of
Tal a-tubulin, galanin, NPY, GAP-43, and cjun transcripts. NT-3 infusion did not
appear to alter the post-trauma mRNA levels of SOM or VIP, nor did it appear that
either of these neuropeptides were coexpressed with trkC. Further, it is of interest to note
that although in the case ofp75 message levels appeared to be upregulated only in those
cells that coexpressed trkC, the influence of NT-3 in regulating post-trauma message
levels for more broadly expressed markers (i.e. NFM, Tal a-tubulin, cjun) was not
limited to the trkC-positive population. These findings may imply that control of the
expression for these markers is less specific, more global, than it is for p75. It is also of
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Table 5.1 Effect of NT-3 infusion on post-axotomy mRNA levels for selected
phenotypic markers in adult rat Ls DRG neurons.
MARKER
trkC
p75
NFM
Tal a-tubulin
galanin
SOM
NPY
VIP
GAP-43
cjun
SNAP-25
POST-AXOTOMY NT-3 EFFECTED MODULATION
positive
positive
positive
negative
negative
no apparent qualitative change
negative
no apparent qualitative change
negative
negative
positive
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importance to note that the regulation of the expression of these markers is complex. The
presence, or absence, of the neurotrophin may result in altered gene expression; control
may be at the level of transcription or be post-transcriptional. For example, since NT-3
effects a downregulation of cjun message levels there may be reduced levels of cJUN,
which would result in reduced levels of AP-l complexes containing that protein, thereby
altering the functional capacity of the AP-l complex in regulating gene transcription (see
Sections 4.3.5, 5.3.4). Further, since NGF has been reported to increase the stability of
GAP-43 mRNA (Perrone-Bizzozero et al., 1993; Nishizawa, 1994; Tsai et al., 1997),
NT-3 might be found to exert similar influences on transcripts for some markers.
Moreover, results appear to be dependent on the concentration of the neurotrophin and
its receptors, and the rate and mode of its delivery. In addition, it is important to consider
that the ability of NT-3 to influence message levels may also be contingent on the
presence ofother cell types and that other trophic molecules may act synergistically or in
opposition to those of the neurotrophin. But, regardless of the mechanism(s) involved,
the findings presented here show NT-3 to be an important molecule in maintaining the
normal phenotype ofat least a subset ofmature DRG neurons.
Future work could use the method of data analysis outlined in Section 4.3.7 to
determine if NT-3 differentially influenced message levels in selected micropopulations.
For example, even though I have shown here that the NT-3 effected upregulation ofp75
mRNA levels appears to be limited to the trkC-positive population, because of the strong
correlation between p75 and trk expression coupled with the extensive colocalization of
trk species, modulation ofp75 mRNA levels might be different in trkC/trkA-expressing
cells compared to trkC-positive/trkA-negative neurons. In addition, because these data
suggest that NT-3 depresses the expression of regeneration-associated genes following
injury (GAP-43, cjun, Tal a-tubulin), future work could be directed towards
determining if this is reflected in a suppression of the ability of these neurons to support
an injury response and to successfully regenerate in vivo.
223
6. THE EFFECT OF NT-3 INFUSION ON THE PHENOTYPE OF INTACT DRG
NEURONS
6.1 Introduction
NT-3 has been shown to be important in the maintenance of normal neuronal
phenotype in at least a subset of adult primary sensory neurons (see Sections 2.2.2.2, 5.2,
5.3), but during some trauma states levels of the trophic factor available to these cells
may decrease (see Section 2.2.1.2). Experiments involving the augmentation of
endogenous NT-3 supply have been employed to test the efficacy of using this molecule
to ultimately treat peripheral neuropathies (Gao et al., 1995; Rodriguez-Pena et al.,
1995; Tomlinson et al., 1996, 1997; Helgren et al., 1997; Fernyhough et al., 1998;
Mizisin et al., 1998) (see Section 2.2.2.2). Even though application of exogenous
neurotrophin may have the desired clinical affect on the injured cells, a number of
factors - including the colocalization of trk species in individual neurons (see Sections
2.1.2, 4.2.2.2, 4.3.1); the presence of the pan-neurotrophin-binding receptor, p75, in up
to 80% of DRG neurons (see Sections 1.1.2.2, 2.1.3, 4.2.2.3, 4.3.1); and the reported
ability of NT-3 to also bind to trkA and trkB (see Section 1.1.2.1.1) - raise the
possibility that increasing the concentration of NT-3 above normal levels might alter
additional facets of sensory neuron phenotype. Indeed, it has been shown that mice
genetically altered to overexpress specific neurotrophins tend to exhibit increased
numbers of trk-positive neurons (see Section 2.2.2.1.1), although such models tend to
underscore the developmental importance of the manipulated gene and may obscure its
role in the adult (see Section 2.2.2.1.4). In this study, I examined whether a 1 week
intrathecal infusion of NT-3 modifies the expression of a number of phenotypic markers
in otherwise normal adult rat DRG neurons.
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6.2 Results
6.2.1 Technical considerations
See Section 4.2.1.
6.2.2 The Effect of Intrathecal Infusion ofNT-3 on trkC mRNA Levels
Qualitative assessment of radioautographs of 6 J.!m thick sections of adult
rat Ls DRG processed for in situ hybridization to detect trkC mRNA show that a 7 day
600 ng/J.!l/h intrathecal infusion of NT-3 does not appear to result in alterations in trkC
message levels from those seen in non-infused tissue (Figure 6.1).
Scatterplots (e.g. Figure 6.2), constructed from data obtained through quantitative
analysis of labeling indices of individual neurons identified in sections of Ls DRG (7
DRG sections/treatment, average 267 neurons/section), processed for in situ
hybridization, and subsequent radioautography, to determine perikaryal diameter and to
detect trkC mRNA show that under normal conditions trkC message is heterogenously
expressed by '" 40% neurons, with the majority being medium to large in size.
Intrathecal infusion of NT-3 does not appear to result in a noticeable change in the
relative levels of trkC mRNA expression or in the number of trkC-positive cells.
Applying exogenous NT-3 may result in increased perikaryal size, but to be able to say
this with scientific accuracy more precise measurements, and a different approach,
would be needed (reviewed in: Pover et al., 1993).
Figure 6.3 highlights the trends in alterations in relative levels of trkC mRNA
expression following NT-3 infusion for five replicate data sets. Whereas properties
inherent to the technique of in situ hybridization do not allow for the comparison of
silver grain densities between replicates, these bar graphs provide a summary of the data
represented in the panel of scatterplots for each replicate set (e.g. Figure 6.2). The
median and the 25th and 75th percentile values for trkC mRNA labeling are plotted for
each treatment condition (intact, intact plus NT-3). Although there may be small
differences between the 75th percentile values of infused and non-infused tissues within
each replicate, there is little difference between the medians under these conditions. In
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Intact Intact + NT-3
Figure 6.1 Expression of trkC mRNA under normal conditions and following in-
trathecal infusion of NT-3.
Scanned stained darkfield photomicrographs of 6 ~m thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect trkC mRNA, under normal conditions
(intact) and following a 7 day 600 ng/~l/h intrathecal infusion ofNT-3 (intact + NT-3).
Scale bar = 40 jJ.m.
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Figure 6.2 Relationship between perikaryal diameter and the relative level of trkC mRNA under normal conditions and with
intrathecal infusion of NT-3.
Scatterplots oflabeling indices of 492-495 individual neurons identified in 6 f.lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect trkC mRNA, depict the relationship between perikaryal diameter
(x axis) and trkC labeling indices (y axis). Panels show a comparison of data under nonnal conditions (intact) and intact with a 7 day
intrathecal infusion of 600 ng/fll/h NT-3 (intact + NT-3). Labeling index refers to the ratio of silver grain density over neuropil devoid
of positive hybridization signal (background) and reflects the relative level of trkC mRNA. For each plot, neuronal profiles situated
above the dashed horizontal line are positive for trkC mRNA.
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Figure 6.3 The effect of intrathecal infusion of NT-3 on trkC mRNA levels.
Graph depicts the relative differences in trkC mRNA labeling indices between
normal conditions (intact) and normal with a 7 day intrathecal infusion ofNT-3 (intact +
NT-3) in the trkC-positive subpopulation. Since the data are not normally distributed,
median labeling indices are presented instead of means. The error bars represent the
labeling indices of neurons falling between 25% and 750/0 of the median. In each of the
replicates, trkC labeling indices for individual neurons were determined from image
analysis of 6 J..lm thick sections of adult rat Ls DRG processed for in situ hybridization,
and subsequent radioautography, to detect trkC mRNA. Labeling index refers to the
ratio of silver grain density over neuropil devoid of positive hybridization signal
(background) and reflects the relative level oftrkC mRNA. Asterisk indicates significant
difference between intact and intact plus NT-3 infused treatments (Mann-Whitney U
Test, P<0.05). Sample sizes (number of neurons) for each treatment are indicated below
each replicate. Total number of neurons identified and analyzed for replicates 1-5
(intact, intact + NT-3) are as follows: 228, 226; 200, 168; 262, 240; 492, 495; 252, 226.
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all cases, there is no statistically significant difference in trkC labeling indices between
nonnal and NT-3 infused tissues (Mann-Whitney U Test). Data from the five replicates
represent analyses of tissues from four different animals; replicates one and two
represent analyses of tissue sections from the same animal.
6.2.3 The Effect ofNT-3 Infusion on the Phenotype oftrkA-Positive Neurons
6.2.3.1 The Effect of Intrathecal Infusion ofNT-3 on trkA mRNA Levels
The mRNA for trkC and trkA are abundantly and heterogenously
expressed in DRG neurons, and although the trkC-positive subpopulation is
predominately medium and large in size and trkA message primarily localized to small
and mediunl diameter neurons, there is a subset of cells in which trkC and trkA mRNA
are coexpressed (Figure 6.4). NT-3 infusion does not appear to affect trkC message
levels, but seems to result in diminished levels of expression for trkA mRNA, in at least
a subpopulation of neurons.
Scatterplots (e.g. Figure 6.5), depicting the relationship between perikaryal
diameter and trkA labeling indices of individual neurons (10 DRG sections/ treatment,
average 250 neurons/section) under nonnal conditions and following NT-3 infusion,
demonstrate in graph form the reduction in trkA mRNA levels effected by exogenous
NT-3. This decrease appears to be most conspicuous in those neurons with higher trkA
message levels and does not seem to be restricted to any specific perikaryal size range.
Further, NT-3, at least at the concentration used here, does not appear to alter the number
oftrkA-positive cells compared to the intact state ('" 40% of the total population).
Scatterplots (e.g. Figure 6.6), comparing trkC and trkA mRNA labeling indices
for individual neurons (6 DRG sections/treatment/probe, average 264 neurons/section)
under normal conditions and following intrathecal infusion ofNT-3, show that the NT-3
induced reduction in trkA mRNA expression is most obvious in those cells with higher
trkA transcript levels, the trkA-positive/trkC-negative subset.
For the trkA-positive subpopulation (Figure 6.7), the majority of replicates (five
of six) show that exogenous NT-3 appears to influence a reduction in median trkA
labeling index values. The NT-3 induced diminution of trkA message levels is evident in
228
trkA·
Figure 6.4 Colocalization of trkA and trkC mRNA under normal conditions and
following intrathecal infusion of NT-3.
Scanned brightfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect trkA (upper panel) or trkC (lower panel)
mRNA, under normal conditions (intact) and following a 7 day 600 ng/JlI/h intrathecal
infusion ofNT-3 (intact +NT-3). Arrows indicate neurons expressing both markers. Scale
bar = 30 Jlm.
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Figure 6.5 Relationship between perikaryal diameter and the relative level of trkA mRNA under the following conditions:
normal and normal with intrathecal infusion of NT-3.
Scatterplots of labeling indices of 21 0-224 individual neurons identified in 6 ).lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect trkA mRNA, depict the relationship between perikaryal diameter
(x axis) and trkA labeling indices (y axis). Panels show a comparison of data under nonnal conditions (intact) and intact with a 7 day
intrathecal infusion of 600 ng/jJl/h NT-3 (intact + NT-3). Labeling index refers to the ratio of silver grain density over neuropil devoid
of positive hybridization signal (background) and reflects the relative level of trkA mRNA. For each plot, neuronal profiles above the
short-dashed horizontal line are considered positive for trkA mRNA. The long-dashed lines serve as references to facilitate data
interpretation.
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Figure 6.6 Relationship between relative levels of trkC and trkA mRNA under normal conditions and with intrathecal infusion
ofNT-3.
Scatterplots demonstrate the relationship between trkC and trkA labeling indices for 226-228 neurons identified in adjacent 6
fJm thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x axis) or
trkA (y axis) mRNA under normal conditions (intact) and normal with a 7 day intrathecal infusion of600 ng/fJI/h NT-3 (intact + NT-
3). Labeling index refers to the ratio of silver grain density over neuropil devoid of positive hybridization signal (background) and
reflects the relative level of indicated mRNA. For each plot, neuronal profiles situated to the right of the short-dashed vertical line, and
above the short-dashed horizontal line, are considered positive for trkC and trkA mRNA, respectively, The long-dashed lines serve as
references to facilitate data interpretation,
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Figure 6.7 The effect of intrathecal infusion of NT-3 on trkA mRNA levels in the
subpopulation of neurons expressing trkA.
Graph depicts the relative differences in trkA mRNA labeling indices between
nonnal conditions (intact) and nonnal with a 7 day intrathecal infusion ofNT-3 (intact +
NT-3) in the subpopulation of neurons expressing trkA mRNA. Since the data are not
nonnally distributed, median labeling indices are presented instead of means. The error
bars represent the labeling indices of neurons falling between 250/0 and 75% of the
median. In each of the replicates, trkA labeling indices for individual neurons were
detennined from image analysis of 6 f-lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect trkA mRNA.
Labeling index refers to the ratio of silver grain density over neuropil devoid ofpositive
hybridization signal (background) and reflects the relative level oftrkA mRNA. Asterisk
indicates significant difference between intact and intact plus NT-3 infused treatments
(Mann-Whitney U Test, P<0.05). Sample sizes (number of neurons) for each treatment
are indicated below each replicate. Total number of neurons identified and analyzed for
replicates 1-6 (intact, intact + NT-3) are as follows: 252, 226; 209, 245; 210, 224; 228,
226;492,495;200,168.
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all replicates for the 75th percentile values; the 25th percentile values also decrease (in
five of six replicates), but these reductions are generally less pronounced. In four of six
cases, the difference in trkA labeling indices between nonnal and NT-3 infused tissues is
statistically significant (Mann-Whitney U Test, p<0.05). Data from the six replicates
represent analyses of tissues from four different animals; replicates three, four, and six
represent analyses of tissue sections from the same animal.
6.2.3.2 The Effect of Intrathecal Infusion ofNT-3 on the Density ofNGF
Binding
Analysis of radioautographs processed to detect trkA mRNA and
125I_NGF binding sites, under nonnal conditions and following a 7 day intrathecal
infusion of NT-3 (Figure 6.8), show that neurons with high levels of NGF binding also
express trkA mRNA and that exogenous NT-3 results in decreased levels of both
markers.
Scatterplots (e.g. Figure 6.9), constructed from data obtained through quantitative
analysis of labeling indices of individual neurons identified in DRG sections (3 DRG
sections/treatment, average 240 neurons/section) and processed for 125I_NGF binding,
depict the relationship between perikaryal diameter and 125I_NGF binding labeling
indices. These graphs show that under normal conditions small and medium diameter
cells exhibit the highest levels of 125I_NGF binding. Infusion ofNT-3 results in decreased
1251-NGF binding labeling index values and this phenomenon does not appear to be
limited to any specific neuronal size class.
To distinguish between specific and nonspecific binding, 2560 I'M unlabeled
NGF was added to the working solution of 40 I'M 125I_NGF (Figure 6.10). Image
analysis data (2 DRG sections/treatment, average 231 neurons/section) demonstrate that
excess unlabeled NGF successfully competes for NGF binding sites, indicating that
labeling index values above the "cut off' point recorded following 40 I'M 125I_NGF
binding experiments represent specific binding of the ligand to NGF receptors.
Scatterplots (e.g. Figure 6.11), depicting the relationship between trkA mRNA
and 125I_NO-F binding labeling indices for individual neurons (3 DRG
233
Figure 6.8 Colocalization of trkA mRNA and high-affinity NGF binding sites under
normal conditions and following intrathecal infusion of NT-3.
Brightfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG sections proc-
essed for in situ hybridization to detect trkA mRNA (upper panel) and for 12sI-NGF bind-
ing radioautography (lower panel) under normal conditions and following a 7 day intrath-
ecal infusion ofNT-3 (600 ng/JlI/h). Arrows indicate neurons expressing trkA that also
display high-affinity NGF binding sites, albeit at much lower levels with infusion. Aster-
isks depict examples ofneurons with no discernible trkA mRNA or binding above back-
ground levels. Scale bar = 40 Jlm.
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Figure 6.9 Relationship between perikaryal diameter and the relative level of 125I-NGF binding under normal conditions and
with intrathecal infusion of NT-3.
Scatterplots of labeling indices of 223-263 individual neurons identified in 6 Ilm thick sections of adult rat Ls DRG processed
for radioautography to detect 12sI_NGF binding depict the relationship between perikaryal diameter (x axis) and 12SI_NGF binding
labeling indices (y axis). Panels show a comparison of data under normal conditions (intact) and intact with a 7 day intrathecal
infusion of 600 ng/J,!l/h NT-3 (intact + NT-3). Labeling index refers to the ratio of silver grain density over neuropil devoid of positive
hybridization signal (background) and is linearly related to the density of high-affinity NGF-binding sites. For each plot, neuronal
profiles situated above the short-dashed horizontal line are considered positive for 125I_NGF binding. The long-dashed lines serve as
references to facilitate data interpretation.
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Figure 6.10 Comparison between relative level of 125I_NGF binding in the absence of, and in the presence of, excess unlabeled
NGF.
Scatterplots of labeling indices of 250-274 individual neurons identified in adjacent 6 Ilm thick sections of adult rat Ls DRG
processed for radioautography to detect 12SI_NGF binding in the absence o:f, and in the presence o:f, excess unlabeled NGF. Panels
show a comparison of ~erikaryal diameter (x axis) and labeling index for 125I_NGF (y axis) under nonnal binding conditions (40 pM
12SI_NGF) and 40 pM 1 5I-NGF with excess, unlabeled NGF (2560 pM). Labeling index refers to the ratio of silver grain density over
neuropil devoid of positive hybridization signal (background) and is linearly related to the density of high-affinity NGF-binding sites.
For each plot, neuronal profiles situated above the dashed horizontal line are positive for 125I_NGF binding.
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Figure 6.11 Relationship between relative levels of trkA mRNA and 125I_NGF binding under normal conditions and with
intrathecal infusion of NT-3.
Scatterplots demonstrate the relationship between trkA and 12SI_NGF binding labeling indices for 223-263 neurons identified in
adjacent 6 Jlm thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkA
mRNA (x axis) or 12SI_NGF binding (y axis), under normal conditions (intact) and intact with a 7 day intrathecal infusion of 600
ng/JlI/h NT-3 (intact + NT-3). Labeling index refers to the ratio of silver grain density over neuropil devoid of positive hybridization
signal (background), and is linearly related to the density of high-affinity NGF-binding sites or reflects the relative level of trkA
mRNA. For each plot, neuronal profiles situated to the right of the short-dashed vertical line, and above the short-dashed horizontal
line, are positive for trkA mRNA and 12SI_NGF binding, respectively. The long-dashed lines serve as references to facilitate data
interpretation.
sections/treatment/marker, average 240 neurons/section), suggest a positive correlation
between 125I_NGF binding and trkA mRNA expression. Treatment with NT-3 appears to
effect a reduction in both the density ofNGF binding sites and trkA message levels.
Figure 6.12 highlights the trend in changes in neuronal 125I_NGF binding labeling
indices following NT-3 infusion for three replicate data sets. Although the NT-3 induced
decrease in the density ofNGF binding sites is evident in all of the replicates, it is most
conspicuous when comparing the 75th percentile values between the two experimental
conditions. In two of the three cases, the difference in 125I_NGF binding labeling indices
between normal and NT-3 infused tissues is statistically significant (Mann-Whitney U
Test, p<0.05). In addition, it is important to note that there is a poor signal to noise ratio
in the aberrant data set. Data from the three replicates represent analyses of tissues from
two different animals; replicates one and two represent analyses of tissue sections from
the same animal.
6.2.3.3 The Effect of Intrathecal Infusion ofNT-3 on SP Expression
Under normal conditions, SP mRNA is detectable in a
subpopulation of small- and medium-sized DRG neurons (Figure 6.13). These cells also
typically exhibit hybridization signal for trkA, but not trkC. A 7 day intrathecal infusion
ofNT-3 appears to result in diminished SP message levels.
Scatterplots (e.g. Figure 6.14), illustrating the relationship between perikaryal
diameter and SP labeling indices for individual neurons (3 DRG
sections/treatment/probe, average 331 neurons/section) under normal conditions and
following NT-3 infusion, reflect the qualitative observations. In the intact state, SP
mRNA is detectable in '" 20% of DRG neurons. Although the neuropeptide is
heterogenously expressed, the majority of SP-positive cells exhibit high labeling index
values and are small in size. NT-3 infusion appears to result in the reduction of the level
of SP hybridization signal, although levels of this neuropeptide are still conspicuously
high and the proportion of neurons expressing detectable SP mRNA does not seem to be
altered.
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Figure 6.12 The effect of intrathecal infusion of NT-3 on 125I_NGF binding levels in
neurons expressing trkA mRNA.
Graph depicts the relative differences in 12SI_NGF binding labeling indices
between normal conditions (intact) and nonnal with 7 day intrathecal infusion of NT-3
(intact + NT-3), for the trkA-positive subpopulation. Since the data are not normally
distributed, median labeling indices are presented instead of means. The error bars
represent the labeling indices of neurons falling between 25% and 75% of the median.
In each of the three replicates, 12sI_NGF binding and trkA labeling indices for individual
neurons were detennined from image analysis of adjacent 6 Ilm thick sections of adult
rat Ls DRG processed for 12SI_NGF binding or in situ hybridization, and subsequent
radioautography, to detect NGF binding sites or trkA mRNA. Labeling index refers to
the ratio of silver grain density over neuropil devoid of positive hybridization signal
(background) and is linearly related to the density of high-affinity NGF-binding sites.
Asterisk indicates significant difference between intact and intact plus NT-3 infused
treatments (Mann-Whitney U Test, P<0.05). Sample sizes (number of neurons) for each
treatment are indicated below each replicate. Total number of neurons identified and
analyzed for replicates 1-3 (intact, intact + NT-3) are as follows: 223, 263; 214, 200;
274,268.
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Figure 6.13 Detection of SP, trkA, and trkC mRNA under normal conditions and
following intrathecal infusion of NT-3 in serial sections.
Scanned stained darkfield photomicrographs of serial 6 ~m thick adult rat Ls DRG
sections processed for in situ hybridization to detect SP (upper panel), trkA (center panel),
and trkC (lower panel) mRNA under normal conditions (intact) and following a 7 day
intrathecal infusion ofNT-3 (600 ng/~l/h). Scale bar = 60 ~m.
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Figure 6.14 Relationship between perikaryal diameter and the relative level of SP mRNA under normal conditions and with
intrathecal infusion of NT-3.
Scatterplots of labeling indices of 492-495 individual neurons identified in 6 Jlm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect SP mRNA, depict the relationship between perikaryal diameter (x
axis) and SP labeling indices (y axis). Panels show a comparison of data under nonnal conditions (intact) and intact with a 7 day
intrathecal infusion of 600 ng/pJ/h NT-3 (intact + NT-3). Labeling index refers to the ratio of silver grain density over neuropil devoid
ofpositive hybridization signal (background) and reflects the relative level of indicated mRNA. For each plot, neuronal profiles above
the short-dashed horizontal line are considered positive for SP mRNA. The long-dashed lines serve as references to facilitate data
interpretation.
Scatterplots (e.g. Figure 6.15), illustrating the relationship between trkC and SP
mRNA labeling indices of individual neurons (3 DRG sections/treatment/probe, average
331 neurons/section), indicate that under normal conditions there is a small
subpopulation of trkC-positive neurons that coexpress low levels of hybridization signal
for both trkC and SP. The majority of SP-expressing cells do not exhibit detectable
levels of trkC mRNA, and while these neurons display a range of SP labeling indices,
this group includes the subpopulation with the highest levels of SP transcripts. Infusion
ofNT-3 effects a reduction in SP message, which is most evident in cells that do not also
express trkC mRNA.
Scatterplots (e.g. Figure 6.16), delineating the relationship between trkA and SP
mRNA labeling indices of individual neurons (2 DRG sections/treatment/probe, average
360 neurons/section) under normal conditions and following infusion ofNT-3, show that
the majority of SP-expressing neurons also exhibit trkA mRNA. This SP/trkA-positive
subpopulation represents neurons with heterogeneous message levels for both markers,
although cells with the highest levels of hybridization signal for SP tend to possess
moderate levels of trkA signal. SP-positive neurons that do not coexpress detectable
trkA mRNA display low to moderate levels of hybridization signal for the neuropeptide.
The NT-3 induced lessening of SP mRNA expression appears to be limited to the trkA-
positive subpopulation.
Figure 6.17 highlights the trend in changes in SP mRNA expression following
NT-3 infusion for three replicate data sets. Although the difference in SP labeling
indices between normal and NT-3 infused tissues is statistically significant in only one
of the three cases (Mann-Whitney U Test, p<0.05), the reduction in SP message levels is
clearly evident when comparing the median and 75th percentile values between the two
treatments for all of the replicates. Data from the three replicates represent analyses of
tissues from two different animals; replicates one and three represent analyses of tissue
sections from the same animal.
6.2.4 The Effect ofNT-3 Infusion on SNAP-25 Expression
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Figure 6.15 Relationship between relative levels of trkC and SP mRNA under normal conditions and normal with intrathecal
infusion of NT-3.
Scatterplots demonstrate the relationship between trkC and SP labeling indices for 226-228 neurons identified in adjacent 6 Jlm
thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkC (x axis) or SP (y
axis) mRNA under normal conditions (intact) and normal with a 7 day intrathecal infusion of 600 ng/JlI/h NT-3 (intact + NT-3).
Labeling index refers to the ratio of silver grain density over neuropil devoid ofpositive hybridization signal (background) and reflects
the relative level of indicated mRNA. For each plot, neuronal profiles situated to the right of the short-dashed vertical line, and above
the short-dashed horizontal line, are considered positive for trkC and SP mRNA, respectively. The long-dashed lines serve as
references to facilitate data interpretation.
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Figure 6.16 Relationship between relative levels of trkA and SP mRNA under normal conditions and normal with intrathecal
infusion of NT-3.
Scatterplots demonstrate the relationship between trkA and SP labeling indices for 492-495 neurons identified in adjacent 6
11m thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkA (x axis) or
SP (y axis) mRNA under normal conditions (intact) and normal with a 7 day intrathecal infusion of 600 ng/)ll/h NT-3 (intact + NT-3).
Labeling index refers to the ratio of silver grain density over neuropil devoid ofpositive hybridization signal (background) and reflects
the relative level of indicated mRNA. For each plot, neuronal profiles situated to the right of the short-dashed vertical line, and above
the short-dashed horizontal line, are said to be positively labeled for trkA mRNA and SP respectively. The long-dashed lines serve as
references to facilitate data interpretation.
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Figure 6.17 The effect of intrathecal infusion of NT-3 on SP mRNA levels.
Graph depicts the relative differences in SP mRNA labeling indices between
normal conditions (intact) and normal with a 7 day intrathecal infusion ofNT-3 (intact +
NT-3) in the subpopulation of DRG neurons expressing SP. Since the data are not
normally distributed, median labeling indices are presented instead of means. The error
bars represent the labeling indices of neurons falling between 25% and 75% of the
median. In each of the replicates, SP labeling indices for individual neurons were
determined from image analysis of 6 f.lm thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect SP mRNA. Labeling
index refers to the ratio of silver grain density over neuropil devoid of positive
hybridization signal (background) and reflects the relative level of SP mRNA. Asterisk
indicates significant difference between intact and intact plus NT-3 infused treatments
(Mann-Whitney U Test, P<O.05). Sample sizes (number of neurons) for each treatment
are indicated below each replicate. Total number of neurons identified and analyzed for
replicates 1-3 (intact, intact + NT-3) are as follows: 228, 226; 492, 495; 283, 262.
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In the intact state, SNAP-25 mRNA is detectable in most DRG neurons,
and therefore, colocalizes to both trkC- and trkA-positive cells (Figure 6.18). Those
neurons with the highest levels of SNAP-25 hybridization signal appear to also express
trkC, but not trkA, mRNA. A 1 week intrathecal infusion ofNT-3 seems to result in a
reduction in SNAP-25 hybridization signal in those neurons with the highest levels of
the marker.
Scatterplots (e.g. Figure 6.19), illustrating the relationship between perikaryal
diameter and SNAP-25 labeling indices for individual neurons (2 DRG
sections/treatment/probe, average 200 neurons/section) under normal conditions and
following NT-3 infusion underscore qualitative observations, demonstrating the
heterogeneous expression of SNAP-25 transcripts and the presence of this marker in the
majority of cells. In the intact state, smaller neurons tend to possess lower levels of
SNAP-25 mRNA; medium and large diameter perikarya express the highest levels,
although some neurons in this size range display more moderate levels of transcripts. A
1 week intrathecal infusion of NT-3 effects a dramatic reduction in SNAP-25 labeling
index values. This change is most conspicuous in medium and large diameter neurons,
where SNAP-25 labeling indices are now low to moderate in the majority ofthese cells.
Scatterplots (e.g. Figure 6.20), illustrating the relationship between trkA and
SNAP-25 mRNA labeling indices of individual neurons (2 DRG
sections/treatment/probe, average 200 neurons/section) under normal conditions and
following intrathecal infusion of NT-3, show that cells expressing trkA are among the
subset of SNAP-25 positive neurons with low to moderate SNAP-25 labeling indices.
Further, in the intact state, virtually all of the neurons with the highest levels of SNAP-
25 transcripts do not appear to coexpress trkA mRNA, although there is also a large
subset of cells that exhibit low to moderate SNAP-25 labeling indices that lack
detectable message for the neurotrophin receptor. Infusion of NT-3 effects a readily
observable decrease in SNAP-25 mRNA levels which is most apparent in neurons with
the highest message levels of SNAP-25 - the subgroup of cells with trkA labeling
index values below background levels.
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trkC
Figure 6.18 Trilocalization oftrkC, SNAP-25, and trkA mRNA under normal condi-
tions and following intrathecal infusion of NT-3.
Scanned brightfield photomicrographs of serial 6 Jlm thick adult rat Ls DRG sec-
tions processed for in situ hybridization to detect trkC (upper panel), SNAP-25 (center
panel), or trkA (lower panel) mRNA, under normal conditions (intact) and following a 7
day 600 ng/JlI/h intrathecal infusion ofNT-3 (intact + NT-3). Arrows indicate examples
of neurons expressing all three markers. Scale bar = 30 Jlm.
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Figure 6.19 Relationship between perikaryal diameter and the relative level of SNAP-25 mRNA under normal conditions and
with intrathecal infusion of NT-3.
Scatterplots of labeling indices of 199-200 individual neurons identified in 6 J.!m thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect SNAP-25 mRNA, depict the relationship between perikaryal
diameter (x axis) and SNAP-25 labeling indices (y axis). Panels show a comparison of data under normal conditions (intact) and intact
with a 7 day intrathecal infusion of 600 ng/J.!llh NT-3 (intact + NT-3). Labeling index refers to the ratio of silver grain density over
neuropil devoid of positive hybridization signal (background) and reflects the relative level of SNAP-25 mRNA. For each plot,
neuronal profiles above the short-dashed horizontal line are considered positive for SNAP-25 mRNA. The long-dashed lines serve as
references to facilitate data interpretation.
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Figure 6.20 Relationship between relative levels of trkA mRNA and SNAP-25 under normal conditions and with intrathecal
infusion of NT-3.
Scatterplots demonstrate the relationship between trkA and SNAP-25 labeling indices for 199-200 neurons identified in
adjacent 6 11m thick sections of adult rat Ls DRG processed for in situ hybridization, and subsequent radioautography, to detect trkA
mRNA (x axis) or SNAP-25 (y axis) under normal conditions (intact) and intact with a 7 day intrathecal infusion of600 ng/Ill/h NT-3
(intact + NT-3). Labeling index refers to the ratio of silver grain density over neuropil devoid of positive hybridization signal
(background) and reflects the relative level of indicated mRNA. For each plot, neuronal profiles situated to the right of the short-
dashed vertical line and above the short-dashed horizontal line are considered positive for trkA mRNA and SNAP-25, respectively.
The long-dashed lines serve as references to facilitate data interpretation.
Figure 6.21 highlights the trends in changes in SNAP-25 mRNA expression
following NT-3 infusion for 2 replicate data sets. The difference in SNAP-25 labeling
indices between nonnal and NT-3 infused tissues is statistically significant in both cases
(Mann-Whitney U Test, p<O.05), with NT-3 effecting a reduction in SNAP-25 labeling
indices that is most strongly reflected at the 75th percentile level. Data from the two
replicates represent analyses of tissues from two different animals.
6.3 Discussion
This study demonstrates that in otherwise nonnal animals, two separate
populations ofmature DRG neurons are affected by NT-3 treatment, both in a seemingly
negative manner. Although a 1 week intrathecal infusion of NT-3 does not alter trkC
message levels, there is a downregulation of trkA mRNA levels, numbers of high-
affinity NGF binding sites, and SP expression. Further, NT-3 effects a reduction in
SNAP-25 message levels in those neurons with the highest levels of the marker.
As stated above, a 1 week infusion of NT-3 neither significantly modified trkC
mRNA levels nor altered the number of neurons expressing the receptor. This is
supported by reports that exogenous NT-3 did not upregulate trkC expression in cultured
embryonic or postnatal sympathetic neurons (Belliveau et al., 1997; Wyatt et al., 1999),
although one study noted a significant increase in trkC levels in cultured embryonic
trigeminal ganglion neurons (Wyatt et al., 1999). Moreover, my findings do not reflect
the ability of NT-3 to counteract the injury-reduced levels of trkC expression (see
Sections 5.2.2.1, 5.3.1), but rather parallel the influence of NGF on trkA levels in adult
primary sensory neurons, where NGF infusion resulted in only a modest increase in
receptor message levels in a population that nonnally expresses low levels of trkA
transcripts (Verge et al., 1990a; Tetzlaff et al., 1992; Karchewski et al., submitted). NT-
3 treatment also appears to effect an overall increase in perikaryal diameter, although
this was not rigorously investigated here. This observation corresponds to the increased
fiber diameters observed in transgenic mice engineered to overexpress NT-3 (Albers et
al., 1996).
250
TREATMENT
r:
• htact
*
1
><;--~]
Q ;::$ 1~ ~
d~~]
~><;~'-'~U'.)~~V)E=:
~ffi
ZUU'.)~
Z~
;:$~
Q~~ C"l IrF187, 1781 IrF1ffi, 2321~ ~ r
-20, -----"'i..---- ---.- --J • htact-+Nf-3
i iREPLICATES
Figure 6.21 The effect of intrathecal infusion of NT-3 on SNAP-25 mRNA levels.
Graph depicts the relative differences in SNAP-25 mRNA labeling indices
between normal conditions (intact) and normal with a 7 day intrathecal infusion ofNT-3
(intact + NT-3) in the SNAP-25 positive subpopulation. Since the data are not normally
distributed, median labeling indices are presented instead of means. The error bars
represent the labeling indices of neurons falling between 25% and 75% of the median.
In each of the replicates, SNAP-25 labeling indices for individual neurons were
determined from image analysis of 6 11m thick sections of adult rat Ls DRG processed
for in situ hybridization, and subsequent radioautography, to detect SNAP-25 mRNA.
Labeling index refers to the ratio of silver grain density over neuropil devoid of positive
hybridization signal (background). Asterisk indicates significant difference between
intact and intact plus NT-3 infused treatments (Mann-Whitney U Test, p<0.05). Sample
sizes (number of neurons) for each treatment are indicated below each replicate. Total
number of neurons identified and analyzed for replicates 1 and 2 (intact, intact + NT-3)
are as follows: 200, 165; 178, 240.
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In sharp contrast to the apparent lack of influence of NT-3 on trkC expression in
normal animals, there are significant reductions in trkA message levels, numbers of
high-affinity NGF binding sites, and in SP mRNA levels, although the percentages of
neurons expressing detectable levels of trkA and SP transcripts are not altered following
NT-3 treatment. Interestingly, it appears that treatment of otherwise normal animals with
NT-3 appears to place the trkA-positive subpopulation in a NGF-deprived state. The
phenomena mimics the injury response in the trkA-positive subpopulation, wherein
levels of all three of these markers are depressed with the loss of target-derived NGF
(Jessell et al., 1979; Raivich and Kreutzberg, 1987; Verge et al., 1989b, 1990a, 1992a,
1995; Anand et al., 1991; Villar et al., 1991; Noguchi et al., 1994; Ji et al., 1996; Ma
and Bisby, 1998b). Further, the NT-3 effected alterations in the phenotype of the trkA-
expressing neurons also parallel the effects of experimentally reduced access to
endogenous NGF seen with in vivo injections of anti-NGF (Ramer et al., 1998; Shadiak
et al., 2001). It would seem that NT-3 is acting in a fashion antagonistic to that ofNGF
in this subset of neurons (Verge et al., 1989a, 1992a, 1995).
That the reduction in trkA mRNA levels effected by NT-3 results in a
concomitant loss of high-affinity NGF binding sites is not surprising, because as seen
here and reported in the past (Verge et al., 1992a), there is a strong positive correlation
between 125I_NGF binding and trkA expression. In addition, the concurrent
downregulation of SP expression is also not unexpected, given the reduction in trkA
message levels, since the neuropeptide is a predominant marker of trkA-positive DRG
neurons (Verge et al., 1989a) (see Section 4.2.4.2) and its expression has been shown to
be regulated in a positive manner by NGF (Lindsay et al., 1989; Verge et al., 1995; Ji et
al., 1996). It is also of interest to note that in experiments that exposed chicken
chorioallantoic membrane to a continual supply of NT-3, the once predominantly
unmyelinated nociceptive fibers attained physiological characteristics associated with
low threshold mechanoreceptors. This suggests that excess NT-3 might not only alter the
phenotype of trkA neurons, but change the physiology of this subset, such that
developing nociceptors become more functionally similar to mechanoreceptors (Lewin,
1996).
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Although trkA and trkC transcripts colocalize in some adult rat LiLs DRG
neurons (see Sections 2.1.2, 4.2.2.2, 4.3.2), it does not appear that this is the
subpopulation most notably influenced by the infusion of NT-3, since the reduction in
trkA expression is most conspicuous in those neurons with the highest labeling indices
for that receptor, the trkA-positive/trkC-negative subset (see Sections 4.2.2.2, 4.3.2).
Similarly, although SP and trkC colocalize in some neurons in the intact state (see
Section 4.2.4.2), the reduction in SP expression is evidenced in those cells with the
highest levels of SP, the trkA-positive/trkC-negative subpopulation. These observations
suggest that the influence of NT-3 in depressing aspects of the phenotype of trkA-
positive neurons does not necessarily occur through the activation of trkC, but
potentially through the neurotrophin binding to other receptors, including trkA or trkAei6,
(see Section 1.1.2.1.1), where it could potentially activate a signal transduction pathway
different from that of NGF (see Section 1.1.2.1.2). Alternatively, NT-3 might effect
these changes through an interaction with p75 (see Section 1.1.2.2). For example,
BDNF, via p75, has been shown to affect a serine phosphorylation on trkA that results in
a dampening of the NGF signaling response (MacPhee and Barker, 1997) and to lower
the affinity state ofNGF/trkA binding (Ross et al., 1998). That NT-3 has been shown to
alter the binding site of p75 in a manner similar to that of BDNF (Shamovsky et al.,
1999), suggests that NT-3 has the potential to behave like BDNF in altering NGF/trkA
binding.
Since trkA neurons are known to function in nociception (reviewed in: Lewin
and Mendell, 1993; Woolf: 1996, McMahon et al., 1997; Millan, 1999; Stucky, 2001),
then the ability of NT-3 to downregulate aspects of their phenotype might be of benefit
in offsetting neuropathic pain states. In support of this, our laboratory has recently
shown that two other markers of this nociceptive population, PACAP and BDNF, are
also influenced by exogenous NT-3. The neuropeptide, PACAP (see Section 2.2.2.2), is
believed to playa role in nociception (Moller et al., 1993; Mulder et al., 1994; Zhang et
al., 1996; reviewed in: Mulder et al., 1999; Vaudry et al., 2000). In nonnal DRG
neurons virtually all PACAP-positive cells coexpress trkA, and NT-3 infusion effected a
dramatic downregulation in the levels of the neuropeptide (Jongsma Wallin et al., 2001).
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Even though the NT-3 induced depression of PACAP signal levels appeared to occur in
both neurons that expressed trkC and in those that lacked detectable trkC transcripts, it
was most evident in the subset of trkA-positive/trkC-negative cells, which normally
express the highest levels of the neuropeptide (Jongsma Wallin et al., 2001). BDNF has
been reported to playa role in central sensitization and in inflammation-associated pain
(Kerr et al., 1999; Mannion et al., 1999), and unlike NT-3 or NGF, it is constituitively
expressed in mature DRG neurons (Emfors et al., 1990b; Wetmore et al., 1991;
Wetmore and Olson, 1995; Apfel et al., 1996; Kashiba et al., 1997b; Michael et al.,
1997, 1999). In the intact state, it is primarily localized to trkA neurons (Apfel et al.,
1996; Kashiba et al., 1997b; Michael et al., 1997, 1999), although some trkC-positive
cells also express the neurotrophin (Michael et al., 1997, 1999). In addition, under
normal conditions NGF has been shown to stimulate both BDNF expression (Cho et al.,
1997a, 1997b) and its release (Michael et al., 1997). In contrast, but consistent with the
findings reported here, we have shown that a 1 week intrathecal infusion of NT-3
resulted in decreased BDNF mRNA and protein levels, in trkC-positive neurons and in
those that lack detectable levels of the receptor (Karchewski et al., submitted).
Moreover, iftrkB is dependent on the presence of its ligand to maintain normal levels of
its expression in DRG neurons, as are other neurotrophin receptors (Johnson et al., 1987;
Verge et al., 1989b, 1992a; Emfors et al., 1993; Funakoshi et al., 1993; Sebert and
Shooter, 1993; Zhou et at., 1996; Kashiba et at., 1998), these data raise the possibility
that NT-3 treatment may also result in reduced trkB levels. Further, a 7 day intrathecal
infusion ofNT-3 in adult rats prevented much of the increased thermal hyperalgesia seen
after chronic constriction injury, but it did not appear to alter post-injury sensitivity to
mechanical stimulation (Wilson and Verge, 2001). But, there are seemingly conflicting
reports. Another study reported that a 14 day intrathecal infusion of NT-3 (200 ng/d)
significantly reduced the threshold to mechanical stimuli in otherwise normal rats,
indicating that NT-3 in this case appeared to act in an algesic, not analgesic, fashion
(White, 1998). The apparent discrepancies between these data and my observations may
be due to the differing concentrations of NT-3 used in each study, between 200 ng/day
for 14 days and 600 ng/J..L1/hour for 7 days. The lesser concentration ofNT-3 may have
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failed to reduce trkA expression and failed to place these neurons in an NGF-deprived
state. The author of that study (White, 1998) attributed the increased levels of sensitivity
to mechanical stimuli to the aberrant A~ fiber sprouting into lamina II of the spinal cord
dorsal hom caused by a similar concentration ofNT-3 (White, 1997b, 1998), mimicking
an injury-induced response seen in these fibers (see Section 2.2.2.2). Interestingly,
intrathecal infusion of GDNF has been shown to prevent this sprouting (Bennett et al.,
1998). Thus, this, coupled with the report that post-axotomy the majority of large
diameter neurons express GFRal, a receptor for GDNF (Bennett et al., 2000b), and that
the sprouting is from Ap, not C fibers, suggests that the population affected by the
infusion of NT-3 in the White study (1998) express trkC, not trkA. In spite of these
conflicting findings, the ability of NT-3 to depress the phenotype of trkA-positive DRG
neurons may be clinically beneficial in conditions when levels of NGF are abnormally
high, as in chronic inflammation (reviewed in: McMahon, 1996); any correlation
between NT-3 treatment and the dampening of nociception needs further study. It would
also be of interest to determine whether the NT-3 effected reduction in trkA mRNA
levels alters the ability of that receptor to interact with p75, since the ratio ofp75 to trkA
appears to be important to trkA signal transduction (see Section 1.1.2.2.2).
SNAP-25, is an important protein in vesicle-membrane fusion and exocytosis
(see Section 4.3.6). Under normal conditions, transcripts are detectable in virtually all
mature DRG neurons, with a subset of trkC-expressing cells exhibiting the highest
labeling indices for SNAP-25 (see Section 4.2.6). Infusion of NT-3 effects a
downregulation of SNAP-25 levels, and this reduction is most evident in those trkC-
positive neurons with the highest levels of SNAP-25. Interestingly, NT-3 treatment does
not appear to significantly alter SNAP-25 mRNA levels in trkA-expressing cells (see
Figure 6.20). This is unexpected, given the downregulation of trkA, SP, BDNF, and
PACAP in predominantly in trkA neurons. It is also interesting because when NT-3 is
provided to peripherally axotomized DRG neurons it tends to effect a return towards the
normal, intact phenotype in trkC-positive cells (see Chapter 5). Further, it is important to
note that the reduction in SNAP-25 mRNA levels apparently occurs without a
concomitant loss of trkC expression. These findings could reflect a similar dose-
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dependent effect (see Section 5.3.1), as evidenced in an in vitro study detailing the
ability ofNT-3 to regulate GAP-43 and Tal a-tubulin (Mohiuddin et al., 1995). That
study found that lower concentrations of NT-3 effected an upregulation in message
levels for both markers, but that the use of higher concentrations of the neurotrophin
resulted in levels of expression only slightly higher than those of untreated cultures
(Mohiuddin et al., 1995). Given the importance of SNAP-25 to synaptic functioning,
including neurotransmitter release (O'Conner et al., 1997; reviewed in: Mochida, 2000),
and given the necessitated high firing rate of putatively trkC-positive rapidly adapting
mechanoreceptors (Carr et al., 1989a) (see Section 2.2.2.2), it would be interesting to
learn whether the reduction in SNAP-25 message levels is translated into a reduced
ability of these neurons to function.
Together, the ability of exogenous NT-3 to effect a dampening of the phenotype
of trkA-expressing neurons and a downregulation of SNAP-25 mRNA levels, suggest
that ifNT-3 is to be used therapeutically (Gao et al., 1995; Rodriguez-Pena et al., 1995;
Tomlinson et al., 1996, 1997; Helgren et al., 1997; Fernyhough et al., 1998; Mizisin et
al., 1998) then these factors should be considered, since not all of the NT-3 induced
changes might be desirable; whether or not these observations are important beyond
their experimental or therapeutic use is unknown.
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7. CONCLUSIONS
The objective of this study was to gain a better understanding of the role ofNT-3
in mature primary sensory neurons. Taken together, my data establish evidence for the
existence of phenotypically unique micropopulations within the subset of trkC-positive
neurons and suggests that NT-3 can act in both a positive and negative manner to
modulate aspects ofneuronal phenotype.
In order to attempt to determine the role of NT-3 in sensory neurons it was
necessary to characterize the phenotype of the putative NT-3 responsive population, the
trkC-positive subset, which represents '- 40% of DRG neurons. My findings (see
Chapter 4, Table 4.1) indicate that, whether under nonnal or axotomized conditions,
beyond the presence of trkC transcripts, no single marker, including trkA, p75, NFM,
Tal a-tubulin, SP, a-CGRP, galanin, NPY, GAP-43, cjun, and SNAP-25, can be used
to define the subgroup ofprimary sensory neurons responsive to NT-3. Rather, the trkC-
positive subset is made up of phenotypically unique micropopulations, each expressing
varying levels of the markers, in variable combinations, which may reflect neuronal
populations with differing sensory functions.
To determine the function of NT-3 in these cells, the neurons were peripherally
axotomized to deprive them of a source of target-derived neurotrophin and then NT-3
was reintroduced via intrathecal infusion. Injury resulted in the upregulation of some
markers and a downregulation of others. If a marker colocalized with trkC then
expression levels of the marker returned towards normal values, at least within a subset
of those cells post-infusion (see Chapter 5, Table 5.1). These findings suggest that NT-3
is important in maintaining these neurons in their nonnal state. But, conversely, when
normal animals were treated with exogenous NT-3 phenotypic markers within two
257
separate subpopulations of neurons appeared to negatively influenced (see Chapter 6).
The biological importance of this observation is not known, but it may be important in
determining the clinical relevance of the neurotrophin.
Although there is little literature (see Section 2.2.2.2) available describing the
role of NT-3 in adult primary sensory neurons, a comparison between it and my
findings, indicates that the influence of the neurotrophin over the expression of
phenotypic markers may be dependent on the concentration of the neurotrophin and on
the mode and rate of its delivery, and of the level of receptor expression (see Sections
5.3.1, 5.3.2). In addition, it also appears to be dependent on specific cell type, whether
other types are present, and whether the experiment is conducted in vitro or in vivo (see
Sections 5.3.2, 5.3.3, 5.3.4). Moreover, delineating the role of NT-3 is even more
complex given its promiscuous nature - that of potentially binding to receptors other
than trkC (see Sections 1.1.2.1.1, 1.1.2.2).
Although the means by which NT-3 can modulate neuronal phenotype were not
examined here, it seems that this too may be dependent on complex interactions between
it and other neurotrophic molecules, or between the neurotrophin and potential receptor
signal transduction pathways. For example, activation of trkA can evoke at least five
different signal transduction cascades, with unique, overlapping, or cooperating second
messenger components (see Section 1.1.2.1.2). Moreover, there may be cooperation or
positive/negative regulation of phenotype through a combination of neurotrophic
molecules. NGF and NT-3 have been shown to influence BDNF expression in DRG
neurons, in a positive and negative manner, respectively (Cho et al., 1997a; Karchewski
et al., submitted), and BDNF has been shown to regulate NT-3 levels in cerebellar
granule neurons (Leingartner et al., 1994). In addition, while NT-3 (see Section 5.2.4.1),
NGF (Verge et al., 1995; Corness et al., 1998; Ramer et al., 1998), and aFGF (Ii et al.,
1996) act to negatively regulate galanin levels, the injury-induced cytokines, IL-6 and
LIF (Curtis et a!., 1994; Murphy et al., 1995, 1999a, 1999b; Kurek et al., 1996a, 1996b;
Sun and Zigmond, 1996; Arruda et al., 1998), appear to be responsible for its
upregulation after nerve injury (Corness et al., 1998; Ramer et al., 1998; Thompson et
al., 1998b; Kerekes et al., 1999; Murphy et al., 1999b). As a further example of the
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potential interconnections between regulatory systems, the ability of NT-3 to depress
cjun mRNA levels (see Sections 5.2.5.2, 5.3.4) may influence the level of cJUN
available to participate as a component of AP-l complexes (see Section 4.3.5), which
can bind to a site on the GAP-43 gene (Eggen et al., 1994; de Groen et al., 1995),
potentially regulating its transcription. This seeming complexity of interactions at the
various levels of regulation may be necessary to allow for fine tuning of the cell's
response to the trophic factor.
With the emerging potential of using the neurotrophins as therapeutic molecules
(Eide et al., 1993; Barinaga, 1994; Schatzl, 1995), it is important to note that the data
presented here should have relevance in humans, since human trks exhibit a high degree
of similarity in gene sequence and tissue expression to their murine counterparts
(Shelton et al., 1995). Even though NT-3 has been shown to be effective in
counteracting aspects of experimentally-induced large fiber neuropathies (see Section
2.2.2.2), the report here that NT-3 may also negatively regulate SNAP-25 expression and
the phenotype of trkA-positive neurons must be taken into account when considering the
efficacy of its use in clinical situations. Moreover, NT-3 may not only influence primary
sensory neurons, it has also been shown to be important in motorneuron survival and
regeneration (Li et a!., 1994; Grill et al., 1997; Sterne et at., 1997b; Simon et al., 2000),
as well as in restoring injured muscle fibers, the target of motorneurons (Sterne et al.,
1997b). Further, the presence of the neurotrophin in many different cell types, including
kidney, spleen, and liver suggests that NT-3 may have an additional role outside of the
nervous system (Zhou and Rush, 1993).
In conclusion, the data presented in this work indicate that multiple subsets of
mature DRG neurons have the potential to be responsive to NT-3. In addition, NT-3 has
been shown to be effective in counteracting many of the injury-induced changes in many
primary sensory neurons, not all of which express trkC. This suggests a role for the
neurotrophin in the maintenance of normal neuronal phenotype. Conversely, infusion of
NT-3 in normal animals resulted in a negative regulation of phenotype in two different
subpopulations, a finding that needs to be taken into account when considering
therapeutic applications for the neurotrophin.
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APPENDIX
0.01 M Sodium Acetate Buffer
0.2 M Stock Solutions
0.2 M Sodium Acetate
Under RNase-free conditions, dissolve 16.6 g sodium acetate in 1
I distilled water.
0.2 M Acetic Acid
Under RNase-free conditions, add 12 ml glacial acetic acid to 988
ml distilled water.
0.01 M Working Solution
Under RNase-free conditions, add 16.5 ml 0.2 M sodium acetate stock
and 3 ml 0.2 M acetic acid stock to 180 ml distilled water. Adjust pH of working
solution to pH 4-4.5 (for toluidine blue) or pH 5.2 (for DTT) with additional 0.2 M
acetic acid.
Diethyl-pyrocarbonate (DEPC) Treated Water and Glassware
0.1% DEPC Treated Water
Under RNase-free conditions and in a fume hood, add 1.0 ml DEPC
(Sigma) to 999 ml distilled water. Leave solution for 12 hours at 37°C. Autoclave the
solution to deactivate DEPC. Also, all glassware and pipette tips that were exposed to
DEPC must be autoclaved.
0.1 % DEPC Treated Glassware
Prepare DEPC solution as described above. Completely submerge
glassware to be treated in the fluid, leave for at least 12 hours, and then deactivate the
DEPC by autoclaving all glassware and pipette tips exposed to DEPC.
5 M Dithiothreitol (DTT)
Under RNase-free conditions, dissolve 15045 g DTT (Ultrapure; United States
Biochemical, Cleveland, OH) in 20 ml 0.01 M sodium acetate buffer, pH 5.2. Filter
sterilize with a 0045 Jlm pore nylon syringe filter (Nalge Nunc International Corp.),
dispense into 1 ml aliquots, and store at -20°C. Return used aliquots to the freezer for
reuse. Do not autoclave DTT or solutions containing DTT.
20/0 Formaldehyde with 2% Glutaraldehyde in 0.1 M PBS, pH 7A
In a fume hood and under RNase-free conditions, heat 200 ml 0.1 M DPBS to 70
°C. With stirring, add 5 g paraformaldehyde. Clear solution with several drops of 1 N
sodium hydroxide. Cool solution to room temperature, adjust pH to 7A, and filter. Add
10 ml 50% glutaraldehyde and bring final volume to 250 ml with 0.1 M DPBS. Fixative
was made within 24 hours ofuse and was stored at 4 °C until needed.
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Hybridization Cocktail Stock
Under RNase-free conditions and in a fume hood, add, with stirring, 50 ml of
deionized fonnamide to 20 ml of 20X SSC. Continue stirring, while adding 1 ml 100X
Denhardt's solution, 10 ml 0.2 M sodium phosphate buffer (pH 7.0), and 10 g dextran
sulfate (Sigma). After all ingredients are dissolved, add 5 ml 20% sarcosyl (N-
lauroylsarcosine; Sigma). Avoid foaming the solution. Store in 5 ml aliquots at -20°C.
Return used aliquots to the freezer for reuse.
Deionized Formamide
Under RNase-free conditions, deionize the required volume by stirring
gently for 1 hour with 1 g of analytical grade mixed-bed ion exchange resin (20-50
mesh, Bio-Rad Laboratories, Hercules, CA) for 10 ml of fonnamide (Fisher Scientific,
Fair Lawn, NJ). Dispense into 5-15 ml aliquots and store at -20°C. Return used aliquots
to the freezer for reuse.
100X Denhardt's Solution
Under RNase-free conditions, add 5 g ficoll (Sigma), 5 g polyvinal-
pyrolidone (Sigma), and 5 g BSA ( Fraction V; Sigma) to 200 ml distilled water. Bring
final volume to 250 ml, dispense into 2.5 ml aliquots, and store at -20°C.
0.2 M Phosphate Buffer, pH 7.0
Add, with stirring, 11.2 g sodium phosphate dibasic and 2.74 g sodium
phosphate monobasic to 400 ml distilled water. Adjust pH of solution to 7.0 and bring
final volume to 500 ml.
Lactoperoxidase, 0.05 mg/1l1 in 0.1 M PB
Prepare solution for 125I_NGF iodination and binding within 24 hours of use and
under RNase-free conditions. Add 100 III cold 0.1 M PB to the shipping vial containing
5 mg lyophilized lactoperoxidase (Sigma). Once the lactoperoxidase is in solution
transfer it to a 1.5 ml microcentrifuge tube to allow for ease in aliquoting; place the tube
and 10 III aliquots (0.5 mg lactoperoxidase) on ice while working. Store aliquots at -70
°C.
Lana's Fixative
In a fume hood, heat 800 ml of 0.1 M PB (pH 7.4) to 60-70 °C and add, with
mixing, 20 g paraformaldehyde. Clear solution with several drops of 1 N sodium
hydroxide. Cool solution to room temperature, adjust pH to 7.4, and filter. Add 15 ml
saturated picric acid and bring final volume to 1 1 with 0.1 M PB. Fixative was made
within 24 hours ofuse and was stored at 4 °C until needed.
0.1 M Phosphate Buffer (PB), pH 7.4
sodium phosphate dibasic"2H20
sodium phosphate monobasic H20
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7.03 g
1.58 g
With stirring, add the above to 400 ml distilled water. Adjust pH of
solution to 7.4 and bring final volume to 500 ml. If to be used for 125I_NGF iodination
and binding, prepare within 24 hours ofuse and under RNase-free conditions.
0.1 M Phosphate Buffered Saline (PBS), pH 7.4
Prepare solution for 125I_NGF iodination and binding within 24 hours of use and
under RNase-free conditions. Add the following ingredients in the order listed to 1.5 I
distilled water; allow each to dissolve completely before adding the next.
sodium phosphate dibasic'2H20 2.67 g
sodium chloride 16 g
potassium chloride 0.4 g
potassium dihydrogen orthophosphate 0.4 g
Adjust pH to 7.4 and bring final volume to 2 1.
Salmon Sperm DNA (Denatured)
Under RNase-free conditions, add 1 g salmon sperm DNA to 100 ml DEPC
treated water, seal container, and let stir at room temperature for 16-18 hours. Dispense
into I ml aliquots in 1.5 ml microcentrifuge tubes. To disrupt the DNA, sonicate at
setting 5 for three times, 15 seconds each (Tissue Tearor model 3985-370; Biospec
Products, Inc., Bartlesville, OK). Store sonicated aliquots at -20°C. Return used aliquots
to the freezer for reuse.
0.05 M Sodium Acetate, pH 4.0
Prepare solution for 125I_NGF iodination and binding within 24 hours of use and
under RNase-free conditions. Add 0.025 g sodium acetate to 40 ml distilled water.
Adjust pH ofsolution to 4.0 and bring final volume to 50 ml.
SSC Buffer
To prepare 20X SSC, dissolve 175.3 g sodium chloride in 800 ml distilled water
under RNase-free conditions. With stirring, add 88.2 g sodium citrate. Adjust pH of
solution to pH 7.0 and bring final volume to 1 1. Autoclave and store at room
temperature. Dilute to IX SSC as needed with additional distilled water.
20% TCA Solution
100% TCA Stock Solution
Prepare TCA stock solution immediately prior to use by adding 20 g TCA
to 20 ml distilled water. The preparation of a concentrated stock solution was necessary
since a directly prepared 20% solution yielded inconsistent results, possibly due to the
hygroscopic nature of the TCA crystals.
200/0 TCA Working Solution
Dilute TCA stock solution to 20% with distilled water.
0.5% Toluidine Blue, pH 4-4.5
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Suspend 0.5 g toluidine blue in 100 ml 0.01 M sodium acetate buffer, pH 4-4.5.
If tissue is difficult to stain add 0.1 % sodium borate to the above solution.
0.05 M Tris-Hydrochloride (Tris- HCI), pH 7.6
Prepare solutions for 125I_NGF iodination and binding within 24 hours of use and
under RNase-free conditions. Do not use DEPC treated water to prepare the solution.
Add 38.5 ml 0.1 N hydrochloric acid to 50 ml 0.1 M Tris. Adjust pH to 7.6 and bring
final volume to 100 ml with distilled water.
0.1 M Tris
Dissolve 1.21 g Tris base in 100 ml distilled water.
0.1 N Hydrochloric Acid
Add 415 ~l of concentrated hydrochloric acid to 50 ml distilled water.
0.05 M Tris-HCI, pH 9.0
Under RNase-free conditions, add 7.0 ml 0.1 N hydrochloric acid to 50 ml 0.1 M
Tris. Adjust pH to 9.0 and bring final volume to 100 ml with distilled water. Do not use
DEPC treated water to prepare the solution.
0.1 M Tris-HCI, pH 8.0
Under RNase-free conditions, prepare 250 ml each of 0.1 M Tris base and 0.1 M
Tris-HCl. Add one to the other to reach pH 8.0, autoclave, and store at 4°C. Do not use
DEPC treated water to prepare the solution. To prepare 0.1 M Tris base, add 3.029 g Tris
base to 250 ml distilled water. To prepare 0.1 M Tris-HCl, add 3.94 g Tris-HCl to 250
ml distilled water.
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